Swvl Holdings Corp is a cleaner-looking version of a familiar public-market problem. The company is not a hollow shell pretending to operate. It reported FY2025 revenue of $24.2 million, up 41% from FY2024, alongside net income of $1.3 million, its first annual profit since going public. Q1 2026 revenue then increased 68% from the prior year to $8.2 million while the operating loss narrowed sharply.

SWVL entered the public market through Queen’s Gambit Growth Capital, a SPAC that sold investors a polished story built around sustainability, mobility access, expansion into 20 countries, and more than $1 billion in annual gross revenue by 2025. SWVL ultimately reported FY2025 revenue of just $24.2 million, roughly 2.4% of that original target; this was not an ordinary forecasting miss. The central growth thesis that justified the transaction never came close to materializing. Public investors appeared to recognize the problem before the deal even closed, redeeming the overwhelming majority of the SPAC trust and leaving SWVL with only $53.3 million of trust proceeds. The minimum cash condition was waived, and the listing went forward anyway.

The next capital-structure reconstruction arrived in August 2026. SWVL raised approximately $14.5 million through two private placements. Coefficient LP led the initial $13 million tranche, which SWVL describes as backed by the Sawiris family of Cairo, alongside HITE Hedge Asset Management. Sofico Holdings Limited joined the next day through a smaller placement. Together, the investors agreed to purchase approximately 10 million newly issued shares at roughly $1.45 per share, an amount approaching SWVL’s entire disclosed ordinary share base before the financing.

SWVL operates a real transportation business, but that does not make its public equity attractive. The bearish thesis does not depend on allegations of fraud or fabricated revenue; it rests on a more visible and measurable problem. The original valuation case collapsed, the SPAC trust was overwhelmingly redeemed, the company still depends on outside capital to finance expansion, and private investors negotiated far better economics and protections than public-market buyers receive.

Two further threads examined later in this report reinforce that picture from opposite ends of the business: a documented pattern of creditor settlements struck at steep discounts under default pressure, engineered into the same headline-profit playbook the company has now run twice; and a large, contemporaneous body of customer complaints describing a platform in real operational distress on the ground, in the exact period management has been marketing as a turnaround.

SWVL may be improving as a business while becoming substantially less compelling as a stock. Public shareholders are left holding the weakest position in a capital structure that continues to be rewritten to benefit better-connected capital. Fugazi Research considers $SWVL uninvestable at any price above zero.

Fugazi Research Analysis

• An independent review of 135 recent Google Play reviews of the SWVL consumer app found 97.8% negative, clustered around unreliable technology, unresponsive support, and inconsistent driver conduct, a real-time picture from paying users that runs directly counter to the turnaround narrative management is presenting to shareholders. See the dedicated section below.

• SWVL’s entire recent stock move traces to a single catalyst: shares jumped over 50% on August 25, 2026, from $1.49 to roughly $2.42, on volume 187x average, the day the Coefficient/Sawiris PIPE was announced as fuel for a US expansion the company says it has “recently begun.” No US revenue, contracts, or operating metrics have been disclosed to support the move. The market this announcement targets already has entrenched, better-capitalized incumbents (Uber, Zeelo, RidePal, and Enterprise’s mobility operations among them) making the $13 million raise look more like a catalyst engineered to justify dilution and re-rate a beaten-down stock than the funding of a credible new market entry.

• SWVL became a public company through a SPAC transaction marketed around proceeds far larger than what the operating company actually received at closing after public shareholders exercised redemption rights. The trust that funded the listing was a small remainder of what was originally raised and marketed, the earliest and cleanest signal that public investors did not believe the deal’s own projections.

• The SPAC’s PIPE financing at the de-SPAC stage was anchored by strategic and financial investors with pre-existing relationships to the sponsor ecosystem, alongside stated potential for strategic and operational collaboration with some of those same investors, a structure common to SPAC financings generally, but one that concentrates negotiating leverage away from the public float from the outset.

• The August 2026 financing round was priced near a fixed reference point well below where the stock has since traded. Public holders are being asked to value the company at whatever the market currently assigns; private buyers locked in their entry point months before that valuation was tested.

• The lead investor in the August 2026 placement received a board designation right, pro rata participation rights in future equity issuances, and consent rights over certain corporate actions, contingent on maintaining a 5%-plus ownership stake, protections that exist by contract for the private buyer and do not exist at all for a public shareholder holding the identical security in the open market.

• The company is contractually obligated to register the newly issued shares for resale within a fixed window following closing. That does not mean the shares will be sold immediately; it means the supply now sits on a calendar, and any analysis of the stock’s forward float has to account for it.

• One of the two purchasers in the initial August 2026 tranche has a settled SEC enforcement action from 2023 involving a short-selling rule violation around a public offering, unrelated to SWVL. The conduct predates this transaction and does not implicate SWVL’s own disclosures, but it is a documented fact about who now sits within the company’s capital structure and should be weighed accordingly.

• The company has disclosed unremediated material weaknesses in its internal financial controls across multiple consecutive reporting periods, and it changed auditors heading into FY2026 after its prior auditor had issued going-concern qualifications in back-to-back years. Neither fact alone is disqualifying. Together, they are a reason to treat any given period’s reported figures, including the profitability the company is now marketing to justify its expansion, with independent verification rather than face value.

• This is not the company’s first restructuring through settlement. In FY2023, SWVL resolved 13 separate creditor and vendor arrangements at an average 85% discount to avoid default, then booked the resulting gain as “other income” large enough to convert an underlying operating loss into a headline operating profit. See the dedicated section below.

Source: Swvl Holdings Corp Form 20-F, fiscal year ended Dec. 31, 2025, filed Apr. 20, 2026.

Source: Swvl Holdings Corp Form 6-K, filed Aug. 25, 2026 (Coefficient/HITE securities purchase agreement, press release).

Source: Swvl Holdings Corp Form 6-K, filed Aug. 26, 2026 (shareholder agreement terms, securities purchase agreement exhibit confirming BVI incorporation).

Source: SEC Litigation Release No. 25643, Feb. 21, 2023, SEC v. HITE Hedge Asset Management LLC et al., No. 1:23-cv-10351 (D. Mass.).

Source: Swvl Holdings Corp reverse share split announcement, filed Jan. 25, 2023.

Financial Summary

• FY2025 net income was $1.3 million, against a net loss of $10.27 million in FY2024, the company’s first annual profit since its 2022 listing. Non-operating contribution to that swing was material: a fair-value gain on derivative warrant liabilities and other income together exceeded the reported net income figure, meaning the underlying operating result for the year remained a loss.

• Q1 2026 revenue was $8.2 million, up 68% from $4.9 million in Q1 2025. Loss narrowing in the same quarter brought the operating loss down to approximately $174,000 from roughly $590,000 a year earlier, a substantial improvement, though gross margin compressed slightly over the same period rather than expanding alongside revenue.

• The August 24, 2026 securities purchase agreement with Coefficient Swvl Holdings, LLC and HITE Hedge Asset Management covered 8,990,317 Class A ordinary shares at $1.446 per share, for gross proceeds of approximately $13.0 million. Same-week follow-on issuance added Sofico Holdings Limited for 1,027,397 shares at $1.46 per share, roughly $1.5 million, bringing the combined round to approximately $14.5 million.

• The combined August 2026 placements created approximately 10.0 million new Class A shares against a pre-raise base the company itself described as “just under 10 million ordinary shares” as of its April 2026 disclosure.

• Accumulated losses stood at $338.5 million as of FY2025 year-end, against shareholders’ equity of $2.95 million, the balance the company relied on to satisfy Nasdaq’s alternative listing-compliance pathway after an October 2025 deficiency notice tied to the exchange’s market-value requirement.

• One purchaser in the August 24, 2026 tranche, HITE Hedge Asset Management LLC, agreed to a $103,591 penalty in a February 2023 SEC settlement, with three affiliated funds disgorging approximately $111,000 in profits plus prejudgment interest, over a Rule 105 short-selling violation involving an unrelated issuer’s public offering in 2021.

Source: Swvl Holdings Corp Form 20-F, fiscal year ended Dec. 31, 2025, filed Apr. 20, 2026.

Source: Swvl Holdings Corp Form 6-K, filed June 16, 2026 (Q1 2026 results).

Source: Swvl Holdings Corp Form 6-K, filed Aug. 25, 2026.

Source: SEC Litigation Release No. 25643, Feb. 21, 2023.

The Headline Business

SWVL’s problem isn’t that it lies outright; it’s that its disclosures are consistently built to be read once, believed, and never checked against the line items two paragraphs below. The 2022 SPAC materials framed SWVL against a “$1 trillion global mass transit market”, a number so large it was never meant to be measured against, only associated with. Three years later, actual revenue landed at $22.9M, a complete disconnect from real numbers, just showcasing how small the market share of SWVL is, compared to the industry total.

Then came the profitability claims, plural, because there have been more than one, and they don’t agree with each other. In December 2023, SWVL announced a “significant milestone”: positive operating cash flow and net profits for H1 2023, language the release itself called proof the Portfolio Optimization Program had “successfully” completed. The FY2023 20-F confirms the number ($3.06 million in profit for the full year) but doesn’t confirm the story. Strip out the $18.83 million in “other income” sitting on that same statement, and the company didn’t turn a corner in 2023; it ran roughly a $6.7 million operating loss and covered it with a one-time gain from creditors accepting 15 cents on the dollar to avoid a company that couldn’t pay them at all.

Source: Swvl Holdings Corp Form 20-F, fiscal year ended Dec. 31, 2023, filed Apr. 30, 2024

Fast forward to 2025, and SWVL is publicly touting its “first profitable year”, a claim that only works if you don’t remember the company already announced being profitable two years earlier, in its own words, in a press release with “milestone” in the framing. Either the FY2023 profit wasn’t real in the way it was sold, or the FY2025 “first” isn’t accurate. Both can’t be true, and the company has offered no reconciliation of the two claims to anyone reading its press releases rather than its financial statements.

The CEO publicly denied discontinuing consumer products that had already been pulled from the site, a claim customers contradicted independently in dated reviews months before any analyst wrote it down. The auditor was swapped out immediately after two consecutive going-concern opinions, with no public explanation. Revenue growth gets announced in percentage terms (”26% growth”) off a base that’s collapsed roughly 94% from what the company told investors to expect at the SPAC.

Customers Filed the First Short Report

Management has a story to tell about SWVL; for them it’s a story about discipline: a leaner cost base, a pivot to enterprise contracts, a first profitable year after four years of bleeding cash. By design, it’s a story told in the language of filings: delayed 20-Fs, 6-Ks, and unaudited 10-Q documents written for auditors and shareholders, not for the people who actually ride the buses. So we went and read what the riders had to say instead. 135 of them: every Google Play review left on the SWVL app between January 11 and September 7, 2026.

Start with the headline number: 97.8% of these reviews are negative. Not lukewarm or mixed, but negative: one- and two-star reviews describe an app that doesn’t work, drivers who don’t show up, and a support line that doesn’t answer. Three of 135 reviews said something nice. This isn’t the sentiment profile of a company executing a turnaround; it’s the sentiment profile of a company whose own customers are actively fleeing, in real time, in writing, with timestamps.

Management wants the market to believe 2026 is the year the operational bleeding stopped, a leaner cost structure, a disciplined pivot to enterprise contracts, the first profitable year in company history. This review says the opposite is happening on the ground: the company is losing market share, not gaining discipline, and it’s losing it for the two most basic reasons a transportation company can fail: the drivers aren’t reliable, and nobody is there when something goes wrong.

Another negative point is the fleet punctuality, vehicle condition, driver competence, and support unreachability, all failing simultaneously, in the same account, from the same rider, on the same day. That’s what happens when a company cuts operating expenses faster than it can replace headcount with technology or process. Seventeen other users read this and recognized their own experience.

Every other exhibit in this section is about service quality; however, this one is about something the board should be worried about, not just the product team: an allegation that a company vehicle struck a rider, and that the company’s response (according to the rider) was to receive the incident report and simply stop engaging. This isn’t a customer-service failure; it’s a company with no functioning claims or incident-response process, or ownership, for the one category of event that carries genuine legal and financial exposure: bodily injury involving a company-operated vehicle. This matches a pattern that recurs elsewhere in this dataset: riders describing drivers with undisclosed histories, unsafe conduct on the road, and a company that treats every complaint channel as a dead end.

SWVL has a confirmed data-security failure on the public record: a June 2020 breach, independently verified via Have I Been Pwned, that exposed the names, emails, phone numbers, and partial payment card data of more than four million users, this is not a rumor, it is documented. What should concern a reader far more than the 2020 incident itself is what’s sitting in this dataset: this is the single most recent review in the entire 135 review sample, filed days before this section went to draft, and it describes the same failure mode recurring, personal data exposed, and the rider identifying SWVL as the source, independently and without any apparent knowledge that this happened before.

Elsewhere in this report, we document that SWVL quietly discontinued its consumer-facing Daily and Travel products while its CEO publicly denied, on the record, that any such discontinuation had occurred, which is a management-credibility problem on its own. This review makes it customer-facing, too, and it predates our own reporting by months, which means the market’s own users noticed the retreat before any analyst wrote it down. Five separate reviews in this dataset independently describe some version of this same experience: routes that vanished, single pickup points in cities that need several, a product that quietly became something smaller than what people originally signed up for. When your own customers document your contraction before your disclosures catch up, you’re not in control of your own narrative.

Technical bugs are the single largest complaint category in this dataset (20% of all 135 reviews), more than any other bucket, including driver conduct. This is the highest-engagement review inside that category, and it’s the one worth featuring because it isn’t describing an inconvenience, but describing a platform whose own errors touch the money. This includes incorrect trip details, charges the rider can’t reconcile with what she actually booked, and a fare policy she describes, explicitly, as functioning like a mechanism for extracting extra payment rather than charging what was agreed. Read that allegation next to the company’s own numbers: a 2023 net income figure driven almost entirely by a one-time debt settlement rather than operating improvement, a revenue base that came in roughly 94% below the company’s own SPAC-era guidance, and management now claiming its first genuinely profitable year on record.

Negative reviews aren’t arriving at a constant rate across these eight months; they’re accelerating. From January through May, the app was drawing complaints at roughly 0.4 a day; however, from June onward, that rate essentially doubles to 0.79 a day, and it doesn’t slow, as August is the single worst month in the entire dataset at 28 reviews, and the partial week of September data we have runs at the highest daily rate of any point in the sample. This is clearly a company whose customer-facing failures are compounding in real time, in the exact months it has been telling shareholders the opposite story. And the acceleration isn’t evenly spread across complaint types; it’s concentrated in the two categories that say the most about operational control. Driver conduct and customer-service complaints both hit their single highest monthly count in August, the same month SWVL closed its $13 million PIPE with Coefficient and Onsi Sawiris and leaned publicly on its improving financials.

The Rally Ran on a Press Release, Not a Product

The stock’s recent run began on August 25, 2026, and the reasoning is in the public SEC filings. The run was not triggered by a revenue beat, a contract win, or an operating milestone, but a private placement announcement. Shares jumped to over 50% that day, from a $1.49 previous day close to end the day around $2.23, on volume roughly 187 times the average, with an intraday peak move reported north of 100% in the premarket. The headline driving it was the $13 million Coefficient/Sawiris PIPE, explicitly framed by the company as fuel to “accelerate its expansion in the United States, where it has recently begun operations.” Strip away the framing and what actually happened is simple: a company sold roughly 9 million new shares at $1.45, said some of the money would go toward entering the US market, and the stock more than doubled in a session.

And “recently begun operations” is doing enormous work in that sentence, the US mobility and employer-shuttle space Swvl says it’s now entering isn’t empty ground waiting to be claimed, it already has incumbents with more capital, more brand recognition, and years more operating history in exactly this market. Uber, through its Uber for Business and shuttle-style offerings, has the largest rideshare network and balance sheet in the industry by an order of magnitude, followed by Lyft. Zeelo has spent years building out employer and school transportation contracts on both sides of the Atlantic, including a real US footprint. RidePal and Enterprise’s mobility and vanpool operations occupy the same corporate-shuttle niche Swvl is now trying to enter from a standing start, backed by a company whose core Egypt and GCC markets are still the overwhelming majority of its revenue. None of these are theoretical competitors, they are established players with existing US customer relationships, and Swvl is arriving late to the game with terrible service, is thinly capitalized (only $13 million), is without a single disclosed US contract, revenue figure, or operating metric to date.

Even using the more conservative $76B private-round figure, Uber was worth roughly 50x Swvl’s peak $1.5 billion SPAC valuation at a comparable point in its own trajectory and that’s Uber pre-IPO, still burning cash, years before it became profitable.

From Billion Unicorn to Micro-Cap: Value Destruction

Swvl’s Nasdaq debut on April 1, 2022 valued the company at approximately $1.5 billion, the first Middle Eastern and North Africa unicorn to list in the U.S., carried there by a SPAC deck promising more than $1 billion in annual gross revenue by 2025. As of today, September 10, 2026, SWVL’s market capitalization stands at $143.7 million. That’s a decline of roughly 90.4% from the valuation the company carried at listing, meaning the stock would need to climb more than tenfold from here just to get back to where it started. Four and a half years, a Portfolio Optimization Program, a reverse stock split, thirteen creditor settlements, two separate “first profitable year” announcements, and multiple rounds of dilutive fundraising later, and the company has recovered less than a tenth of what it lost.

Source: SWVL- TOS 5-year chart showing a massive decline.

The path there was not a straight line, and the shape of the decline matters as much as the size of it. Within six months of listing, the stock was already trading below $1 and the market cap had cratered to roughly $53 million, essentially wiping out the entire premium the SPAC deal had created over what was actually sitting in the trust after redemptions.

What makes the destruction harder to explain away is that it happened despite the company continuously raising and spending capital specifically to prevent it. The B. Riley equity line, the January 2023 reverse split undertaken explicitly to preserve the Nasdaq listing, and now the $14.5 million Coefficient placement were all deployed, at different points, as tools to keep this company solvent and listed.

Source: Swvl Holdings Corp Form 20-F, fiscal year ended Dec. 31, 2025, filed Apr. 20, 2026

Source: Swvl Holdings Corp reverse share split announcement, filed Jan. 25, 2023.

The Queen’s Gambit Was the Sponsor Promote

SWVL did not enter the public market through a conventional operating-company IPO. It arrived through Queen’s Gambit Growth Capital, a blank-check company whose own IPO prospectus said it was formed to pursue a business combination and intended to focus on companies providing solutions that promote sustainable development, economic growth, and prosperity.

When Queen’s Gambit announced the SWVL transaction, that positioning became even more explicit. The deal materials described SWVL’s tech-enabled mobility platform as aligned with Queen’s Gambit’s mission of removing barriers to social and economic opportunity. They also highlighted Queen’s Gambit’s female-led board and advisory team, which it said provided differentiated perspectives and global relationships. The pitch was ambitious, as the transaction announcement contemplated gross proceeds of up to approximately $445 million, including a $100 million PIPE, to accelerate a plan targeting more than $1 billion in annual gross revenue and expansion to 20 countries by 2025.

Queen’s Gambit’s own proxy warned investors that the sponsor had paid substantially less for its founder shares than public investors paid in the IPO. As a result, the sponsor and its affiliates could still earn a positive return even if public shareholders lost money. The filing further acknowledged that these interests could influence the SPAC directors’ recommendation that shareholders approve the transaction. SWVL ultimately reported FY2025 revenue of $24.2 million. While reported IFRS revenue is not necessarily identical to the “gross revenue” measure used in the original projection, the reported figure is equivalent to roughly 2.4% of the $1 billion headline target.

Immediately before the business combination, Queen’s Gambit’s trust account held $345.0 million. At closing, holders redeemed 29,175,999 Class A shares for $291.85 million, leaving just $53.26 million in the trust account. In cash terms, redemptions returned about 84.6% of the pre-closing trust rather than leaving it in the combined company. SWVL’s own closing announcement confirmed the result: of approximately $164.8 million in gross proceeds delivered at closing, $111.5 million came from the upsized PIPE, and only $53.3 million came from Queen’s Gambit’s trust account net of redemptions.

Queen’s Gambit’s IPO filing also disclosed voting mechanics under which, in a minimum-quorum scenario, a limited number of anchor holders voting in favor could potentially approve the business combination without additional public shares voting yes. That disclosure describes the structure, not the actual SWVL vote, which should be verified against the final proxy before publication. The transaction announcement named Agility, Luxor Capital Group, and Zain as leading investors in the $100 million PIPE and described potential strategic collaboration with some of those same parties. This reflects the transaction ecosystem surrounding the de-SPAC, sponsor capital, anchor investors, strategic narratives, and a public shareholder base that largely chose redemption.

Source: Queen’s Gambit Growth Capital Form S-1

Source: Swvl Holdings Corp Form 20-F, fiscal year ended Dec. 31, 2025.

The Sawiris Name & the Purchase Agreement

On August 25, 2026, SWVL announced a $13 million strategic investment round led by Coefficient LP, which the company described as a Houston-based investment firm backed by the Sawiris family of Cairo. That headline apparently carries obvious reputational weight.

The actual securities agreements are more informative, Coefficient Swvl Holdings, LLC, a Delaware entity associated with Coefficient LP, and HITE Hedge Asset Management agreed to purchase 8,990,317 Class A ordinary shares at $1.446 per share. The following day, Sofico Holdings Limited added 1,027,397 shares at $1.46. Together, the placements created approximately 10 million new shares at roughly $1.45.

As long as Coefficient and its affiliates hold at least 5% of SWVL’s fully diluted shares, Coefficient retains several contractual rights. These include a board nominee (initially founder Abdalla Ali) pro rata participation in future equity issuances and certain consent rights over corporate actions. Those provisions are not inherently unusual for a negotiated institutional investment, they are nevertheless economically meaningful because public shareholders purchasing the same class of security in the open market do not receive them.

HITE deserves separate mention, as in February 2023, HITE Hedge Asset Management settled SEC charges involving Rule 105 of Regulation M after short selling an unrelated company’s stock during the restricted period preceding a public offering and subsequently purchasing shares in that offering. HITE paid a $103,591 penalty, while three affiliated funds disgorged approximately $111,000. The conduct was unrelated to SWVL and occurred more than three years before this investment. It is included here because it is documented history concerning a named counterparty in SWVL’s current financing, nothing more.

Two purchase agreements, signed twenty-four hours apart, added roughly 10 million shares to a company that had 9.96 million outstanding five days earlier, which means the private placement alone increased the share count by more than 100%. Existing public shareholders didn’t get diluted by a raise. They got diluted by a company that effectively doubled in size overnight, and they had no vote, no participation right, and no seat at the table where the price was set. And the float hasn’t stopped growing since: verified current share count sits at roughly 22.03 million, meaning another 2 million shares have been added on top of the post-raise total in the weeks since closing, with no single disclosed event yet identified to explain the gap. The 180-day lock-up on the Coefficient, HITE, and Sofico shares means none of that new stock can be sold into the market until early 2027, but the lock-up only restricts when the new holders can sell. It does nothing to restrict how much smaller everyone else’s slice of the company got the moment those agreements were signed. Dilution isn’t a future risk here, it already happened, in full, on August 24th and 25th, the only thing still pending is when the people who benefited from it are allowed to cash out.

Source: Swvl Holdings Corp Form 6-K, filed Aug. 25, 2026.

Source: Swvl Holdings Corp Form 6-K, filed Aug. 26, 2026 (shareholder agreement, securities purchase agreement).

Source: SEC Litigation Release No. 25643, Feb. 21, 2023, SEC v. HITE Hedge Asset Management LLC et al., No. 1:23-cv-10351 (D. Mass.).

Conclusion

SWVL’s numbers say the business is improving; its customers say something else, and they’re not shy about it. Revenue is growing on paper; losses are narrowing on paper. But 135 riders left reviews of this company in the same eight months management has been telling that story, and 97.8% of them describe a company that can’t keep its app working, can’t staff a support line, and can’t consistently keep its drivers from hurting people. Paper and practice have stopped agreeing, and when they diverge this cleanly, we trust the people standing at the pickup point over the people writing the press release.

This is also the second time this company has asked its shareholders to believe the turnaround is real. It said so in December 2023, called it a milestone, and financed that milestone with $18.7 million in creditor discounts struck at the edge of default. It is saying so again now, and the mechanism underneath the FY2025 number is the same one that produced the last “profitable year”, a below-the-line gain doing the work an operating business hasn’t done yet. A company doesn’t get to announce its first profitable year twice; something in that story isn’t what it’s being sold as, and the riders describing broken buses and unanswered complaints in the exact same window are telling you which half is fiction.

SWVL went public on a projection of over a billion dollars in annual revenue. It has delivered only $24.2 million; that isn’t a miss but a thesis that never had a chance of being true, dressed up well enough to survive a SPAC vote and three and a half years of restructurings since, restructurings its own customers have been quietly documenting from the outside the entire time, watching routes vanish and support disappear months before any analyst wrote it down. That thesis has cost the market almost everything it was once willing to pay for it: from a $1.5 billion valuation at listing to $143.7 million today, SWVL has destroyed roughly 90% of its value since the day it went public, and no financing round since has bought back more than a fraction of what was lost.

Now the company is funding its next act with $14.5 million in fresh private capital, sold near $1.45 a share to investors who did not buy in on faith. They negotiated a board seat; they negotiated participation rights; they negotiated consent rights over what the company can do next. What they also got, and what public shareholders were never offered a vote on, was roughly 10 million new shares issued in a single week, more shares than existed in the entire company five days earlier.

The company says this capital funds a US expansion it has “recently begun,” and the stock more than doubled in a single session on that promise alone, days before a single US contract, dollar of US revenue, or US operating metric had been disclosed. The market it’s entering already belongs to incumbents operating at a scale SWVL has never approached at any point in its nine-year history: Uber alone commands roughly three-quarters of US rideshare spending, a position built over seventeen years against a company that spent its own version of that head start losing 90% of its public market value. Zeelo, RidePal, and Enterprise’s mobility operations already hold the specific corporate-shuttle niche SWVL says it’s now targeting. A press release promising entry into that market isn’t a strategy; it’s a narrative timed to a dilutive raise, and the stock’s reaction proves the narrative worked exactly as intended, regardless of whether the business behind it ever materializes.

The market wants to read this financing as validation. But read the agreement instead; better yet, read the reviews and consider them for yourself. Smart money didn’t confirm the public price was fair; it told you, in the terms it demanded, exactly what it thought the stock was worth. The riders and users are now telling you what the product is really worth; however, neither number appears in the press release that tells you what the product is actually worth.

Fugazi Research considers $SWVL uninvestable at any price above zero.

Disclaimer

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our,”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority. All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions-long, short, or otherwise-in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

This is not the first time this entity has been examined this closely, and the earlier record dates to August 2021, when White Diamond Research published a short report on this same public company (then Flora Growth Corp.) after sending a seasoned trader and investigator, David Capablanca, to physically inspect the flagship asset the company’s entire public narrative rested on in person: a cannabis cultivation facility outside of Bucaramanga, Colombia. Upon arrival, Capablanca found a site reachable only by motorcycle over unpaved mountain terrain plagued with Colombian cartels. He was twice denied a promised tour of the public company’s physical site and discovered that the company’s SEC filed Colombian office address did not correspond to an actual office. The company’s on site manager on the investigator’s second visit, spotted his recording equipment and attempted to seize his phone before the investigator escaped the property on his motorcycle.

Five years and one crypto rebrand later, the pattern Capablanca documented on the ground, has simply changed asset class, as his own account adds texture the White Diamond report’s summary points don’t fully capture: the cultivation site was nearly impossible to locate on the map beforehand and a separate stop at the address the company listed for its outside auditor turned up to be a storefront with no connection to the company at all. Where the 2021 story was a cultivation facility that could not be toured, inspected, or located at its stated address, the 2026 story is a meme token treasury whose valuation depends on the fair-value marks of thinly-traded digital assets and a self-published, non-GAAP “discount to NAV” framing the company has no independent obligation to substantiate. The 2021 report also documented a paid promotion apparatus timed to a specific insider liquidity event: the company engaged multiple stock promotion services in the weeks ahead of its first share lockup expiration, and separately paid for a third party research report whose own bullish framing conceded the company’s core export claims were unworkable.

ZeroStack Corp, wants investors to believe they are looking at a newly positioned decentralized artificial intelligence treasury company built around ownership of the 0G token and exposure to the emerging AI infrastructure economy as ZeroStack is not a newly formed AI company, but Flora Growth Corp., (the former Nasdaq cannabis company traded as FLGC), now operating under a new name, a new ticker, a new corporate domicile, and a radically different investment narrative. It is important to note that ZeroStack’s 0G is an actual meme token. Meme tokens derive from memes, which are meant to be jokes or fun gambling vehicles. They are not meant for any serious investing whatsoever. Both Flora Growth and ZeroStack have spent years cycling through businesses, acquisitions, capital raises, operating losses, asset impairments, reverse stock splits, and strategic resets. The company has recorded a series of reverse splits, in order to regain compliance with Nasdaq’s $1 minimum bid requirement, resulting in massive shareholder equity destruction.

Flora Growth recorded enormous impairments, persistent operating losses and an accumulated deficit that reached $158.1 million by the end of 2024, its 2024 annual report disclosed only $6 million in cash, and substantial doubt about its ability to continue as a going concern, and by September 2025, Flora had sold its legacy hemp and cannabis businesses transforming now into ZeroStack. Today, the company describes itself as a decentralized AI treasury and AI focused asset management company whose primary strategy centers on ownership of the native token, Zero Gravity (0G) blockchain.

For the six months ended June 30, 2026, ZeroStack reported $20.9 million of total revenue and a $61.3 million net loss. Meanwhile, the company’s digital asset segment recorded $82.5 million of losses from changes in the fair value of digital assets. Now the company had just $2.6 million of cash, and an accumulated deficit of $339.1 million. Management explicitly stated that substantial doubt exists regarding the company’s ability to continue as a going concern. ZeroStack says it expects to fund itself primarily by monetizing digital assets earned from staking and potentially by selling the underlying treasury assets. Proving that changing the business name, and pivoting industry did not help whatsoever in making the balance sheet or cash flow stronger, but merely worked as a PR pivot in order to keep riding the tailwind of the hottest sector. Fugazi Research considers Zero Stack shares uninvestable at any price above zero.

Fugazi Research Analysis

• In 2021, White Diamond Research’s investigator, trader David Capablanca, physically inspected the company’s then flagship operating asset and found conditions inconsistent with the commercial-scale story the company was telling the market, an inaccessible site, a denied tour, and a field office address that did not exist. That episode establishes a documented precedent, from this exact company, of a public narrative outrunning what direct inspection could support.

• David Capablanca’s chapter in Short Selling Master describes searching unsuccessfully for the site on standard mapping tools and only locating it after cross-referencing a company Instagram photo showing a hand-lettered farm sign against satellite imagery, a company whose flagship operating asset could not be found through ordinary due diligence tools without an in person trip.

• Capablanca’s account describes the stock’s behavior ahead of the 2021 report, a rapid price run-up accompanied by paid promotional outreach, including text-message campaigns whose fine print disclosed compensation for the promotion, as consistent with a pattern he associates with underwriters that have a documented history of share dumps roughly 180 days after an offering, timed to prior price run-ups just before lockup expiration.

• The 2021 report documented a web of loans between the company’s then-Executive Chairman’s affiliated entities and the company itself, with the same individual serving as CFO across several of those entities simultaneously. The present-day structure differs in mechanics but rhymes in form: a token contributor installed as President concurrent with the asset contribution, and a CEO, Executive Chairman, and CFO who are themselves named sellers in the registration statement built around the same transaction.

• The substantial majority of total assets consists of digital assets and restricted digital assets, non-yielding, fair-value-marked cryptocurrency positions, not cash, receivables, or productive assets tied to the legacy pharmaceutical distribution business.

• ZeroStack is Flora Growth Corp. with a new name and no meaningful change to the underlying pharmaceutical distribution business it still carries on its books. The company redomiciled jurisdictions, abandoned a cannabis/CBD identity for an “AI-focused asset management” identity, and adopted a crypto treasury strategy. (The second strategic reinvention in the company’s public life inside a single year).

• The token position that was the entire premise of the company’s rebrand was carried at a fair value representing a small fraction of its original cost by the following quarter. This is the company’s own fair value mark in its own filing.

• Management’s liquidity assessment moved from “sufficient for the next twelve months” to “substantial doubt” in the space of a single quarter, with the reversal attributed directly to the collapse in fair value of the company’s treasury holding rather than to any change in the underlying operating business.

• Weeks after warning it might not survive the year, the company entered into an even larger token acquisition, priced at a steep premium to its own trading price, for a token whose independent liquidity and market depth have not been established in any filing reviewed to date.

• The individual described in the company’s own 8-K as “a significant source of the Digital Assets contributed to the Company” was appointed President effective at the closing of that same transaction, with an employment agreement negotiated concurrently with the asset contribution itself.

• The bulk of the shares issuable in the transaction cannot be exercised without a future shareholder vote, and the token contributing investors whose shares are subject to that same vote are bound by concurrent voting agreements to vote as directed by a company-designated proxyholder, with an irrevocable proxy running for a decade.

• The resale registration that covers the new warrant shares also covers shares held by the CEO, the Executive Chairman, and the CFO, issued via earlier private placements and warrant exercises tied to the same string of 2026 crypto transactions.

• Days after the second token deal closed, the company issued a press release valuing its combined treasury on a per-share basis and framing its trading price as a steep “discount” to that figure, a non-GAAP metric that the release itself concedes is subject to significant volatility and liquidity limits.

• Fugazi Research considers $ZSTK uninvestable at any price above zero.

Source: David Capablanca, Short Selling Master, Chapter 4, “Adventures in Bucaramanga, Unmasking a Blatant Pump and Dump”

Source: White Diamond Research, “Flora Growth: A Cannabis Company of Deception, Unprofessionalism, and Stock Pump and Dumps,” Aug. 26, 2021.

Source: ZeroStack Corp. Form 10-K, fiscal year ended Dec. 31, 2025, filed Feb. 27, 2026.

Source: ZeroStack Corp. Form 10-Q, quarterly period ended June 30, 2026, filed July 31, 2026.

Source: ZeroStack Corp. Form 8-K , filed Aug. 19, 2026.

Source: ZeroStack Corp. Form S-3 , filed Aug. 21, 2026.

Financial Summary

• The accumulated deficit jumped from $277.8 million as of Dec 31, 2025 to $339.1 million as of June 30, 2026, up $61.3 million in six months.

• Two reverse splits (20 to 1) in June 2023 and (39 to 1) in August 2025, for a cumulative 780 to 1 ratio.

• Per Yahoo Finance, ZSTK’s 5-year total return as of Feb 23, 2026 was -99.81%, against the S&P 500’s +76.17% over the same window.

• FY2025 net loss was $119.7 million (comprehensive loss attributable to ZeroStack of $119.331M), versus $15.988 million in FY2024, the loss widened by roughly $103 million year over year.

• Total assets of $130.2 million as of December 31, 2025 were dominated by digital assets ($71.95 million) and restricted digital assets ($49.0 million), against total liabilities of $59.7 million, including $50.7 million of long-term debt consisting primarily of the Zero Gravity Convertible Note.

• As of June 30, 2026, the company held 75,101,767 0G tokens at a cost basis of $163.4 million and a fair value of $15.2 million, a decline of approximately 91% plus a nominal Bitcoin position, for total digital assets of $15.2 million against a combined cost of $163.4 million.

• The company recorded an $82.5 million fair value loss on digital assets and a net loss of $61.3 million for the six months ended June 30, 2026, against $3.8 million of staking revenue earned on the 0G position over the same period.

• Cash stood at $2.6 million with negative working capital of $600,000 and an accumulated deficit of $339.1 million as of June 30, 2026, the balance-sheet basis for management’s going concern disclosure.

• The President appointed concurrent with the MemeCore closing receives a $500,000 annual base salary, a contractual entitlement to 125,000 restricted shares (subject to shareholder approval), and severance of up to 30 months of base salary in a qualifying change in control termination.

• The August 21, 2026 resale registration covers 54,609,992 shares, comprising 10,028,935 private-placement shares issued across the March 31, July 20, and August 19, 2026 transactions, 5,954,743 shares issued to CEO Daniel Reis-Faria upon exercise of earlier pre-funded warrants, 2,428,020 shares underlying executive stock options, and the 36,198,294 MemeCore warrant shares.

• An August 24, 2026 press release valued the combined 0G and MemeCore treasury at approximately $1.06 billion, or $18.19 per partially diluted share ($17.33 fully diluted), against a $4.71 reference trading price, implied discounts of 74.1% partially diluted and 72.8% fully diluted.

Source: ZeroStack Corp. Form 10-K, fiscal year ended Dec. 31, 2025, filed Feb. 27, 2026.

Source: ZeroStack Corp. Form 10-Q, quarterly period ended June 30, 2026, filed July 31, 2026.

FloraGrowth before ZeroStack

The most important fact in understanding ZeroStack may be the one receiving the least attention from traders discovering the ticker today. Before it was ZeroStack, this entity’s public story was a 246-acre cannabis cultivation operation in the mountains outside Bucaramanga, Colombia, a story nobody at the company could actually produce access to when someone showed up and asked to see it.

The company was incorporated in 2019 as Flora Growth Corp. and went public in May 2021 at $5 per share. At the time, Flora presented itself as an international cannabis cultivation and consumer products company positioned to capitalize on global cannabis legalization and commercialization, during its initial public offering it sold 3.33 million shares before subsequent reverse splits, with an additional overallotment option available to underwriters.

The public story expanded quickly as the company released a series of PR’s showcasing acquisitions in the cannabis related business. The language surrounding these transactions was ambitious as management said the JustCBD acquisition was expected to accelerate top and bottom line growth and generate major distribution synergies. Flora spent aggressively to assemble those stories, however those investments did not produce the durable economics investors might have expected from the language surrounding them. And by 2023, Flora reported more than $23 million of goodwill impairment and more than $16 million of additional asset impairments, while net loss from continuing operations accelerated to $46.7 million.

By the end of 2024, Flora’s accumulated deficit had reached $158.1 million. The cannabis empire that had once been presented as a platform for international expansion was ultimately dismantled, and the company’s current filings state that it finalized the sale of its legacy hemp and cannabis businesses on September 26, 2025, by this time FloraGrowth had no other option but to pivot to the hottest theme available, in order to keep surviving, enter ZeroStack.

“The Mountain That Wasn’t on the Map” (White Diamond Research’s 2021 Field Investigation)

By White Diamond Research’s account, Flora Growth Corp. was, structurally, a roll-up: a shell built up through a series of small acquisitions, anchored by a Colombian cultivation asset, purchased for roughly $80,000 in October 2019, a nominal sum for what the company would go on to market as the foundation of a global, low-cost cannabis export business. The company’s own IPO prospectus, months later, disclosed that it had not yet grown or harvested a commercial crop and lacked the infrastructure to extract cannabis oil in any material amount. In the weeks before its first share-lockup expiration in August 2021, the company published a run of press releases, and engaged in multiple paid stock promotion services.

White Diamond’s report rested on more than filings analysis, as the firm sent an investigator, David Capablanca (author of Short Selling Master), to the company’s stated cultivation site in person. Capablanca’s recently published 2026 book recalls that the site was difficult to even locate on standard maps, as he found it only after matching a company Instagram photo of a hand lettered farm sign against satellite imagery. The location itself, in a remote mountain community outside Bucaramanga was reachable only by motorcycle over unpaved, muddy terrain in which no local driver he approached was willing to make the trip. Capablanca resorted to going up the mountain to the Flora Growth site on a motorbike. The bike used on this first attempt sustained mechanical damage from the conditions and had to be repaired before a second visit was possible. The company’s on site manager in Colombia declined to grant the promised tour and, on noticing Capablanca’s recording equipment, attempted to physically take his phone before Capablanca and his guide left the property. Both White Diamond’s published report and Capablanca’s recently published book describe the same sequence of events independently.

A separate check of the company’s SEC-filed Colombian office address, and of the address listed for its outside auditor, found no functioning company presence at either location, in the auditor’s case, a storefront with no apparent connection to the company. White Diamond’s report separately documented a web of related-party loans between the company, its then-Executive Chairman’s other ventures, and a shared CFO who held the same role across several of those entities simultaneously. Capablanca’s recently published book, Short Selling Master recounts that the stock declined substantially following the report and that the company was subsequently forced into repeated reverse stock splits to maintain its Nasdaq listing. This is confirmed in this report’s own SEC sourced research: a 20 to 1 split in June 2023 and a 39 to 1 split in August 2025, for a cumulative 780 to 1 ratio.

Source: FLGC- TOS 5-year chart showing a decline massive decline & reverse split history over time

This is the same public company Fugazi Research is examining today, five years and one identity change later, the specific facts are new, a token treasury instead of a cultivation facility, a self published NAV metric instead of paid stock promotion, a President appointment instead of an Executive Chairman’s loan network, but the pattern White Diamond and Capablanca documented on the ground in 2021 is the same pattern this report documents in the current filings: a public narrative that outgrows what can actually be verified about it, and the one time someone checked closely, it didn’t hold up.

The Reverse Split History

Public investors evaluating ZeroStack should understand how much compression has already occurred in the historical share structure. In June 2023, Flora Growth completed a 20 to 1 reverse stock split, subsequently in August 2025, Flora completed another reverse split, this time at a ratio of 39 to 1, those two actions alone represent a cumulative 780 to 1 consolidation of the historical share count. An investor holding 780 shares before the first reverse split would theoretically hold about one share after both splits, ignoring fractional-share treatment and any trading activity in between.

The 2025 split was directly connected to maintaining the company’s Nasdaq listing, FloraGrowth subsequently reported the shares remained above the required $1 bid price for ten consecutive trading days and that Nasdaq notified the company in August 2025 that it had regained compliance. Reverse splits do not, by themselves, destroy shareholder value, but repeated reverse splits matter most when they occur alongside recurring operating losses, equity issuance, and continued dependence on external financing. In this case for Flora shareholders, the denominator has been reset more than once.

Cannabis Out, AI Treasury In

On September 19, 2025, Flora Growth (then still a cannabis and CBD operator) announced a $401 million financing built around the Zero Gravity (”0G”) token, comprising $35 million in cash and over $366 million in non-cash digital assets, and rebranded as ZeroStack shortly after. Management framed this as a “cornerstone” of a new decentralized-AI treasury strategy and, on eliminating the associated convertible note in March 2026, stated the company would be “operated debt free.” Then on January 29, 2026, Flora Growth Corp. (FLGC) officially became ZeroStack Corp (ZSTK). ZeroStack now describes itself as a decentralized AI treasury and AI-focused asset management company investing in the future of artificial intelligence, its first major strategy is ownership of 0G, the native token of the Zero Gravity blockchain.

By the second quarter of 2026, the same treasury that was the entire basis of the rebrand had lost roughly 91% of its cost basis, and management’s own going-concern disclosure attributes the reversal directly to “the steep decline in the reported fair value of the 0G holdings.” Staking revenue of $3.8 million over six months did not come close to offsetting an $82.5 million fair-value loss over the same period.

Source: 0G 1-year chart showing a decline of +97% decline from its peak, less than a year ago.

0G is currently trading at $0.1653, down 97.05% over the trailing year, a chart that reads less like a volatile crypto asset and more like a token in terminal decline. This is the same token ZeroStack restructured its entire corporate identity around in September 2025, the asset a $401 million financing was built on, the “cornerstone” management said would anchor a debt-free, decentralized-AI treasury strategy.

A treasury built on a single collapsing token would, in most companies, be a five-alarm signal to diversify, or at minimum de-risk. ZeroStack’s response was to do it again, larger, as one month after disclosing going concern doubt tied directly to the 0G collapse, the company entered a second token acquisition roughly an order of magnitude bigger, paid for in stock and warrants priced at a steep premium to the market. There is no visible mechanism in any filing reviewed to date that would prevent the MemeCore position from tracing the same curve now showing on the 0G chart and management has not demonstrated it learned anything from the first chart before building the second bet.


Source: Wojack meme character emotionally destroyed from bagholding worthless meme coins.

Quarter Over Quarter Value Destruction

Three consecutive balance sheets tell the same story from three different angles. Total assets fell from $130.235 million at December 31, 2025 to $45.2 million at March 31, 2026 to $25.187 million at June 30, 2026, an 80.7% collapse in two quarters. Cash followed the same direction, falling from $5.596 million to $2.640 million over the same window, a 52.8% decline that leaves the company with barely two and a half months of its own starting cash balance left on hand. The main culprit behind the broader collapse is the digital assets line itself: non-current digital assets fell from $71.950 million at December 31, 2025 to $14.148 million at June 30, 2026, an 80.3% decline that, combined with the near-total elimination of the company’s restricted digital assets over the same period, accounts for the overwhelming majority of the drop in total assets.

Source: ZeroStack Corp. Form 10-Q, quarterly period ended June 30, 2026, filed July 31, 2026.

Shareholders’ equity followed the identical trajectory: $70.552 million, then $36.797 million, then $13.818 million, a decline of 47.8% in the first quarter alone and a further 62.5% in the second, for a cumulative destruction of 80.4% of equity in six months.

Source: ZeroStack Corp. Form 10-Q, quarterly period ended June 30, 2026, filed July 31, 2026.

The one balance-sheet item that improved looks better than it is. Long-term debt fell from $50.767 million to essentially zero between year-end 2025 and June 30, 2026, which reads on its face like deleveraging. It isn’t. The company settled its only material debt obligation, the Zero Gravity Convertible Note, by transferring 50 million 0G tokens directly to the noteholder on March 31, 2026, paying down debt with treasury assets rather than operating cash flow or refinancing. The balance sheet looks cleaner because the company handed over the thing that was supposed to be the whole investment thesis.

Source: ZeroStack Corp. Form 10-Q, quarterly period ended June 30, 2026, filed July 31, 2026.

The share count adds a final layer most of the destruction above doesn’t even capture. Shares outstanding roughly doubled in the first quarter, from 1.046 million to 2.430 million, then held flat through June 30. The dilution came after, by August 23, 2026, following the Texas Blocker exchange, the MemeCore private placement, and related warrant exercises, shares outstanding reached approximately 21.8 million (nearly nine times the June 30 count), in under two months. A shareholder holding the stock at the June 30 balance sheet date has since watched their proportional claim on whatever assets remain shrink by roughly 89% on top of the equity losses already sustained.

A History of Equity Financing

Flora Growth’s capital markets history did not begin with the 0G treasury transaction. In November 2021, only months after its IPO, Flora Growth priced a $30 million follow-on public offering of 10,000,000 units, each consisting of one common share and one-half warrant — and closed it larger, after the underwriters exercised their over-allotment option in full, at $34.5 million and 11,500,000 units, introducing 11.5 million common shares and 5.75 million warrant shares exercisable at $3.75.

Additional financings followed. A September 2023 unit offering raised approximately $2.7 million and issued 1,369,000 investor warrants at a $2.50 exercise price, plus 54,760 placement-agent warrants at $2.39; as part of the same transaction, the company repriced 66,245 warrants from the November 2021 offering and 624,995 warrants from a December 2022 offering downward, from $8.00 to $2.50 per share.

The company later established a standing mechanism for issuing stock in smaller, more flexible increments. In 2024, it filed a Regulation A offering circular authorizing the sale of up to 44,910,179 common shares at a fixed price of $1.67 per share. The company drew only a small fraction of that capacity (425,000 shares, for gross proceeds of $0.7 million) before the year’s reported financing activity shifted to a separate $3.6 million registered direct offering at $1.25 per share. The gap between what was authorized and what was actually sold is itself notable: a Regulation A filing of that size gives the company standing authority to sell tens of millions of additional shares on short notice, largely outside the scrutiny a fully underwritten offering would draw, whether or not it is ever fully used.

Source: Flora Growth Corp. Form 253G3, “Offering Circular,” 2024.

These historical figures must be adjusted for the two subsequent reverse splits 20 to 1 in June 2023 and 39 to 1 in August 2025, and therefore cannot simply be added to today’s share count. Across a roughly $30 million underwritten offering, a warrant-repricing transaction, and a Regulation A shelf authorizing tens of millions more shares, this is a company that has repeatedly turned to equity issuance for capital, well before crypto treasury accounting entered the picture.

Going Concern, Again

This is not the company’s first going-concern warning either. Flora’s FY2024 annual report already disclosed substantial doubt about the company’s ability to continue as a going concern: management reported $6.1 million of cash and cash equivalents at December 31, 2024, a $15.9 million net loss for the year, and an accumulated deficit of $158.1 million, and stated plainly that its cash position was not sufficient to continue investing in growth while meeting its obligations as they came due.

ZeroStack’s most recent financial statements contain another going-concern warning, the second in three fiscal years, now under a different corporate identity and a different business model entirely. As of June 30, 2026, the company had $2.6 million in cash and Management states that it expects to fund operations primarily by monetizing digital assets generated through staking and, if that proves insufficient, by monetizing the underlying digital asset portfolio itself. The company nevertheless states it cannot conclude that these plans are probable of alleviating the conditions raising substantial doubt about its ability to continue operating over the following twelve months.

Source: ZeroStack Corp. Form 10-Q, quarterly period ended June 30, 2026, filed July 31, 2026.

Insider and Related-Party Relationships

The 0G transaction becomes more interesting once you examine who was on both sides of it. ZeroStack Executive Chairman Michael Heinrich is also the Chief Executive Officer of Zero Gravity Labs Inc., which was among the largest participants in the 0G token contribution. Before the share exchange that brought those tokens onto ZeroStack’s balance sheet, Zero Gravity Labs held 4,608,684 shares (50.6%) of Texas Blocker, the private vehicle formed to receive the contribution. At closing, Zero Gravity Labs received 4,608,864 ZeroStack common shares in exchange.

The related-party structure runs deeper than one director’s outside role. Texas Blocker, the entity that actually received the 0G tokens and was later exchanged into ZeroStack was formed by CEO Daniel Reis-Faria and CFO Dany Vaiman, and its board of directors consisted of exactly those two people. The company’s own CEO and CFO, in other words, created and controlled the private company on the other side of a transaction that their own employer would later acquire. Separately, of the 71.77 million 0G tokens contributed through the company’s original Token Private Placement in September 2025, 50 million (valued at $150 million), more than a third of the entire $401 million financing the company has publicly credited as its founding transaction, came from Daniel Reis-Faria personally.

The question for public shareholders was never whether the relationships were disclosed, but the real question is what economic interests those relationships created, and how those interests interact with ZSTK’s public market valuation. On May 5, 2026, the company’s independent directors granted Reis-Faria, Vaiman, and Heinrich a massive amount of stock options respectively, vesting in tranches tied to the stock hitting VWAP price thresholds between $7.65 and $17.85, compensation that pays out specifically when the share price rises, awarded to the same three executives who control the timing and structure of the token transactions that move that price.

Source: ZeroStack Corp. Form 8-K, filed May 6, 2026.

Source: ZeroStack Corp. Form S-4.; ZeroStack Corp., “Transparency First: An Update on ZeroStack’s Financials and Progress,” Oct. 9, 2025.

What Happened to the Original Businesses?

One of the more revealing exercises with this company is simply following the businesses it once told investors would drive its future. Flora Growth’s founding story was Colombian cannabis cultivation, the company IPO’d on a claim of producing cannabis at $0.06 a gram from a 246-acre outdoor facility. Those Colombian operations were sold to an unnamed private buyer for CAD $800,000 in 2023. Flora Growth had separately spent tens of millions building out a consumer-facing cannabis portfolio.

The rest of that portfolio was disposed of on September 20, 2025, under an Equity Transfer and Debt Repayment Agreement the company calls the “Cannabis Sale Agreement,” which transferred JustCBD, Vessel, United Beverage Distribution Inc., and High Roller Private Label LLC out of the company.

Source: ZeroStack Corp. Form 10-K, fiscal year ended Dec. 31, 2025, filed Feb. 27, 2026, Note 5.

Phatebo, the company’s German pharmaceutical distribution subsidiary, remains and continues to generate the overwhelming majority of the company’s conventional operating revenue. But Phatebo is not the reason investors are chasing ZSTK, the token treasury is. That distinction matters: the operating business generating most of the company’s actual revenue is not the business generating most of the market’s excitement, and the company’s valuation increasingly depends on the market’s willingness to treat a volatile pool of digital assets as a growth platform, held by a company with a long and now-documented history of turning to whatever asset story is currently available, cannabis cultivation, consumer cannabis brands, and now crypto to fund itself.

Conclusion

ZeroStack is a new name attached to an old public company, and the old company’s record is the most relevant diligence available on the new one. Before decentralized AI, there was cannabis: Colombia, Vessel, JustCBD, a European expansion story, and a run of acquisitions that ended in impairments, losses, two reverse splits, and a going-concern warning. In 2021, an independent investigator physically inspected the company’s flagship operating asset and found a story that collapsed on direct contact, a facility that couldn’t be toured, an office that didn’t exist, paid promotion timed to an insider lockup.

This is the company’s second going-concern warning in three fiscal years. Total assets fell 80.7% and shareholders’ equity fell 80.4% in the two quarters following the 0G treasury’s adoption, driven by an 87.4% collapse in the digital assets that were supposed to be the entire investment thesis. The company generated $20.9 million in revenue over the first six months of 2026 against a $61.3 million net loss, with only $3.8 million of that revenue coming from the digital-asset staking activity the treasury exists to justify, along with a share count that grew from roughly 2.4 million to over 21 million in a matter of months, largely to fund transactions structured by the people who benefit from the resulting share price.

Our work on ZSTK is continuing, particularly around the fully diluted capital structure, historical promotion, insider economics, 0G token liquidity, the economics of staking, and the relationship between ZeroStack and Zero Gravity Labs. Based on what we have reviewed so far, we believe those details are likely to make Flora Growth’s history considerably more relevant, not less. For these reasons, Fugazi Research believes ZSTK shares are uninvestable at any price above zero.

Disclaimer

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our,”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority.

All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions—long, short, or otherwise—in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

TEN Holdings, Inc. is not a software company hiding inside an events business. It looks much more like a tiny webinar and event production company that discovered software clothing at precisely the moment Wall Street became obsessed with AI. Unfortunately, the income statement never got the wardrobe change. It is not a technology company in any meaningful sense but a services vendor with a proprietary platform wrapped around it. Total revenue for fiscal 2025 was approximately $3.1 million, down from $3.5 million in 2024, an 11.4% decline against a net loss of $19.5 million.

Behind the story sits one of the most visible names in the small-cap pump-and-dump stock frenzy, which regulators have spent years trying to shut down: Bancroft Capital LLC. Bancroft priced TEN Holdings IPO at $6 a share in February 2025, being one of at least fourteen small-cap IPOs Bancroft led and underwrote between 2024 and 2025, roughly one a month, of which twelve completed and raised a combined $100 million, each paying Bancroft the standard 7% underwriting fee regardless of what happened to the stock afterward. XHLD opened at $6, spiked to just over $100 on its first trading day, valuing the company near $200 million, then tanked to roughly $31 the next day, $18 four days later, and traded at around $1.50 for months.

Of the twelve Bancroft IPOs that Bancroft has underwritten and completed, nine traded between 54% and 98% below their IPO price as of May 2026, and two were halted (one delisted) by Nasdaq, outright, for the kind of extreme volatility regulators associate with pump-and-dump activity, as Bloomberg independently named Bancroft among ten underwriters of “apparent pump-and-dump deals”. XHLD shows every visible symptom of a pump-and-dump scheme run by unidentified third parties exploiting a thin float and a low-quality underwriter IPO structure. However, in every case Bancroft cashed in, fees were collected on the way up, while the losses were sucked up entirely by whoever was still holding shares on the way down.

In May, Nasdaq notified TEN Holdings that it had fallen below the exchange’s $2.5 million minimum stockholders’ equity requirement, and roughly a month later, the company sold 7.5 million new shares at $1.00 each and said it believed the financing restored compliance. Revenue could not fix the problem, and the company resorted to an equity purchase arrangement with Lincoln Park Capital, opened the gate to millions of shares being issued through assorted financing and advisory deals, and then authorized a 15-to-1 reverse split, more $1-per-share sales, and then a June 2026 financing on top of all of it. In one of their latest stretches of toxic dilution, XHLD entered 2026 with 3.98 million shares outstanding and closed June 2026 with 11.98 million, a roughly 201% increase in six months, with that single June 30 offering alone responsible for about a 168% increase.

TEN Holdings received subpoenas and information requests from both the DOJ and the SEC concerning the company’s IPO and four contracts it executed after going public (a live disclosed federal inquiry). TEN Holdings’ own Board, acting on an internal investigation, concluded that certain agreements executed by former management in connection with the IPO “lacked economic substance and any direct benefit to the Company” and may have “solely benefited the counterparties to those agreements rather than the Company.” The disclosure landed within weeks of a Nasdaq stockholders’ equity deficiency notice and the resignation of CEO Randolph Wilson Jones III, replaced by CFO Virgilio Torres, who now holds both titles at once, running finance and the company at the same moment federal investigators are asking questions about both. Every officer and director who ran the company at the time of the IPO are now gone.

In August 2026, the pattern came full circle, as XHLD closed at $0.80 on August 5 (an all-time low); one trading session later, it reached $5.42 on nearly 69 million shares of volume. By August 19, it had touched $8.30 (a move of more than 900% in roughly two weeks), except this time the business is still tiny, revenue is lower, and the losses continue. Eighteen months and a reverse split later after the IPO date, XHLD investors got a rerun of the exact same show. Fugazi Research considers XHLD shares uninvestable at any price above ZERO.

Fugazi Research Analysis

• A grand jury subpoena in October 2025 became a parallel SEC investigation within 24 hours, which became a second SEC subpoena naming the former CEO five months later; now every officer and director in place at the time of the IPO is gone.

• CEO Randolph Wilson Jones III resigned May 8, 2026, weeks before a Nasdaq stockholders’ equity deficiency notice and a disclosed DOJ/SEC inquiry into the company’s IPO and four post-IPO contracts. CFO Virgilio Torres now holds both the CEO and CFO titles simultaneously.

• A “market awareness agreement” with MicroCap Advisory, LLC ($100,000 a month plus warrants), for “investor outreach” and “media planning”, was signed in June 2025, inside the time window as the company was under DOJ and SEC scrutiny. TEN Holdings was paying an outside party specifically to shape market perception of its stock at the exact moment its stock was behaving exactly the way regulators associate with manipulation.

• An active Lincoln Park Capital equity line, a forced 15-to-1 reverse split, repeated sub-$1 and $1 share sales, and a 168% single-day share-count expansion in June 2026 collectively describe a company financed by continuously issuing itself away, not by operating cash flow.

• Bancroft was paid in full before the float ever found a real price, as it collected its standard 7% fee on TEN Holdings’ $10 million IPO regardless of what happened to the stock afterward, and what happened was a collapse from over $100 to roughly $18 within four trading days.

• Of the twelve Bancroft-underwritten IPOs completed between 2024 and 2025, nine traded 54–98% below issue price as of May 2026, and two were halted outright for volatility regulators associated with pump-and-dump activity. Bloomberg independently named Bancroft among ten underwriters of “apparent pump-and-dump deals.”

• One of Bancroft’s most recent IPOs, Fitness Champs Holdings, spiked past $100 within three weeks of listing before Nasdaq halted trading over the volatility; it settled near $1.10 days later. Fitness Champs is now the named defendant in a shareholder suit citing seven other Bancroft IPOs as “similarly disastrous.” No regulator has charged Bancroft, and the one court to examine the theory declined to let it proceed on the pleadings offered.

• Premium Catering (Holdings) Ltd. was suspended by the SEC in October 2025 over suspected social-media-driven manipulation, then halted outright by Nasdaq “for additional information requested from the company” and has not traded since. Magnitude International Ltd. followed an identical sequence in December 2025 and, eight months later, received a Nasdaq delisting determination specifically because the exchange concluded a stock vulnerable to this kind of manipulation cannot support fair and orderly markets. Both are Bancroft-underwritten IPOs, exactly like XHLD.

• TEN Holdings increasingly emphasizes artificial intelligence, automation, analytics, personalization, and AI-powered content capabilities. None of that is inherently problematic. What matters is whether those initiatives produce revenue, customer growth, operating leverage, and cash flow. So far, the financial statements do not show an AI business remotely large enough to support the current valuation.

• The stock’s 52-week range spans $0.76 to $128.10, a 168x peak-to-trough spread, on a company whose implied market capitalization fell from roughly $200 million at the IPO-day high to under $5 million in the non-affiliate valuation reported (as of the 10-K’s stated record date) for FY2025, shows mostly a pump-and-dump pattern than a value investment.

• Fugazi Research considers XHLD uninvestable at any price above zero.

Source: TEN Holdings, Inc. Form 10-K, fiscal year ended Dec. 31, 2025, filed March 18, 2026.

Source: TEN Holdings, Inc. Form 8-K (Nasdaq compliance plan), filed July 20, 2026.

Source: Philadelphia Inquirer, “Social media ‘pump and dump’ fraudsters targeted tiny Nasdaq stocks, including this Philly firm’s IPOs, says lawsuit,” May 12, 2026.

Source: Bloomberg, “How Apparent Pump-and-Dump Scams Thrive on Wall Street,” Jan. 29, 2026.

Source: TEN Holdings, Inc. Form S-1, filed April 6, 2026.

Financial Summary

• TEN Holdings lost nearly $20 million in 2025 while generating only $3.1 million of revenue. It lost another $5.9 million during the first six months of 2026 against $1.6 million of revenue.

• Total revenue declined 11.4% year over year to approximately $3.1 million in FY2025, from $3.5 million in FY2024, while net loss expanded approximately 550% to $19.5 million, from $3.0 million, a loss more than six times the revenue that produced it.

• Q2 2026 revenue fell 34.5% year over year to $0.7 million, from $1.1 million in Q2 2025, with the same single-customer concentration flagged in the FY2025 10-K driving the decline directly.

• The accumulated deficit grew in three consecutive steps: $21.4 million (Dec. 31, 2025) to $24.3 million (March 31, 2026) to $27.3 million (June 30, 2026), a 28% expansion in six months, against net cash used in operations of $10.1 million for FY2025 alone.

• The company recognized a $4.2 million impairment on capitalized software in FY2025, reducing gross intangible assets of $4.9 million to essentially nil net of impairment and accumulated amortization; management’s own stated trigger was “recurring operating losses and negative cash flows.”

• Cash climbed from $0.08 million (March 31, 2026) to $5.8 million (June 30, 2026) entirely on the back of the $6.6 million net proceeds from the June 30 share sale , as the company’s operating business generated none of it.

• The company paid $100,000 per month plus warrants to a third-party “market awareness” advisor beginning June 2025, a cash outflow for stock promotion services layered on top of an already negative cash-flow business.

• Research and development expenses grew about 900%, from $0.1 million (2024) to $1.0 million (2025), even as revenue moved in the opposite direction.

• Total shareholders equity fell 61% in one quarter, from $4.279 million (Dec. 31, 2025) to $1.662 million (March 31, 2026), the direct precursor to Nasdaq’s May 26, 2026 deficiency notice under the $2.5 million minimum equity standard.

• A single customer accounted for 66.7% of total FY2025 revenue, up from 64.6% in FY2024, concentration risk that increased in the same year total revenue declined.

• Shares outstanding grew from 3,977,443 (Jan, 2026) to 11,977,443 (June, 2026) a 201% increase in six months, with the single June 30 offering of 7,500,000 shares at $1.00 alone responsible for a 168% increase against its immediate pre-offering base of 4,477,443 shares.

Source: TEN Holdings, Inc. Form 10-K, fiscal year ended Dec. 31, 2025, filed March 18, 2026.

Source: TEN Holdings, Inc. Form 8-K (Nasdaq compliance plan), filed July 20, 2026.

Source: TEN Holdings, Inc. Form 10-Q, quarter ended June 30, 2026.

Source: TEN Holdings, Inc. Form S-1, filed April 6, 2026.

Bancroft’s Microcap IPO Record

Our review of SEC filings identifies at least 12 Bancroft-underwritten microcap IPOs completed during 2024 and 2025. The Philadelphia Inquirer’s May 2026 analysis examined 11 of those deals. SEC filings identify another completed Bancroft deal in the same period: Ten-League International, which priced its IPO in July 2025 with Bancroft as underwriter. Across eight of Bancroft’s IPOs tracked through May 1, 2026, the combined paper losses to investors exceed $1 billion. Seven of the 12 issuers operated from Singapore, four from Hong Kong, and TEN Holdings was the only U.S. company in the group.

Source: Philadelphia Inquirer, “Social media ‘pump and dump’ fraudsters targeted tiny Nasdaq stocks, including this Philly firm’s IPOs, says lawsuit,” May 12, 2026.

Bloomberg’s own data settles whether Bancroft’s pattern is coincidence or business model. In an analysis of the microcap underwriting market, Bloomberg mapped every investment bank that took companies public on Nasdaq’s smallest listing tier against the share of those deals that later became apparent targets of pump-and-dump schemes, hyped in chatrooms, spiked, and dumped. Bancroft sits in a cluster of firms, alongside names like Revere, D. Boral, Dominari, and Cathay, whose half of the deals they underwrote were later identified as apparent pump-and-dump targets, and unlike the smaller, more erratic bubbles further out on Bloomberg’s chart representing one or two questionable deals apiece, Bancroft’s bubble reflects a real volume of business. Bloomberg’s analysis found that just eight underwriters accounted for nearly three-quarters of every Nasdaq microcap company later targeted by these schemes, including Bancroft.

Source: Bloomberg, “How Apparent Pump-and-Dump Scams Thrive on Wall Street,” Jan. 29, 2026.

The Bancroft Capital Connection

Bancroft Capital LLC served as lead underwriter for TEN Holdings’ February 2025 IPO. XHLD sold approximately 1.67 million shares at $6.00 per share, raising roughly $10 million gross.

On its first trading day, the stock exploded above $100. The move briefly valued TEN Holdings near $200 million despite annual revenue of only a few million dollars. The stock then collapsed and eventually traded below $1.

Source: XHLD- TOS 2-year daily chart showing a decline of +90% decline from its peak

Bancroft collected its standard 7% fee on TEN Holdings’ $10 million IPO regardless of what happened to the stock afterward, and it collapsed from over $100 to roughly $18 within four trading days, then traded below $1 within the year. In August 2026, the same stock that closed at $0.80 on August 5 traded as high as $5.42 the very next session on nearly 69 million shares (several multiples of the company’s entire float) and kept climbing to $8.30 by August 19.

The Looming T12 Risk

Two companies from Bancroft’s 11 completed microcap IPOs have followed a far more serious path than an ordinary volatility halt. Nasdaq maintains discretionary authority to halt a stock outright when its price action itself becomes evidence of a problem, a mechanism distinct from routine volatility circuit-breakers, triggered when the exchange requests additional information from the company and refuses to let trading resume until it gets answers.

Premium Catering (PC) went public in September 2024 with Bancroft as underwriter. On October 16, 2025, the SEC ordered trading suspended after citing potential manipulation involving recommendations made by unknown persons through social media that appeared designed to artificially inflate the stock’s price and trading volume. Nasdaq then asked Premium Catering for additional information and documents. When the SEC suspension expired on October 30, trading did not resume. Nasdaq kept the stock halted while it waited for the requested information.

Magnitude International (MAGH) followed a similar sequence two months later. Magnitude completed its Bancroft-led IPO at $4.00 in August 2025. On December 4, the SEC suspended trading after citing potential manipulation involving social-media recommendations telling investors to buy, hold, or sell MAGH and, in some instances, send screenshots of their transactions. When the SEC suspension expired on December 18, Nasdaq did not reopen the stock. On December 19, Nasdaq announced that MAGH would remain halted while it sought additional information from the company.

Above: Bancroft underwritten IPOs which remain halted and/or delisted

A trading halt is not hypothetical for this underwriter’s cohort, as XHLD’s stock price action follows the same pattern that preceded both the Premium Catering and Magnitude International halts: a thin float, a sudden multiple-hundred-percent swing, and no disclosed business development to explain it. For a shareholder, a T12 halt is not a pause, as once Nasdaq freezes a stock “pending additional information,” there is no exit, no way to sell, cut a loss, no resolution date, no interim market, and no guarantee the stock ever reopens at anything close to the price it closed at. If a stock is halted and later delisted outright, the practical outcome for most retail holders is a forced move to the OTC market, meaning thinner liquidity, wider spreads, and often a fraction of the pre-halt price, assuming a market exists to sell into at all.

Source: Premium Catering (Holdings) Ltd. Form 6-K, “Suspension of Trading,” filed Oct. 24, 2025.

Source: Nasdaq, “Nasdaq Halts Magnitude International Ltd,” Dec. 19, 2025.

Source: Magnitude International Ltd. Form 6-K, “Announces Receipt of Nasdaq Delisting Determination Notice,” Aug. 5, 2026.

The $5.4 Million IPO Money Trail

On the same day TEN Holdings’ IPO closed (February 18, 2025), the company signed four advisory and services agreements and paid the counterparties $5.4 million upfront, roughly 61% of its $8.9 million in net IPO proceeds, in a single day.

On October 27, 2025, TEN Holdings received a grand jury subpoena from the U.S. Attorney’s Office for the Southern District of New York, seeking documents relating to the company’s IPO. The SEC opened a parallel investigation the next day. Five months later, on March 10, 2026, the SEC issued its own subpoena, this one naming TEN’s former CEO personally. Every officer and director who ran the company at the time of the IPO is now gone.

Source: TEN Holdings, Inc. Form 10-K, fiscal year ended Dec. 31, 2025, filed March 18, 2026.

Following an internal investigation, TEN’s own Board concluded that those agreements, executed at the direction of former management, “lacked economic substance and any direct benefit to the Company,” and may have “solely benefited the counterparties to those agreements rather than the Company.” The company has informed the DOJ and SEC of these findings directly. In July 2026, TEN terminated all four agreements without response.

V-Cube, Inc. (TEN’s controlling shareholder and former parent) disclosed that it could not confirm clear evidence that the contracted services had actually been provided, and identified discrepancies between the parties named in the contracts and the parties who actually received the payments. V-Cube further disclosed that its then-representative director, Naoaki Mashita, had issued a document in V-Cube’s name promising financial support for the payments without prior approval from V-Cube’s own board. V-Cube’s independent auditor, Grant Thornton Taiyo, subsequently issued a disclaimer of opinion on V-Cube’s financial statements for fiscal year 2025, refusing to certify the accounts, having failed to obtain sufficient audit evidence regarding the fee payments. Nobody involved, not the company or its former parent, has yet been able to say what TEN actually got for it.

Source: TipRanks, “V-cube Launches Special Probe Into TEN Advisory Fee Irregularities,” Apr. 24, 2026.

Source: TipRanks, “V-cube hit with auditor disclaimer over Nasdaq-linked fee probe,” May 8, 2026.

The Share Count Was the Business Plan

TEN Holdings completed a 15-to-1 reverse stock split in December, 2025. The split reduced the number of shares outstanding and mechanically increased the quoted share price. Just three weeks later, the company entered a private placement for 991,000 shares at $2.27 per share, raising approximately $2.25 million and granting the investors registration rights; the share count had been compressed for exactly 21 days before it started bloating again.

In May 2026, Nasdaq notified TEN Holdings that the company had fallen below the exchange’s $2.5 million minimum stockholders’ equity requirement. The company’s solution was to sell stock. In May, it sold 500,000 shares at $1.00 per share; then, on June 30, TEN Holdings sold 7.5 million shares at $1.00 each, producing $7.5 million gross and roughly $6.6 million net. Before that offering, approximately 4.48 million shares were outstanding; immediately after, the share count had exploded to roughly 11.98 million shares. In a single transaction, the float increased by 168%, for a total increase of about 201% over six months.

Source: TEN Holdings, Inc. Form 8-K, filed July 20, 2026.

At the August 21, 2026 closing price of $7.66 and 11,977,443 shares outstanding, XHLD’s market cap was about $91.7 million, against $3.1 million in FY2025 revenue and $3.17 million in annualized first-half 2026 revenue. That prices the stock at roughly 29x annualized revenue, multiples associated with high-growth technology companies, applied to a company whose revenue is declining, whose losses dwarf that revenue by a factor of approximately six, with negative cash flow, and going-concern language.

Source: TEN Holdings, Inc. Form 8-K, filed Dec. 3, 2025.

Source: TEN Holdings, Inc. Form 8-K, Exhibit 99.1, “TEN Holdings Announces $2.25 Million Private Placement of Common Stock,” Dec. 29, 2025.

Source: TEN Holdings, Inc. Form 8-K, filed July 20, 2026.

$500,000 From a Chinese-Owned Farm

On May 22, 2026, TEN Holdings sold 500,000 shares of common stock to a single investor, Wang Huaqiu, for $500,000 ($1.00 per share), priced under Regulation S, with registration rights attached so the shares could later be resold into the public market. The filing lists Wang Huaqiu’s address as Production Team No. 006, 21st Production Team, 2nd District, Xihua State-owned Farm, Danzhou City, Hainan Province, an agricultural collective in China, not the kind of address ordinarily associated with a half-million-dollar allocation into a Nasdaq-listed company under a foreign private placement exemption. We present this information because it is exactly the kind of detail a reader doing their own diligence would want to see: unregistered stock, sold quietly to an individual buyer in China (outside of the reach of securities authorities), days before the company would need to demonstrate to Nasdaq that it had solved a stockholders equity deficiency, with a resale registration filed shortly after.

Above: satellite imagery of the “corporate offices” of TEN Holdings’ $500,000 investor, Xihua State-Owned Farm, Danzhou City, Hainan Province. Fugazi Research could not locate a boardroom or corporate office.

The path from private placement to public liquidity moved quickly, as TEN Holdings filed the resale registration statement on July 24, 2026 (roughly two months after Wang Huaqiu’s shares were issued) converting what had been an unregistered private placement into freely tradeable stock. The filing discloses that Wang Huaqiu holds no other position, office, or material relationship with the company beyond this single 500,000 share stake, and that TEN has no arrangement or understanding with him regarding how or when he sells. Once the registration became effective on August 5, 2026, he was free to sell into the open market at any price, at any time, through ordinary brokerage transactions, without further disclosure of the timing or size of any sale. Apparently, since August 7th the stock has been magically ascending on a daily basis on what appears to possibly be wash-trading on very light volume and liquidity. This is almost a mirror image of how MAGH traded before being T-12 halted for possible manipulation.

Source: MAGH- TOS 4-month daily chart showing the manipulated rise before T-12 halting.

$100,000 a Month for Market Awareness

In July 2025, TEN Holdings entered into a market awareness agreement with MicroCap Advisory LLC. The agreement called for a $15,000 setup fee, $100,000 per month, and 33,333 warrants exercisable at $6.00 per share for two years, with anti-dilution protection built in for any future reverse split. The stated services include “investor communications, positioning, media planning, and campaign execution”.

Source: TEN Holdings, Inc. Form 10-Q, quarter ended June 30, 2026, Note 15 — Consulting and Advisory Agreement.

A September 11, 2025 press release, distributed via GlobeNewswire and syndicated across financial news outlets, carried the headline “TEN Holdings Powers Up with SaaS Pivot,” claimed the company was positioned to “capitalize on the $1 trillion global SaaS market,” cited an unnamed “All-Star Analyst” reaffirming a bullish outlook, and teased “at least one acquisition before year-end” that never materialized in any subsequent filing. The release’s own disclosure footnote states plainly that its publisher “has been paid by Microcap Advisory for providing ongoing XHLD market outreach and other services.”

Source: 24/7 Market News, “TEN Holdings Powers Up with SaaS Pivot,” GlobeNewswire, Sept. 11, 2025 — via Taiwan News.

TEN Holdings was, by its own contractual arrangement, paying to generate bullish media coverage of a stock it now discloses is the subject of a DOJ and SEC investigation into its IPO and post-IPO contracts. Whether that coverage rises to the level regulators associate with coordinated promotion is a matter of reader due diligence and pattern recognition.

The Platform That Still Looks Like Small Events Contractor

TEN Holdings describes itself as an event planning, production, and broadcasting company supporting virtual, hybrid, self-service, and physical events through its Xyvid Pro and TEN Pro platforms. For the six months ended June 30, 2026, platform usage revenue declined from approximately $1.5 million to $1.3 million, while professional and managed services revenue increased modestly, from approximately $268,000 to $324,000, but that improvement was not enough to offset the platform decline. Management attributed lower first-half revenue primarily to reduced expected business from one of its largest customers, with some opportunities shifting into the third quarter.

As of December 31, 2025, TEN Holdings employed 25 full-time people, 15 in management and administration, six in sales and marketing, two in shared services, and exactly two in development. Research and development spending for FY2025 totaled $1.0 million, run by a team the company itself describes as “approximately two research and development specialists.” TEN competes against Zoom, ON24, Cvent, GlobalMeet, Bizzabo, and Meeting Tomorrow, companies with materially larger platforms and materially larger engineering organizations. The company’s own filings show that the service agreement with its largest customer states that “the services outlined in the purchase orders and actually provided by the Company do not include any SaaS offerings.”

The company increasingly emphasizes artificial intelligence, automation, analytics, personalization, and AI-powered content capabilities in its public communications. As of the FY2025 10-K, the company’s entire disclosed AI use case is captioning and transcription, expanded from 8 to over 70 languages in the first quarter of 2026. Everything beyond that is pure wishful thinking: TEN says it “will be incorporating AI-based Business Intelligence capabilities,” that its platform “will analyze your event for the highlights and generate short-form clips,” and that “Generative AI capabilities will be leveraged to provide a summary” of missed events. However, none of these initiatives produce revenue, customer growth, operating leverage, or cash flow. So far, the financial statements do not show an AI business remotely large enough to support the valuation this stock has.

Source: TEN Holdings, Inc. Form 10-Q, quarter ended June 30, 2026.

Source: TEN Holdings, Inc. Form 10-K, fiscal year ended Dec. 31, 2025, filed March 18, 2026.

Before June, There Was Lincoln Park

TEN Holdings had already established a substantial equity financing mechanism with Lincoln Park Capital Fund LLC. In June 2025, the company entered into an agreement allowing it, subject to specified conditions, to direct Lincoln Park to purchase up to $20 million of common stock. The related resale prospectus registered millions of shares connected with the arrangement.

TEN Holdings later disclosed that it issued 4,454,818 shares to Lincoln Park at a weighted-average price of about $0.32 per share, generating about $945,542. The company also issued 2 million shares to Spirit Advisors LLC for advisory services related to financing initiatives; a third-party filing analysis has estimated that roughly $18 million of capacity may remain under the Lincoln Park arrangement. An equity line of credit like this functions as a standing option to dilute; it does not require Nasdaq pressure or a specific catalyst; it only requires management to decide the company needs money and the market will bear the sale.

Source: TEN Holdings, Inc. Form 10-Q, quarter ended June 30, 2026, Note 11 — Stockholders’ Equity.

Conclusion

TEN Holdings, by its numbers alone, is a twenty-five-person events-services company with two developers, declining revenue, a net loss six times that revenue, an accumulated deficit approaching $30 million, and a going-concern qualification from its own auditor. That company would not command a $91.7 million valuation on any exchange, under any circumstances, on its own merits.

An underwriter whose other Bancroft-led IPOs show a coin-flip rate of apparent pump and dump targeting, on a share of the market that regulators and Congress are actively investigating. A federal grand jury and the SEC are examining the company’s own IPO and the four contracts it signed the day that IPO closed, contracts TEN’s own Board now says had no economic substance, contracts that pushed a still unexplained 61% of net proceeds out the door in a single afternoon. A former parent whose auditor refused to certify its books because it could not verify TEN’s own advisory fees were real, a capital structure kept alive not by revenue but by serial dilution, a reverse split, a private placement to an investor registered at a Chinese state farm, a $20 million standing credit line, and a share count that has more than tripled in under a year. A paid media campaign promoting a “SaaS pivot” the company’s own filings admit isn’t SaaS, running at the same time federal investigators were asking questions about the company that funded it, and a stock chart that has now staged the identical pump-and-dump pattern twice, eighteen months apart, on a business that got smaller in between.

Any single one of the previously mentioned facts would be a serious flag on its own. Together they describe a company whose survival depends entirely on its ability to keep finding buyers for newly printed shares faster than the underlying business erodes, a race that dilution always wins, eventually, at the expense of whoever is still holding the stock when it does.

Fugazi Research considers XHLD uninvestable at any price above Zero.

Disclaimer

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our,”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority. All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions-long, short, or otherwise-in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

Interestingly, this report was prompted by an initial tip from a Fugazi Research reader writing under the name “Value Checker,” who flagged Aeva’s decade-long pattern of partnership and customer announcements. Fugazi Research treated this as a starting lead, as every claim in this report was independently verified against primary SEC filings, and the financial analysis, valuation work, and structural findings presented here are the product of Fugazi’s own review of Aeva’s 10-K, 10-Q, and 8-K filings.

Aeva Technologies is valued as though it has already crossed the bridge from technology demo to scaled commercial platform; this is not the case. As of August 19, 2026, Aeva’s market capitalization is approximately $1.3 billion against fiscal 2025 revenue of $18.1 million (a price to sales ratio of approximately 72x). By comparison, Oracle trades roughly 6x sales and Coreweave at 7-10x, despite both companies generating actual, contracted hyperscaler and AI-infrastructure revenue at scale. An insane pricing considering Aeva’s $21 million of trailing revenue and a joint development agreement whose first deployment isn’t targeted until the second half of 2027. The filings describe an early stage company that has “primarily sold or otherwise provided prototypes and non-recurring engineering services” and has made only “immaterial commercial deliveries.”

Aeva Technologies entered the market via despac at a price around $18-$19 during the 2021 SPAC frenzy. The average 3-year buy-and-hold return of despacs during this period was -73%. Aeva Technologies in particular bled shareholders out through constant dilution where by March 2024 the stock was down to just .80 (split adjusted) and in need of a reverse split to probably meet Nasdaq minimum exchange requirements. Historically, it is a revelation of toxic dilution and bad management when a stock goes on a downward spiral for 4 straight years and resorting to a reverse split to get back to life.

The company’s reported history is a monument to capital consumption. Aeva disclosed net losses of $145.4 million in 2025, $152.3 million in 2024, and $149.3 million in 2023, and states that broad-based commercial deliveries are not expected to occur in 2026 and may not occur at all. Investors are being asked to pay an extraordinary sales multiple for a company still waiting for the commercial inflection it was originally supposed to reach years ago.

In December 2024, Aeva Technologies, Inc., co-founders Soroush Salehian Dardashti and Mina Rezk, and SPAC sponsor Ahmed Fattouh, among other defendants, reached a $14 million settlement in the Delaware Court of Chancery to resolve stockholder litigation arising from the 2021 SPAC merger. The suit alleged that InterPrivate Acquisition Corp. provided false or misleading proxy materials in connection with the merger and impaired stockholders’ redemption and voting rights. The settlement, which does not constitute an admission of liability by any defendant, provided class members nominal damages of $0.10 per share plus additional recovery tied to shares sold below $10.07 between March 2021 and March 2024

Aeva has attached its technology to autonomous vehicles, industrial automation, defense, NVIDIA, Daimler/Torc, SICK, Railergy, Audi, NASA, and now AI data center optical connectivity. The pattern is that the announcements keep arriving, the markets keep expanding, and the financial statements keep showing a company that has not commercialized products at meaningful scale. The latest pivot is optical connectivity for AI data centers. On August 5, 2026, Aeva announced the launch of this business alongside a joint development agreement targeting initial hyperscaler deployment in the second half of 2027 and production ramp in 2028, that´s more than a year and a half away, with no committed volume.

Alarmingly, Aeva does not fund itself through operations, it keeps refinancing through continuous dilution. A $125 million standby facility with Sylebra, open through November 8, 2026 and a follow-on offering closed on June 5, 2026 (5,168,539 shares and underwriters’ options exercised in full), raised a total of $115.0 million in capital (Approximately 6x Aeva’s FY 2025 revenue). Two financing instruments with one purpose: extend the lifeline on a business that has never covered its own losses with its own revenue.

The mechanism is simple: premium valuation, demo stage economics, serial partnership announcements, and dilution funded survival. Fugazi Research considers Aeva’s shares speculative, and uninvestable at any price above zero.

Fugazi Research Analysis

• Aeva trades at approximately 72x sales, or 47x its own forward guidance at best. The stock is priced like a scaled software compounder while the company files like a pre-commercial or demo-stage lidar developer.

• Aeva describes itself, in its own risk factors, as an early-stage company that has primarily sold prototypes and non-recurring engineering services, with immaterial commercial deliveries to date and no assurance that broad-based commercial deliveries occur in 2026, or ever.

• Aeva has built its entire commercial thesis on FMCW lidar (a more expensive, higher-power approach) while the two most consequential players in the industry have moved the opposite direction. Tesla has built its autonomy program entirely on camera-based computer vision, rejecting lidar altogether. Mobileye, a leading physical-AI and ADAS developer, ended its own internal lidar development program in 2024, citing advances in computer vision and the falling cost of competing lidar approaches. Aeva is not simply competing for design wins; it is betting the company on a technical architecture that two of the industry’s most influential players have each independently declined to build around.

• Aeva, co-founders Salehian and Rezk, and SPAC sponsor Fattouh settled Delaware stockholder litigation for $14 million, resolving claims of misleading merger proxy materials, no admission of liability, but the same disclosures that first revealed Aeva’s internal control weaknesses.

• Projected Aeva metrics are defined by a forward-looking cumulative billings estimate, built on projected pricing and estimated rates, not contracted revenue. No customer is contractually committed until testing, validation, integration, and market-readiness determinations are all complete.

• Three customers accounted for 64% of 2025 revenue, two customers accounted for 72% of 2024 revenue. For the first half of 2026, two customers alone accounted for 59% of revenue. The company simply cannot afford to lose any of its revenue streams.

• Aeva has spent nearly a decade attaching its name to NVIDIA, Daimler/Torc, SICK, Railergy, NASA, Audi. Each name generates a stock reaction, while none has yet generated the scaled, recurring revenue the current valuation requires.

• Aeva closed an offering on June 5, 2026 for 5,168,539 shares at $22.25 (underwriters exercising their option in full) raising $115 Million. It separately maintains a $125 million standby facility with Sylebra through November 8, 2026, and carries $100 Million of 4.375% convertible senior notes due 2032. This is set against an accumulated deficit of $871.9 million and a first half 2026 net loss of $114.6 million.

Source: Aeva Technologies, Inc., Form 8-K, filed June 4, 2026.

Source: Aeva Technologies, Inc., Form 10-K for the year ended December 31, 2025, filed March 20, 2026.

Source: Aeva Technologies, Inc., Form 10-Q for the quarterly period ended June 30, 2026, filed August 6, 2026.

Source: Notice of Proposed Settlement, In re InterPrivate Acquisition Corp. Stockholder Litigation, Consol. C.A. No. 2024-0221-LWW (Del. Ch.).

Financial Summary

• Aeva incurred net losses of $145.4 million in 2025, $152.3 million in 2024, and $149.3 million in 2023, approximately $447.0 million in cumulative losses over three fiscal years.

• First-half 2026 net loss was $114.6 million against revenue of $12.4 million, meaning Aeva lost approximately $9.24 for every $1 of revenue generated in the first six months of 2026.

• First half 2026 revenue was $12.4 million, which annualized, amounts to roughly $25 million, still far short of the $36 million the company itself has guided to for the full year.

• Customer revenue concentration was 64% (three customers) in fiscal 2025, 72% (two customers) in fiscal 2024, and 59% (two customers) for the six months ended June 30, 2026.

• Total stockholders’ equity was $27.5 million as of June 30, 2026, against a market capitalization of approximately $1.32 billion, investors are paying roughly 48x the company’s entire book value for a business with $871.9 million in accumulated deficit sitting behind that thin equity cushion.

• Aeva closed a public offering on June 5, 2026 of 5,168,539 shares at $22.25 per share, an offering price of approximately $115 million.

• Aeva maintains a $125 million standby equity purchase agreement with Sylebra, available through November 8, 2026, and carries $100.0 million of 4.375% convertible senior notes due 2032.

• Total available liquidity was approximately $302 million as of June 30, 2026, against an accumulated deficit of $871.9 million and a first-half 2026 net loss of $114.6 million.

• Shares outstanding were 69,705,758 as of July 30, 2026, up from 62,947,689 as of March 10, 2026, an increase of roughly 10.7% in under five months.

• At $18.87/share (August 20, 2026), market capitalization is approximately $1.32 billion, implying 72x trailing FY2025 revenue, 53x annualized H1 2026 run-rate, or 39x the company’s own FY2026 guidance midpoint.

Source: Aeva Technologies, Inc., Form 10-K for the year ended December 31, 2025, filed March 20, 2026.

Source: Aeva Technologies, Inc., Form 8-K, filed June 4, 2026.

Source: Aeva Technologies, Inc., Form 10-Q for the quarterly period ended June 30, 2026, filed August 6, 2026.

Valuation by Adjacency: Autonomous Cars, Defense, NVIDIA, Data Centers, Still No Scale

Aeva’s valuation problem is not subtle, the stock is not being valued on what the company currently sells, instead it is being valued on what the company might eventually become if every major market it invokes becomes real, adopts Aeva’s technology, moves through validation, enters volume production, avoids delays, avoids customer cancellation, and produces margin. Currently that is not a business model, but a chain of good wishes which guarantee that everything will go according to plan, without any contingencies.

The research captures the pattern clearly. Aeva has spent years attaching its technology to market investors wanting to believe in: self-driving vehicles, industrial automation, robotics, defense, NVIDIA’s automotive ecosystem, and now AI data-center optical connectivity. The research does not claim these references are fabricated, instead it argues that the commercial result has been consistently disappointing relative to the stock-market reaction and the scale implied by the company’s valuation.

The company’s filings validate that skepticism, Aeva discloses that it has not commercialized its products or services in a material amount. Customers do not commit to volume until extensive testing and validation are complete, and that definitive volume production orders arrive only after customers finish integration and make their own market-demand and product-readiness determinations.

Aeva spent $85.4 million on research and development in fiscal 2025 (nearly five times the company’s entire $18.1 million in revenue for the year). This is a company whose core technology still costs more to develop than the business generates in total sales, R&D spending did fall from $102.7 million in 2024, and Aeva frames this as evidence of a maturing product line moving past its most capital-intensive phase. Even so, at $85 million against $18 million of revenue, Aeva’s R&D bill alone exceeds total revenue by more than four and a half times.

Source: Aeva Technologies, Inc., Form 10-K for the year ended December 31, 2025, filed March 20, 2026.

A company trading at 47x–86x sales, depending on the revenue base used, should have visible recurring revenue, expanding margins, and a commercial engine that scales with volume. Aeva however has only development programs, prototypes, non-recurring engineering services, customer concentration, and financing facilities. The multiple is not attached to current revenue, but to a chain of narrative and continuous PR’s that the company uses to keep its value up to finance itself by selling equity.

The phrase for this mechanism is valuation by adjacency, Aeva does not need to show scaled automotive lidar sales if the market is willing to value a defense adjacency. It does not need to show scaled defense revenue if the market is willing to value an NVIDIA adjacency. It does not need to show NVIDIA-derived revenue if the market is willing to value a hyperscaler data-center adjacency. The stock market pays for the noun; the filing discloses the conditions.

Source: Aeva Technologies, Inc., Form 10-K for the year ended December 31, 2025, filed March 20, 2026.

Selling Into Strength

Aeva’s stock rallied sharply following the August 5, 2026 optical-connectivity announcement, climbing from roughly $19.61 to a peak above $25 within the following week. Insiders did not wait to see whether the rally would hold, but took full advantage of price strength to sell different tranches of shares amounting to approximately $12 million, roughly the same amount of revenue for the first half of 2026.

On August 10 and 11, 2026, five and six trading days after the announcement, at the top of the post-earnings spike, CEO Soroush Salehian Dardashti and CTO Mina Rezk together sold 405,099 shares at prices ranging from $23.81 to $25.69 for combined proceeds of approximately $9.79 million. One week later, on August 18, 2026, departing CFO Saurabh Sinha, who had disclosed his resignation effective September 5, 2026, less than three weeks earlier sold 70,000 shares for approximately $1.48 million, at a lower price of $21.21, as the rally had already started to fade. After his recent selling, he still has 585,000 shares to sell after he resigns.

The entire executive team, in sequence, began selling into the same announcement-driven spike this report identifies as the mechanism behind Aeva’s valuation. In aggregate, Aeva insiders sold approximately $11.9 million in stock over the trailing three months, entirely through prearranged trading plans, with no open-market insider purchases in the same window.

Rule 10b5-1 plans are structured to remove the appearance of opportunistic timing, trades are scheduled in advance, without knowledge of the specific date a plan will execute. But a plan’s schedule does not choose the news; management chooses when to file the 8-K. The August 5 hyperscaler announcement, and the price spike that followed it, arrived directly ahead of the largest cluster of insider selling in recent history. Whether by design or coincidence, the executives closest to Aeva’s operations converted paper gains into cash as the market pushed higher leaving the insiders feeling fomo as this was a great opportunity to sell. Just 2 years ago the stock was depressed all the way to .80 with no hope in sight. Then, all of the sudden, after a reverse split the stock grabbed onto the hype and has offered the insiders to get rich.

Above: CEO’s disposal of shares at the top.

The Announcement Treadmill

Aeva has announced relationships or market associations involving Audi, ZF, Denso, Plus, NVIDIA, Daimler/Torc, SICK, Railergy, Forterra, NASA, and others across nearly a decade. The argument is straightforward: a long sequence of announcements has not yet produced the large-scale revenue, profit, or operating cash generation required to justify the current valuation.

This is the most important part, because Aeva’s equity story relies almost completely on hype driven announcements. A big customer name can move the stock before the revenue exists, a sector label can re-rate the stock before the product is validated, and a development milestone can be framed like a commercial contract even when the filing language remains without any value or substance.

The company’s own risk-factor disclosure fits the same pattern and describes it clearly, as Aeva says its development cycles can be long, including up to seven or more years in automotive, and that customers may cancel or postpone implementation. It also says there is no assurance that customers included in Order Book estimates will complete testing, enter definitive production agreements, or produce forecasted billings.

Source: Aeva Technologies, Inc., Form 10-K for the year ended December 31, 2025, filed March 20, 2026.

The Hyperscaler Costume

The August 2026 optical-connectivity announcement is the latest example of the announcement related to pumps. On August 5, 2026, Aeva launched an Optical Connectivity business and signed a joint development agreement for a hyperscaler Near-Packaged Optics deployment (initial deployment targeted for the second half of 2027, production ramp targeted for 2028). Not a customer. Not a contract. A development agreement with a production ramp eighteen months away and no disclosed committed volume.

The stock rallied on the news, and it jumped from around $19 to over $24 on the announcement alone. Oppenheimer (one of three joint book-running managers) then floated the possibility of billions of dollars in future orders. A bank that helped price Aeva’s stock weeks earlier was now pricing its total addressable market in the billions, off a joint development agreement with a 2028 production target.

Above: Key company highlights with no disclosed numbers, revenue, or volume. Just forward looking statements, and good wishes.

Source: Aeva Technologies, Inc., Form 8-K, filed August 5, 2026.
Source: Aeva Technologies, Inc., Form 8-K, filed June 4, 2026.

The Advantage That Isn’t

Aeva’s entire commercial pitch rests on a single technical bet: that Frequency Modulated Continuous Wave (FMCW) lidar is a meaningfully better architecture than the Time-of-Flight (ToF) approach used by most of the industry. The company has spent nearly a decade and hundreds of millions of dollars building around that bet. However the two companies with the most influence over how autonomous vehicles have gone a very different way. As Tesla does not use lidar at all, the company has built its entire autonomy program on camera-based computer vision, explicitly rejecting lidar as a necessary sensing modality for full self driving.

Also Mobileye, a leading developer of the physical AI systems that power ADAS and autonomous driving stacks across the industry, announced in September 2024 that it was ending its internal development of next-generation FMCW lidar specifically, the same architecture Aeva has built its business around, and winding down the R&D unit responsible for it, affecting approximately 100 employees.

Source: Mobileye Global Inc., “Mobileye to End Internal Lidar Development,” press release, September 9, 2024.

Aeva is not simply late to commercialize a technology the market wants, on top of it, has committed a decade of capital to a specific architecture that two of the industry’s most consequential players have independently declined to build around, one by altogether skipping lidar entirely, the other by walking away from developing it at all.

The Order Book Is Not an Order

Aeva’s filings define “Order Book” as a forward-looking cumulative billing estimate over the expected lifetime of production programs, based on projected pricing terms and good-faith estimates of take rates. It is not a binding backlog in the sense of the public-market investors interpretation of what they want to see in the word “Order.”

The company’s own disclosure takes the air out of the metric, as customers do not make contractual commitments to use Aeva’s lidar sensors and software until testing and validation are complete, integration plans are finalized, market demand exists, and their products are ready for market. Aeva then states there is no assurance that any customer included in Order Book estimates will complete validation, enter a definitive volume agreement, or generate the billings forecasted.

That is the sort of filing language that should sit directly underneath any investor presentation slide mentioning future production opportunities. There is a gap between “Order Book” as a “marketing” phrase and “Order Book” as a disclosed risk factor and that is exactly where the valuation disconnect lives.

Source: Aeva Technologies, Inc., Form 10-K for the year ended December 31, 2025, filed March 20, 2026.

Equity-Funded Survival, Not Operating Leverage

Aeva’s financing structure tells the story more plainly than the product deck. On June 5, 2026, the company completed an underwritten public offering of 5,168,539 shares at $22.25 per share, including the full exercise of the underwriters’ 674,157-share option, for an aggregate offering price of approximately $115.0 million, yielding net proceeds of $108.8 million after $5.8 million in underwriting discounts and $0.4 million in offering costs.

That financing followed years of losses and sits alongside the Sylebra facility, which permits Aeva to sell up to $125 million of convertible redeemable non-voting preferred stock, subject to conditions, through November 8, 2026, and $100.0 million of 4.375% convertible senior notes due 2032 held by Apollo Global Securities. Total available liquidity stood at $302.9 million as of June 30, 2026 against an accumulated deficit of $871.9 million and a first-half 2026 net loss of $114.6 million.

It’s not an accusation, but straight forward math. Aeva consumes cash before scaled commercialization. It raises equity and equity-linked capital to extend the runway. It announces large future markets to support the equity price at which that capital can be raised. The common shareholder is not merely participating in upside; the common shareholder is being used as the funding mechanism and good, old-fashioned exit liquidity.

The research flags additional dilution from convertibles, warrants, preferred stock, and stock-based compensation. The specific share-count bridge in that research (54.1M → 61.5M → 68.6M) is superseded by confirmed primary-source figures: 62,947,689 shares outstanding as of March 10, 2026, rising to 69,705,758 as of July 30, 2026 — a roughly 10.7% increase in under five months. Warrant liabilities stood at $73.961 million as of June 30, 2026.

The key point is fully supported: the company is not funding itself through operating cash flow. It is funding itself through the capital markets.

Source: Aeva Technologies, Inc., Form 8-K, filed June 4, 2026.
Source: Aeva Technologies, Inc., Form 10-K for the year ended December 31, 2025, filed March 20, 2026.
Source: Aeva Technologies, Inc., Form 10-Q for the quarterly period ended June 30, 2026, filed August 6, 2026.

The LG Innotek Circularity Lead

When looking into AEVA, the research raises a potentially important related commercial-structure issue around LG Innotek (LGIT). It describes an investment, joint-development agreement, and manufacturing relationship in which LGIT invested in Aeva, received equity at a discount, entered a development relationship, and became a manufacturing partner. The research frames this as a conflicted cycle: LGIT may benefit from manufacturing or development economics while Aeva remains the loss-making party trying to commercialize the product.

Aeva’s Form 10-K confirms the existence of a strategic collaboration with LG Innotek, entered in May 2025, and warns that such initiatives may prove more expensive than anticipated and may not generate revenue sufficient to offset higher expenses or achieve profitability. Separately, Aeva’s own Q4/FY2025 earnings materials describe the LG Innotek collaboration as including a commitment of up to $50 million for joint product development, which corroborates the general scale of the relationship cited in the reader submission.

This angle should not be overstated until the investment agreement, private placement terms, and joint development agreement are fully reviewed. The safe Fugazi formulation is: the LG relationship should be treated as a financing, development, and supply-chain structure, not merely as validation from a strategic partner. If LGIT’s economics include equity upside, development payments, and manufacturing revenue while Aeva continues to absorb losses, the structure becomes a shareholder question, not just a partnership headline.

Source: Aeva Technologies, Inc., Form 10-K for the year ended December 31, 2025, filed March 20, 2026.

Conclusion

The short thesis is not about Aeva being flagged because lidar is useless, the FMCW technology cannot work, or the fact that management is alleged to be dishonest. The thesis is much simpler: the valuation is disconnected from the business the company actually reports.

Aeva files as an early-stage company with a history of losses, immaterial commercial deliveries, prototypes, non-recurring engineering services, long customer validation cycles, no assured volume commitments, and material customers. The stock trades as though those risks have already been solved when they simply have not.

The research gives the proper narrative context: Aeva has spent years producing announcements around attractive markets and recognizable counterparties. Those announcements may be real, but real announcements are not the same as scaled revenue, profits, or cash generation. The business model does not justify a valuation between 47x and 86x sales, depending on which revenue base is used.

The August 2026 optical-connectivity announcement reveals the hyped up nature of the stock when it ran from $15 to almost $28 a share on unwarranted speculation. Aeva has moved from autonomous vehicles into industrial, defense, NVIDIA-related autonomy, and now AI data-center optics- a market where the company’s own timeline places initial deployment eighteen months out and production ramp-up in 2028. The company keeps finding markets that investors are willing to capitalize before it has proven it can commercially dominate the last one. It has managed to do all of this after their stock price ran into the ground in its first 3 years on the market. All of the sudden, as it gained momentum after a reverse split and for no real reason, the stock price has trended higher and higher benefiting insiders with the opportunity to get super rich.

This is equity-funded commercialization drift masquerading as valuation by adjacency. In reality this is just another 2021 toxic, overhyped despac that belongs with the other 73% of despacs in the despac gutter trading under $5 with constant incoming dilution to depress the stock price even further. The market reacts for Aeva’s constant, ever-flowing pump-style press releases, but the filings show something different. These filings show the same current business: small revenue, large losses, conditional customer commitments, and dependence on capital-market access. Common shareholders are not buying operating leverage; they are funding the next chapter of a story that has already consumed $447 million in losses over three years without producing scaled commercialization.

Fugazi Research considers Aeva’s shares speculative and uninvestable at any price above zero.

Disclaimer

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our,”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority.All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions-long, short, or otherwise-in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

T3 Defense Inc. reported Q1 2026 revenue of $3.6 million and a net loss of $26.3 million, meaning the company lost roughly $7.22 for every $1 of revenue during the quarter. The loss was not a rounding error; it was the mechanical output of a structure that generated $371,000 of gross profit, recorded $4.182 million in operating expenses, and absorbed a $26.6 million market hit from stock purchase warrant liabilities.

T3 Defense began as Brilliant Acquisition Corp., became Nukkleus (NUKK) following its December 2023 business combination, and rebranded as T3 Defense on February 9, 2026, pivoting from financial technology to an aerospace and defense acquisition platform under CEO Menachem “Menny” Shalom.

The capital structure moved faster than the business. Common shares outstanding increased from 19 million at December 31, 2025 to 38 million at March 31, 2026, and to 60 million by May 20, 2026. Then at the beginning of July 2026, a share resale of 30 million shares and after that, the company announced a Project 35 acquisition paid partly with another 21 million of shares issuance and, later disclosing the intent of reverse split sequence first described as 50 to 1 in an 8-K and then described as 125 to 1 in a company press release after “recent stock activity.” Which implies that the shares outstanding before the latest reverse split was north of 139 million shares which would signal a share explosion of 630% increase or a 7x multiple of dilution in less than a year.

This is not a new structure. Under its prior identity as NUKK, the company executed nearly the same sequence eighteen months earlier: a reverse split, followed weeks later by a headline acquisition that triggered a 1,000% plus squeeze, followed by a 4.5x share count explosion diluting straight into the spike. T3 didn’t stumble into this playbook twice by accident, it is run by a CEO simultaneously sitting on top of eight related entities, including a company he sold to himself for $69.4 million and two separate SPACs holding over $425 million in trust, one of which just abandoned its only deal with nothing to show for it. Roughly $172.5 million of that trust money sits consolidated on T3’s own balance sheet, while being completely unavailable to fund a single dollar of T3’s operations or its going concern shortfall.

Strip away the defense narrative and what remains is an acquisition vehicle dependent on maintaining a sufficiently elevated share price to finance itself. Fugazi Research believes the company’s capital structure (not its operating business) has become its primary product, leaving DFNS shares completely uninvestable and of little to no fundamental value.

Fugazi Research Analysis

• Operating Losses: T3 Defense generated $3.65 million of Q1 2026 revenue but reported a $26.35 million net loss, losing approximately $7.22 for every $1 of revenue.

• Weak Operating Economics: Gross profit totaled just $371,000 against $4.18 million of operating expenses, meaning operating expenses exceeded gross profit by more than 11x before interest expense and warrant remeasurement.

• Business Pivot: Formerly a blockchain payments company, T3 sold its Digital RFQ business for £1,000 before rebranding as a defense acquisition platform in February 2026.

• Extraordinary Dilution: Shares outstanding increased from approximately 19 million at December 31, 2025 to approximately 139.8 million immediately before the July 2026 reverse split—a roughly 630% increase (7x) in less than seven months.

• Equity as Currency: During Q1 alone, the company issued shares for warrant exercises, stock compensation, acquisitions, debt conversions, ELOC financing, and related-party debt settlements, using common equity as its primary source of capital.

• Nasdaq Compliance: After receiving a minimum bid-price deficiency notice, the board increased its planned reverse split from 1-for-50 to 1-for-125 under shareholder authority granted at the June 24, 2026 special meeting.

• Going Concern: At March 31, 2026, T3 reported approximately $69 million of negative working capital and disclosed that additional financing would be required to support operations over the next twelve months.

• Project 35 Acquisition: T3 acquired a 60% interest in Project 35 using more than 21 million shares, a $1.25 million promissory note, and a $2.5 million investment commitment, while financial statements for the acquired business remained unavailable for up to 71 days following closing.

• Management Structure: CEO Menachem Shalom simultaneously serves in leadership roles across multiple affiliated entities, including Star 26 Capital, two defense-focused SPACs, and additional public companies.

• Consolidated SPAC Assets: Approximately $172.5 million of SC II Acquisition Corp.’s trust assets appear on T3’s consolidated balance sheet under GAAP despite being unavailable to fund T3’s operations or liabilities.

• A Repeatable Pattern: Under its former identity as NUKK, the company executed a reverse split, announced a headline acquisition, experienced a 1,000%+ short squeeze, and subsequently expanded its share count 4.5x. T3 followed a strikingly similar sequence again in 2026.

• Fugazi Research considers DFNS uninvestable at any price above zero.

Source: T3 Defense Inc. Form 10-K, filed April 9, 2026.

Source: T3 Defense Inc. Form 10-Q, filed May 20, 2026.

Source: T3 Defense Inc. Form 8-K, filed July 9, 2026

Source: T3 Defense Inc. Form 8-K, filed July 16, 2026

Source: T3 Defense Inc. Form 8-K, filed July 15, 2026 — SC II Acquisition Corp. LOI termination.

Financial Summary

• Q1 2026 revenue was $3.6 million, cost of revenue was $3.2 million, and gross profit was $371,000. Gross margin was approximately 10.2%, leaving only ten cents of gross profit for every dollar of reported revenue.

• Q1 2026 operating expenses were $4.2 million against gross profit of $371,000. Operating expenses were approximately 11.3 times gross profit.

• Q1 2026 net loss was $26.3 million against revenue of $3.6 million. Meaning that the company lost approximately $7.22 for every $1 of revenue.

• Net cash used in operating activities was $4.9 million in Q1 2026, while cash, cash equivalents, and restricted cash from continuing operations at quarter-end were $7.6 million. That combined balance equaled roughly 4.7 months of Q1 operating cash burn on a simple run-rate basis; actual operating liquidity may be lower because the balance includes restricted cash and excludes additional acquisition-related needs.

• Total current assets were $22.8 million and total current liabilities were $91.6 million at March 31, 2026. Resulting in a current deficit of approximately $68.8 million.

• The accumulated deficit increased from $122.5 million on December 31, 2025 to $149.6 million on March 31, 2026. The company added $27.147 million to the accumulated deficit in just one quarter.

• Shares outstanding continued expanding after the March 31, 2026 quarter end, reaching approximately 139.8 million immediately before the July 2026 reverse split, an increase of roughly 630%, or a 7.3x multiple, from the 19.026 million shares outstanding at December 31, 2025.

• Negative working capital grew from approximately $30 million at December 31, 2025 to approximately $68.8 million at March 31, 2026, an increase of roughly $39 million, or approximately 130%, in a single quarter.

• Of the $91.625 million in total current liabilities at March 31, 2026, approximately $56 million, or roughly 61%, consisted of stock purchase warrant liabilities, which do not require cash settlement but are marked to fair value each period and flow directly through net income.

• Goodwill increased from $7.6 million at December 31, 2025 to $100 million at March 31, 2026, and total assets grew from $202.3 million to $315.4 million over the same period, an increase driven overwhelmingly by non-cash purchases from paper-funded acquisitions rather than organic asset growth or operating cash generation.

Source: T3 Defense Inc. Form 10-K, filed April 9, 2026

Source: T3 Defense Inc. Form 10-Q, filed May 20, 2026.

One CEO, Eight Entities: The Shalom Network

T3 Defense’s chief executive did not arrive as a single operator. Menachem “Menny” Shalom has served as T3’s CEO and a board member since September 2024, drawing total 2025 compensation of $3.97 million, of which roughly 92.2% was paid in stock and options rather than cash (meaning the overwhelming majority of his pay is a direct bet on the same equity he is simultaneously promoting through acquisition announcements).

Public filings show Shalom simultaneously holding leadership roles across at least eight related entities, several of which have conducted transactions with one another.

• Star 26 Capital — Self-Dealing: Controlled both sides of T3’s $69.4 million acquisition of Star 26, generating $72.3 million of goodwill from a target with negative working capital.

• B. Rimon Agencies Ltd. — Circular Fee Arrangement: Management fees flowed between related entities chaired by Shalom.

• Zero One Capital LLC — Private Value Extraction: Management fees were paid to a privately controlled entity with limited public disclosure.

• SC II Acquisition Corp. — Consolidated Trust Assets: Approximately $172.5 million of SPAC trust cash appears on T3’s balance sheet under GAAP despite being unavailable to fund T3’s operations.

• Kochav Defense Acquisition Corp. — Concurrent SPAC Leadership: Simultaneously sponsors and manages a separate $253 million defense-focused SPAC.

• Hold Me Ltd. — Concurrent Executive Role: Serves as sole director, CEO, and CFO while simultaneously leading T3 and multiple affiliated entities.

• Motomova Inc. — Repeatable Corporate Structure: Previously executed a similar shell-company, reverse-merger, and stock-funded acquisition strategy under Shalom’s leadership.

Only two of these companies (SC II and Kochav) are true blank-check SPACs, sitting on other people’s money while they hunt for something to buy, while the rest appear to be operating businesses, but dig deeper and several of them share the same origin story: take a dormant shell, give it a new name and a defense-adjacent story, then feed it acquisitions paid for mostly in stock instead of cash, and then after a massive dilution reverse split to keep Nasdaq compliance. This isn’t a structure, but a playbook in which Shalom is the only constant across every part of it, the company’s own 10-K states plainly: Menachem Shalom, our Chief Executive Officer, also serves as the Chief Executive Officer of Star 26, Motomova Inc., and Hold Me Ltd. These roles require Shalom to devote significant time and resources to the management and strategic direction of these other companies, which may reduce the time and attention he can dedicate to T3 while implying that his main focus is not improving T3’s business but planning a next acquisition target, while taking advantage of the financial markets.

Source: T3 Defense Inc. Form 10-K, filed April 9, 2026.

Source: Kochav Defense Acquisition Corp. Form S-1/Prospectus, filed with the SEC.

Source: T3 Defense Inc. Form 8-K, filed February 20, 2026 — Billio Ltd. consulting agreement, Zero One Capital and B. Rimon management fee disclosures.

Source: T3 Defense Inc. Form 8-K, filed July 15, 2026 — SC II Acquisition Corp. LOI termination.

The $172.5 Million That Is Not Theirs

When reading T3’s balance sheet at first glance it looks like a company sitting on a real scale, with total assets north of $200 million at year-end 2025. The balance sheet appears substantially larger than the operating business because GAAP requires consolidation of SC II Acquisition Corp.’s trust account.

T3’s wholly owned subsidiary, Nukkleus Defense Technologies Inc., controls the sponsor entity behind SC II Acquisition Corp (the blank check SPAC that raised $172.5 million in its November 2025 IPO). Control of a sponsor is not ownership of the SPAC, and it is certainly not ownership of the SPAC’s trust account, however under consolidation rules, T3’s control of the sponsor is enough to require SC II’s financials (trust account included) to be folded directly into T3’s own consolidated balance sheet.

None of the $172.5 million can be used to fund T3’s operations, service T3’s debt, or address the negative working capital and going concern doubt disclosed in the very same filing. And yet it sits there, on T3’s own balance sheet, counted as an asset, because GAAP consolidation asks only whether T3 controls the entity, not whether T3 can spend its money.

It requires only that a reader trust a summary total without reading three notes deep, which is exactly how most retail investors, and more than a few algorithmic screeners, actually read a balance sheet. Fugazi Research treats this as a standing caution applicable to every consolidated figure T3 reports, any total that touches SC II’s trust account should be assumed inflated relative to what is actually available to T3 common shareholders, until proven otherwise.

Source: T3 Defense Inc. Form 10-K, filed April 9, 2026.

Source: T3 Defense Inc. Form 10-Q, filed May 20, 2026.

The December 2024 NUKK Squeeze

NUKK changed its ticker to DFNS on February 9, 2026, when Nukkleus Inc. formally became T3 Defense Inc. Under its former identity as NUKK, there was a Nukkleus stock story, and it is worth understanding because the playbook never really changed, it was the same repeating pattern on both companies.

By mid October 2024, short interest in NUKK had reached approximately 70% of the float, turning any type of news into a short squeeze detonator. On December 15, 2024, Nukkleus announced it had acquired a 51% controlling stake in Star 26 Capital, its first announced move into the defense sector. The stock went from $1.39 to over $17 in a single trading day on December 16, marking a move of more than 1,000%, and kept climbing from there, closing above $40 by December 26. In the same window the squeeze was unfolding, shares outstanding expanded from approximately 1.18 million to 5.31 million, marking a 4.5x increase in a matter of weeks.

Above: NUKK 3500% short squeeze December 2024 riding crypto hype.

Eighteen months later, the company repeated a remarkably similar sequence following its July 2026 reverse split.

On July 16, 2026, the company announced a 125 to 1 reverse split, effective July 20. The split collapsed shares outstanding from approximately 139.8 million to roughly 1.12 million, in a stock that thin any volume moves the price violently, and buying pressure arrived: DFNS traded from sub $1 levels in the days immediately following the split to a high of $108 within a week. The outcome each time was the same, a stock price disconnected from fundamentals, moving on technical mechanics rather than operating results, in a capital structure that has consistently treated share count as a lever to be pulled rather than a fixed measure of ownership.

Above: DFNS short squeeze July 2026

The Fintech Corpse Wearing a Defense Helmet

T3 Defense is the latest name on a structure that has already been through Brilliant Acquisition Corp. and Nukkleus Inc. The company completed its business combination on December 22, 2023, began trading as NUKK, then changed its name to T3 Defense on February 9, 2026 and began trading under DFNS.

Source: T3 Defense Inc. (f/k/a Nukkleus Inc.) Form 8-K, filed February 9, 2026, Exhibit 99.1 — “Nukkleus Inc. Announces Corporate Rebranding: Changes Name to T3 Defense Inc. and Ticker Symbol to DFNS.

The company transitioned from a SPAC shell to a blockchain payments business before ultimately repositioning itself as a defense acquisition platform within roughly two years.

Rather than demonstrating an established defense contractor, the filings describe an acquisition vehicle funded primarily through equity issuance and goodwill creation.

The Project 35 Acquisition: Another Defense Asset, Another Paper Print

On July 6, 2026, T3 Defense acquired 60% of Project 35, an Israeli developer of counter-drone interceptors, paying with 21,059,871 shares of common stock, a $1.25 million note at 12% interest, and a commitment to invest another $2.5 million over the next year. The seller is disclosed only as X S.A. Security and Defense Ltd., no beneficial ownership, no stated relationship to the company or its officers, and unlike the Star 26 transaction, no acknowledgment one way or the other of whether this is a related party.

The company issued 21.1 million shares to acquire a 60% interest in Project 35 despite investors having no access to the target’s financial statements for up to 71 days.

Source: T3 Defense Inc. Form 8-K, filed July 9, 2026 (event dated July 6, 2026) — Project 35 acquisition, Stock Purchase Agreement, Promissory Note.

The deal closed July 6, the shares were issued, and the interceptor narrative was live in the market for over two months before anyone outside the transaction could check a single audited number against it, a window that happens to open ten days before T3’s 125 to 1 reverse split and lands directly ahead of the low-float squeeze that took DFNS from sub $1 to a +$100 intraday high.

While the timing may ultimately prove coincidental, the sequence mirrors the pattern documented elsewhere in this report.

Source: T3 Defense Inc. Form 8-K, filed July 16, 2026 — 1-for-125 Reverse Stock Split, superseding the 1-for-50 ratio disclosed in the Form 8-K filed July 13, 2026.

Shareholders approved this reverse split on June 24, 2026. Three days later, on July 16, the board reached back into that same stale authorization and pulled out 125 to 1 reverse split instead, 2.5x times more aggressive, executed with a signature and a press release, no new vote required, no shareholders consulted twice.

The acquisition blatantly added another business, another note, another investment commitment, and another 21 million shares to a company that was already disclosing Nasdaq bid-price issues and relying on equity-linked financing, the public shareholders own a rollup machine disguised as a self-funding defense business or a that converts defense vocabulary into common share supply.

The Playbook: Twice Executed

Cycle One (October to December 2024). On October 11, 2024, Nukkleus shareholders approved a reverse split at a discretionary range and, at the same meeting, approved raising authorized shares from 40 million to 150 million. The board executed a 8 to 1 split on October 24, 2024, cutting shares outstanding from 16.9 million to roughly 2.1 million to cure a Nasdaq bid-price deficiency. Seven weeks later, on December 15, 2024, Nukkleus announced its first move into defense, the Star 26 stake acquisition already documented in this report as the trigger for a squeeze that took the stock from $1.39 to an all-time high close of $52.10. Within weeks of that squeeze, shares outstanding expanded from approximately 1.18 million to 5.31 million, a 4.5x increase, diluting directly into the spike the reverse split had helped set up.

Cycle Two (June to July 2026). On June 24, 2026, shareholders approved a reverse split at a range once again, the same discretionary mechanism, the same blank check for the board to fill in later. On July 6, 2026, the company issued 21.06 million new shares to acquire Project 35, a paper funded deal with financials deferred 71 days, already examined in this report.

One week later, on July 13, the board disclosed a 50 to 1 reverse split; three days after that, on July 16, it upsized the ratio to 125 to 1 without a new shareholder vote. The split took effect July 20, collapsing the float from 139 million to roughly 1.12 million shares, and within days the stock ran from sub $1 to a $108 intraday high.

Line the two cycles up and the sequence is nearly identical: a discretionary range shareholder vote, a paper funded acquisition announcement timed close to the split, a float contraction, a squeeze, and dilution absorbed into the resulting volatility. The only real difference is where the dilution sits in the sequence; in 2024 the company diluted after the squeeze, selling into strength it didn’t create; and in 2026 it diluted before the split, paying for an acquisition with stock and then tightening the float around the shares it had just issued, a different tactic run by an operator who has since learned to front load the paper instead of trailing it.

When the Capital Structure Becomes the Business.

Every issue identified in this report—related-party transactions, repeated reverse splits, stock-funded acquisitions, and persistent dilution—ultimately points to the same problem: T3’s operating business does not generate enough cash to sustain itself.

On March 31, 2026, the company reported approximately $69 million of negative working capital and acknowledged substantial doubt about its ability to continue as a going concern. Management’s primary solution is continued access to equity-linked financing through its Equity Line of Credit (ELOC) with Esousa Holdings, while acquisitions continue to be funded largely with newly issued shares rather than internally generated cash.

The result is a self-reinforcing capital structure. Acquisitions support the narrative, the narrative supports the share price, and the share price enables additional equity financing and stock-funded acquisitions. Durable operating cash flow plays only a limited role in that cycle. Should investor appetite for the story weaken, the company’s ability to finance future operations and acquisitions could weaken alongside it.

Conclusion

DFNS presents itself as an emerging defense platform. Its SEC filings describe something materially different: persistent operating losses, substantial dilution, repeated reliance on equity financing, related-party transactions, negative working capital, and a management team simultaneously overseeing numerous affiliated entities.

Under both the NUKK and DFNS names, the company followed a strikingly similar sequence of reverse splits, acquisition announcements, speculative price appreciation, and dramatic growth in shares outstanding. Whether viewed individually or collectively, those events raise serious questions about whether shareholder value is being created through operating performance or through repeated capital markets activity, for this reason, Fugazi Research believes DFNS stock has little to no fundamental value and is uninvestable at any price above zero.

Disclaimer

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our,”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority.All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions-long, short, or otherwise-in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

Sadot Group (SDOT) has spent two years shedding every business it has ever operated. It first began as a restaurant company, pivoted into agricultural commodity trading under the “Sadot Agri-Foods” banner, and today it’s neither. During the first quarter of 2026, the commodity operation that generated $132.2 million in the prior-year quarter reported no revenue ($0.0 million). The restaurant brands were sold to Marv Brands in December 2025; the Zambia farm was lost to a court judgment in the same month; and, on a new series of developments, on June 26, 2026, the company sold its Latin America trading subsidiary, Sadot Latam LLC, for $1,000 in cash. (less than a monthly rent for an apartment in the Houston Metro area) As of today, there is no longer an operating business generating revenue.

However, what remains is a financial hole: total liabilities of $60.8 million are offset by total assets of $2.4 million, resulting in a shareholders’ deficit of $58.4 million. Unrestricted cash is roughly $409,000, while some of their notes payable are in default at stated rates of up to 46% (practically loan-shark levels). The company incurred approximately $93.5 million in losses in FY2025 and has an accumulated deficit of $181.5 million. This is not a liquidity problem to be fixed; in reality, it is already a balance sheet insolvency, even as management discloses substantial doubt about the company’s ability to continue as a going concern.

Into that hole, management is stacking narrative. Within weeks of selling the last real business for $1,000, Sadot “acquired” a UAE software shell, Anira Consulting FZC and its “TradeOS” commodity trading platform, for $12 million, which is 97% non-cash paper, then took a six-month option on a $125.5 million California residential real-estate portfolio paid for in stock–which to exercise, would require cash or new Series C preferred stock. Neither counterparty has filed audited financials, raising serious questions about the viability of both projects. At the end of the day, SDOT is a Nasdaq-listed shell being recycled through serial pivots, while common holders are diluted by an authorized-share expansion from 2 million to 250 million and a cumulative 1-to-2,000 reverse-split sequence. Now, it leaves common equity as a residual claim, standing behind $60.8 million in liabilities and $2.4 million in assets; for this reason, Fugazi Research considers SDOT shares completely uninvestable and of ZERO fundamental value.

The make-or-break moment will occur on August 13th, when Q2 2026 earnings will be released. With so little cash at the end of Q1 and a “going concern” warning, investors will gain greater clarity on the very low odds of Sadot surviving such high-risk pivots.

Fugazi Research Analysis

• In the quarter ended March 31, 2026, Sadot reported $0.0 USD in commodity sales, down from $132.2 million in the same quarter a year earlier. The entire agri-commodity trading operation that defined the company’s equity story generated no revenue.

• Sadot is insolvent, not merely illiquid, as total liabilities of $60.8 million rest on total assets of $2.4 million, yielding a shareholders’ deficit of $58.4 million, a working capital deficit of $57.8 million, and, on top of that, Management discloses substantial doubt about its ability to continue as a going concern.

• On June 26, 2026, the company sold 100% of Sadot Latam LLC (its Latin America trading subsidiary) to a buyer in Costa Rica for $1,000 in cash, plus a 27.5% share of receivables it does not expect to collect. With quarterly revenue already at zero, that $1,000 is the cleanest available mark on what the trading business is actually worth.

• The restaurant brands (Muscle Maker Grill, Pokémoto) were sold to Marv Brands for $2.9 million in December 2025, and the Zambia farm (once the centerpiece of the agri-foods narrative) was lost to a court judgment the same month and written down by $11.8 million. Management has been liquidating the operating company piece by piece.

• Notes payable of $11.1 million are current and largely in default; the most mature is due on December 31, 2025, and was subsequently extended to June 4, 2026, in exchange for an additional 25% original-issue discount applied to the principal. Stated interest rates range from 3.75% to 46.00%

• Sadot has executed three reverse stock splits in nineteen months, 10 to 1 (October 2024), 10 to 1 (September 2025), and 20 to 1 (May 27, 2026), which amounts to a cumulative 2,000 to 1, each explicitly to hold the $1.00 Nasdaq minimum bid. In April 2026, authorized shares were simultaneously raised from 2 million to 250 million, restoring the capacity to dilute that the splits had just removed.

• The company’s financing facility is engineered to convert into selling pressure. The Helena equity line permits sales of up to $10 million of stock at 97% of the lowest daily VWAP over the pricing period, with further downward adjustments for intraday volatility and cash-payable liquidated-damages triggers.

• The headline $12 million Anira acquisition is 97% non-cash paper that was stripped of convertibility within six days. Structured on June 2, 2026, as $405,000 of common plus $6.595 million of Series B preferred and a $5 million note (originally convertible at $3.00) the preferred and note were re-cut by June 8, 2026, as non-convertible and non-voting, with the note bearing zero interest and maturing in 2028.

• Management valued its own common stock at two incompatible prices in the same week. The Anira consideration priced SDOT shares at $3.00 on June 2, 2026; four business days later, the real-estate option fee was settled in shares struck at a $7.85 five-day VWAP. The Anira seller’s common tranche was therefore marked at roughly 38% of the VWAP the company itself applied days later, rendering the disclosed $12 million and $1.04 million consideration figures unreliable on their face. The option-fee tranche was sized to exactly 17.71% of shares outstanding, deliberately below the 19.99% threshold that would have required a shareholder vote.

• Nasdaq has issued a stack of non-compliance notices over the trailing year: a late Form 10-K notice dated April 17, 2026; a failure to hold an annual meeting; and preferred-stock voting rights, all of which are layered on top of the recurring $1.00 minimum-bid deficiency that the reverse splits are intended to remedy.

• Fugazi Research considers SDOT uninvestable at any price above ZERO.

SDOT Financial Summary

• Total liabilities of $60.8 million rest on total assets of $2.4 million. On a coverage basis, existing assets fund just 3.9% of obligations, meaning liabilities exceed assets by more than 25-to-1, and every dollar of book liability is backed by roughly 4 cents of book assets. Put differently, a meaningless price-to-book value of this stock (as of the April 2026 quarterly earnings) is -$5.16 compared to its after-hours price on Thursday of $52.34 a share, a massive value disconnect.

• Total shareholders’ deficit was $58.4 million as of March 31, 2026, widening from $54.8 million at year-end 2025. Before the non-controlling interest, the deficit attributable to Sadot itself is $61.1 million, so the common equity carries a negative book value of $58 to $61 million.

• Current liabilities of $60.1 million are offset by current assets of $2.4 million, resulting in a working-capital deficit of $57.8 million and a current ratio of 0.04 (four cents of current assets for every dollar of near-term obligations). No solvent operating company runs at this ratio; it is a liquidation-stage balance sheet.

• Cash totaled $679k, of which $270k is court-restricted, leaving approximately $409k of unrestricted cash. Measured against $60.1 million of current liabilities, unrestricted cash covers roughly 0.7% of what the company owes within twelve months.

• The net loss was $4.87 million in Q1 2026. For full-year 2025, the accumulated deficit widened from $83.2 million to $176.6 million, meaning the company lost approximately $93.5 million in a single fiscal year (a loss larger than its current revenue base).

• Accumulated deficit reached $181.5 million as of March 31, 2026, against a par-and-paid-in capital base that has been repeatedly raised and diluted since the restaurant era. The company has consumed all this invested capital and returned a balance sheet with negative equity.

• Notes payable of $11.1 million are entirely current and largely in default, carrying stated interest rates ranging from 3.75% to 46.00%. Most matured on December 31, 2025, and were extended to June 4, 2026 only after the company agreed to stack an additional 25% original-issue discount onto principal, the company is borrowing at rates reaching 46% while holding $409k in unrestricted cash.

• Impairments in FY2025 totaled approximately $31.0 million, including $11.8 million written off on the Zambia farm and $13.4 million on carbon credit assets. Roughly $31 million of previously capitalized asset value was written off in a single year, most of it tied to the “agri foods” narrative that has since been abandoned.

• Accounts payable and accrued liabilities of $49.0 million include approximately $25.7 million of commodities payable and $13.8 million of accrued litigation. The company owes $13.8 million on legal exposure alone, more than 33 times its unrestricted cash, while defending claims including the Lombard Trading and factoring disputes.

• Shares outstanding rose from 522,514 (December 2024) to approximately 14.8 million by May 2026, before the 20-to-1 reverse split compressed the count back to roughly 744,000. In April 2026, in the middle of this sequence, authorized shares were expanded from 2 million to 250 million (a 125-fold increase in dilution capacity granted just weeks before new issuance resumed).

• The company has executed three reverse stock splits in nineteen months: 10-to-1 (October 2024), 10-to-1 (September 2025), and 20-to-1 (May 2026), for a cumulative 2000-to-1 reverse-split ratio.

• In the same weeks, it disposed of Sadot Latam for $1,000 in cash; the company booked a stated $12 million Anira acquisition, comprising $405k of common stock, $6.6 million of non-convertible preferred, and a $5 million zero-interest non-convertible note. A $12 million acquisition and a $1,000 divestiture were recorded within the same three-week window, a contradiction in internal valuations that makes no financial sense.

Source: Sadot Group Inc. Form 10-K, fiscal year ended December 31, 2025.

Source: Sadot Group Inc. Form 10-Q, quarterly period ended March 31, 2026.

Source: Sadot Group Inc. Form 8-K, Anira Consulting FZC acquisition, event dated June 2, 2026. Filed June 3, 2026.

Source: Sadot Group Inc. Form 8-K, Amendment to Anira Share Purchase Agreement and Series B Certificate of Amendment, event dated June 8, 2026. Filed June 10, 2026.

The Ever-Changing Business

Sadot Group has been three different companies in six years and is currently none of them; it was listed as Muscle Maker, Inc., a chain of fast-casual burger and wellness restaurants (Muscle Maker Grill, Pokémoto, SuperFit Foods). In 2022, it discovered that grilling chicken did not move a stock price, formed Sadot LLC, and reinvented itself overnight as a global agri commodity trading house, adopting the Sadot Group name and positioning itself in investor materials alongside ADM, Bunge, Cargill, and Louis Dreyfus.

However, by 2025, it had begun dismantling that identity too. Nowadays, with zero revenue and a $58.4 million shareholders’ deficit, management is mid-pivot into two more unrelated businesses at once: a United Arab Emirates commodity-trading software platform and a portfolio of California apartment buildings.

The agri commodity chapter is important because it demonstrates how little the “revenue” ever really meant. Physical commodity trading has enormous gross turnover against very thin margins, as a trader can run $100 million of grain through its books and keep only a fraction of a percent. In the case of Sadot, which generated $132.2 million of commodity sales in Q1 2025 and still lost money, then watched that line fall to $0.0 million in Q1 2026. The business that supposedly justified the equity story never generated value, while the accumulated deficit ballooned to $181.5 million.

The table shows a company that terminated its foreign management partner, sold its restaurants for less than a single quarter’s former overhead, wrote off its flagship farm, stopped generating revenue entirely, and then (in the same three-week window) booked a $12 million acquisition and a $1,000 divestiture. Management assigned a value to an unaudited UAE software shell company that was 12,000 times what it accepted for its own operating subsidiary days later. This is the recognizable terminal behavior of a reverse-merger vehicle. When the operating business is gone, but the listing still has value, the listing becomes erratic, but at the same time, the final product is a clean Nasdaq ticker into which new stories, new offshore counterparties, and new paper can be injected to sustain a tradeable price. The next investor buying SDOT is not buying a commodity trader, a software company, or a landlord. They are buying whatever management decides to announce next, on a balance sheet that already owes $60.8 million it cannot pay.

Paid Promotion History under former Ticker GRIL

For years, GRIL/SDOT relied on a paid investor-promotion ecosystem that included sponsored research, compensated financial media, investor conferences, and an unusually high volume of promotional press releases. As the underlying business changed (from restaurants to commodity trading to software and real estate), the promotional machinery remained remarkably consistent.

On July 27, 2023, the Nasdaq ticker GRIL was replaced by SDOT. GRIL was Muscle Maker Grill, which was then owned by Sadot LLC, and was sold for just over $4 million, becoming Sadot Group (SDOT). GRIL had a history of paid stock promotions and, at one point, was even tied to Jonathan Lebed’s stock-promotion company, the “National Inflation Association.” It is important to note that Jonathan Lebed, at age 15, made financial history as the first minor charged with stock market fraud by the U.S. Securities and Exchange Commission (SEC)

Above: Jonathan Lebed: Stock Manipulator, S.E.C. Nemesis -- and 15

Above: GRIL history of paid promotional stock campaigns by Jonathan Labed’s National Inflation Association

The $1,000 Liquidation

On June 26, 2026, Sadot Group sold 100% of Sadot Latam LLC, the operating subsidiary that anchored what remained of its Latin American commodity-trading business, for just $1,000. Not one thousand shares or one thousand in some other stated value, but one thousand USD, payable by wire transfer, basically giving the company away for free. The telephone number on Sadot’s own Form 8-K carries an 832 Houston, which is a Texas area code. In that area, $1,000 is roughly a month’s rent for an ordinary small apartment. Basically, Sadot’s board convened, negotiated, and executed a definitive Share Purchase Agreement to convey an entire operating company for the price of a small one-bedroom’s rent in Houston until the end of July.

Above: Sadot’s (Sadot Latam LLC) sale for the absurd amount of $ 1,000 USD in cash.

Above: For comparison, monthly rent for a random condo in Houston, TX.

The absurdity deepens when you read what was inside the box. Appendix A to the SPA lists the assets transferred to the buyer, and the first line item is a Citizens Bank deposit of approximately $250,000. Sadot handed over a subsidiary containing a quarter million dollars in disclosed cash, plus a portfolio of receivables and litigation claims, and accepted just $1,000 for it. The buyer paid a minuscule $1 dollar for every $250 of cash sitting in the entity’s own bank account, this is either a gift or a liability shedding maneuver disguised as a sale, as Sadot was not selling an asset; but paying a counterparty to absorb a legal and financial problem, and the $1,000 exists only to satisfy the technical requirement that a sale have consideration.

The genuine purpose is disclosed one item down in the filing: deconsolidation. Under ASC 810, once Sadot ceases to control Sadot Latam, the subsidiary’s liabilities are removed from Sadot’s consolidated balance sheet. The company did not raise $1,000.

The bottom line is that this stock is running on fumes. It’s a company that is out of cash, deeply indebted, has no operations that could raise cash, hasn’t posted any of its quarterly reports on its website since April 2025, and is rotating out Directors and executives to present some level of activity, and now its 20 to 1 reverse stock split is likely only being executed so the main shareholders can find the next story to milk retail investors out of their hard earned cash.

Zero Revenue Is Not a Typo

Companies report a lot of ugly numbers. They rarely report this one. In the quarter ended March 31, 2026, Sadot Group generated $0.0 million in revenue. Not “revenue declined.” Not “revenue missed.” Zero. In the same quarter one year earlier, the same business line, a physical commodity trading under Sadot Agri-Foods, recorded $132.2 million in sales. A company does not travel from $132.2 million to nothing in twelve months by losing customers or missing a season. It gets there by ceasing to have a business, which is precisely what happened.

It is worth being clear about what that $132.2 million was, because its disappearance and its existence are equally damning. Commodity trading books enormous gross turnover against margins measured in fractions of a percent, in which a trader can push a hundred million dollars of grain across its ledgers and keep almost none of it. Sadot ran nine figures of revenue through that model and still lost money every year it operated. So the collapse to zero did not destroy a profit engine; there was never a profit engine to destroy. It removed the appearance of scale, the single large number that let a going-concern shell describe itself in the same paragraph as ADM, Bunge, Cargill, and Louis Dreyfus. Strip the turnover, and what is left is the economic reality that was always underneath it: a company that consumed capital to move other people’s commodities and kept nothing for the trouble.

For a going concern, that zero is fatal in a way the market has not priced. A company with $409,000 of unrestricted cash and $60.1 million of current liabilities survives only on its ability to generate cash internally or raise it externally. Internal generation is now definitionally impossible: you cannot fund operations from operations that produce no revenue. That leaves external capital as the sole source of survival, which is exactly why the 250-million-share authorization and the Helena equity line matter, and exactly why they exist. The zero on the revenue line and the dilution machinery are the same fact stated twice. One explains the other. A business that earns nothing must sell stock to breathe, and a business that must sell stock to breathe will keep selling it until there is nothing left to sell.

Conclusion

Sadot Group would like investors to believe it is a commodity trading company. Depending on which week’s press release you read, it would also like you to believe it is a UAE software company, a California real estate investor, and, for old times’ sake, a chain of health-conscious burger restaurants. Today, it is effectively none of these.

Instead, Sadot is a Nasdaq-listed company with a Texas mailing address, a going concern warning, and $60.8 million in liabilities supported by just $2.4 million in mostly reserved or restricted assets. Revenue has fallen to $0.0 million, down from $132.2 million one year earlier. Shareholders’ equity stands at-$58.4 million. The current ratio is 0.04, a figure so far below 1 that it no longer measures liquidity and instead reflects a balance sheet in severe financial distress. Some of the debt carries stated interest rates as high as 46% and was extended beyond its December default only after the company agreed to increase the original issue discount by an additional 25%.

The transaction that best illustrates the company’s trajectory unfolded over a three-week period in June. Management sold Sadot Latam, the last operating business it actually built, for just $1,000. The subsidiary left with approximately $250,000 of disclosed bank cash and the litigation associated with its operations. Within weeks, Sadot announced the $12 million acquisition of Anira Consulting FZC, an unaudited software company based in Sharjah. The consideration consisted almost entirely of preferred stock and a non-interest-bearing, non-convertible promissory note, a structure that raises obvious questions about how management arrived at a $12 million valuation. In other words, management accepted $1,000 for the operating business it knew best while assigning a $12 million valuation to one it neither audited nor built. The company has offered investors little basis for reconciling those dramatically different valuations.

Meanwhile, in April, just weeks before the reverse split reset the outstanding share count, the board quietly expanded the company’s authorized common stock from 2 million shares to 250 million (a 125-fold increase) in future dilution capacity. No company with $409,000 of unrestricted cash and a viable self-funded operating business would ordinarily require that level of issuance capacity. The reverse split compresses the share count to preserve the Nasdaq listing; the expanded authorization refills the barrel. The businesses are disposable. The dilution capacity remains.

Viewed through a traditional liquidation framework, the math is difficult to ignore. $2.4 million of low-quality assets would not travel far up a capital structure burdened by $60.8 million of liabilities before being exhausted, leaving common shareholders at the very end of the line, not so much with a claim as with a hope.

Perhaps the most revealing datapoint is that the only observable arm’s-length price the company has assigned to one of its own operating businesses was $1,000, which is the amount paid for everything that remained of Sadot Latam. The market continues to value the common stock far above that implied assessment, but investors should consider whether the company’s own transactions tell a more reliable story than its promotional narrative.

Sadot Group increasingly resembles a company that has outlived its operating businesses while attempting to preserve its public listing through successive strategic pivots. The stories will likely continue because, for a company in this position, the only thing worse than another implausible acquisition is the silence that precedes a delisting. Based on the company’s balance sheet, capital structure, and recent transactions, Fugazi Research believes SDOT common stock has no meaningful fundamental value and is unsuitable for investment.

Disclaimer

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our,”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority.

All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions-long, short, or otherwise-in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

Subscribe now

Share

Redwire (RDW) has become one of Wall Street’s most compelling space and defense stories. The company operates in attractive markets (orbital infrastructure, defense technology, autonomous systems, and national security) and its contracts, products, and customers are real. That narrative has helped drive significant investor enthusiasm. Our concern is not with the industries Redwire serves, but with how the business has been financed and operated.

Since late 2025, Redwire has relied heavily on the equity markets to fund its operations, authorizing more than $1.1 billion of at-the-market (”ATM”) equity issuance while common shares outstanding have nearly tripled in roughly fifteen months. Operating cash flow remains negative, and recent increases in cash have been driven by equity issuance rather than internally generated cash flow.

At the same time, the company’s governance and financial reporting raise additional concerns. KPMG issued an adverse opinion on Redwire’s internal control over financial reporting for fiscal 2025, concluding that the company did not maintain effective internal controls. The acquisition of Edge Autonomy (which represented approximately one-third of Redwire’s 2025 revenue) was excluded from that assessment because of acquisition timing, leaving investors with limited assurance over a significant portion of the business.

Redwire’s operating history also raises questions about execution. Revenue has expanded primarily through acquisitions, but profitability has remained elusive. The company has never generated sustained positive free cash flow under its current structure, accumulated deficits continue to grow, and shareholder dilution has become an increasingly important source of liquidity.

This report examines three central issues. First, whether Redwire’s operating business is capable of funding itself without continued reliance on equity issuance. Second, how the Edge Autonomy acquisition reshaped the company’s capital structure and created significant additional share supply. Third, whether Redwire’s governance, financial controls, and board oversight are adequate given the company’s operating and financing history.

Based on our review of SEC filings, court records, audit reports, and other publicly available information, we believe the market is placing a premium valuation on a business whose underlying economics and governance profile do not justify that premium. In our opinion, Redwire’s equity remains materially overvalued relative to the risks disclosed in its own public filings.

Fugazi Research Analysis

• Redwire is an integrated space and defense company that has failed to demonstrate a viability on either business. The space segment swung from $3.2 million in operating income in Q1 2025 to a -$4 million operating loss in Q1 2026 on flat revenue, while the Defense Tech segment generated a -$46.9 million operating loss in its first quarter.

• Redwire entered its first ATM facility in November 2025 for $250 million through four institutional agents; it was effectively exhausted in only five months. On May 6, 2026, management replaced it with a $350 million facility, and on June 9, 2026, management terminated it and entered a third ATM for $500 million through ten agents, making a total of $1.1 billion authorized ATM capacity across all three tranches since November 2025.

• Operating cash flow in Q1 2026 was negative $6.7 million, Investing activities consumed an additional $6 million. The company’s $50 million cash increase for the quarter was sourced entirely from $63.5 million in net ATM equity proceeds.

• Common shares outstanding went from 67 Million on December 31, 2024 to almost 200 Million on March 31, 2026, representing a staggering 197% share count increase in 15 months with no floor in sight, as an additional 16,079,001 shares sit in the convertible preferred stack convertible at $3.05 (more than 60% below the current stock price). At the Q1 2026 weighted average ATM sale price of $9.38, fully deploying the current $500 million facility requires the issuance of approximately 53.3 million additional shares, which would represent a further 27% dilution on shares already outstanding.

• Management backed out of $46.7 million in equity compensation, $11.3 million in D&A, $2.9 million in debt costs, $2.0 million in capital market advisory fees, and $0.4 million in litigation expenses. Adjusted EBITDA remained negative at -$9.2 million , meaning that the business generates negative economic value before it finances itself.

• A derivative lawsuit filed in 2022 settled in 2025 for zero monetary recovery. The complaint alleged defendants failed to maintain adequate internal controls and issued materially false or misleading statements. Defendant insurers paid $912,500 in attorneys’ fees, while the individual defendants (CEO Peter Cannito and seven board members) deny all allegations and admit no liability.

• The settlement extracted nonexistent governance structures that should have existed at the SPAC closing in 2021. Settlement required the company to create a risk Committee, a Disclosure Committee, a Chief Compliance Officer position, enhanced audit committee procedures, and a strengthened whistleblower policy.

• Fugazi Research considers RDW shares extremely overvalued, of no fundamental value, and purely speculative.

Financial Summary

• Common shares outstanding increased from 67,002,370 on December 31, 2024 to 198,918,728 on March 31, 2026, a 197% share count explosion in a period of 15 months.

• Three ATM facilities totaling $1.1 billion in authorized capacity have been opened since November 2025, the most recent for $500 million on June 9, 2026. Additional shares sit in the form of convertible preferred stock, which if overall triggered can enable a further 27% dilution on top of shares already outstanding.

• Edge Autonomy contributed $36.41 million in revenue and a net loss of -$54.9 million in Q1 2026. This is the asset for which Redwire paid $1.02 billion, recognized $722.99 million in goodwill, and issued 49.8 million shares at $19.08, while the stock price has plummeted 55% since share issuance.

• Redwire reported a net loss of -$76.5 million in Q1 2026, after stripping $46.7 million in equity compensation, $11.3 million in D&A, $2.9 million in debt costs, $2.0 million in capital market advisory fees, and $0.4 million in litigation expenses, Adjusted EBITDA remained negative at -$9.2 million.

• True free cash flow in Q1 2026 was negative -$12.7 million. Annualized, this implies a burn rate of approximately $51 million per year, against a cash balance that was itself funded entirely by $63.5 million in ATM equity proceeds in the same quarter.

• The accumulated deficit of $698.3 million as of March 31, 2026 represents 188% of last 12 months of revenue of $370.96 million, meaning the company has destroyed nearly two full years of its own revenue base in cumulative losses since inception. The deficit increased $76.5 million in Q1 2026 alone, $149.5 million in the trailing twelve months, and is on pace to cross $900 million before December 31, 2026.

• Last twelve months revenue of $370.96 million per the book-to-bill KPI table implies a current revenue multiple of 4.6× at $8.50 per share. Considering the fact that this business has negative Adjusted EBITDA, unresolved material weaknesses across every operating unit, and 197% share count dilution in 15 months.

Source: Redwire Corporation Form 10-Q, Period Ended March 31, 2026.

Source: Redwire Corporation Form 8-K, Filed June 9, 2026.

Source: Notice of Proposed Derivative Settlement, Yingling v. Cannito et al., Case No. 3:24-CV-01172-TJC-LLL, Filed June 8, 2026.

Interview with a Space Industry Expert: Redwire’s Business Structure and Viability

The following statements represent a space expert’s opinion based on their more than two decades of working in the space industry.

Fugazi Research: Redwire often gets highlighted for its growing backlog and the potential for margin expansion in the space and defense sector. But when you step back and look at it as an investment, what’s your actual take on the company? What concerns you most about their business structure and financial viability?

Space Expert: “As an investment, everything is just wrong with Redwire. Going back over several years and listening to their earnings calls and you hear the same script: record backlog, improving margins, operational leverage coming. But that narrative breaks when you look at the important number--profitability. Redwire management burns cash with widening net losses, and maintains EBIT margins at near -77%, one of the worst in the industry. More importantly, their balance sheet is a joke: 776M in goodwill and 326.7M in intangibles, representing 73% of their 1.51B in total assets. Only 410M is tangible—cash, receivables, real property. They’re basically a roll-up that paid massive premiums for acquisitions, and we’re already seeing Edge Autonomy hemorrhage almost 55M in losses. At 73% goodwill, Redwire is in the worst quartile in the defense, even versus aggressive roll-ups that cap out at 60-70%. If revenue growth slows or margins don’t inflect, that balance sheet gets decimated.”

Fugazi Research: “Redwire management often points to their nearly $500 million backlog as proof of strong demand and future growth. How much weight do you actually give that backlog number when evaluating the company? And what’s your view on their repeated delays in reaching profitability?”

Space Expert: “The 498M backlog they keep touting is meaningless if you don’t generate positive unit economics converting it. Management keeps pushing profitability down the road (now to 2028) while diluting shareholders every single year. That’s a bet that aerospace customers will suddenly become profitable for them without the margin improvement trajectory we should already be seeing from a mature company.”

Fugazi Research: Redwire went public in late 2020 around $10 a share and is still trading near that level nearly six years later. What do you see as the main reason the stock has gone nowhere, especially when the broader space sector has real contracts and several profitable players?”

Space Expert: “This company was created in Nov 2020 at 10 dollars a share. Nearly 6 years later, it’s hovering just above 10 dollars a share. The problem isn’t the industry or the customers--space is real, customers are real, contracts are real, and there are several profitable space companies. The problem is that Redwire is continuously issuing stock for survival capital without fixing their business. And it has to be noted that management issued over 46M in equity-based compensation last quarter alone (for what, I’m not sure). The backlog question is masking the dilution question--how many new shares will it take for Redwire to reach profitability, and how much will that cost current shareholders?”

The KPMG Adverse Opinion

KPMG LLP, Redwire’s independent registered public accounting firm, issued an adverse opinion on the effectiveness of Redwire’s internal control over financial reporting as of December 31, 2025 (the most severe of the four conclusions an auditor can render on internal controls). An adverse opinion does not mean controls are weak or need improvement. It means the auditor concluded that Redwire did not maintain effective internal control over financial reporting.

The company has a history of poor financial controls that has led to shareholder lawsuits. Most recently, Redwire’s auditor (KPMG) issued an “adverse opinion” on Redwire’s internal financial controls, the most severe of the four opinions an auditor can provide. This means the company can not provide reliable financial reporting. Importantly, even this audit excluded the acquisition of Edge Autonomy, even though the acquisition occurred mid-year and that it represented one third of Redwire’s revenue for 2025. This same issue is the core of previous shareholder lawsuits, and could represent the basis of future shareholder lawsuits.

The adverse opinion covers material weaknesses across U.S. operations and European operations, the same deficiencies management disclosed as active and unremediated in the Q1 2026 10-Q filed May 7, 2026. KPMG’s conclusion and management’s own disclosures are saying the same thing: this company cannot provide reliable financial reporting, and has not been able to for years.

FY2025 free cash flow was negative -$200.6 million, the company consumed $177.3 million in operating cash against $335.4 million in revenue, a cash consumption rate of 52.8 cents for every dollar of revenue generated. This is the financial performance that KPMG’s adverse opinion was issued against. The control failure is not a disclosure technicality. It is the audit trail of a business that burned through more than half its revenue in cash from operations in a single year.

With likely more than 60% of total backlog coming from US government contracts at a time when the likelihood of another government shutdown is uncomfortably high, Redwire’s already anemic financials will likely face exceptional pressure in the 2nd half of CY2026. Should this occur, Redwire will likely tap its massive ATM .

Source: Redwire Corporation Form 8-K, Exhibit 99.1 — Full Year 2025 Financial Results. Filed February 25, 2026.

Source: Redwire Corporation Form 10-Q, Period Ended March 31, 2026. Item 4 — Controls and Procedures.

The Acquisition Was the Exit

The Edge Autonomy acquisition created two things simultaneously: a defense-drone narrative compelling enough to move retail sentiment, and a stock block (49,764,847 shares issued directly to an AEI-affiliated seller at close). The S-3 followed four months later, registering up to 117,677,386 selling-stockholder shares for resale while the story was still fresh. AEI-linked entities began Form 4 open-market sales in January 2026. By May, the preferred had converted into common (15,247,586 additional shares sold into the market at $13 to $15.80 on a $3.05 conversion cost). Another layer of the original position liquidated into public hands at a 4× to 5× return, while retail investors were buying the space and defense narrative.

Meanwhile, Redwire’s own ATM quietly exhausted $350 million in proceeds and was immediately replaced with a new $500 million facility filed the same day the prior one was terminated. Two parallel tracks running simultaneously: the insider resale lane unwinding the acquisition-era position, and the company ATM funding operations that cannot self-finance.

Source: Redwire Corporation Form S-3, Filed August 7, 2025.
Source: Redwire Corporation Form 424B5, Filed June 9, 2026.
Source: Redwire Corporation Form 4 Filings, AE Red Holdings LLC / Edge Autonomy Ultimate Holdings LP, January–May 2026.

The ATM Playbook

Redwire entered 2025 as a space infrastructure company with chronic negative operating cash flow. The Edge Autonomy acquisition added defense drones and autonomous systems, a stronger narrative than traditional space hardware, and one that commands premium market attention when tied to national security. The acquisition was paid mostly in stock: $160 million in cash and $765 million in common stock, resulting in 49,764,847 shares issued to the AEI-affiliated rollover seller.

The investor rights agreement required Redwire to file a resale registration covering securities held by selling stockholders. The August 2025 Form S-3 registered up to 117,677,386 common shares for selling stockholders and up to 2,000,000 warrants. Redwire would receive none of those proceeds. The company-side lane ran through ATM issuance ($518.4 million in common stock issuance proceeds in FY2025 alone).

As of the release of this report, on June 9, 2026, Redwire filed a new $500 million ATM prospectus and disclosed in the same filing that $350 million had already been sold under the May 2026 equity distribution agreement. The May ATM was terminated the same day the new one was filed. Now shares may be sold indiscriminately, through market makers, in block transactions, and in privately negotiated transactions. Agents collect commissions of up to 3% of gross sales price. Proceeds may be used for working capital, debt repayment, acquisitions, and research and development. At the prospectus’ assumed offering price of $18.57, the full $500 million facility adds 26,925,148 shares, bringing total shares outstanding to 265,750,493. Massively bloating the outstanding shares.

And if history is any guide, a meaningful portion of those proceeds will likely fund the next acquisition. That prospect raises an obvious question. The last acquisition was an AE Industrial Partners portfolio company acquired at a valuation many investors viewed as excessive. Today, Redwire carries approximately $776 million of goodwill on its balance sheet, yet management has not recognized an impairment. Given AE Industrial Partners’ control of the board, its role in appointing the CEO, and its repeated pattern of converting preferred securities and selling into acquisition-driven rallies, investors should ask a simple question: Who is the next acquisition really designed to benefit, Redwire’s common shareholders, or the sponsor that controls the company?

Source: Redwire Corporation Form S-3, Filed August 7, 2025.
Source: Redwire Corporation Form 10-K, Fiscal Year Ended December 31, 2025. Filed February 27, 2026.
Source: Redwire Corporation Form 424B5, Filed June 9, 2026.

The AEI Exit Lane

AEI’s involvement in Redwire appears across multiple SEC filings, including the proxy statement, Form S-3, Form 4, Schedule 13D/A, and Form 8-K. Redwire’s 2026 proxy statement identifies the Edge Autonomy seller as an AEI-affiliated “Rollover Seller,” which received 49,764,847 Redwire shares as part of the deal. In August 2025, Redwire filed a Form S-3 to register shares for sale by existing stockholders. The filing showed that AE Industrial Partners and its affiliates owned 115.2 million shares before the offering and planned to sell 79.5 million shares plus 2 million warrants. After the sale, they would still hold approximately 35.6 million shares. Importantly, Redwire would not receive any proceeds from these sales and the money would go directly to the selling stockholders.

The filings show that AEI-related entities sold a large number of Redwire shares in mid-January 2026. On January 13 and 14, AE Red Holdings and other related parties reported selling a total of approximately 14.3 million shares. After these sales, they still owned 61.5 million shares. In April 2026, they filed an updated Schedule 13D/A, which disclosed further reductions in their ownership through additional open-market sales. Following these transactions, the group’s beneficial ownership stood at 41.5 million shares, or 19.8% of Redwire.

On May 20, 2026, Redwire announced that AEI converted all of its remaining preferred shares into common stock. Specifically, AEI converted 46,505.13 preferred shares into 15,247,586 common shares. After the conversion, no preferred shares remained outstanding. This move effectively completes AEI’s exit from Redwire.

AEI’s ties to Redwire appear in several SEC filings. The 2026 proxy statement shows that the Edge Autonomy seller is an AEI-affiliated party, which received nearly 50 million Redwire shares as part of the deal. In August 2025, Redwire filed a registration statement allowing existing shareholders to sell their shares. AE Industrial Partners and its affiliates planned to sell roughly 79.5 million shares and 2 million warrants. Even after those sales, they would still own about 35.6 million shares. Importantly, Redwire would not receive any proceeds from these sales as the money would go directly to the selling shareholders.

The Space-Strawberry Thesis

On June 4, 2026, three days after Jefferies downgraded the stock, and the same week AEI was selling hundreds of millions of dollars of common stock into the rally, Redwire issued a press release announcing a contract to grow wild strawberries in space. The stock went up 19%. This is the valuation framework Redwire’s investors are operating under.

Growing strawberries in space does not generate revenue. A strawberry grown in orbit is worth exactly as much to a Redwire common shareholder as a strawberry grown in a garden in Jacksonville, Florida… which is to say, nothing.

There is no dollar figure attached to this transaction in any public documents. The most telling detail about Redwire’s so-called “greenhouse partnership” is that the technology was co-developed with Tupperware Brands, a company that filed for Chapter 11 bankruptcy in September 2024. Redwire’s world-first commercial space greenhouse is, in the most technically accurate description possible, a Tupperware container bolted to the International Space Station.

Redwire partnership with Tupperware (TUP, no longer listed on Nasdaq)

The counterparty on this “landmark & breakthrough” commercial announcement is Astrobiome Space, a Luxembourg based startup that makes “super-postbiotics” and proprietary microbial extracts called “Champion Strains.” Astrobiome Space has no disclosed revenue, no disclosed contract history, and no disclosed valuation. Redwire did not disclose the contract value either. The stock price has bled out from roughly $22 to now $11 in just two weeks after that announcement which confirms the bearish assessment of the undisclosed contract details.

At the end of the day, Redwire is a company with $698 million in accumulated deficit, an adverse KPMG opinion, $776 million in goodwill never tested for impairment, a board controlled by a sponsor that converted its preferred at $3.05 and sold into the high 10’s, and a stock that went up 19% the day it announced a no-value contract to grow strawberries in a Tupperware container for a Luxembourg probiotic startup that makes something called Champion Strains. In a sector that runs on pure hype and wishful thinking, this “contract” definitely wins as the most ridiculous type of PR we have come across.

Governance Issues and Class Action Lawsuits

Another concern are shareholder investigations launched by prominent plaintiff firms, including Kaskela Law, Grabar Law, and Robbins LLP, which exposes a pattern of alleged deception and systemic corporate malfeasance at Redwire. The complaints charge Redwire and its senior executives with actively fabricating a narrative of robust governance and integrity while deliberately concealing severe, pervasive breakdowns in the company’s internal control over financial reporting (ICFR). This deceptive campaign culminated between late 2021 and 2022, when management was forced to abruptly postpone earnings, confess to “potential accounting issues” at a subunit, and ultimately admit to even deeper, unaddressed ICFR failures.

The roots of this systemic deception trace back to the company’s pre-merger phase, where firms like Brodsky & Smith and Hagens Berman alleged that Redwire, and its leadership, issued false and misleading statements leading up to and following its September 2021 SPAC merger with Genesis Park Acquisition Corp. To win investor confidence, management allegedly touted a dedication to conducting business with efficiency, fairness, and integrity. In reality, leadership was actively hiding structural flaws in how they tracked revenue, specifically at their business subunit, LoadPath. Legal complaints detailed that LoadPath completely lacked standard internal accounting control procedures, allowing leadership to engage in improper revenue recognition to artificially inflate revenue and present a false image of rapid, robust growth following the public listing.

Despite knowing about these pervasive material weaknesses in their ICFR, executives desperately sought to hide them from the public. Because of these unaddressed control gaps, plaintiff firms asserted that all of management’s positive forward-looking statements regarding Redwire’s operations, business prospects, and integration success completely lacked a reasonable factual basis. According to a Bloomberg Law report, investors successfully advanced a relatively novel legal theory demonstrating that senior leaders willfully fostered a corporate environment where ethical financial standards were disregarded to shield executive interests and keep stock values artificially high. This systematic deception abruptly unraveled on November 10, 2021, when an internal whistleblower report forced management to delay their Q3 earnings. This disclosure, followed by subsequent admissions of further ICFR failures, caused a devastating multi-day stock plunge that destroyed significant shareholder value.

These damning episodes reveal a toxic “tone at the top” and a deceptive disclosure culture, laying bare allegations that senior leadership knowingly masked critical control failures to mislead investors and protect their own interests. Ultimately, these extensive legal battles culminated in Redwire agreeing to pay an 8 million dollar class-action settlement to resolve the claims of hidden accounting irregularities and failed internal controls.

This is material, and a mere four years later, KPMG, one of the most respected auditing firms in the world, issued a scathing opinion of Redwire’s financial controls, which is the core issue that resulted in the earlier litigation issues. As such, the chances of future shareholder legal action is far from zero.

Source: Redwire Corporation Securities Litigation, Case No. 3:21-cv-01254 (M.D. Fla.) — Stanford Securities Class Action Clearinghouse, Case ID 107845. Filed December 17, 2021. Settled November 15, 2024.

Top Analyst Downgrading concurs with our sentiment

The Jefferies downgrade on June 1st, 2026 is the most useful third party information in this report as it agrees with our thesis. As Jeffries now believes that the stock has run too far to keep going and which has now become a valuation concern.

While the downgrade went from BUY to HOLD, this is rarely a good signal, as it signals investors that the stock has run out of fuel, as it now has no fundamentals, no story behind to run with, and which smart money will now usually get out, while leaving FOMO chasers with heavy losses. The downgrade marked the beginning of the end of the rally which double-topped almost exactly at previous all-time highs at $26 from the 2025 January run. Analyst downgrades in a sector mania such as space, where investors are excited to buy without much discernment is a terrible sign. The stock has been in freefall ever since.

Schwab Thinkorswim Chart showing RDW January 2025, June 2026 double top

This can be corroborated as Multiple Form 144 filings showed that a major holder or RDW insider was preparing to sell restricted shares . As AEI converted the entire stack of preferred shares into more than 15 million of common stock while selling every single share into the open market at prices ranging between $13 to $16.

The Fugazi Verdict

We believe the evidence presented throughout this report points to a company whose governance, incentives, and capital allocation decisions have consistently favored its controlling sponsor over its common shareholders. As long as those incentives remain unchanged, investors should expect the same pattern to continue. The question is not whether another acquisition, another capital raise, or another promotional narrative will emerge. The question is who will ultimately bear the cost when those strategies can no longer sustain the valuation? In our view, that burden is likely to fall on Redwire’s common shareholders.

At the end of the day Redwire is the same company with the broken internal controls that triggered a securities class action in 2021 and which remain unsolved up to date. The same governance failures that were settled for zero monetary recovery that should have been in the first place is the company that now tries to sell new narratives, hype new PR’s all while maintaining a massive deficit. The same sponsor that structured the SPAC, controlled the board, sold the Edge Autonomy acquisition to Redwire at a valuation its own goodwill balance may never justify is the same sponsor that retains board control, nomination rights, and the contractual ability to force a sale process at a time of its own choosing. Now the stock is trading at a very premium multiple to a business that has never generated positive cash flow, has a horrible auditor opinion on its own internal controls, and has funded all of its public existence by pure shareholder dilution. The filings show a company in which no intelligent investor would put his/her hard earned money in, but a pure capital extraction vehicle doomed from the beginning. For this reason Fugazi research considers RDW shares merely speculative and of no fundamental value.

Disclosure

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our,”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority.

All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions-long, short, or otherwise-in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

Executive Summary

FreeCast, Inc. has become another speculative microcap momentum vehicle whose stock price has detached from the business’s financial reality. On paper, the company wants to project an image to investors and present itself as looking to the future of streaming. The company talks about streaming aggregation, advertising technology, telecom partnerships, sports distribution, platform services, and a massive addressable market. On paper, it sounds like a company operating at a massive scale, a “massive” scale that translates to $600k of revenue a year in a highly competitive sector in which the company provides absolutely NO moat, NO differential factor, and NO advantage over its competitors.

CAST recently traded between approximately $0.64 and an intraday high of $12.20 over just a few trading days. At that high, the market briefly valued FreeCast at several hundred million dollars. With the entire market suddenly obsessed with SpaceX and Starlink, FreeCast became one of the first companies to capitalize on the frenzy. A June 18th press release referencing Starlink was enough to ignite a speculative frenzy; the same day, more than 100 million shares changed hands as the stock doubled.

Buried beneath the headlines sits a detail many investors probably never considered. Unlike a traditional IPO, FreeCast entered Nasdaq through a direct listing, a structure that creates ZERO lockup periods, allowing for immediate liquidity and dilution for existing shareholders, while bringing no meaningful operating capital into the business itself. Whilst traders chased headlines, FreeCast continued operating with just $119,302 of cash, over $10 million in cumulative losses, and a $50 million equity facility quietly waiting in the background.

The complete filings tell the whole story, for the latest quarter ending March 31st, 2026, FreeCast generated just $92,909 in revenue while losing more than $4.5 million. That’s nearly $49 lost for every dollar brought in. Its latest nine-month revenue totaled just $350,859, which is less than the annual sales of your favorite local restaurant. FreeCast’s recent SEC filings flag “substantial doubt” about the company’s ability to continue as a going concern, given minimal cash, recurring losses, and dependence on new capital raises.

We believe the market is currently valuing potential headlines and trading mechanics, while being completely disconnected from fundamentals. The filings show something very different: a capital-starved company that has relied on related-party funding, converted debt, preferred stock, warrant amendments, and an equity purchase agreement to keep the story alive and maintain market access. CAST is streaming a dream, the filings are streaming reality. We view CAST shares as extremely overvalued and fundamentally of ZERO value.

Fugazi Research Analysis

• FreeCast trades at a 579x P/S ratio, that’s a multiple you’d expect to see on a company doubling revenue every quarter with a clear path to dominating its category, not one whose revenue just fell 15% year-over-year, whose own filings carry a going-concern qualification, and whose cash balance wouldn’t cover a week of payroll without the CEO writing himself another check. Strip away the Starlink headline, and the market is paying $579 for every $1 of sales in a company that’s never once turned a profit.

• The Starlink Business agreement itself (the reason why the stock started trading higher), per available disclosure, is a non-exclusive reseller arrangement with no disclosed minimum purchase commitment, contract value, or revenue target. Despite the market reaction, it was a transformative catalyst for a company that had disclosed substantial doubt about its ability to continue operating for the next 12 months.

• FreeCast’s continued operation is financed almost entirely by its own controlling shareholder. CEO William Mobley and his majority-owned entity, Nextelligence, supplied the substantial majority of the company’s external financing over the trailing nine months via a revolving convertible note.

• The terms of the insider financing moved in the lender’s own favor immediately after quarter-end. The Nextelligence revolving note converted from a fixed $8.00 conversion price to a floating price tied to the prior day’s closing price, and Nextelligence began converting at that lower, self-set price within days of the change, a related party renegotiating the terms of its own debt, in its own favor, with itself effectively on both sides of the transaction.

• A $120,000,000 liquidation preference sits ahead of all common stockholders via the Series A Preferred Stock, held by Nextelligence. The preference is explicitly benefiting Nextligence, meaning Mobley’s holding company would be paid out ahead of public Class A and Class B holders in the event of an acquisition.

• Voting control is structurally locked to one person, as Class B common stock carries 15 votes per share and, by the company’s articles of incorporation, can only be issued to or held by CEO Mobley. That structure alone delivers roughly 88% of total voting power to the CEO, independent of his economic ownership stake.

• FreeCast’s “revenue” isn’t really revenue from customers; it’s Mobley billing himself. Celebrity Cigars, where he’s the sole director and his son works, accounted for over a third of quarterly sales. When Celebrity Cigars and Test Drive Live couldn’t cover what they owed FreeCast, Nextelligence (Mobley’s other company) quietly paid it off for them, then booked the payoff as a brand-new loan FreeCast now owes back to Nextelligence. So the CEO’s holding company pays his other companies’ bills to a third company he also controls, and FreeCast comes out the other end deeper in debt to him for the favor, a blatant circular money play.

• The $50,000,000 equity line of credit, priced at 95% of five-day VWAP, became drawable on May 6, 2026, just ahead of a string of promotional announcements (an expanded DIRECTV partnership on June 11, a Starlink Business reseller agreement on June 18) that drove the stock up sharply on thin disclosed deal economics.

• Investor appetite for FreeCast stock, even on insider-favorable terms, has recently proven to be extremely thin. When the board repriced 6.7 million warrants to a deep in-the-money strike just weeks before the Starlink rally, the overwhelming majority still expired unexercised, a real-world demand test that the subsequent narrative-driven spike doesn’t appear consistent with.

• Freecast is a balance-sheet-insolvent company kept alive almost entirely by its own CEO’s debt, voting-controlled by that same CEO at a structural 88%, with $120 million of insider preferred stock standing ahead of every public shareholder in any exit. The Starlink and DIRECTV headlines didn’t change the balance sheet; they are mere PR’s manufactured to lure hype shareholders into buying a stock with no fundamental value. For this reason, Fugazi Research considers Freecast uninvestable at any price above ZERO.

Financial Summary

• Cash of $119,302 against nine-month cash used in operating activities of $8,083,926 (average $898,214 per month), implies less than a week of cash runway at the current burn rate, absent additional financing.

• FreeCast trades at a price-to-sales ratio of approximately 579x. For context, software companies with sustained revenue growth and expanding margins rarely sustain multiples above 30x.

• Working capital deficit of $7,285,937 (current assets of $622,847 against current liabilities of $7,908,784).

• Of $7,670,043 raised through financing activities in the nine months ended March 31, 2026, $4,970,043 (64.8%) was sourced from CEO William Mobley or his controlled entity, Nextelligence; $2,700,000 (35.2%) came from third-party Class A stock purchases.

• Nine-month revenue declined 15.2% year-over-year, from $413,837 to $350,859; subscription revenue declined 54% over the same period.

• With a nine-month net loss of $10,180,305 against total revenue of $350,859, the company lost $29 for every $1.00 it earned.

• Accumulated deficit of $205,415,506 exceeds total additional paid-in capital of $198,414,784 by $7,000,722 (103.5% of all capital ever raised by the company has been lost.)

• Revenue per subscriber, excluding FAST and ad revenue, declined from $0.12 to $0.05 over the trailing nine months (a 58.3% decrease).

• Interest expense of $194,969 for the nine months equals 55.6% of total revenue (up 23.8% year-over-year), driven entirely by interest accruing on debt owed to the CEO’s own entity

• The company issued 6,743,587 warrants to 137 accredited investors at $4.25 per share. When 96.3% expired unexercised, the board repriced the strike to $1.33 and extended the deadline. After the reprice, 96.3% still expired unexercised. Two investors exercised, generating $332,500 in proceeds.

Source: FreeCast, Inc. Form 10-Q, quarterly period ended March 31, 2026. Filed May 15, 2026.

Source: FreeCast Inc. Form 8-K, filed May 28, 2026.

The Unsubstantial Starlink “Reseller” Agreement

On June 18, 2026, FreeCast issued a press release announcing a reseller agreement, which is actually more like a third-party affiliate for Starlink Business services (It’s the equivalent of a small travel agency getting approved to book Delta flights), sending CAST shares up as much as 170% intraday on volume of approximately 61 million shares. The entire document contains no disclosed contract value, no minimum purchase commitment, no exclusivity provision, no revenue target, and no signed customer. What it does contain is eleven bullet points of markets FreeCast “intends to target,” eleven bullet points of solutions customers “may gain access to,” and eleven bullet points of revenue streams the combined offering “may enable.”

When our team signed up for a FreeCast profile, the emails went directly to spam, and it’s unclear how to sign up for their services. If someone wanted to get Starlink, why would they choose FreeCast as their source? Nothing on their website insinuates that anyone can order StarLink services.

Additionally, SpaceX/Starlink has not announced anything whatsoever about FreeCast being affiliated with them. No binding commitment from SpaceX to FreeCast beyond reseller status is disclosed. Starlink Business reseller agreements are available to qualifying commercial partners on a broad basis; this is not a joint venture, a technology integration, or an exclusive distribution arrangement. It is permission to resell a third-party product. FreeCast is just using this non-event to spark hype on the stock price. This contributed to the company’s market cap surpassing $400 million at its current peak, which will inevitably come crashing down once reality sets in.

The $400 million Disconnect

On June 18, 2026, FreeCast’s implied market capitalization crossed $400 million on the back of the hype-ridden Starlink reseller press release. To understand how disconnected that number is from the underlying business, consider what $400 million is actually being assigned to.

Above: The corporate headquarters of a $400 million “industry innovator,” looking more like an executive office on the back of your local Best Western.

FreeCast’s total assets as of March 31, 2026, were $1,121,579. Its cash position was $119,302. Its accumulated deficit was $205,415,506. The company’s own auditors filed a going concern qualification before the stock moved. At the peak intraday price, the market was valuing FreeCast at roughly 356 times its total assets, and approximately 3,367 times its cash on hand, an insane disconnection from its true valuation, which only highlighted that the price was running on fumes.

There is exactly one analyst covering CAST. That analyst is Maxim Group’s Allen Klee, who maintained a Buy rating with a $6.00 price target in May 2026. Notably, Maxim Partners received 125,000 shares of FreeCast Class A common stock, valued at $1,000,000, as compensation for advising on the company’s direct listing.

The Direct Listing Did Not Fix the Balance Sheet

FreeCast’s March 2026 Nasdaq listing was not a traditional IPO; it was a direct listing. Investopedia points out that “Companies choose a direct listing over a traditional IPO to mostly avoid hefty underwriter fees and bypass 180-day insider lock-up restrictions.”

This is important to note because Nextelligence Inc. owns over 25 million of the 41.5 million outstanding shares. Because the company is a direct listing as of March 10th, 2026, Nextelligence Inc. has no lockup restrictions and could dump its shares at any time. If CAST were a traditional IPO, there would be a 180-day lockup at a minimum, and the supply could not dump before then. In this situation, with CAST being a direct-listing stock, the 25 million Nextelligence Inc. shares could be dumped at any time. (Mobley sold 87,500 shares at $4/share; 200,000 shares at $6/share; and 218,750 shares at $8/share).


Source: AskEdgar CAST dilution tab

In a typical IPO, a company sells newly issued shares and raises cash. In FreeCast’s direct listing, the prospectus registered shares for resale by existing shareholders. FreeCast stated that it would not receive proceeds from the sale of shares by registered shareholders.

This is critical because FreeCast entered the public market with an already-stressed balance sheet. The company had only $433,363 of cash as of December 31, 2025. It had $4.8 million of total liabilities. It had an accumulated deficit of $200.9 million. Its own filings raised substantial doubt about its ability to continue as a going concern.

The latest Form 10-Q shows that the balance sheet stress did not improve after the listing. As of March 31, 2026, FreeCast had only $119,302 of cash, $8.12 million of total liabilities, a $205.4 million accumulated deficit, and a $6.99 million stockholders’ deficit.

A direct listing creates public trading, but it does not automatically create operating liquidity. Most of the public is unaware of the toxic nature of CAST’s direct listing. Most retail investors and traders do not even know the difference between an IPO and a direct listing. As CAST is trading over 3000% from its initial runup from .50, most traders and investors caught up in the hype, sounding press releases about StarkLink, etc., do not even know that a massive amount of shares can be dumped on them at any moment since CAST is a direct listing stock with no lockups. Investors may be treating CAST as if a Nasdaq listing itself validates the business, which it does not. The Nasdaq listing status provides the company with a public currency, increases trading visibility, and may help it access capital. However, the underlying financial condition remains unchanged unless capital is actually raised.

FreeCast’s direct listing appears to have done two things particularly well. First, it created a public trading vehicle. Second, it provided existing holders with a path to liquidity. It did not meaningfully change the company’s operating economics, which is important to note after a parabolic move in a stock’s price. A company with minimal revenue, limited cash, and a newly created public market can see violent price swings. However, volatility does not equal fundamental value.

Related-Party Transactions Are Central to the Story

FreeCast’s related-party arrangements are not incidental to the business. They are the business. The company’s core technology, its primary financing, and a material portion of its reported revenue all flow through entities owned or controlled by the same person: William A. Mobley, Jr., FreeCast’s founder, CEO, Chairman, and the beneficial owner of 93.1% of the company’s outstanding shares.

Nextelligence (corporation wholly owned and controlled by Mobley) holds the revolving convertible promissory note (bearing 12% annual interest, convertible into Class A shares at Nextelligence’s sole discretion) that has functioned as FreeCast’s primary and only lifeline. Mobley, through Nextelligence, lends money to FreeCast at 12% interest. When the stock rises, whether from a Starlink press release, a DIRECTV announcement, or any other catalyst, Nextelligence can convert debt into equity at or near the elevated price, receiving shares worth more than the debt extinguished. Those shares, once issued, can be sold into the market.

Mobley benefits as a lender through interest accrual, as a converter through share issuance at favorable prices, and as a majority shareholder through any valuation narrative that supports a higher stock price. All while eliminating all checks and balances to the transaction, as he controls the entire structure through 93.1% beneficial ownership of a company whose board cannot meaningfully check any transaction he proposes, because he controls the votes required to approve it.

Calling it what it is, Mobley built a company, made himself the landlord, the banker, and the majority shareholder all at once, and then started charging his own company 12% interest to stay alive. Every dollar FreeCast borrows from Nextelligence puts money in Mobley’s pocket twice… once as interest while the debt sits on the books, and again when he converts that same debt into shares at whatever price he negotiates with himself.

The Revenue Base Is Almost Nonexistent

FreeCast’s business description reads like a company operating across every large addressable market simultaneously (streaming aggregation, advertising technology, FAST channels, telecom partnerships, broadband operators, multifamily housing, and sports distribution). In reality, the company’s whole business model is hanging for on dear life.

For the three months ended December 31, 2025, FreeCast reported total revenue of $62,090. For the six months ended December 31, 2025, total revenue was $257,950. That is the entire commercial output of a company that was briefly valued at over $400 million by the market. But the story doesn’t end there, the company is currently on a spiral of shrinking subscription revenue, in all of its fronts. Subscription revenue declined 51% for the six-month period, FAST revenue declined 29%, and Ad Revenue declined.

Above: Revenue recognition disclosing shrinking numbers in all fronts.

If FreeCast were a private company approaching institutional investors with these metrics, it would not be discussing a $400 million valuation. It would be discussing survival terms, conversion discounts, and whether the existing capital structure could be restructured into something a rational investor would touch. However, in the public market, momentum traders briefly assigned it disproportionate valuation on the back of press releases with no disclosed contract value, no minimum commitments, and no signed customers, something worth of a company which thatdefinitely crash when fundamentals arrive.

The Controlled-Company Structure Weakens Minority Shareholder Protection

FreeCast has two classes of common stock. Class A common stock carries one vote per share. Class B common stock carries 15 votes per share. Class B shares may only be issued to and held by William A. Mobley, Jr. and certain permitted entities owned and controlled by him.

The company also disclosed that it qualifies as a controlled company under Nasdaq rules because William Mobley holds a majority of the combined voting power. Controlled-company status allows FreeCast to rely on exemptions from certain Nasdaq corporate governance requirements. Public shareholders buying Class A stock after a speculative run may have economic exposure, but they do not have meaningful governance influence. In practice, FreeCast remains under the control of its founder.

Controlled-company structures are not inherently improper. Many large companies have dual-class stock. But when combined with related-party transactions, going-concern language, minimal revenue, and a parabolic move in a microcap stock, we believe the governance structure warrants greater scrutiny.

Investors are not buying a clean, institutionally governed public company with a long operating history and mature financial controls. They are buying a newly publicly controlled company in which the founder’s voting power, related-party financing, and technology relationships are central to the story.

The $50 Million Equity Purchase Agreement Is the Real Financing Backstop

FreeCast entered into an equity purchase agreement with Amiens Technology Investments, LLC in December 2025. Under the agreement, FreeCast has the right to sell up to $50 million of Class A common stock over a period of up to 36 months following the direct listing. This is the financing machine investors should focus on.

CAST’s filings state that the company entered into the equity purchase agreement to provide a flexible source of potential liquidity. The company also disclosed that issuances under the agreement may result in substantial dilution, and the investor resales may cause the stock price to decline. This is exactly the risk.

The company has a going-concern warning. The company has minimal cash and has large operating losses relative to revenue. They’ve stated that they expect to seek additional funding through debt or equity financing.

The equity line provides a potential path to raise cash, but not without dilution. This is why the stock’s recent run is so important- the rising share price can make equity financing more attractive. It can also create the conditions for the company to issue stock into the market liquidity.

The existence of the equity line is significant because the company’s financial condition makes future equity highly plausible. The real risk for retail investors chasing the move is that today’s momentum can easily become tomorrow’s exit liquidity.

The Warrant Amendment Was Not a Sign of Strength

In April 2026, FreeCast issued warrants to 137 accredited investors to purchase up to 6,743,587 Class A shares at $4.25 per share. In May 2026, the board amended the warrants by reducing the exercise price to $1.33 per share and extending the expiration date.

Only two investors exercised, and FreeCast issued 250,000 shares, receiving $332,500 of proceeds. The remaining 6,493,587 warrant shares expired unexercised and returned to authorized but unissued status. Some investors may have interpreted the expiration of warrants as a positive because it removed a near-term overhang. We believe that misses the more important point, which is broken down as follows:

The company lowered the exercise price from $4.25 to $1.33 to encourage exercise, yet only a tiny portion of the potential warrant shares were exercised. That suggests limited willingness among warrant holders to put additional capital into the company, even at the reduced price.

The expiration of warrants may reduce one specific near-term source of dilution. However, it does not solve the company’s capital problem. FreeCast still has a going concern warning, minimal revenue, and an equity purchase agreement, with a constant need for capital.

We believe the warrant amendment should be viewed as evidence of funding stress, not evidence of financial strength.

The DIRECTV and FPUnet Headlines Sound Larger Than the Filings

FreeCast’s recent news cycle included agreements with DIRECTV Multifamily and FPUnet Communications to make CAST’s platform available to more than 30,000 homes in the Fort Pierce region.

The DIRECTV announcement states that FreeCast is authorized to market and sell DIRECTV streaming services in multifamily housing. No financial terms were disclosed. The FPUnet announcement describes FreeCast’s platform being made “available” to subscribers across a service footprint. The reported economics are not visible in the filings.

These announcements sound commercially relevant, but investors should distinguish between the ability to offer service and actual reported revenue. A distribution agreement is not synonymous with high-margin recurring revenue. A platform simply being made available is not the same as real consumer adoption.

We believe these types of announcements are useful for momentum, but insufficient for valuation. The stock market may reward headlines in the short term. Eventually, the numbers have to show up.

CAST has yet to show that these announcements are translating into meaningful revenue.

The Regional Sports Narrative Looks Like Another Story: Searching for a Business

One of FreeCast’s latest pitches to investors is its Regional Streaming Sports Channel initiative, an effort to position the company as a solution for the ongoing collapse of traditional regional sports networks.

At first glance, the story sounds compelling. Regional sports networks are under pressure. Teams are searching for new distribution models. Consumers are increasingly moving away from cable bundles. Those trends are real.

The problem is that FreeCast appears to be marketing itself as a participant in a market it has not yet demonstrated any meaningful ability to penetrate.

Sports distribution is not a business that rewards ambition alone. It requires rights agreements, production infrastructure, distribution scale, advertiser relationships, customer acquisition, and most importantly, capital. Lots of it. Sports media is one of the most competitive and expensive industries in the world, attracting competition from billion-dollar broadcasters, technology giants, streaming platforms, and telecommunications companies.

FreeCast generated just $350,859 of revenue during the first nine months of fiscal 2026. That figure is difficult to reconcile with management’s apparent desire to become a meaningful player in the sports media ecosystem.

The company frequently speaks about opportunities, partnerships, markets, and future potential. What remains notably absent are signed rights agreements, meaningful recurring revenue, or any evidence that sports organizations are choosing FreeCast over larger, better-capitalized competitors.

Investors should remember that there is a significant difference between identifying an industry trend and building a business capable of monetizing it. Every struggling microcap eventually finds a large narrative to latch onto. Artificial intelligence. Crypto. Space. Quantum computing. Streaming. Sports. The theme itself may be legitimate, but that does not mean the company promoting it has earned a place within it.

From our perspective, FreeCast’s sports initiative looks less like a business segment and more like another attempt to attach the company to an attractive headline. Until investors see actual economics, actual contracts, and actual revenue, we believe the regional sports narrative belongs in the same category as the rest of FreeCast’s promotional material: ambitious, speculative, and unsupported by the company’s financial reality.

The Series A Preferred Stock Creates Another Layer Above Common Equity

FreeCast has 4,000,000 shares of Series A Preferred Stock outstanding. The Series A Preferred has no voting or conversion rights, but it carries economic preferences that common shareholders should understand. If the company generates more than $50 million of revenue in a fiscal year, the Series A holder is entitled to receive an annual cash dividend equal to 10% of revenue above $50 million until aggregate dividend payments reach a maximum threshold. The Series A Preferred also has a liquidation preference of $30 per share.

The company disclosed that Nextelligence forfeited and canceled 20,000,000 Class A shares in exchange for 4,000,000 Series A Preferred shares. This structure is important because common stock investors are not the only economic claimants on future upside. This upside is most likely nothing but a pipe dream, and if FreeCast does not achieve that scale, common shareholders are still exposed to dilution, operating losses, and financing risk.

In other words, public common shareholders appear to face the downside of the current funding needs while insiders and related parties retain significant structural claims.

The Valuation Requires a Business That Does Not Yet Exist

When CAST opened up at $12.20 per share on 6/18/2026, it briefly traded as if FreeCast were already a meaningful public streaming technology company. Hours before the open, the company issued a press release about its Starlink reseller deal, sending its shares up as high as $16.20 in the premarket. The stock began to sell off right at the open, indicating the Starlink news was more of a sell-the-news, liquidity event, highly likely marking the beginning of the end to the big run-up from $.50 to $16.20.

Since CAST is a direct-listing stock, Nextelligence Inc., which owns 25 million shares, could begin dumping as much of its position as it would like, since it has no lockups preventing it from waiting the usual 180 days. The volume of Starlink news likely triggered a liquidity event, with more selling imminent.

The filings reveal what this company really is: A massive opportunity and vehicle for insiders to get rich. FreeCast’s latest six-month revenue was $257,950. Its latest six-month operating loss was $5.6 million. Its cash was $433,363. Its accumulated deficit was $200.9 million. Its stockholders’ deficit was $3.5 million.

To justify even a fraction of the recent valuation, FreeCast must rapidly convert partnerships and platform announcements into material revenue. It must stabilize advertising monetization. It must fund operations without crushing dilution. It must prove that related-party revenue is not masking weak third-party demand. It must scale into markets where far larger companies are already competing.

The bullish case requires several things to go right at once. The bearish case requires only that the filings continue to matter.

We believe the most likely path is continued dilution, continued volatility, and eventual repricing toward a valuation that reflects the company’s actual revenue base and financing needs.

Conclusion

FreeCast’s recent rally has created the appearance of a rapidly emerging streaming technology company. The filings tell a very different story. Beneath the Starlink headlines, DIRECTV announcements, regional sports ambitions, and broadband partnerships sits a company that generated just $350,859 of revenue over the last nine months while losing more than $10 million. The company ended the latest quarter with only $119,302 of cash, a working capital deficit exceeding $7 million, and auditors expressing substantial doubt about its ability to continue as a going concern. Despite briefly achieving a market capitalization exceeding $400 million, FreeCast has yet to demonstrate meaningful commercial adoption, meaningful operating scale, or any credible path to profitability.

What makes FreeCast particularly concerning is that nearly every road eventually leads back to William Mobley. The company’s primary lender is Mobley through Nextelligence. The preferred stockholder ahead of common shareholders is Mobley through Nextelligence. The controlling shareholder is Mobley. Mobley controls approximately 88% of the voting power. A material portion of reported revenue is tied to entities controlled by Mobley. Even the technology underpinning the business originates from an entity controlled by Mobley. Public shareholders are not investing alongside an aligned founder whose interests rise and fall with theirs. They are investing beneath a structure in which one individual appears positioned to benefit, regardless of whether common shareholders ever realize a return.

As the stock price rises, that structure becomes even more advantageous for insiders. Debt can be converted into equity. Equity can be sold into market enthusiasm. The company has access to a $50 million equity facility. Nextelligence faces no traditional IPO lockup restrictions. Mobley himself faces no traditional IPO lockup restrictions. Unlike public shareholders, who buy into the narrative, insiders can identify rather than depend on it. The recent surge in CAST has not solved the company’s financial problems. It has simply created a more attractive environment for capital raises, debt conversions, and insider liquidity.

Investors should remember that FreeCast did not go public through a traditional IPO. It entered the market through a direct listing. The same structure that avoided underwriter fees and lockup restrictions also created an immediate path to liquidity for existing holders. While retail investors chase headlines and momentum, more than 25 million shares controlled by Nextelligence remain eligible for sale. The company itself continues to require financing. The equity line remains available. The need for capital has not disappeared simply because the stock price moved higher.

The Starlink reseller agreement did not solve the revenue problem. The DIRECTV partnership did not solve the revenue problem. The sports streaming narrative did not solve the revenue problem. The balance sheet remains impaired. The company remains deeply unprofitable. The cash position remains critical. The need for additional capital remains unavoidable. What changed was not the business. What changed was the story.

Ultimately, we believe investors are assigning hundreds of millions of dollars in value to a business that has failed to prove demand, scalability, profitability, or its ability to survive without continuous access to outside financing. The market is valuing FreeCast based on what management claims the company could become, while the financial statements reveal what it actually is.

History is full of microcap companies that briefly became stories before ultimately becoming financings. Based on FreeCast’s financial condition, insider-controlled structure, dependence on external capital, and long history of value destruction, we believe the company is far more likely to continue enriching insiders than creating value for public shareholders. Fugazi Research believes CAST’s recent valuation bears no resemblance to economic reality and that the stock is fundamentally worth ZERO.

Disclaimer

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority.

All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions, long, short, or otherwise, in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

Subscribe now

Share

The publicly traded space sector is not an industry but a collection of dreams that are too absurd to actually come true. The commercial space sector now sits above $500 billion in market value, yet most of it is concentrated in companies that generate little cash, rely on continuous dilution and capital raises to survive, and depend on technological milestones still decades from commercial viability.

A parade of capital-intensive thought experiments has plagued the industry, ranging from asteroid mining and lunar real estate to orbital data centers. While often presented as transformative business opportunities, these concepts frequently lack a compelling economic rationale beyond the story itself. Rather than solving meaningful problems more efficiently than Earth-based alternatives, they introduce enormous costs, operational hurdles, and uncertain demand, all while offering little evidence of a defensible competitive advantage. The result is an ecosystem where compelling narratives often receive more attention than basic questions of economic viability.

Three catalysts will close the price-to-reality gap. First, the SpaceX drain: generalist capital exits proxy positions to own SPCX directly, removing the single largest source of speculative demand from the public names. Second, the hardware reckoning: the New Glenn explosion reminded a retail-dominated shareholder base that rockets are not software. Hardware failures destroy expensive assets instantly and set timelines back by months, years, or permanently; such was the case with the Concorde, which was forever grounded. Third, the dilution spiral: pre-revenue companies burning hundreds of millions annually will repeatedly return to equity markets on progressively worse terms until they cannot do so.

The sector’s valuation FOMO rests on a single event horizon… the SpaceX IPO. The smart money consensus is to buy the public proxies before the private giant goes public and exits into the IPO. SpaceX is already priced at $135 per share, implying a $1.75 trillion valuation. The space sector has followed the same familiar pattern as the AI boom and EVs: a genuine technological opportunity, a very long timeline, a market that collapses that timeline to zero, and a financial reckoning when reality hits. The space stocks covered in this short report are highly likely to become defunct in the near- to long-term. Past hypomanias, such as the 1999 dot-com boom-and-bust, serve as examples. From the internet mania, very few stocks actually ended up doing anything in the long term. Almost all of those who went along for the ride soon ended up with little to no return on investment.

Fugazi Research believes the sector’s current valuations bear little resemblance to the economic realities of the underlying businesses and considers the majority of publicly traded space-sector companies to have no fundamental value.

Fugazi Research Analysis

• The sector’s entire valuation was built on a single assumption (that SpaceX’s inevitable IPO would re-rate the public proxies upward); however, this is about to be proven otherwise when SpaceX begins trading under SPCX, giving capital direct access to the only space company with actual revenue, actual launch dominance, and actual recurring cash flows, eliminating the structural reason to hold any of the six companies in this report at any premium above their standalone fundamental value.

• The sector’s combined market capitalization of $33.2 billion rests on $361 million in combined trailing revenue, of which $295 million belongs to a single company (ASTS) that trades at 95x those revenues, leaving the remaining five with $66 million in combined sales against a $5.24 billion collective market cap, a combined price-to-sales ratio of 79 times against a sector median of 4.4 times, which showcases capitalized wishes instead of true growth premiums.

• The sector’s primary revenue model is not commercial operations but the recycling of capital from public shareholders through related-party structures, government contracts with no path to commercial scalability, and one-time engagements that management describes as pipelines and projected recurring revenue but whose primary source filings reveal as single-customer dependencies that collapse the moment one contract ends.

• Every company in this cohort carries a going concern qualification, a material weakness disclosure, or a formal auditor warning about the adequacy of capital to fund twelve months of operations, and every one of them has responded not by generating revenue, but by issuing more shares. A recurring and red-flag-raising pattern across the majority of the space sector.

• The sector’s business plan portfolio reads as a list of sci-fi wishes rather than a collection of investable commercial opportunities: asteroid mining operations targeting metallic rocks twenty-two million miles from Earth with a combined success rate of zero missions across three attempts; microgravity pharmaceutical crystal growth for drug companies that have not confirmed commercial orders; orbital data centers whose theoretical latency advantages exist in no anchor tenant agreement or signed contract visible in any SEC filing; lunar real estate conveyed under legal frameworks no sovereign government has ratified; and, as of June 4, 2026, a contract to grow strawberries aboard the International Space Station for a Luxembourg biotech company whose founder’s stated ambition is to taste Earth from Mars.

• The single most reliable financial signal in the publicly traded space sector is not revenue growth, backlog expansion, or launch cadence; it is the reverse stock split, a mechanism deployed exclusively by companies whose share price has declined to levels triggering Nasdaq delisting requirements and which accomplishes nothing operationally while resetting the clock on the next round of dilution at a higher nominal price.

• Fugazi Research has reviewed the filings, the mission statements, the backlog disclosures, the related-party footnotes, the going concern qualifications, the reverse split histories, the ATM prospectuses, the asteroid mining roadmaps, the orbital strawberry contracts, and the press releases of companies that renamed themselves space businesses eleven days before publication, and from all this we have come to the following conclusion: the publicly traded space sector, in aggregate, is not an industry in the conventional sense of the word but a capital recycling mechanism dressed in the aesthetic of human ambition, sustained by retail enthusiasm, narrative momentum, and fundamental valuation that, if taken in all seriousness, amounts to zero.

Financial Summary

• ASTS (AST SpaceMobile): Despite $3.9B in cash, the company is a cash-burning machine, spending $191M net loss in Q1 2026 alone. Shelf registrations enable massive future dilution; launch delays cast doubt on 2026 guidance; current valuation ($28B+) assumes flawless execution of an unproven business model.

• ASTS reported Q1 2026 revenue of $14.7 million against analyst consensus of $37 million (a 60% miss) and a loss of $0.66 per share against consensus of $0.20, then reaffirmed full-year 2026 revenue guidance of $150 to $200 million without reduction.

• ASTS at $27.96 billion in market cap against $150 to $200 million in 2026 guidance implies a forward P/S of 140x to 186x, which is higher than the trailing multiple, because the stock has outrun even management’s own optimistic revenue ramp.

• ASTS’s outstanding shares increased by 69% over the past year, a major risk for analysts, while the company simultaneously requires average annual earnings growth of 57% to meet consensus 2027 profit forecasts.

• ASTS at 4.4 times its own 2026 guidance midpoint of $175 million implies a market cap of $770 million, compared with a current market cap of $27.96 billion (a 97.2% decline).

• RDW (Redwire Corporation) is a rollup machine with governance dysfunction, systematic shareholder dilution through a combined $850M ATM, insider selling, and a CEO executing acquisitions while the cash runway compresses. The board lacks continuity; the company is subject to ongoing securities litigation.

• SPCE at 4.4 times its consensus 2026 revenue estimate of $33.3 million implies a market cap of $146 million against $190 million, and that math uses an estimate that has been revised downward 86.67% in three months and requires commercial flights to begin in five months from a vehicle that has completed one unpowered glide test.

• SPCE (Virgin Galactic), meanwhile, carries a consensus analyst revenue estimate for Q2 2026 of $244,800, a number that has been revised downward 86.67% in the past three months alone. From a company that has guided the commercial flight commencement in Q4 2026 for four consecutive years.

• SIDU at 4.4 times its $9 million 2026 analyst revenue forecast implies a market cap of $39.6 million, down from $381 million (an 89.6% decline in the company’s current valuation).

• SIDU (Sidus Space): Too many pivots, trivial revenue ($3M annually), and astronomical valuation multiples (72x P/S). The company raised $100M in June 2026 and will need more (shareholders face chronic dilution from a company that has not demonstrated a viable business model)

• MNTS (Momentus Inc.) presents the sector’s cleanest mathematical proof that analyst forward revenue estimates are disconnected from any primary-source reality: the forecasted annual revenue for Momentus in 2026 is $167 million, against trailing twelve-month revenue of $1.1 million and a business whose entire Q1 revenue improvement was driven by NASA engineering services and hosted payload work that its own filings describe as project-based and non-recurring. Shares outstanding rose from 2.2 million to 10 million between Q4 2025 and Q1 2026 (a 355% increase in a single quarter) driven entirely by equity raises rather than business self-sufficiency, while the improved balance sheet was characterized by analysts as a function of financing activity, not operational cash generation.

• RKTO (Rocket One), which just 2 weeks ago was known as Hoth Therapeutics, formerly a clinical-stage dermatology company with no approved products, which now contributes to this Financial Summary the only data points that matter for a company with zero revenue, zero space operations, and a going concern disclosure filed eleven days before its space sector rebrand: cash and cash equivalents of $4,047,198 as of March 31, 2026; accumulated deficit of $75,571,808; net cash used in operating activities of $3,050,000 in Q1 2026 alone; and an explicit going concern qualification stating the company does not believe its current cash is sufficient to fund operations.

• The definitive quantitative verdict on the publicly traded space sector, the number that requires no valuation model, no forward estimate, and no analytical framework beyond arithmetic, is the combined accumulated deficit of the six companies in this report: $4.72 billion in losses recorded since inception, against $361 million in combined trailing twelve-month revenue, a ratio of $13.08 destroyed for every single dollar ever collected from a paying customer across the entire cohort’s collective public market history.

• At current market prices, the six companies in this report require their combined forward revenue to grow by a factor that has no precedent in the history of publicly traded aerospace and defense. Even the most optimistic analyst scenarios, when stress-tested against primary-source execution records, yield price targets implying material downside from current levels.

WHEN THE DUST SETTLES

Nine days before SpaceX began trading on the Nasdaq, Morningstar published the most important sentence written about the space sector this decade. It did not concern AST SpaceMobile (ASTS), Redwire (RDW), Virgin Galactic (SPCE), Sidus Space (SIDU), Momentus (MNTS), or Rocket One (RKTO). It concerned SpaceX itself.

“We think the company has been significantly overvalued and investors will have opportunities to buy the stock at more attractive levels after the IPO.”

Morningstar valued SpaceX at $63 per share (a 53% discount to the IPO offering price of $135), arriving at that figure not through skepticism but through mathematics, constructing three probability-weighted scenarios, and concluding that even giving SpaceX the benefit of the doubt in several key forecasts, only the most optimistic moonshot scenario approaches the IPO offering price.

Morningstar’s lead analyst Nicolas Owens wrote that SpaceX’s economic moat is “indeterminate” and that xAI poses a “material threat of value destruction” to the company, the private AI venture that Elon Musk controls separately and which competes directly with Starlink for the orbital computing market, upon which every space sector bull thesis depends.

What follows is the forensic record of what happens when the sugar rush ends, not for SpaceX, which has the revenue, the technology, and the launch cadence to survive a valuation correction, but for the six companies that borrowed SpaceX’s halo without its fundamentals and built $33.2 billion in combined market capitalization on $361 million in combined revenue, $4.72 billion in combined accumulated losses, and the collective assumption that proximity to the narrative was the same thing as participation in the business.

Aside from that, there is the crowding-out effect resulting from capital rotation in a market where SpaceX itself is now directly purchasable at a price that Morningstar already considers overvalued, making every proxy position simultaneously redundant and out of consideration for true investors. This is firstly damning for ASTS, which trades at approximately 260 times forward revenue on a direct-to-cell satellite broadband thesis, the precise market that Starlink is pursuing with 10,000 satellites, $11.3 billion in annual revenue, 39% operating margins, and the lowest launch costs in human history, not one of the six companies in this report appears in all of the institutional-grade analysis dedicated specifically to identifying investable alternatives to a SpaceX position.

Source: Morningstar Equity Research. SpaceX IPO Deep Dive: The Hype, the Price, and the Opportunity. Nicolas Owens. June 9, 2026.

THE BLOWUP RISK: Why a Single Explosion Exceeds the Market Cap of Four Companies in This Report

Source: 2026 New Glenn Rocket Explosion. Cape Canaveral Launch Complex 36. May 28, 2026.

The publicly traded space sector has spent seven years arguing that rocket launches are infrastructure events, routine, scalable, replicable, and ultimately subject to the same cost-curve dynamics that governed cloud computing, electric vehicles, and mobile broadband. On May 28, 2026, at approximately 9:00 PM Eastern Time at Cape Canaveral Launch Complex 36, that argument received its most expensive counterargument to date. Blue Origin’s New Glenn rocket exploded during a static fire test (a routine pre-launch engine ignition conducted while the vehicle remains anchored to the ground), destroying the booster and severely damaging Launch Complex 36, Blue Origin’s only operational New Glenn launch site. The explosion was believed to be the most powerful rocket explosion since the Soviet Union’s N1 moon rocket was destroyed during its second launch attempt.

The financial consequences are massive, as New Glenn costs approximately $2.5 billion to develop and manufacture, and each launch costs between $68 million and $100 million. Blue Origin spent more than $1 billion rebuilding Launch Complex 36 prior to the explosion (the facility that is now destroyed). The combined replacement cost of a new rocket, a rebuilt launchpad, and a reconstituted launch manifest places the total event cost conservatively above $3.5 billion. For context: that single static fire test failure cost more than the combined market capitalization of Virgin Galactic, Sidus Space, Momentus, and Rocket One (four of the six companies in this report), with billions remaining.

Blue Origin’s CEO, Dave Limp, publicly stated that the company will resume operations on New Glenn before the end of 2026. NASA Administrator Jared Isaacman, who visited the destroyed launchpad the morning after the explosion, told CNBC the repair timeline could extend to 2028 (a gap of approximately two years between the company’s public commitment and the government’s independent assessment)

The cascading consequences extend well beyond Blue Origin’s balance sheet. NASA’s entire lunar exploration program is now dependent on SpaceX for the foreseeable future, and promises regarding Blue Origin, which was slated to deliver lunar rovers and a human landing system for the Artemis program, NASA has been forced to seek alternative launchers for missions already under contract, as New Glenn was central to the existing timeline, threatening the entire schedule.

This is the fundamental risk that retail investors are not considering or even aware of. As we mentioned before, rocket explosions are not software failures, but hardware failures. The history of spaceflight is a history of hardware failures at the worst possible moments, at costs that exceed the entire capitalization of the companies in this report, on timelines that compress against regulatory deadlines and customer commitments simultaneously. The sector’s entire forward revenue model assumes that launch vehicles will be available, functional, and on schedule. The historical record of spaceflight establishes that this assumption fails regularly, expensively, and without warning. The financial consequences of each failure are measured in billions of dollars and years of delay, while the market capitalizations of the companies in this report range from hundreds of millions to tens of billions of dollars.

A message from NASA Administrator Jared Isaacman to the NASA workforce

Source: 2026 New Glenn Rocket Explosion. Cape Canaveral Launch Complex 36. May 28, 2026.

THE USUAL SUSPECTS

What follows is not a collection of investment opinions but a forensic record of six publicly traded companies that collectively represent every structural failure mode available in a capital market driven by hype and narrative. Each company is distinct in its particular species of dysfunction: one is a governance trap, one is a dilution engine, one is an eternal promise, one is an absurdist science project losing a quarter-billion dollars annually, one is a binary hardware bet whose launch vehicle keeps exploding, and one is a failed dermatology company that put on a spacesuit eleven days before this report was written.

AST SpaceMobile, Inc. (ASTS)

ASTS is a pre-revenue cash-burning machine priced at $28B on the assumption of perfect execution. Launch delays, cash-burn acceleration, and shelf registration dilution are all risks that could trigger a sharp re-rating. ASTS is the most liquid vehicle for shorting the space bubble.

Cash Burn Reality

AST SpaceMobile reported a net loss of $191M in Q1 2026, with operating expenses of $164.1M and property/equipment/spectrum investments of $379.3M. The trailing 12-month net loss stands at $487M, and the company is forecast to incur an additional $213M in losses over the next year.

The company holds $3.9B in liquidity as of Q1 2026, which, at current burn rates, leaves less than 18 months of cash. Analyst models show no path to positive free cash flow until 2029 at the earliest.

Launch Delays & Over-Promising

In April 2026, ASTS experienced a significant setback: the BlueBird 7 satellite failed during launch. At the same time, satellite analyst Tim Farrar of TMF Associates has been skeptical that ASTS will meet its 2026 targets, citing a pattern of delays and missed guidance.

Dilution via Shelf Registrations

ASTS has a shelf registration statement on file and recently filed an additional $166M ESOP-tied shelf registration in May 2026. The company has already increased shares outstanding by 33% over the past year and raised $460M through convertible notes. As cash burn accelerates, shelf registrations become the means of staying solvent.

Valuation

ASTS has a market capitalization of $28–36B (as of early June 2026), with cumulative losses of $487M. Wall Street analysts have a Hold consensus rating and a $74.80 price target, representing a 25% downside from current levels as of June 9, 2026.

Source: AST SpaceMobile, Inc. Form 10-Q, Quarter Ended March 31, 2026. Filed May 2026.

Source: AST SpaceMobile, Inc. Form 10-K, Fiscal Year Ended December 31, 2025. Filed March 2, 2026.

Source: AST SpaceMobile, Inc. Form S-8 Registration Statement ($166.02M ESOP). Filed May 15, 2026.

Redwire Corporation (RDW)

Redwire is a roll-up company disguised as a growth story. The reality: CEO Cannito is executing his playbook (acquire, integrate, exit), funded by systematic shareholder dilution through a total of $850M in ATM offerings. The board is weak and turning over rapidly. Governance issues (securities litigation, accounting misstatements) suggest structural problems. Cash runway is compressed to less than 12 months absent additional capital raises. The stock is trading at 7.1x sales on an unprofitable base, a valuation that assumes flawless execution in an environment where integration risk is acute.

The Valuation Disconnect

Redwire has surged, fueled by sector-wide enthusiasm ahead of the SpaceX IPO. Yet the company remains unprofitable, trading at a P/E ratio of -5.7 (negative earnings), and a price-to-sales ratio of 7.1x. For context, defense contractors with proven profitability typically trade at 2–3x sales; RDW’s 7.1x valuation is priced for a scale-up story rather than risk-adjusted returns.

RDW incurred -$200M in trailing-twelve-month net losses (driven primarily by the integration of acquisitions). Assuming a conservative 50% improvement in burn as acquisitions are integrated, the company has less than 12 months of cash runway before it must either achieve profitability or raise more capital. The company has stated that it has improved liquidity by $45M from December 2025 to March 2026, suggesting recent capital raises or operational improvements. However, this improvement comes entirely from external capital raises, not operations.

Systematic Shareholder Dilution via ATM

First, the ATM situation is worse than previously reported. The $350 million program wasn’t just authorized, it was fully exhausted and immediately replaced with a $500M program filed June 9. That’s $850M+ in combined ATM issuance in a single year.

The cumulative effect: shares outstanding have increased 94% in the past year. This is not a one-time raise; it is a rolling dilution program that erodes shareholder value with each offering. The $350M ATM represents roughly 15–20% of the current market cap, depending on the stock price. If fully deployed, it will dilute current shareholders by that percentage. Given the company’s cash burn, the full $350 million is likely to be deployed within 18–24 months.

.Management: Acquisition & Dilution Specialist, CEO

Pete Cannito, CEO since September 2021, is a seasoned roll-up executive. His prior role was CEO of Polaris Alpha (2016–2018), a company he helped form by merging three entities (EOIR, Intelligent Software Solutions, PROTEUS Technologies). Polaris was subsequently sold to Parsons in 2018

Cannito’s playbook is clear: acquire, integrate, and exit via acquisition or IPO. At Polaris Alpha, he executed this strategy and handed off to Parsons. At RDW, he is pursuing the same model: rolling up space companies, consolidating, and betting on M&A to drive growth. The problem is that this strategy works only when integrations succeed, and customer concentration risk is managed. RDW’s losses, impairments, and securities litigation suggest integration is proving difficult.

Securities Litigation & Accounting Issues

In March 2025, Redwire settled a securities class action lawsuit for $8 million. The settlement covers investors who purchased securities between March 25, 2021 (the SPAC merger announcement) and March 31, 2022. The allegations: Redwire and its executives, Peter Cannito and William Read, made materially false statements about internal controls and accounting practices.

This is a critical red flag. False statements about internal controls are not minor accounting issues; they suggest systematic problems in how the company records and reports financial information. For a roll-up company with 10 acquisitions in 18 months, internal controls are essential for managing integration risks and ensuring reliable financial reporting. The company’s false statements about controls suggest either incompetence or intentional misrepresentation.

Source: Redwire Corporation, Form 10-Q, Quarter Ended March 31, 2026. Filed May 7, 2026.

Source: Redwire Corporation, Form 8-K, Q1 2026 Earnings Press Release. Filed May 6, 2026.

Source: Redwire Corporation, Form 8-K, $500M ATM Equity Distribution Agreement. Filed June 9, 2026.

Source: Redwire Corporation, Prospectus Supplement, $350M ATM Program. Filed May 6, 2026.

Source: Redwire Corporation, Prospectus Supplement, $500M ATM Program. Filed June 9, 2026.

Virgin Galactic Holdings, Inc. (SPCE)

Virgin Galactic has spent $2.82 billion in accumulated losses since its 2019 SPAC listing, generating less than $15 million in cumulative revenue. The auditors have now documented what the filing record has always shown: that the Q4 2026 commercial flight timeline has been stated in every annual report since 2022. The Delta-class spacecraft has completed only ONE unpowered glide test. The company holds $250.5 million in cash against $418.7 million in debt and a $180 million burn before first commercial revenue.

The Valuation Disconnect

Virgin Galactic has spent years promising routine commercial spaceflight, yet revenue remains negligible relative to the capital consumed. The company generated only a few hundred thousand dollars of revenue in Q1 2026 while continuing to lose tens of millions of dollars per quarter. Management continues to target commercial Delta-class operations in late 2026, but the company must still prove that demand, pricing, utilization rates, and operating economics can support a sustainable business.

The balance sheet remains dependent on capital market access rather than internally generated cash flow. While investors continue to model substantial future revenue growth, the company has repeatedly extended commercialization timelines and remains years removed from demonstrating a profitable operating model.

Another overlooked risk is that Virgin Galactic’s addressable market remains largely theoretical. While management has highlighted customer reservations and long-term interest in space tourism, the company has yet to demonstrate repeat demand, sustainable flight frequency, or economics capable of supporting a large-scale operation. The business model assumes that affluent customers will continue paying premium prices for a product that remains operationally complex, weather-dependent, and subject to significant safety considerations. Even if commercial service begins as planned, investors may ultimately discover that proving demand is considerably easier than building a profitable business around it.

Source: Virgin Galactic Holdings, Inc. Form 10-Q, Quarter Ended March 31, 2026. Filed May 2026.

Source: Virgin Galactic Holdings, Inc. Form 10-K, Fiscal Year Ended December 31, 2025. Filed March 2026.

Source: Virgin Galactic Holdings, Inc. Form 8-K, Q1 2026 Earnings Press Release. Filed May 14, 2026.

Sidus Space, Inc. (SIDU)

Fugazi Research documented the SIDU governance trap in January 2026. Every subsequent filing has confirmed the original thesis and added to it. The CEO’s private company remains the primary customer and receivables counterparty, and internal controls remain not effective. Two capital raises in six weeks, totaling $158.5M (against $3.4M in annual revenue), extend the runway without addressing the business model.

This is not a new finding; we have published two forensic reports on SIDU establishing the related-party structure, dilution mechanics, and governance failures documented above. The Q1 2026 filings confirm every original thesis pillar, and several have materially worsened.

The Valuation Mismatch

Sidus Space generated $3 million in annual revenue and trades at a $400 million market capitalization, a price-to-sales multiple of 98x. Q1 2026 results show the depth of the disconnect: revenue was just $359K, up 51% year-over-year, but the company reported a net loss of $5.2 million. The company is not scaling; it is burning cash.

Chronic Dilution

In June 2026, Sidus Space announced a $100 million direct offering. The stock sank on the news as each capital raise compresses existing shareholder value. With a valuation of $400 million and a history of failed pivots, Sidus faces a doom loop: it must raise capital to survive, each raise dilutes existing shareholders, and the diluted stock falls further, making the next raise more painful.

The company’s valuation is particularly difficult to justify when viewed through the lens of execution risk. At its current size, even modest commercial setbacks can materially impact financial results, yet the market continues to assign a multiple typically reserved for businesses demonstrating rapid and durable growth. With limited revenue visibility, a history of strategic pivots, and continued reliance on external financing, Sidus remains highly vulnerable to investor sentiment shifting from future potential toward present-day fundamentals.

Source: Sidus Space, Inc. Form 10-Q, Quarter Ended March 31, 2026. Filed May 2026.

Source: Sidus Space, Inc. Form 8-K, $100M Registered Direct Offering Pricing. Filed May 27, 2026.

Source: Sidus Space, Inc. Form 8-K, $58.5M Registered Direct Offering. Filed April 2026.

Source: Fugazi Research. “SIDU — The Final Orbit Before Disaster.” Prior forensic report establishing original thesis.

Momentus Inc. (MNTS)

Momentus has executed three reverse stock splits in thirty months, each to satisfy the same Nasdaq minimum bid requirement, each followed by the same sequence: capital raise, share count explosion, stock price erosion, repeat. The consensus 2026 revenue estimate of $167M requires 15,182% growth from Q1’s annualized run rate, from a company whose primary revenue is described in its own filings as project-based and non-recurring. The dilution engine is the only way for the company to continue surviving.

A space infrastructure story financed primarily through shareholder dilution.

Momentus has attracted investor attention through ambitious projections regarding orbital transportation and space infrastructure services. The underlying financial reality is considerably less impressive. Recent revenue growth has been driven primarily by engineering services, hosted payload contracts, and government-supported activities rather than a scalable commercial platform.

Although the company’s liquidity position improved during 2026, the improvement was largely driven by financing transactions rather than operational success. At the same time, the share count expanded dramatically, diluting existing shareholders at a pace that exceeded underlying business progress.

Above: Timeline of MNTS history of reverse-splits

Momentus also faces a credibility problem common among early-stage space companies: analyst forecasts imply a business that does not yet exist. Consensus revenue estimates assume an acceleration that would require rapid customer adoption, successful execution, and commercialization at a pace rarely achieved within the aerospace industry. Historically, aerospace programs tend to encounter delays, cost overruns, and extended qualification periods. The market appears to be valuing Momentus based on projected future scale rather than demonstrated commercial demand, leaving substantial downside if execution falls short of expectations.

The Reality of the Business

Momentus remains heavily dependent on capital markets to fund operations. Revenue growth has yet to demonstrate the recurring characteristics necessary to justify current expectations, while dilution continues to erode shareholder ownership. Fugazi Research believes the market is assigning a valuation based on future possibilities rather than present business fundamentals.

Source: Momentus Inc. Form 10-Q, Quarter Ended March 31, 2026. Filed May 2026.

Source: Momentus Inc. Form 8-K, 1-for-17.85 Reverse Stock Split. Filed December 15, 2025.

Source: Momentus Inc. Form 8-K, 1-for-14 Reverse Stock Split. Filed December 2024.

Source: Momentus Inc. Press Release, Reverse Stock Split Announcement. December 15, 2025.

Rocket One Inc. (RKTO)

Rocket One is the sector’s most damning data point: a company that received a Nasdaq minimum bid deficiency notice on April 30, filed a going concern disclosure on May 15, announced a space sector rebrand on May 19, and gained 92% in a single session on May 27, all of this without generating a dollar of revenue in any quarter of its existence. The space strategy and pivot are just a press release, and oblivious shareholders will have to ask themselves: What exactly is Rocket One?

A recent corporate rebrand is attempting to capitalize on the space narrative.

Rocket One was known as Hoth Therapeutics until its recent transition into a space-focused company. Prior to the rebrand, the business operated as a development-stage biotechnology company with no meaningful commercial revenue and a substantial accumulated deficit. The company’s new strategy encompasses space infrastructure, AI, semiconductors, and satellite-related technologies despite having limited operating history in any of those industries.

The timing of the transition is equally noteworthy. Rocket One emerged during one of the most speculative periods for both space and AI-related stocks, allowing the company to align with multiple market narratives simultaneously. While thematic enthusiasm can temporarily support valuations, long-term shareholder returns are ultimately driven by revenue, cash flow, and execution. To date, investors have received a strategic vision, but little evidence that the company possesses the assets, technology, customer relationships, or operational infrastructure necessary to compete in any of the industries it now claims to target.

The Narrative Hijack

Rocket One’s valuation appears to be driven primarily by narrative rather than by operating results. The company has not yet demonstrated meaningful participation in the space economy, yet trades as though that transition has already occurred. We believe the company’s recent transformation raises a more fundamental question: if the underlying business were succeeding, why would such a dramatic reinvention be necessary in the first place? Hoth Therapeutics failed to establish a viable commercial biotechnology business, and investors are now being asked to finance an entirely new strategic direction with little evidence that management possesses either the operational experience or competitive advantages required to succeed in the space sector.

Source: Hoth Therapeutics, Inc. (now Rocket One Inc.) Form 10-Q, Quarter Ended March 31, 2026. Filed May 15, 2026.

Source: Hoth Therapeutics, Inc. Form 8-K, Strategic Repositioning Announcement. Filed May 19, 2026.

Source: Rocket One Inc. Form 8-K, Corporate Name Change to Rocket One Inc. / Ticker Change to RKTO. Filed May 27, 2026.

Source: Rocket One Inc. Form 8-K Exhibit 99.1, Press Release — Rebrand and Nanomagnetic Chip License Announcement. May 27, 2026.

Source: Rocket One Inc. Form 8-K Exhibit 99.1, Dr. Bandyopadhyay Technical Advisor Appointment. June 1, 2026.

Conclusion

The SpaceX IPO has created a halo effect across the publicly traded space sector that bears little resemblance to the fundamentals of the companies benefiting from it. Investors have rewarded businesses with minimal revenue, persistent operating losses, repeated dilution, and unproven business models simply because they operate under the broad umbrella of the space economy. In our view, narrative has overwhelmed analysis.

AST SpaceMobile, Redwire, Virgin Galactic, Sidus Space, Momentus, and Rocket One differ in size, strategy, and market capitalization, but they share the same underlying vulnerabilities: valuations disconnected from current business performance, dependence on external capital, ambitious forward projections, and business models that remain largely unproven at commercial scale. In nearly every case, investors are paying today for revenue, profitability, and execution that may never arrive.

The central flaw in the sector’s investment thesis is the assumption that participation in the space economy is inherently valuable. History suggests otherwise. Railroads, airlines, automobiles, internet infrastructure, clean energy, electric vehicles, and artificial intelligence all experienced periods where investor enthusiasm dramatically exceeded economic reality. The technology often succeeded. Many of the companies did not. In our view, the sector’s current valuations already discount an extraordinarily optimistic future while leaving little room for the delays, dilution, failures, and capital shortages that have historically defined the space industry.

The arrival of SpaceX as a publicly traded company may ultimately accelerate that reckoning. For years, investors seeking exposure to the commercial space industry had few alternatives. Soon, they will have direct access to the dominant launch provider, the dominant satellite operator, and the company responsible for much of the industry’s technological progress. As capital migrates toward the sector’s strongest participant, the speculative premium currently embedded in many secondary and tertiary players may begin to disappear.

In reality, this will be treated like a rocket launch, and rocket launches do not carry the launchpad into orbit. Every dollar of capital that rotates into SPCX is a dollar that no longer needs ASTS as a Starlink proxy, SPCE as a space-tourism concept, SIDU as a satellite manufacturer, MNTS as an orbital-transportation story, RDW as a space-infrastructure roll-up, or RKTO as anything at all. The rocket does not carry the launchpad. It leaves it behind, scorched, inert, and emptied of everything not useful. The six companies in this report are the launchpad.

We believe the publicly traded space sector has become a market in which valuations are driven primarily by aspiration rather than by demonstrated economic value. Fugazi Research considers the publicly traded space sector to be of NO fundamental value.

Disclaimer

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our,”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority.

All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions-long, short, or otherwise-in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

Subscribe now

Share

Astrotech Corporation has spent a decade randomly (but at the same time strategically, according to its executives’ deep pockets) rotating from one business model to another. Since 2018, the company has repositioned itself five times, going from aerospace to industrial tech to COVID breath analysis to airport security to its current standpoint as a defense and aviation security play anchored to a pilot program of the Tracer 1000 explosives detector. Narrative in which they have hooked themselves just to attract speculative capital. All of the pivots since its inception have resulted in $262 million of destroyed shareholder value, $1 million of annualized revenue, and a balance sheet for just about 4 months of cash runway.

The man at the center of every pivot is Thomas Boone Pickens III, who simultaneously holds the titles of CEO, CTO, Chairman of the Board, and Principal Financial Officer, four roles in total that have absolutely no independent oversight, representing a massive governance red flag that, adding to his past history, raises true alarms. This is not the first time Pickens has been involved in a conflict of interest.

In 2013, a shareholder derivative suit alleged that Pickens “mismanagement and self-dealing” drove an 89% share price decline. His former CFO, John Porter, sued him separately, alleging he “funneled tens of millions of dollars” from Astrotech to subsidiaries via loans characterized as fraudulent transfers and billed over $100,000 in personal expenses to the company in violation of his own employment agreement. Both cases produced a documented behavioral pattern that the current 10-Q quietly shows; one CEO’s son-in-law received $211,000 in consulting fees for software services during the nine months ended March 31, 2026, equivalent to nearly 30% of total company revenue for the same period, approved by the company, which by coincidence he is judge, jury, and executioner.

The filings describe a capital consumption vehicle with 4 months of runway, a CEO who answers to no one, and years of accumulated losses that have consumed 95 cents of every dollar ever entrusted to this enterprise. Fugazi Research currently assesses ASTC shares value only momentum driven and fundamentally uninvestable at any level above zero, implying a 99% correction.

Fugazi Research Analysis

• Astrotech has executed five distinct strategic pivots since 2018 (aerospace, industrial tech, COVID breath analysis, airport security, and defense) without achieving commercial success in any of them; each pivot has been fueled with speculative capital inflows. The accumulated deficit stands at $262 million as of March 31, 2026, against total paid-in capital of $274 million, meaning that the company has destroyed 95 cents of every dollar ever invested in this company.

• Thomas Boone Pickens III serves simultaneously as Chief Executive Officer, Chief Technology Officer, Chairman of the Board, and Principal Financial Officer. Currently there is no Chief Financial Officer, and all financial certifications are signed by one individual who has no checks and balances over him.

• In 2013, Reid Collins & Tsai filed a shareholder derivative action alleging Pickens’ “mismanagement and self-dealing” were directly responsible for an approximately 89% share price decline. Former Astrotech CFO John Porter subsequently filed suit alleging Pickens funneled tens of millions of dollars from the parent company to subsidiaries via loans characterized as fraudulent transfers and submitted over $100,000 in personal expenses for company reimbursement in violation of his employment agreement.

• For the nine months ended March 31, 2026, the company paid $211,000 in consulting fees to an individual identified as the son-in-law of the Chief Executive Officer for software services. This amount equals roughly 30% of total company revenue for the same period.

• For the three months ended March 31, 2026, one customer accounted for substantially all of the $99,000 in service revenue. Total Q3 revenue of $343,000 was generated across a handful of relationships with no evidence of a diversified or expanding customer base after three-plus years of commercialization effort.

• The company operates six wholly owned subsidiaries ( ATI, 1st Detect, AgLAB, BreathTech, Pro-Control, and EN-SCAN). Of these, only one generates substantially all product revenue. Six operating entities, six cash-burning structures, and only one revenue-generating product.

• Series D Preferred Stock (280,898 shares outstanding) converts to common stock on a 1-to-30 basis, producing 8,426,940 shares upon full conversion against 1,758,953 common shares currently outstanding. Meaning there is a full risk of dilution overhang that could expand the outstanding shares by a factor of 5.8x. The holder of Series D shares can convert at their sole discretion.

• Based on the documented fact that Astrotech Corporation generates $1.05 million in annualized revenue against $14.9 million in annualized cash burn, has never produced a single dollar of positive cash flow from operations in its history, has destroyed 95 cents of every dollar ever invested through five consecutive failed strategic pivots, has a serious governance risk and conflict of interest, Fugazi Research considers ASTC’s shares uninvestable and of ZERO fundamental value.

Financial Summary

• Total liquid assets as of March 31, 2026 amount to $6,582,000 (including cash and short term investments). Considering an annualized burn rate of $14,887,000, the true runway for the company is just about 4 months.

• The company’s short-term investment portfolio went from $15,108,000 at June 30, 2025 to $3,903,000 at March 31, 2026 representing a 74.2% reduction in nine months. The company is not investing but liquidating its reserves to fund operations and presenting the proceeds as positive investing cash flow.

• Nine-month revenue amounted to $787,000 compared to operating expenses of $11,152,000 for the same time period. The business only covers 7 cents of every dollar it spends.

• Product revenue collapsed from $543,000 to $220,000 for the nine-month period (a 59.5% decline year-over-year).

• $740,000 for stock based compensation for the nine month period. This non-cash expense equals 94% of total revenue for the same period. The company is compensating employees and directors at a rate nearly equal to what it earns from customers.

• Accumulated deficit stands at $262 million vs $274 million of total invested capital, at this rate the company has destroyed 95.4 cents of every dollar ever invested in it.

• Working capital declined from $19,524,000 at June 30, 2025 to $9,494,000 at March 31, 2026 a roughly 50% reduction in working capital over nine months driven entirely by investment liquidation, not operational improvement.

• Series D dilution math: 280,898 preferred shares converting at 30-to-1 equaling roughly to 8,426,940 new common shares potential dilution, representing a 6x potential dilution overhang.

Source: Astrotech Corporation, Form 10-Q for the quarterly period ended March 31, 2026, filed May 14, 2026.

Source: Reid Collins & Tsai LLP, Shareholder Derivative Lawsuit Press Release, September 12, 2013

Source: Courthouse News Service, “Former CFO Sues T. Boone Pickens Son,” coverage of John Porter v. Thomas Boone Pickens III

Source: Courthouse News Service, “Pickens Family Feuding Over Tell-All Blog,” parallel litigation context

The Pivot Pattern: One Platform, Many Markets

Astrotech Corporation was incorporated in 1984 as SPACEHAB, a NASA contractor providing pressurized modules for Space Shuttle missions. That business (the only one in the company’s history that generated meaningful, recurring revenue) ended when the Space Shuttle program wound down. Since then, the company has repositioned its identity five times in eight years, only highlighting the lack of direction and the opportunistic nature of the top leadership, who has proven time after time to be more inclined to extract capital from speculative investments rather than rely on a single business or going full into a specific industry, but jumping around from narrative to narrative depending on the timeline and the hot theme of the moment.

Each pivot followed the same script, a new subsidiary formation or product announcement, a wave of press releases positioning the technology as addressing a massive addressable market, speculative capital inflows, and then quiet operational failure with no formal acknowledgment that the prior thesis had not worked, all pivots replacing each other time after time.

However, the financial signature of the pattern is equally consistent, the company has never generated positive operating cash flow in any fiscal year of its existence. The accumulated deficit grew from approximately $190 million in 2018 to $262 million as of March 31, 2026 ($72 million consumed across the last three pivots alone).

What sustains the operation between pivots is not revenue, it is equity issuance and reserve liquidation. The short-term investment portfolio declined from $15,108,000 at June 30, 2025 to $3,903,000 at March 31, 2026 representing by itself a 74% drawdown in nine months. When that reservoir empties, the only remaining financing mechanism is a Shelf Registration capped at $1,974,354 under Baby Shelf limitations, which at current stock prices can be tapped at any moment when the stock closes above $54, leaving the door open to another round of dilutive potential.

The Governance Structure

Astrotech Corporation has a complete governance absence. Thomas Boone Pickens III holds four titles simultaneously: Chief Executive Officer, Chief Technology Officer, Chairman of the Board, and Principal Financial Officer, as of their latest filing there is no Chief Financial Officer in the company, nor an independent board chair. The individual who sets strategic direction, controls the technology roadmap, chairs the meetings at which his own performance is evaluated, and signs the financial certifications of the company. Creating an environment in which there is no check and balances system, everything runs through one person, and that person reports to no one.

This structure has historical precedent at Astrotech specifically. In 2013, the plaintiffs’ firm Reid Collins & Tsai filed a shareholder derivative action alleging that Pickens’ “mismanagement and self-dealing” was directly responsible for an approximately 89% decline in the company’s share price. The suit sought to hold him and the board personally liable. Separately, former Astrotech CFO John Porter filed suit alleging Pickens had funneled tens of millions of dollars from the parent company to subsidiaries through loans Porter characterized as fraudulent transfers, and had submitted over $100,000 in personal expenses for company reimbursement in violation of his own employment agreement. Both instances produced a documented behavioral record that predates the current filing period by more than a decade.

Source: Reid Collins & Tsai LLP, Shareholder Derivative Lawsuit Press Release, September 12, 2013

Source: Courthouse News Service, “Former CFO Sues T. Boone Pickens Son,” coverage of John Porter v. Thomas Boone Pickens III

What the governance structure has produced over its twenty four year existence is a $262 million financial hole in the in the form of accumulated losses, five failed strategic pivots, a CEO who acts as judge, jury and executioner, and a board that renews its own anti-takeover protection every December like clockwork. The board which by the way is chaired by the same man it is supposed to oversee.One man controls the strategy, the technology, the finances, and the board room, but the losses belong to shareholders.

Inside the Numbers

In FY 2025, Astrotech spent roughly $14.50 in operating expenses for every $1 dollar of revenue. For the three months ended December 31, 2025, the company produced $148,000 in revenue and $8,000 in gross profit while absorbing $3.909 million in operating expenses in the same quarter.

The cash position did not stay near $3.1 million because the business funded itself. For the six months ended December 31, 2025, Astrotech consumed $7.479 million in operating cash. The balance held steady because the company systematically liquidated its short-term investment portfolio (created by the way from previous equity raises) and presented the proceeds as investing activity. The investment portfolio that stood at $15.1 million at June 30, 2025 had been drawn down to $3.9 million by March 31, 2026, representing a $11.2 million drawdown in nine months. As of current numbers the portfolio is nearly gone,and when it empties, the operating cash burn will land directly on the cash balance with nothing left to offset it.

Operating cash outflow for the nine months ended March 31, 2026 was $11.165 million against total liquid assets of $6.582 million at quarter end. The company is burning more in nine months than it currently holds in total liquidity. Equity remains practically the only exit or alternative of the runway. The company is telling shareholders, in its own filing language, that survival depends on capital markets it does not control, at terms it cannot predict, through a Shelf Registration capped at $1,974,354 enough only to fund six weeks of operations.

The Product Reality: TRACER Economics Are Thin

The 2019 Form 10-K describes TRACER 1000 as the first certified mass-spectrometer-based explosives trace detector and says ECAC or TSA certification is necessary to sell into the airport market. The filing states that TRACER entered ECAC evaluation in 2018 and officially launched in June 2019. The same filing says TSA programs carried no assurance of approval.

In May 2026, it announced ECAC/EU G1 approval for aviation security. The problem is conversion. Years of certification, testing, deployments, and market claims have not produced financial scale. Fiscal 2025 revenue declined to $1.0 million because 1st Detect sold fewer devices compared to the prior year, according to the company’s own financial results release. The reality is that the product is a weak public-equity story. TRACER has not given Astrotech a self-funding business.

The Rotating Narrative Stack

After TRACER, Astrotech’s story becomes a sequence of new market opportunities built on the same underlying platform. Rather than developing entirely new technologies, the company repeatedly repositions its core detection capabilities toward different industries and use cases.

The pattern was already visible in the 2019 Form 10-K. At the time, management was promoting AG-LAB-1000 as a solution for agricultural testing, particularly within the pesticide, hemp, and cannabis markets. The product was marketed to growers, distributors, retailers, regulators, and law enforcement agencies as a way to rapidly detect pesticide contamination and reduce the risk of spoiled inventory.

By fiscal 2025, the same broad technology platform had been repacked into several new initiatives. BreathTech was described as developing BreathTest-1000, a breath-analysis tool to screen VOC metabolites that may indicate a compromised condition. Pro-Control was framed around industrial process control. EN-SCAN was framed around environmental testing and monitoring.

What stands out is how closely the company’s risk disclosures track these product narratives. Alongside the market opportunity, Astrotech repeatedly reminds investors that commercialization remains uncertain. The filings note that the company may never successfully develop BreathTest-1000 or its other products, that AgLAB remains heavily dependent on the hemp and cannabis industry, that cannabis-related equipment could create Controlled Substances Act (CSA) risks, and that AgLAB could eventually face regulation from agencies such as the FDA or ATF.

The strongest line sits in the company’s own risk section: “Our business units are in the development stage. They have earned limited revenues and it is uncertain whether they will earn any revenues in the future or whether any of them will ultimately be profitable.”

That single sentence captures the central reality behind every new product announcement. Regardless of how the narrative shifts (from agricultural testing to breath analysis, industrial controls, or environmental monitoring) the underlying challenge remains the same: no business whatsoever.

The 2026 Moon Pivot

On May 27, 2026, Astrotech announced that its Board approved a strategic lunar resource and infrastructure initiative.

The language was pure hype detached from the reality of the reputation of the company’s recent past. Astrotech is riding the coattails of the hot space industry, just as they’ve done with other hot industries throughout their history. Lunar resource development. Autonomous lunar industrial infrastructure. Moon-based advanced computing. Semiconductor manufacturing. Silicon-28. Helium-3. AI infrastructure. High-performance computing. Quantum fabrication. NASA Artemis. CLPS. Commercial lunar transportation systems. All space jargon to hype their stock as much as possible with the ultimate goal of a highly possible lucrative financing which they desperately need to remain in business.

The hype driven narratives are clear in their press releases. In there it says the initiative is intended to position Astrotech to “evaluate” emerging opportunities. Astrotech “expects to evaluate” infrastructure concepts. The initiative remains in an “early evaluation and development phase.” No customers, contracts, funded missions, partners or budgets are ever disclosed.

That is the key turn. After years of terrestrial instrumentation narratives, the company returned to space branding through lunar resources and quantum computing. The old space identity came back. The current income statement did not change with it. Astrotech once again trying to ride sector hype for a pump into a potential big raise.

Capital Structure: The Shelf Is Open

The January 2026 Form S-3 gives Astrotech a registered path to issue stock, preferred stock, debt securities, warrants, and units up to $30 million.

In practice, the company’s immediate financing capacity was much smaller. The same filing calculated public float at approximately $5.92 million, triggering the SEC’s baby-shelf limitation and restricting sales to roughly $1.97 million of securities during the applicable period.

As of January 26, 2026, Astrotech had approximately 1.76 million common shares outstanding against a pool of 250 million authorized shares.

The Series D Preferred Stock occupies a particularly influential position. According to the January 2026 S-3, Series D holders have liquidation preference over junior securities, and certain actions that would adversely affect the Series D class require approval from those holders. In other words, the capital structure contains multiple layers of claims and protections that extend beyond the common stock.

The company’s history also reflects repeated adjustments to that structure. The 2025 Form 10-K notes that a 1-for-30 reverse stock split became effective on November 22, 2022, with corresponding adjustments to common shares, warrants, options, and the conversion mechanics of the Series D Preferred Stock.

Taken together, this is not a simple dilution story driven by a single financing instrument. It is a capital structure built with multiple avenues for future massive dilutive financing and recapitalization.

That flexibility matters because the operating business continues to consume cash while pursuing commercialization across multiple development-stage initiatives. The products create the narrative, but the capital structure provides the runway. One generates the need for funding; the other preserves the ability to obtain it.

Pickens, Series D, and the Control Layer

Thomas B. Pickens III sits at the center of Astrotech’s modern filing record.

In 2019, Astrotech disclosed two capital raises involving Pickens and another long-term accredited investor. One transaction sold Series B convertible preferred stock to Pickens and common stock to the other investor. Another sold Series C preferred to the investor and Series D preferred to Pickens. The Series D preferred was convertible into common stock at the option of the holder.

The same 2019 Form 10-K disclosed a separate $1.5 million secured promissory note issued to Pickens at 11% interest, secured by collateral of the company and subsidiaries and guaranteed by subsidiaries.

By 2026, the Series D preferred still mattered. The S-3 states that 280,898 Series D Preferred shares remained issued and outstanding as of January 26, 2026.

The governance concentration is also visible. A February 2026 Form 8-K was signed by Pickens as Chief Executive Officer, Chief Technology Officer, Chairman of the Board, Principal Executive Officer, and Principal Financial Officer.

The compensation table adds another uncomfortable ratio. Pickens’ 2025 total compensation was $954,851. Fiscal 2025 revenue was $1.049 million. Net loss was $13.850 million.

Rights Plan: The Gate Around the Cap Table

Astrotech’s rights plan was adopted on December 21, 2022. The January 2026 S-3 states that the rights plan gave each shareholder one preferred share purchase right for each common share, with a purchase price of $58.00 per one one-thousandth preferred share. The plan was extended in December 2023, December 2024, and December 2025. The latest extension pushes expiration to December 20, 2026 unless extended again or redeemed earlier.

For a company with small revenue, a large authorized share base, remaining preferred securities, recurring losses, and a live shelf, the rights plan belongs in the report. It is part of the control architecture.

Conclusion

Astrotech is not a real company, it is a capital consumption machine disguised as the “hot theme of the moment business” that has operated continuously for over two decades without ever producing a self-funding business. The filing records throughout the years show a company that has burned $262 million in accumulated losses across five strategic pivots, never once generating positive operating cash flow, with a CEO who controls the strategy, the technology, the board room, and the finances simultaneously (same individual whose former CFO alleged in civil litigation that he funneled company funds through fraudulent transfers and billed personal expenses to the company he ran).

The May 2026 lunar announcement is not a strategic pivot but a mere press release. Lunar resource development, quantum fabrication, Silicon-28, Helium-3, autonomous lunar industrial infrastructure, none of these things come with a customer, a contract, a partner, or a budget. What it comes with is a company that had $445,000 in six-month revenue and a $7.4 million net loss at the time of the announcement, a Shelf Registration that funds six weeks of operations, and a CEO whose compensation of $954,851 in fiscal 2025 exceeded total company revenue by nearly every measure that matters.

The moon story is the company’s sixth pivot, and like the five before it, it arrives precisely when the market has something shinier to chase. The SpaceX IPO fever is the new theme the company can monkeybranch to, at the time oblivious retail capital is flooding into anything with a rocket or a radar attached to it. And now the moon, announced within days of the most anticipated space IPO in a generation, with zero customers, zero contracts, zero budget, and zero credibility left to spend. Fugazi Research considers ASTC common equity uninvestable at any price above zero.

Disclaimer

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our,”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority.

All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions-long, short, or otherwise-in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

MMTEC is a holding company that, through its subsidiaries, operates a U.S.-registered broker-dealer and a Beijing-based financial technology platform purportedly serving Chinese institutional investors seeking access to overseas capital markets. The U.S. subsidiary, MM Global Securities, Inc., is a FINRA-registered broker-dealer licensed for equity trading and investment banking services. The Chinese subsidiary, Gujia (Beijing) Technology Co., Ltd., provides software and technical infrastructure to institutional clients. In reality, the combined entity generated $807,500 in total revenue in its most recent fiscal year (entirely from placement agent fees), against $3.98 million in operating expenses, and has never achieved profitability from operations to this day.

The company’s entire commercial existence relies on MM Global Securities, Inc., a FINRA-registered introducing broker previously sanctioned for $450,000 for failing to detect hundreds of instances of potential market manipulation on its own platform, and which, by itself, generates 100% of MMTEC’s $807,500 annual revenue. Without MM, MMTEC displays no U.S. revenue, operational presence, and justification for its Nasdaq listing.

MMTEC has a history of operating with the same script for years: tight float, a catalyst, a violent spike, and then a slow grind back to reality as convertible note holders resume converting into the elevated price. The November 2025 squeeze (a run from 31 cents to over $3.89 in a span of two market sessions), followed by a steady grind, was not an anomaly. At the time, the company was on the verge of getting delisted. Somehow, they managed to stay listed as the stock price rose and rose for no apparent reason, which is one of the motives for our report.

As of this report, MTC trades at a market capitalization of $495 million, suggesting a valuation wildly disconnected from fundamentals. Based on its most recent revenue, the stock is pricing in 605x sales, a multiple far exceeding even the most aggressive AI growth companies. We view MTC shares as extremely overvalued and poised for a potential 90-99% correction.

Fugazi Research Analysis

• MMTEC is incorporated in the British Virgin Islands (BVI is notorious for shady companies), operates through subsidiaries in Hong Kong, Beijing, and New York, and holds its primary asset through a VIE structure in China. This incorporation imposes minimal fiduciary obligations, as U.S. investors hold shares in a BVI holding company with no direct ownership of any operating assets and no practical enforcement mechanism against management. Creating an entangled web of jurisdictions meant to confuse and mislead investors, and create potential roadblocks for regulators.

• MM Global Securities is MMTEC’s sole revenue source, as 100% of MMTEC’s $807,500 in revenue consisted of placement agent fees earned exclusively through MM Global. This is the same broker-dealer that was censured by FINRA, fined $450,000, and prohibited from providing market access to customers for two years following a September 2022 AWC finding that it failed to detect hundreds of instances of potential market manipulation occurring on its own platform, in its own affiliate’s stock, by customers it could not identify.

• Total insider ownership across all officers and directors is 0.046% combined out of 99,587,811 shares outstanding. The CEO himself drew $141,527 in salary in FY2025 from a company that lost $56 million from continuing operations. This shows there is no alignment between management compensation and shareholder outcomes.

• The March 31, 2023, convertible note (Note 2) carries a variable-rate conversion price set at 75% of the lowest closing price during the five trading days immediately preceding the conversion notice, subject to a $0.30 floor. This is a textbook death-spiral mechanic: the holder is economically incentivized to suppress the stock price over the five-day lookback window to cheapen the conversion price and receive more shares per dollar of debt converted

• The 4.99% beneficial ownership cap embedded in Note 2 prevents the holder from exceeding 4.99% of outstanding shares at any one time, forcing conversion in tranches. This allows the holder to convert and sell continuously without triggering a Schedule 13D disclosure threshold.

• Two reverse splits, 10 to 1 in July 2022 and 8 to 1 in December 2024, artificially tightened the float on each reset. As of today, the cumulative split ratio is 1-for-80, and the company disclosed ongoing Nasdaq minimum bid compliance risk in the FY2025 20-F, signaling a third split is very probable.

• In December 2023, MMTEC sold Alpha Mind to XChange for $153 million, with the entire purchase price paid in a promissory note. From this transaction, the company recognized a $53.8 million gain, which was the sole driver of its only profitable year as a public company. However, on April 12, 2025, MMTEC sold $52 million of value of the XChange Note to an unnamed third party for $5,000,000 (a realized loss of $46,988,242).

• MTC has a documented history of violent, low-float squeezes with no operational catalyst. The November 2025 short squeeze (a move from $0.31 to $3.89 across two market sessions) occurred on no material news, no earnings release, and no SEC filing.

• Based on the fact that the operating business generates $807,500 in annual revenue against $3.98 million in expenses, has never produced a dollar of cash from operations, has no growth catalysts, and 99.6 million shares outstanding after a single conversion event added 74.4 million shares at barely $.50, our analysis shows that this is a squeeze, not a business. Fugazi Research considers MMTEC shares uninvestable at any price above ZERO.

MMTEC Financial Summary

• $807,500 in FY2025 revenue compared to $3.9 million in total operating expenses, which represents a 5× expense to revenue ratio. At this rate, the company spent $4.93 for every $1 dollar earned.

• At a current market capitalization of approximately $489 million and trailing twelve-month revenue of $807,500, MTC trades at roughly 605 times revenue. For context, high-growth software companies with consistent annual revenue growth and expanding margins rarely sustain revenue multiples above 30 times.

• Gross margin fell from 81.6% in 2024 to 21.6% in 2025, a 60% collapse in a single year.

• Two consecutive credit losses recognized, totaling $114.1 million ($90.2 million in FY2024 and $23.9 million in FY2025), combined, exceed MMTEC’s total assets of $18.4 million by 6x.

• A serious dilution event occurred between December 2024 and December 2025, during which shares outstanding increased from 25,186,864 to 99,587,811, showing that 74,400,947 new shares were issued in a single year, representing a 295% increase in share count.

• The cumulative reverse split ratio as of today is 80-to-1. Since the split-adjusted IPO price was $320 per share and the current price is approximately $4.85, IPO investors have lost approximately 99% in split-adjusted terms.

• Insiders own 45,325 shares across all officers and directors (0.046% of 99,587,811 outstanding), which signals that executive and top management have zero conviction or stake in the company’s future, while relying solely on shareholders who buy the company’s stock to keep afloat, leaving the losses to outsiders.

• Interest expense was $8.68 million for FY2025, compared to $2.4 million the previous year. This represents a 258.6% increase in interest expense driven by the interest on Note 2 prior to its conversion. On $807,500 in revenue, interest expense alone was 10x total revenue.

• The accumulated deficit stands at $123,994,872, while total additional paid-in capital is $130,728,219. This means that the company has destroyed 94.9 cents of every dollar ever invested in it.

• Taken together, these figures describe a company that has never generated cash from operations, has destroyed 94.9 cents of every dollar ever invested in it, trades at 605 times revenue on the back of a squeeze, and whose primary balance sheet asset is a promissory note its own management sold in the secondary market for 9.6 cents on the dollar.

Source: MMTEC, Inc. Form 20-F, fiscal year ended December 31, 2025. Filed April 2, 2026.

Source: MMTEC, Inc. Form 6-K, Securities Purchase Agreement and Senior Convertible Note, Exhibit 4.1. Filed March 31, 2023.

Source: MMTEC, Inc. Form F-3/A, Amendment No. 1 to Registration Statement under the Securities Act of 1933. Filed July 30, 2025.

Source: MM Global Securities, Inc., FINRA Letter of Acceptance, Waiver, and Consent No. 2019062623001. Accepted September 9, 2022. Available via FINRA BrokerCheck, CRD No. 2509.

The Playbook

MMTEC did not need a business to generate one of the most violent price dislocations in the China microcap space in late 2025. It needed a structure, which the filings show exactly what that structure looked like and how it was assembled.

By September 2025, the capital structure had been engineered into a configuration that required no fundamental catalyst to produce extreme price movement. The operating business generated $807,500 in annual revenue and lost $3.8 million from operations. The stock was trading below $0.50 and had been under the Nasdaq minimum bid price deficiency for months. On October 27, 2025, Nasdaq issued a formal delisting determination. MMTEC was, by every observable metric, a company on the verge of losing its listing.

What happened was that after the Nasdaq delisting determination, the stock created a predictable market dynamic. Short sellers accumulated positions expecting continued deterioration or delisting, which made the borrow crowded, and the stock became violently responsive to any single large buy order in a thin tape. On November 5, 2025, MTC moved from $0.31 to $3.89 across two market sessions. The move occurred on no material news, no SEC filing, and no operational development of any kind.

The December 2025 series of events confirmed this setup. MTC regained Nasdaq compliance, and through the filing, it was discovered that weeks before the November squeeze (September 2025), the company had already completed the conversion of $36.475 million in principal and $7.495 million in accrued interest into 74,400,947 new shares at $0.591. By the end of December 2025, shares outstanding now stood at 99,587,811.

The stock has continued to grind higher on volume that, since the November spike, has rarely exceeded 500,000 shares on any single trading day and on most days trades fewer than 20,000 shares. Which only means that the price is just being held by a thread.

Any material news, any regulatory development, any additional dilution event, any Nasdaq compliance notice, or simply the exhaustion of the momentum holding the price in place is sufficient to trigger a cascading sell-off with no structural floor to arrest it. The last time this chart looked like this, the stock lost more than 90% of its value in a straight line.

MM Global: The Only Thing Standing

MM Global Securities, Inc. is a FINRA-registered broker-dealer incorporated in Illinois and employs only three registered persons. It is also important to note that it has no disclosed clients, pipeline, or backlog.

In 2023, it contributed $45,837 in placement agent fees, representing 5.2% of MMTEC’s total revenue that year, with consulting services and software development accounting for the rest. In 2024, consulting and software went to zero, and MM Global’s placement fees accounted for 99.6% of MMTEC’s total revenue. In 2025, placement fees fell 56.7% to $807,500, and to date, that figure represents 100% of MMTEC’s total net revenue.

Source: MMTEC, Inc. Form 20-F, fiscal year ended December 31, 2025. Filed April 2, 2026.

A $489 Million Ghost

The company is in itself a phantom shell trading at $489 million in market capitalization (as of 05/16/2026) with zero analyst coverage, zero institutional ownership of record, 31 employees, and a primary business domiciled across BVI, Hong Kong, and Beijing (jurisdictions that offer U.S. investors no practical legal protection).

Source: MMTEC, Inc. Form 20-F, fiscal year ended December 31, 2025. Filed April 2, 2026.

Up to this date, no Wall Street firm covers this stock, and there is no institutional fund holding it, which only shows that the price is not a reflection of research or true price discovery, but only a reflection of retail momentum on a name that has been through two documented squeeze cycles, two reverse splits, and a near-delisting.

MM Global: The Only Business, Already Sanctioned

MM Global Securities (MMTEC’s sole revenue-generating subsidiary) was censured by FINRA and fined $450,000 following a September 2022 AWC (Case No. 2019062623001) for three categories of violations:

1. Failing to establish an AML (Anti-Money-Laundering) compliance program capable of detecting suspicious trading activity, including wash trades, matched orders, spoofing, and layering.

2. Failing to implement its Customer Identification Program.

3. Failing to preserve communications of registered representatives in violation of Exchange Act Rule 17a-4.

Source: MM Global Securities, Inc., FINRA Letter of Acceptance, Waiver, and Consent No. 2019062623001. Accepted September 9, 2022. Available via FINRA BrokerCheck, CRD No. 2509.

In FINRA’s own words, the firm lacked reasonable written AML procedures for the surveillance of trading for suspicious activity. MM Global’s own written AML procedures claimed the firm would “make every effort to detect ongoing manipulation in the market,” while simultaneously containing no security applications whatsoever to identify any forms of manipulative trading.

The FINRA’s letter of AWC reveals that MM Global’s primary institutional customer during 2019 (identified as “Customer A”) was a foreign financial institution with over 150 individual traders from a high-risk money laundering jurisdiction, which accounted for nearly all of MM Global’s trading activity that year, and was affiliated with the founders of “Company A,” one of MM Global’s own affiliates.

Separately, in 2020, twelve MM Global customers located in China and Hong Kong placed coordinated sell orders in Company A’s stock on a single day (some within milliseconds of one another & suggesting coordinated trading activity). Most of these customers had been referred to MM Global by Company A itself. MM Global’s registered representatives conducted securities business related to Company A’s IPO via WeChat and personal email accounts, none of which were preserved.

Source: MMTEC, Inc. Form 20-F, fiscal year ended December 31, 2025. Filed April 2, 2026.

The AWC establishes that the coordinated trading activity in Company A’s stock originated from customers located in China and Hong Kong. Fugazi Research notes that MM Global’s disclosed corporate structure includes subsidiaries domiciled in Beijing and Hong Kong, and that MMTEC currently maintains over 11,000 square feet of undisclosed purpose office space across two Beijing locations. Additionally, a presence in Shenzhen, none of which are associated with any disclosed revenue-generating activity in their 20-F for 2025.

Based on the trading behavior since the November 2025 run-up, the price action raises serious concerns that speculative or potentially manipulative activity may be contributing to the stock’s continued elevation despite the absence of any meaningful operational improvement. Nothing in the underlying business appears to justify the move from sub-$0.25 levels to nearly $5 per share. The stock has seen minuscule volume since November, with most days only trading dozens of thousands of shares. This indicates that trading activity raises serious concerns that artificial or coordinated buying may be contributing to the stock’s continued rise, creating a trading environment that appears increasingly disconnected from legitimate business fundamentals. Similar trading dynamics have historically appeared across highly speculative China-linked microcaps, where price action became detached from underlying operating fundamentals

Inside the Numbers

While Revenue fell from approximately $1.87 million during 2024 to just $807,500 during 2025, gross margin deteriorated from 81.6% to 21.6%, Net losses expanded from roughly $4.8 million to more than $56 million over the same period and customer concentration along with single source revenue also became extreme, with Form 20-F disclosing essentially all 2025 revenue came from a single customer relationship tied to placement-agent activity.

Source: MMTEC, Inc. Form 20-F, fiscal year ended December 31, 2025. Filed April 2, 2026.

Gross profit showcases a 60 percentage-point destruction in a single year, driven entirely by increased costs associated with placement agent services at MM Global, the company’s only revenue-generating subsidiary. Gross profit fell from $1,525,250 to $174,500 over 12 months, even as revenue declined 56.7%.

Source: MMTEC, Inc. Form 20-F, fiscal year ended December 31, 2025. Filed April 2, 2026.

General & Administrative expenses totaled $1,099,638, including $436,912 in rent and utilities across five office locations, $90,100 in Nasdaq application and listing fees, $176,519 in travel and entertainment, and $56,699 in regulatory fees. The company spent $90,100 to maintain its Nasdaq listing and $436,912 on office space, while generating $807,500 in total revenue.

Source: MMTEC, Inc. Form 20-F, fiscal year ended December 31, 2025. Filed April 2, 2026.

Operating loss deteriorated 24.2% despite revenue declining, headcount costs remaining flat, and management cutting compensation. The operating loss is moving in the wrong direction across every metric: revenue down 56.7%, gross profit down 88.6%, and operating loss up 24.2%.

Nothing in the income statement resembles the profile of a rapidly scaling fintech platform; the company’s market behavior, however, is increasingly detached from those operating realities as the capital structure became larger and more active than the underlying business itself.

Source: MMTEC, Inc. Form 20-F, fiscal year ended December 31, 2025. Filed April 2, 2026.

The $9,000,000 in investing cash inflows represents $4,000,000 in XChange note principal repayments and $5,000,000 from the fire sale of $51.99 million face value of the XChange note at a 90.4% loss.

The balance sheet tells a similar story: cash increased during 2025, but not because operations improved (the company remained cash-flow negative); the increase came primarily from financing activity, debt restructuring, and capital-structure changes.

Non-Compliance and Share Count Explosion

The share count history is a dilution extraction record. On April 23, 2021, MMTEC had 25,120,000 shares issued and outstanding, equivalent to 314,000 shares on a split-adjusted basis applying the company’s cumulative 1-for-80 reverse split ratio.

By December 31, 2025, that figure stood at 99,587,811 shares. On a split-adjusted basis, the share count increased 316 times over four years, this should alarm every shareholder in existence as every dollar of value held by a 2021 shareholder has been divided by 316 through a combination of toxic convertible note issuances, original issue discounts, and interrupted twice by reverse splits designed not to return value to shareholders but to reset the minimum bid price clock and enable the next round of dilution. This sequence is a notorious strategy to enrich insiders and orchestrators while leaving investors with worthless shares, as they keep running the stock price to the ground and reverse-split, diluting in a never-ending cycle at the peril of unsuspecting retail investors.

Source: MMTEC, Inc. Form 20-F, fiscal year ended December 31, 2025. Filed April 2, 2026.

What makes the current setup more dangerous is what sits behind the price. In November 2025, MMTEC completed a single-note conversion that issued 74,400,947 new shares at $0.591 (a 295% increase in share count in a single transaction), with shares outstanding rising from 25.2 million to 99.6 million overnight. That supply is now sitting directly above a stock that has just run from sub 50 cents to a high of $9.10 and is being held up by thin volume and no true catalyst. The wall of supply created by the November conversion hasn’t moved yet. This is a company with $807,500 in annual revenue trading at a market cap that the underlying business cannot begin to justify, and the last time this chart looked like this, it lost 93% in a straight line in May 2024.

The Nasdaq Clock

By late 2025, MMTec was operating under significant Nasdaq compliance pressure tied to prolonged minimum bid-price deficiencies. The company ultimately disclosed a delisting determination during October 2025, reinforcing what the market already understood: the stock was running on borrowed time unless something changed structurally.

Compliance windows create unusual conditions in small-cap stocks by compressing incentives into a short period. Short sellers begin positioning for eventual deterioration or delisting, while management teams often rely on reverse splits or capital-market activity to preserve exchange status. The stock itself becomes highly reflexive as positioning, liquidity, and compliance timelines begin to interact.

MTC entered that environment carrying an already fragile capital structure.

This is where many China-linked microcaps become dangerous. Once a stock develops crowded short positioning under a compliance clock, it no longer trades purely on business fundamentals. It begins trading on mechanics: borrow availability, halt bands, SSR restrictions, liquidity gaps, and forced covering behavior. This is what happened on November 5th, when MTC had an almost 1000% run and held up amid erratic short-squeeze behavior while trading hundreds of millions of shares. Short sellers were betting on the delisting and were caught offside. The float at that time of the short, overcrowded squeeze was 25 million. Later in December, MTC regained compliance and immediately diluted its stock to almost 100 million, while its stock price kept floating higher and higher with no demand whatsoever. Since the less than 7-day period of November 5th-10th, MTC has not traded more than 500,000 shares for any single day. Most of these days, it trades barely 20,000 shares. For the stock price to keep going higher and higher on such little volume raises a massive red flag of wash trading stock manipulation from overseas, which is highly probable due to the company’s history regarding this behavior and the fact that it has been fined by FINRA in the past.

The 20‑F explicitly states that the company has incurred substantial losses and may remain loss‑making if revenue does not scale, which is framed as a material risk to the business.

https://www.sec.gov/Archives/edgar/data/1742518/000121390026039499/ea0284046-20f_mmtecinc.htm

Source: MMTEC, Inc. Form 20-F, fiscal year ended December 31, 2025. Filed April 2, 2026.

The China Microcap Pattern

MTC belongs to a category of offshore Nasdaq issuers that became widely scrutinized after The China Hustle documentary brought attention to U.S.-listed China microcaps: offshore holding companies, limited operating visibility, recurring reverse splits, financing-heavy capital structures, and trading behavior disconnected from the scale of the underlying business. These days, the Nasdaq is ripe with China scam stocks, ranging from blatant pump-and-dumps orchestrated by fake characters who infiltrate WhatsApp groups and social media, looking for unsuspecting, lonely victims to swindle into buying stock and eventually dumping it. Unfortunately, these events are very common these days and are tracked by StopNasdaqChinaFraud.com. MMTec displays all the characteristics of being manipulated overseas as a China Hustle-style pump-and-dump scam stock.

Still, the similarities are difficult to ignore. MMTec operates through a multi-jurisdiction structure involving offshore entities, Hong Kong operations, and PRC-linked activities while simultaneously relying on U.S. capital markets for liquidity and exchange access. The company’s operating scale remained extremely limited even as the stock experienced periods of violent speculative activity tied more closely to positioning and float dynamics than to financial performance.

The 20‑F notes that the company is a British Virgin Islands (BVI) holding company and not a U.S. domestic issuer, so it follows BVI law and Nasdaq foreign‑issuer exemptions, which typically allow less stringent governance (e.g., on shareholder rights and board practices).

MMTec is categorized as a non‑accelerated foreign filer; its auditor has not provided a Section 404(b) attestation of internal control over financial reporting, which is permitted but leaves investors more reliant on management’s self‑assessment. The CEO, Xiangdong Wen, also serves as Chairman of the Board, combining executive and oversight roles and reducing the need for independent oversight at the top. This confusing, entangled structure, which is a common theme with overseas scam stocks, is straightforward with MMTec. Combined with their previous run-ins with FINRA, the stock’s upward movement on extremely low volume makes it appear highly suspicious of illegal wash trading, an activity they have been suspected of in the recent past.

Source: MMTEC, Inc. Form 20-F, fiscal year ended December 31, 2025. Filed April 2, 2026.

Typical Wash Trading Scenario:

In low-volume stocks, wash trading is a manipulative tactic in which traders or coordinated groups repeatedly buy and sell the same shares across controlled accounts, creating artificial volume and price movement with virtually no real change in ownership or economic exposure. Much like a frantic game of hot potato, small batches of shares are rapidly passed back and forth at progressively higher prices, simulating buying interest and upward momentum despite almost no genuine outside participation. This illusion draws in unsuspecting investors until the manipulators suddenly dump their holdings in a “rug pull,” causing the price to collapse and leaving retail buyers with heavy losses.

Conclusion

MMTec is not trading on business fundamentals, as there are barely any left to justify the valuation. The company generated just $807,500 in annual revenue while losing tens of millions of dollars, massively diluting shareholders, and relying on financing activity and note restructurings to survive. Beneath the ticker is a business that has never demonstrated sustainable operations, scalable growth, or anything close to what a nearly half-billion-dollar valuation would normally imply.

What drove MTC higher was not execution or institutional demand. It was structured: a tight float, Nasdaq compliance pressure, aggressive convertible mechanics, crowded short positioning, and an illiquid tape that could move violently on very little real volume. The late-2025 squeeze created the appearance of strength, but the filings describe something very different beneath the surface: collapsing margins, recurring losses, an exploding share count, and a balance sheet increasingly dominated by financing activity rather than actual business performance.

This is the recurring pattern seen across speculative China-linked microcaps. Momentum temporarily disconnects the stock from reality; traders chase volatility rather than fundamentals; and the price action itself becomes the story. But eventually liquidity fades, and the underlying business reasserts itself. When that happens, these types of structures historically do not unwind slowly.

MTC now has nearly 100 million shares outstanding, a history of reverse splits, toxic dilution, ongoing Nasdaq risks, and a valuation completely detached from the scale of the underlying operation. Fugazi Research believes MTC’s underlying business doesn’t justify its current valuation and that the stock will ultimately collapse back below $1 in a violent rug-pull before going to zero, just like many worthless Chinese scam stocks.

Disclaimer

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our,”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority.

All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions-long, short, or otherwise-in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

Subscribe now

Share

Executive Summary

CUE Biopharma is a clinical-stage company that has never sold a single commercial product, has never received an FDA approval, and has never generated a dollar of revenue from anything other than licensing rights to assets it developed but could not advance on its own.

Other than its lead oncology program, CUE-101 (which has been in phase 1b for years without a path to commercialization), its most significant endeavors and revenue sources have been terminated since 2025. Its flagship LG Chem partnership produced zero revenue in 2025, and its most recent transaction, which is an $18.9 million licensing arrangement with ImmunoScape, required CUE to accept a 40% equity stake in ImmunoScape as partial consideration, a stake that the company wrote down to zero within the same reporting period it was received.

CUE’s Q4 2025 revenue of $21.94 million was not evidence of a recovering business. It was the upfront licensing payment from ImmunoScape that inflated the annual revenue figure to $27.47 million, creating an illusion of recovery. CFRA’s consensus projects 2026 revenue of $1 million. The company has run this scheme before: in 2021, revenue spiked to $14.94 million from collaboration deals, then collapsed by 91.6% to $1.25 million in 2022.

As of December 31, 2025, CUE had only $27.1 million in cash, and an auditor confirmed that it was a going concern. After accounting for the PIPE net proceeds of $28 million and the $15 million upfront payment to Ascendant Health Sciences, the company’s real cash position is about $40 million. Given their current cash burn rate of $35 million to $40 million per year, the runway is closer to 12 to 16 months, making the next capital raise structurally imminent.

CUE executed an aggressive reverse split, which compressed the float from approximately 97.7 million shares to roughly 3.26 million, in an attempt to restore visibility, regain Nasdaq compliance, and create manufactured momentum. All of these events were followed by a new CEO appointment, a $30 million PIPE deal, and the acquisition of a freshly licensed drug asset from a Cayman Islands company on April 30, 2026. What is even more insidious is that the 3 million post-reverse-split share count was already primed to be diluted by another 4 million shares included in the pipe deal, a 235% expansion in outstanding shares in less than a month. Worth noting is the fact that the PIPE instruments alone covered more than the entire post-split common share base.

The company still has several dilution mechanisms, which it will fully exploit as required by the structure, leaving shareholders with an increasingly diluted position in a company that has accumulated $368.5 million in losses without ever selling a single approved product.

Fugazi Research Analysis

• Since its Nasdaq listing, CUE has remained dependent on licensing transactions and repeated equity issuance rather than a self-sustaining commercial business.

• The FY2025 revenue increase was overwhelmingly driven by a one-time licensing recognition event rather than recurring commercial activity.

• Since its Nasdaq listing in 2022, CUE has raised capital entirely through equity issuance and licensing sales, never through product sales. Between September 2024 and December 2025, the company executed three direct offerings at successive prices of $0.79, $0.50, and $0.28 per share, each offering being cheaper than the last. All while simultaneously maintaining an $80 million ATM facility with Jefferies Securities under which it sold shares for $2.5 million in net proceeds during 2025.

• On April 30, 2026, CUE announced a $30 million PIPE alongside a new CEO, a new drug license, and a narrative package designed to justify the post-split price. What the press release did not headline was the fact that $15 million of those gross proceeds left the company immediately as the upfront payment to Ascendant Health Sciences, reducing the real net cash inflow to approximately $13 million after placement agent fees and expenses.

• The April 30 PIPE was structured as pre-funded warrants covering 2,727,272 post-split shares at a $0.001 exercise price and accompanying common warrants covering 1,363,636 shares at an $11.00 exercise price (currently in the money as of May 06, 2026), which represents a combined 4,090,908 shares that exceeds the entire estimated post-split common base of 3,255,360 shares before a single instrument is exercised.

• The 30-to-1 reverse split executed on April 23, 2026, compressed a share count of 97.7 million shares, which, in itself, was more than double the 47.2 million shares outstanding at December 2023, into a base of approximately 3.26 million shares outstanding.

• The April 30 Form 8-K put Shao Lee Lin in the spotlight. The same filing also appointed her as president, CEO, principal executive officer, principal financial officer, and principal accounting officer (all financial controls simultaneously), while granting her 327,537 restricted stock units that were fully vested on her first day of employment.

• Shao Lee Lin’s prior public-company CEO record is documented in the same filing: she founded ACELYRIN, Inc., led its $540 million IPO in May 2023, and departed in May 2024, fourteen months after ACELYRIN’s lead program failed its primary endpoint and the stock fell 61.61% over two trading sessions. Her reported compensation at ACELYRIN over 2023 and 2024 totaled $98.1 million, while the company’s market cap stood at $322.6 million as of June 2024. To put that into perspective, her compensation was more than that of the CEOs of trillion-dollar market cap companies, Jen-Hsun Huang (50M) and Tim Cook (74M).

• There has even been a lawsuit, supposedly, during the time between May 4 and September 11, 2023, Acelyrin and its executives misled investors by overstating the efficacy and commercial prospects of their lead drug candidate, Izokibep, particularly for treating Hidradenitis Suppurativa (HS). The company allegedly promoted strong early clinical results and claimed the drug’s high potency and small molecular size would produce differentiated, superior outcomes, while failing to disclose that the drug was less effective than represented in the placebo-controlled Phase 2b/3 trial. When the company announced on September 11, 2023, that the trial failed to meet its primary endpoint, Acelyrin’s stock price fell more than 60%, allegedly revealing that prior statements had been materially false or misleading in violation of federal securities laws.

• The filing record shows a clinical-stage company that has never commercially succeeded at anything it has tried, a reverse split executed to solve a compliance problem rather than a business problem, a massive overhanging dilution, and a CEO whose only prior public-company leadership ended in a clinical failure and securities litigation, all covered by a headline transaction whose obligations exceed the company’s own market capitalization. We consider CUE shares to be significantly overvalued at current prices.

CUE Financial Summary

• CUE’s accumulated deficit stands at $368.5 million against $394.8 million in total paid-in capital since inception, meaning the company has destroyed $0.93 cents of every dollar ever put into it across its entire operating history, without producing a single approved product or a dollar of commercial revenue to show for it.

• With $53.9 million in total operating expenses against $27.5 million in reported FY2025 revenue, CUE spent approximately $1.96 for every $1.00 it earned.

• Net loss from operations for FY2025 was $26.6 million, against reported revenue of $27.5 million, resulting in a loss margin of 97%. The company has never reported a profitable year, a profitable quarter, or a period of positive operating cash flow in its public filings.

• Without the $26.3 million in financing activity executed during FY2025 (three equity offerings and an ATM program) the company would have entered 2026 with less than $1 million on hand. The FY2025 closing cash balance of $27.1 million is a financing artifact, not an operating achievement.

• Since its Nasdaq listing in 2022, CUE has raised capital through equity issuances each fiscal year, including registered direct offerings, warrant issuances, and ATM programs. The April 30, 2026, PIPE extended that pattern with $28 million in net proceeds against an immediate $15 million cash outflow committed to Ascendant in the same transaction.

• With 29 employees and $53.9 million in total operating expenses, CUE spends approximately $1.86 million per employee annually to operate a business with $5.0 million in forward contracted revenue.

• General and administrative expenses grew 11% in FY2025, from $14.6 million to $16.2 million, in the same fiscal year that the company lost both its Chief Executive Officer and its Chief Medical Officer to departures requiring severance payments, and disclosed going concern language confirmed by its auditors.

• On April 30, 2026, the company granted incoming CEO Shao-Lee Lin a compensation package with a combined day-one cost of approximately $6.3 million, against $5 million in total forward contracted revenue. This was awarded to the same executive whose prior public company, ACELYRIN, reported $98.1 million in her compensation across 2023 and 2024 before its lead program failed and the stock fell 61.61% in two sessions.

Source: Cue Biopharma, Inc. Form 8-K, Filed April 30, 2026.

Source: Cue Biopharma, Inc. Form 10-K, fiscal year ended December 31, 2025.

Source: Securities Purchase Agreement by and between Ascendant Health Sciences Ltd. and Cue Biopharma, Inc., Exhibit 10.1

Source: CFRA Quantitative Stock Report, Cue Biopharma, Inc., May 3, 2026. Data provided by S&P Global Market Intelligence.

The Playbook

Between March 16 and April 30, 2026 (a 45 day period) the following events occurred at Cue Biopharma in this exact order: auditors confirmed going concern, four simultaneous lock-up agreements expired, the acting CEO announces her resignation, a Nasdaq delisting warning was issued, a 30 to 1 reverse split was executed, a new CEO was installed, a $30 million private placement was announced, and a drug license from a Cayman Islands company arrived as partial consideration.

Make no mistake, these were engineered events; the sequence was not the product of coincidence. It was part of the plan, which is a common toxic dilution cycle method, to enrich certain people involved with the company. Every piece arrived exactly when the structure required it, the reverse split to reset the float when it needed compressing, the narrative when the reset needed covering, and the capital when the narrative needed credibility.

Source: CFRA Quantitative Stock Report, Cue Biopharma, Inc. May 3, 2026. Data provided by S&P Global Market Intelligence.

CUE’s Form 10-K already showed the setup before the Apr. 30 financing window opened. The company had no product sales revenue, no FDA-approved commercial product, negative operating cash flow, a going-concern warning, and a share count that had expanded to 97.7M shares before the reverse split.

1. The first move was accounting optics. The FY2025 revenue increase came primarily from non-recurring licensing recognition tied to the ImmunoScape transaction, not commercial demand. The apparent improvement in operations preceded another financing reset.

2. The second move was Nasdaq optics. On Apr. 23, 2026, CUE executed a 1-for-30 reverse split under its Form 8-K. The split reduced the visible common share base from 97.7M to roughly 3.26M. Authorized common shares remained unchanged. The denominator was compressed. The issuance runway remained open.

3. The third move came eight days later. On Apr. 30, CUE filed a Form 8-K covering a new CEO, the Ascendant license, a $30M PIPE, pre-funded warrants, common warrants, Rule 5635 stockholder approval gates, lock-up releases, top-up rights, and resale registration obligations. One filing window rebuilt the share-supply stack that the reverse split had just compressed.

CFRA’s quarterly revenue data shows that from Q1 through Q3 2025, revenue averaged $1.84 million per quarter. Q4 2025 spiked to $21.94 million on the ImmunoScape upfront recognition event; Q1 2026 is expected to be $2.50 million, which would represent an 88.6% quarterly collapse from the peak.

Source: CFRA Quantitative Stock Report, Cue Biopharma, Inc. May 3, 2026. Data provided by S&P Global Market Intelligence.

The PIPE offering alone covered 4.09M shares equivalent. That is larger than the estimated post-split common base. Ascendant received another 551,724 pre-funded warrants as license consideration. The Form S-8 then registered 3.0M shares under the 2026 Inducement Stock Incentive Plan.

CUE reduced the visible common base to roughly 3.26M shares. The Apr. 30 Form 8-K and Form S-8 added or registered roughly 7.64M additional shares-equivalent before Ascendant top-up shares, Lin’s top-up option, older warrants, the S-3 shelf, or ATM capacity.

Registration rights create the exit path. The PIPE Registration Rights Agreement requires CUE to file a resale registration statement within 30 days after closing. The Ascendant agreement requires CUE to register resale of the Ascendant warrant shares within 45 days after issuance. Private paper becomes registered paper on a filing schedule.

The ownership table adds another layer. The DEF 14A shows Bleichroeder affiliates with 9.99% beneficial ownership, while the footnote excludes 6.746M additional warrant shares due to beneficial ownership blockers. The cap limits reported ownership. It does not eliminate the inventory.

Management economics were added to the same reset. CEO Shao-Lee Lin received options and RSUs covering 982,611 shares, representing roughly 30% of the estimated post-split common base, plus a top-up path to approximately 8.5% fully diluted ownership upon specified milestones. The Form S-8 registered the inducement pool the same day the Form 8-K disclosed the financing stack.

The sequence is the signal, here:
license revenue first → reverse split second → PIPE and licensor warrants third → resale registration → inducement equity alongside it.

Source: Cue Biopharma, Inc. Form 10-K, fiscal year ended December 31, 2025.

Source: Cue Biopharma, Inc. Form 10-K, fiscal year ended December 31, 2025.

CUE’s largest reported quarter came after the company licensed CUE-100 series oncology rights to ImmunoScape. The Form 10-K states that the ImmunoScape transaction price included $15.0M in upfront payments and $3.9M in fair value for a 40% equity interest in ImmunoScape. The Form 10-K also states that the revenue was recognized at a point in time when the licenses were granted.

That is the key accounting event.

The Q4 revenue spike was due to the monetization of pipeline rights. It was not evidence of approved product demand. The Form 10-K still shows a business dependent on licensing monetization and external financing despite the temporary revenue spike. The cash-flow statement did not confirm a turnaround. CUE generated $27.5M of FY 2025 collaboration revenue and still used $21.7M of cash in operating activities. The Form 10-K also disclosed substantial doubt about the company’s ability to continue as a going concern.

The share count moved in the other direction. CUE ended FY 2024 with 61.8M shares outstanding and FY 2025 with 96.6M shares outstanding. By Mar. 13, 2026, the Form 10-K cover page showed 97.7M shares outstanding before the 1-for-30 reverse split. The numbers show the structure: a license-accounting revenue spike, negative operating cash flow, an expanding accumulated deficit, and pre-split share count growth. The Form 10-K revenue line did not remove the financing need. The reverse split was smoke and mirrors as the stock price before the split was less than .50 a share with incoming dilution set to drag it down even lower.

The CEO Reset: Shao-Lee Lin’s Public-Market Precedent

CUE’s Apr. 30 Form 8-K placed Shao-Lee Lin at the center of the post-reverse-split reset. The same filing appointed Lin as President, Chief Executive Officer, board member, principal executive officer, principal financial officer, and principal accounting officer. It also gave her PIPE participation, inducement equity, and a top-up path tied to fully diluted ownership.

Source: Cue Biopharma, Inc. Form 8-K, Filed April 30, 2026.

On April 30, 2026, the company simultaneously structured one of the most generous executive compensation packages in its history for an incoming CEO joining a going concern business with 29 employees and no commercial revenue. Shao-Lee Lin received a $660,000 base salary, a 55% target bonus, and 327,537 restricted stock units fully vested on her first day of employment (representing approximately $4.3 million in immediate equity value at the April 30 closing price). Her initial equity package of 982,611 shares across RSUs and options represents approximately 30.2% of the entire post-split common share base, with a contractual top-up path to 8.5% of fully diluted shares following specified milestones. The outgoing interim CEO, Lucinda Warren, received a separation package totaling $584,010. Combined, the executive transition cost CUE approximately $7.9 million (157% of the company’s total forward-contracted revenue) in the same filing window that management described as a transformative financing event.

Source: Cue Biopharma, Inc. Form S-8, Filed April 30, 2026.

The timing is the point. The CEO package arrived in the same filing window as the Ascendant license, the $30M PIPE, pre-funded warrants, common warrants, Rule 5635 approval gates, resale registration obligations, lock-up releases, and top-up rights. Lin’s prior public-company CEO record is relevant because CUE’s own Form 8-K identifies her as ACELYRIN’s founding CEO and director from July 2020 to May 2024. ACELYRIN priced its IPO at $18.00/share, sold 30.0M shares, and raised $540M in gross proceeds. ACELYRIN Form 424B4, May 5, 2023

The ACELYRIN IPO-to-readout sequence became a securities litigation event. The class action complaint names ACELYRIN, Shao-Lee Lin, Mardi Dier, and Gil Labrucherie as defendants. The complaint alleges false or misleading statements tied to Izokibep’s clinical and commercial prospects during the May 4, 2023, to Sept. 11, 2023, class period. It also states that ACELYRIN sold 30.0M IPO shares at $18.00/share and received $502.2M after underwriting discounts and commissions. The complaint alleges that ACELYRIN announced on Sept. 11, 2023, that Izokibep failed to meet statistical significance on the primary HiSCR75 endpoint in the Phase 2b/3 trial for hidradenitis suppurativa. The complaint states that ACELYRIN’s stock fell $17.19/share, or 61.61%, over the following two trading sessions, closing at $10.71/share on Sept. 13, 2023.

Lin’s compensation remained material through the ACELYRIN reset. ACELYRIN reported $88.7M of total compensation for Lin in 2023 and $9.4M in 2024. The same Form 10-K reported aggregate non-affiliate market value of approximately $322.6M as of June 30, 2024. ACELYRIN Form 10-K, FY 2024

Anatomy of the Mirage

CUE entered April 2026 with a Nasdaq minimum-bid problem, going-concern language, no product-sales revenue, and a pre-split share count of nearly 97.7M shares. The Form 8-K sequence shows the mechanics of the reset.

The Apr. 23 Form 8-K compressed that base through a 1-for-30 reverse split. The Apr. 30 Form 8-K then loaded the post-split structure with PIPE warrants, Ascendant warrants, resale rights, Rule 5635 approval gates, top-up mechanics, and inducement equity.

The post-split share count was stale within eight days.

The PIPE reload

On Apr. 30, 2026, CUE reloaded with upcoming near-term dilution with a PIPE. The PIPE instruments alone cover more shares than the estimated post-split common base.

Registration rights: the exit path

The April 30 PIPE came with a resale registration statement covering the shares underlying the PIPE pre-funded warrants and common warrants within 30 days after closing. This means that there will be incoming downward selling pressure from a new, significant supply soon.

Ascendant’s ownership protection

CUE licensed Ascendant-221 / UB-221 from Ascendant Health Sciences Ltd., a Cayman limited company. The Form 8-K gives CUE rights outside mainland China, Hong Kong, Macau, and Taiwan, while Ascendant retains defined rights in those territories. CUE agreed to pay $15.0M upfront, up to $676.5M in potential milestones, and tiered royalties on future net sales.

Existing common holders face dilution from the transaction, while Ascendant receives a contractual mechanism designed to preserve ownership and value thresholds.

The lock-up release schedule

Ascendant’s lock-up restricts transfer of subject securities, but the release schedule is already set in the Form 8-K, which will trigger immediate market supply.

Assuming Apr. 30, 2026, as the reference date, the lock-up releases on this calendar:

The S-8 layer

On April 30, 2026, CUE filed a Form S-8 registering 3.0M shares under its 2026 Inducement Stock Incentive Plan. The filing fee table values the registered shares at $43.98M. In reality, CUE registered a new equity pool equal to roughly 92% of the visible post-split common base.

The CEO-specific economics are addressed separately. The S-8 shows how quickly the post-split denominator reopened.

The post-reset supply bridge

The reverse split made the share count look smaller, while in reality, the April 30 filings made the structure larger. The estimated post-split common base was approximately 3.26M shares. The Apr. 30 Form 8-K and Form S-8 added or registered approximately 7.64M additional share equivalents.

Bleichroeder and the blocker inventory

The DEF 14A identifies affiliates of Bleichroeder LP as a five-percent holder. The beneficial ownership table discloses 4,997,240 common shares and 5,265,630 shares underlying warrants as beneficially owned, with ownership capped at 9.99%.

At CUE, the 9.99% cap marks the point where ownership disclosure ends and warrant inventory continues.

The Reverse Split that became sellable inventory

CUE’s Form 10-K describes an at-the-market program with Jefferies under an $80M open market sale agreement. The pattern is capital access through repeated equity-linked issuance: ATM shares, underwritten stock, pre-funded warrants, and common warrants.

Conclusion

CUE entered April 2026 with no commercial product revenue, negative operating cash flow, going-concern language, and a capital structure already stretched by years of repeated issuance. The company then executed a 1-for-30 reverse split, temporarily compressing nearly 98 million shares to roughly 3.26 million shares outstanding, creating the appearance of scarcity while leaving the underlying financing framework intact.

Within days, that compressed structure was rebuilt with PIPE warrants, pre-funded warrants, inducement equity, resale registration obligations, top-up protections, and additional issuance pathways. The visible float was reduced, but the underlying supply stack expanded almost immediately. In our view, the reverse split did not repair the business; it reset the financing mechanism.

The company’s apparent FY2025 improvement was also built on non-recurring licensing and accounting recognition, rather than on sustainable commercial demand. Q4 revenue created the illusion of a recovery, while forward estimates already point to a return to collapse. CUE still has no evidence of a durable commercial business capable of funding itself without repeated access to external capital.

The April 30 filings also introduced structural protections for counterparties that common shareholders do not share. Through top-up rights, resale registration obligations, change-of-control protections, and warrant-heavy financing mechanics, the structure increasingly protects the paper above and around common equity while leaving ordinary shareholders exposed to dilution, supply, and downside.

Ultimately, we believe the filings describe a company engineering temporary stability through capital structure mechanics rather than solving the underlying economic reality of the business. As registration windows open and additional supply reaches the market, shareholders may discover that the post-split scarcity narrative was temporary, while the dilution infrastructure behind it was permanent. In our view, the warning is clear: CUE does not need a failed clinical outcome to damage shareholders; the capital structure is already built to do that on its own.

At these levels, CUE shares are pricing a narrative that the filing record does not support. Prior to the reverse split, CUE was non-compliant and trading at almost pennies on the dollar. We consider CUE shares to be significantly overvalued and on the verge of a drastic 95% correction back to sub-$1 per share, once fully diluted.

Disclaimer

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our,”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority.

All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions-long, short, or otherwise-in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

Subscribe now

Share

Akanda has been trading the same way for years (sharp, narrative-driven spikes followed by steady, grinding fades). The business has never caught up, and it hasn’t needed to. Each cycle resets with a new angle, a tighter float, and just enough momentum to pull buyers in before the underlying structure reasserts itself. The latest telecom pivot doesn’t break that pattern. It looks like the next version.

What’s different now is the starting point. The legacy cannabis business is gone, the replacement asset is small, and the balance sheet is materially worse. Cash is down to roughly $1.3 million, debt has expanded to approximately $26 million, and the company continues to operate under going concern language. The structure is tighter, the margin for error is gone, and the amount of supply sitting behind the current float is larger than at any point in the company’s history, with over 6.7 million shares registered for resale (reverse split adjusted) against roughly 534.4 thousand shares outstanding, according to the company’s April 2026 6-K filing.

It is worth pausing on what Akanda actually is: a Canadian cannabis distributor that shut down its only revenue-generating subsidiary in March 2025, as disclosed in its annual report; has never harvested a single unit of product from its British Columbia cultivation facility; and has now pivoted into Mexican telecommunications infrastructure following its August 2025 acquisition of First Towers & Fiber Corp., a sector with no operational, regulatory, or strategic overlap with anything the company has previously operated.

The setup is more fragile than at any prior point in the company’s history. Less cash, more debt, a larger overhang, a replacement business that is real but immaterial, and a financing structure that is designed to convert into selling pressure. The story may trade, but the structure will not hold.

Source: Akanda Corp. Form F-1/A2, Filed March 20, 2026.

Source: Akanda Corp. Form F-1, Filed March 20, 2026.

Fugazi Research Analysis

• Akanda Corp (AKAN) is a 2022 Nasdaq-listed company that has never achieved true commercial scale, generated meaningful revenue, or achieved any path to profitability. In April 2025, Akan lost Canmart Ltd., its sole operating subsidiary and its only source of revenue in the previous year. Which, in theory and based on our analysis, would bring the already small revenue ($836,664 in FY 2024) to zero without its subsidiary.

• On May 1, 2026, the company cited an inability to compile required disclosures without unreasonable effort or expense. However, they included a preliminary financial summary which disclosed a full year 2025 revenue of approximately $258,075 against operating expenses of approximately $4,827,720, which represents an operating loss ratio of 18 dollars spent for every 1 dollar earned.

• On March 26, 2026, Akanda issued a press release announcing a $2 million contract for fiber infrastructure in Mexico. However, the spread is across a 10-year term, and the contract generates approximately $200,000 per year in contracted revenue against an operating burn rate of more than $4 million annually.

• Since its Nasdaq listing in March 2022, Akanda has raised capital entirely through equity issuance and debt, never through operations. In 2024 alone, the company executed seven or more registered direct offerings and underwritten public deals, raising approximately $11.5 million at share prices ranging from $32.48 to $2.00.

• Christopher Cooper is central to the First Towers transaction. The Form F-1/A states that Cooper was a director of Akanda and a co-founder, shareholder, executive, and director of First Towers. The same filing states that he recused himself as an Akanda board member for purposes of the transaction and was removed from Akanda’s audit committee.

• Between September 2025 and January 2026, Akanda raised $19 million in toxic convertible notes and paid $6.725 million (35% of gross proceeds) to IR Agency, LLC, a retail stock promotion firm. This is a documented dilution loop: raise notes, pay promoters to push stock, note holders convert at an 85% VWAP discount, price falls, execute a reverse split, and repeat.

• Since March 2023, Akanda has executed six reverse stock splits, the last one being a 1 for 4.5 (April 2026). The cumulative ratio is approximately 1 for 56,340. The company has explicitly stated its intent to execute additional splits in 2026 and beyond, with Board authorization for a cumulative ratio of up to 1 for 100 without requiring further shareholder approval.

• As of April 9, 2026, following their most recent reverse split, Akanda had approximately 534,400 common shares outstanding. The January 2026 convertible notes, adjusted for the 1-for-4.5 April 2026 reverse split, represent approximately 6.7 million shares registered for resale (more than 12 times the current float) at an adjusted floor conversion price of approximately $1.14 per share.

• The filing record shows a failed legacy cannabis platform, a small replacement telecom asset, heavy financing reliance, promotional spending funded from note proceeds, repeated reverse splits, and a registered conversion-share supply far larger than the visible share count. We consider AKAN shares to be uninvestable at any price above liquidation value, which, in this case, considering the debt structure, cash burn rate, and going concern of the business, is likely near ZERO.

AKAN Financial Summary

• Total accumulated deficit stands at $57.4 million, against $63.3 million in total paid-in capital since inception, meaning the company has accumulated losses equal to 91% of every $1 invested in it.

• For the fiscal year ended December 31, 2024, Akanda generated $836,664 in revenue entirely from Canmart’s UK cannabis distribution operations. That subsidiary was shut down in March 2025.

• Preliminary financial results show 2025 revenue of approximately $258,075, which represents one-third of what the company spent on salaries alone during the same period and less than one-twentieth of its total operating expenses of approximately $4,827,720.

• Net loss from continuing operations for FY2024 was $3.26 million against $836,664 in revenue (a loss margin of approximately 391%). The operating loss was $4.38 million for FY2024.

• Akanda burned through $3.9 million in operating cash during FY2024, up from $1.5 million the year before, a year-over-year increase of approximately 165%.

• Cash fell from $3.8 million at December 31, 2024, to approximately $1.3 million as of February 28, 2026, a 66% decline in roughly 60 days following the January 2026 note offering, highlighting continued cash burn even after financing activity.

• Akanda raised approximately $10 million through equity issuance during fiscal year 2024 alone, while generating $836,664 in total revenue. That is a ratio of roughly $12 in revenue from selling shares for every $1 in revenue from selling a product.

• In twelve months, Akanda’s total debt went from $3.64 million to approximately $26 million. A 7x increase in debt engineered not by growth, but by the acquisition of a director-controlled company whose own pre-existing debts were assumed at closing.

Source: Akanda Corp. Form 20-F, fiscal year ended December 31, 2024. Filed April 30, 2025.

Source: Akanda Corp. Form F-1/A3, Filed March 20, 2026.

Source: Akanda Corp. Form 6-K, Exhibit 99.1, Filed March 26, 2026.

Source: Akanda Corp. Form NT-20F, Filed May 1, 2026.

The Setup

In the most recent development, AKAN notified Nasdaq that it will not be able to file its Form 20-F on time. The company cited an inability to compile the required disclosures, offering no further explanation. Besides the fact that these types of developments are true red flags, the most important development is that the company itself is now recognizing only $258,075 in revenue for the twelve months ended December 2025. This all stems from the First Tower fiber-optic contract and confirms our thesis that their cannabis business is practically dead. To confirm that the company is pivoting away from marijuana, one just needs to look at their latest filing and their most recent NT-20F. There is no single revenue source from their purported cannabis-related business. This is all disclosed by the company in plain sight. The company did not even make $1 in the weed industry since February 2025, with no hint of resuming weed operations in the future.

Source: Akanda Corp. Form NT-20F, Filed May 1, 2026.

Source: Akanda Corp. Form NT-20F, Filed May 1, 2026.

The run-up of AKAN began on April 22, 2026, when breaking news about the Trump administration’s expected reclassification of marijuana as a less dangerous drug. On Thursday, April 23, the US policy change went through. However, AKAN isn’t even focused on marijuana anymore. The company’s social media posts feature outdated stock images of marijuana and have not been updated since 2022. Their last paid promotions didn’t even mention anything about marijuana. The paid promotion mentioned a new large fiber network in central Mexico related to telecommunications infrastructure. (A zero relationship with the marijuana business.) This is misleading to potential momentum traders who are buying on the Trump marijuana headline. Retail investors are not looking deeper into the company and realizing it has pivoted to something completely different from the marijuana industry. AKAN is focusing marginally more on its fiber business in Latin America, which has nothing to do with weed and is also a minimal-scale revenue stream at best. As for a company that burned almost $5 million in operating expenses in FY2025, $258K in revenue is meaningless to cushion the already enormous and increasing deficit. If the company were focused on marijuana, they would likely have mentioned it in their paid promotions, which they have spent more on than the company's market cap.

Source: Akanda Corp. Form NT-20F, Filed May 1, 2026.

The Non-Existent Business

On their social media, Akanda has not updated any new information since November 2022; in that same post, they are promoting their indoor grow facility in Sintra, Portugal. However, it is important to note the fact that the Portugal facility has been sold since the beginning of 2024.

Back in 2022, AKAN was actually involved in the marijuana industry, as they had $2.6 million in revenue from cultivation and distribution. In 2023, they had $2.1 million, followed by $836,000. The pattern is clear: their weed business was declining and not working out, and to remain solvent, they would have to come up with anything they could to stay listed on the public markets. The miracle solution: fiber optic towers in Mexico doing $200k a year, while their shareholders get diluted as they desperately hold on to the idea that their investment is in the future of marijuana. As they are getting diluted in perpetuity, the market cap of AKAN keeps shrinking, down to a minuscule $1.5 million by April 23rd, 2026, during the run-up on Trump administration weed news.

While the company describes itself as a “leading integrated medical cannabis company,” it’s clear that Akanda is not a cannabis company; it has not been one for over a year, and now its own investor page and social media accounts have not acknowledged this.

What stands out most is the stock rising by over 2,000% in less than 2 weeks. This is artificially elevated at these levels due to an imbalance between supply and demand, as the stock is coming off a recent reverse split. AKAN had a reverse split on April 12 to keep the illusion of compliance or to maintain themselves out of the radar of regulators, as this is done in a consistent basis under different ratios to maintain the minimum price bid in order to keep existing in the market and taking advantage of their capital structure, they had to do a reverse split because their stock price was too low and trading for under a dollar for more than 30 days. When they did their sixth split in 3 years of 4.5 to 1, their float became 540,000. Their float is small for now; it is easy to manipulate to higher prices to do toxic, death-spiral financings, which will lead to more and more reverse splits until there is nothing left.

The legacy cannabis business no longer provides a base, and the company’s 2024 revenue came from Canmart; it completely ceased operations in 2025. The remaining now is a low-revenue pivot into a Mexican telecommunications asset that carries a new story but lacks true scale. This also generates problems on its own, as the same telecom transaction added leverage, including a $14.1 million note at 16% interest, while subsequent financings introduced a large convertible component. (A $19 million worth of convertible notes using toxic discount formulas.)

Source: Akanda Corp. Form F-1/A3, Filed March 20, 2026.

What remains is a company with 500k shares outstanding, against almost 7 million shares tied to resale registration just by convertibles alone. Or, in a simple context, if we had to define Akanda in 2026, it would be a failed business that has lost its original revenue base, replaced it with a smaller asset, layered on additional liabilities, and now carries a multiple of its float in potential supply sitting behind it.

Ownership and Float Reality

Akanda looks like a tight float only if investors ignore the registered conversion shares underlying the reported share count. The Form F-1/A destroys that argument: the visible share count is small, but the registered conversion-share pool is more than 12x larger. As of March 20, 2026, Akanda reported only 2,404,882 common shares outstanding, while the Form F-1/A registers 30,314,961 shares for resale upon conversion of the January Notes. The reported float appears tight only because the registered conversion supply has not yet fully been reflected in the common share count.

The problem is what happens next. Those shares are not passive. They come with conversion mechanics tied to discounted pricing, which creates a natural incentive to resale registration into sellable inventory once conversion shares are issued.

This is also where the impact of repeated reverse splits becomes harder to ignore. According to company filings, Akanda has executed six reverse splits since 2023, with a cumulative ratio of roughly 1-for-56,340. Adjusted for those splits, the current ~$60 price equates to a pre-split value measured in pennies — roughly in the $0.02–$0.05 range depending on the reference point — but in reality, we’re talking value in fractions of a penny, not dollars. In other words, what appears today as a high-priced equity is, on a normalized basis, still trading at levels typically associated with distressed microcaps.

That matters more than it seems. Reverse splits don’t create value — they compress share count and reset optics. The effect is psychological as much as mechanical. A $60 stock reads differently than a $0.03 stock, even if the underlying economics are the same. In names like this, that difference tends to attract incremental buyers at exactly the point where underlying supply is preparing to come through.

That disconnect between perceived float, visible price, and actual supply is the core of the trade.

Source: https://app.askedgar.io/ticker/AKAN/dilution

Promotion and Distribution

During the events of the paid promotions, it is important to mention that the company has spent 4x its market cap at the time, considering that at the time of their latest reverse split, their market cap was around $1.5 million (market cap April 12, 2026), against $6.7 million spent in paid promotions in the past two years to the IR Agency alone. Nobody can argue that AKAN has spent more on paid promotions than what their company is worth. This is a fact that is not only clear in all the disclaimers of the paid promotions, but it is also clearly mentioned in the filings.

Source: Akanda Corp. Form F-1/A3, Filed March 20, 2026.

Between September 2025 and January 2026, the company raised approximately $19 million in convertible notes, and a portion of those proceeds was directed toward “investor awareness campaigns” AKA “promo pumps”.

Companies with real operating traction and sufficient internal funding do not need paid promotion to generate investor demand; companies with a history of blatant paid stock promotion are notorious for pump-and-dump trading activity. The company pays for a “marketing campaign,” which generates temporary volume from unsuspecting, naive investors who eventually become the liquidity for those who paid for the campaign in the first place. The cost of the “marketing campaign” is covered by the rug-pull dumping of shares, leaving the losses to oblivious retail investors.

In structures like this, promotions are likely engineered events created by top management to obtain financing on an already distressed balance sheet, and they also don’t have a path to a true revenue or income stream. Discounted convertibles require liquidity to convert into, and that liquidity is often supported by visibility and outreach targeted at retail participants. By using StockPromotionTracker.com, we can see the recent documented history of paid promotions in which AKAN has been involved. The unique situation with AKAN is that the company openly admits it runs paid promotions. Usually, the modus operandi of shady companies is to cover their tracks when it comes to paid promotions or “marketing campaigns.” The fact that AKAN explicitly states in their filings that they engage in paid promotions is not only a red flag but also a warning to those buying. In the case of AKAN, the company can afford not to hide its paid promotions because the supply of its stock is so low that a small amount of volume would push it up, and at the same time, short sellers would have a tough time shorting it because of the tight supply, which could lead to a squeeze. The reverse split, together with the paid promotions, indicates the squeeze was likely manufactured.

The pattern is consistent. Capital is raised, attention increases, and the stock finds unsuspecting buyers. The mechanics behind it do not change, while history shows the rest.

Source: IR Agency LLC “Secret Stock” (AKAN) .

The Structure

To date, the company has completed 10 offerings totaling approximately $46 million USD, equivalent to 30x its standard market cap. Its IPO and subsequent offerings have all been done by lower-tier investment banks and underwriters. Just as with companies with a history of paid promotions, it is no secret that lower-tier underwriters are associated with shady companies. The archetype of this is AKAN. A company that, unaware, investors and hobbyist traders think is a weed company, when in fact it is a fiber optic tower company on the outskirts of Mexico for lower-end cell phone services. This shows that the company is not in the business of producing, distributing, or improving operational efficiency. But in complete capital market dependency.

Source: Dilution Tracker AKAN Completed Offerings

At the current scale, the revenue contribution is minimal relative to operating burn, expanded debt load, and the registered conversion-share overhang. Even with growth, the business would need to scale materially just to support the existing structure before any value accrues to equity.

The more important change is what came with the acquisition. Akanda layered on significant obligations, including a high-interest, secured note. That shifts the equation. The question is no longer whether the telecom business exists; it’s whether it can scale fast enough to carry the liabilities, interest burden, and dilution structure already attached to it. The telecom pivot gives Akanda a new operating story, but it does not change the financial reality underneath it.

The need for continuous dilution

Over the past year, the company moved from a lightly levered structure to one that is defined by its obligations. Total debt after the First Towers transaction was approximately $26 million, up from just a few million the year prior, while cash has declined to around $1.3 million.

That shift changes everything. The company is no longer operating with optionality; it is operating against a balance sheet that requires capital, time, and execution. A meaningful portion of those obligations comes from the telecom transaction itself, including a $14 million note carrying a 16% interest rate and secured by substantially all assets. That in itself is not passive capital; rather, it sits ahead of a behemoth of equity and accrues regardless of the business’s performance.

From here, the company has limited ways to bridge the gap. It can either raise more capital through dilution (the path of least resistance) or attempt to grow into the obligations (no healthy lender would take the risk). Each path has implications, but none of them leave equity untouched.

Conclusion

At these levels, the stock is no longer being bought on what the business is; it’s being bought on what the move has been. The company isn’t even in the weed business anymore. They are installing fiber-optic towers in Mexico. They have completely shifted away from weed, yet the herd, groupthink mentality of momentum traders chasing the “next hot weed stock” is not even aware that the company is focusing on their towers in Mexico. AKAN has not had any income from weed in over a year; they dilute shareholders based on their outdated reputation of being in the weed industry.

In addition, the company’s existence at this point is to finance sleazy paid-promotion marketing companies rather than contribute anything productive to society.

The current tight supply setup can plunge sharply at any moment, with dislocating price action to the downside. Eventually, shareholders will be getting the short end of the stick as the company looks to dilute at current inflated stock prices, which they have done through 10 toxic raises in just 4 years. In essence, the company has burned through over 45 million in cash while its market cap dwindled to less than 2 million before the run-up on April 22, 2026.

The filings still show the same picture: the legacy cannabis business is gone, the replacement telecom asset remains small, cash is limited, and the liability structure has expanded beyond what the current business can support. A tight visible float can drive price, but the registered supply sitting behind it does not disappear; it works over time. Reverse splits may reset the optics, but they don’t remove the overhang.

At these levels, this ranks among the more fragile long-term investments in the market, reliant on continued momentum rather than underlying support. We consider AKAN’s shares to be uninvestable and to have zero fundamental value.

Disclaimer

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our,”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority.

All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions-long, short, or otherwise-in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

Subscribe now

Share

Executive Summary

Avis Budget Group’s most recent filings show a business generating $11.65 billion in annual revenue while reporting a $889 million net loss attributable to shareholders in 2025. This all follows a $1.8 billion loss in 2024. These two years alone represent $2.71 billion in cumulative losses, occurring alongside rising interest expense, declining retained earnings, and continued balance sheet deterioration. The company now carries $25.3 billion in total indebtedness against negative stockholders’ equity of $3.1 billion, placing the capital structure in a deficit position where liabilities exceed any residual equity value. Recent price action has further demonstrated the extent to which positioning and float constraints can drive valuation independently of underlying fundamentals. The company generated only about $0.56 in operating earnings for every $1.00 of interest owed, highlighting that it no longer generates sufficient earnings to cover its interest burden.

What the numbers above fail to capture is the secondary architecture that transformed a fundamentally distressed business into the most structurally violent short squeeze since GameStop. Two institutional funds (SRS Investment Management and Pentwater Capital Management) accumulated combined economic exposure exceeding 100% of Avis Budget Group’s shares outstanding, SRS through nine years of debt-funded float engineering that installed its own partners as CEO and Executive Chairman, Pentwater through a systematic accumulation culminating in a full repositioning to unhedged long exposure in March 2026 via its Merger Arbitrage Master Fund. Together, they held the float hostage. The result was a prisoners’ dilemma that held the stock at prices six times its fundamental value until April 22, 2026, when the announcement of Q1 earnings on April 29 collapsed the remaining runway simultaneously for both funds, the leveraged long overhang liquidated in a single session, and the stock fell 40% in one day. What remains (a company with negative equity, 8x leverage, $6.8 billion in mandatory vehicle purchases due in twelve months, and a Moody’s downgrade window opening in August 2026) must now be priced on fundamentals alone.

• Capital Structure and Financing Risk:

  • The company’s capital allocation over the past decade shows a sustained pattern of balance-sheet contraction through share repurchases, funded in part by debt issuance. Avis deployed approximately $10.75 billion into share buybacks, including $3.3 billion in 2022 alone, while simultaneously increasing corporate debt to $6.1 billion.

  • These transactions reduced stockholders’ equity while introducing fixed obligations that the business no longer has the earnings capacity to support.

  • The May 2025 issuance of $600 million in 8.375% Senior Notes (the highest coupon in its recent history) further increased financing costs while being used in part to refinance existing obligations rather than reduce leverage.

• Earnings Quality and Metric Adjustments:

  • Management’s primary performance metric, adjusted EBITDA, has been redefined multiple times to exclude recurring costs. In 2024, $2.47 billion in fleet impairments were excluded, followed by an additional $518 million in 2025, alongside the introduction of new exclusion categories tied to vehicle disposal losses.

  • These adjustments remove material expenses that directly arise from the company’s core operating model, resulting in a performance metric that materially diverges from economic reality and does not reflect the full cost structure required to sustain the fleet.

• Governance Structure and Ownership Concentration:

  • Over a multi-year period, SRS Investment Management increased its ownership position from approximately 20% to 45%, ultimately exceeding the size of the non-affiliate public float.

  • This increase occurred during a period in which the company executed substantial share repurchases using corporate capital

  • A shareholder derivative action filed against directors, officers, and a significant stockholder alleged governance failures in connection with these transactions and related disclosures.

  • While the case was dismissed on procedural grounds, the court acknowledged the shareholder’s influence as a governance consideration requiring oversight.

Source: Delaware Court of Chancery — Shareholder Derivative Action Opinion, Avis Budget Group, Inc. Dismissed December 2025 on procedural grounds. Delaware Courts, Opinions.

• Liquidity Pressure and Structural Constraints:

  • The company continues to operate under fixed financial obligations that do not adjust with performance. At current levels, the business generates approximately $971 million in monthly revenue while incurring $74 million in net losses, excluding interest expense.

  • In addition, Avis faces $6.8 billion in mandatory vehicle purchase commitments over the next 12 months, which must be funded regardless of market conditions, residual values, or demand trends.

  • These obligations create a structure in which capital requirements persist even as operating performance declines.

Fugazi Research Analysis

• Non-stop Losses with No End in Sight.
  Avis Budget Group has reported net losses attributable to shareholders of $889 million in 2025 and $1.8 billion in 2024—two consecutive years of significant losses on a business generating $11.65 billion in annual revenue. The combined two-year loss of $2.71 billion occurred while the company paid no dividends, did not repurchase meaningful shares, and issued its most expensive debt in recent history. Those losses were driven by fleet impairments, disposal losses, and rising interest expense. In two years, the company has erased a substantial portion of its retained earnings, effectively consuming its equity base. Levi & Korsinsky, LLP is currently investigating Avis Budget Group for potential securities law violations, focusing on the gap between prior earnings expectations and the $748 million in adjusted EBITDA the company ultimately delivered. This further highlights the disconnect between reported performance and investor expectations.

Source: Avis Budget Group, Inc. Class Action Lawsuit – CAR | Levi & Korsinsky

• Temporary Short Squeeze with Potential for Catastrophic Collapse.

SRS’s endgame is not a future event. The result is a float so compressed that the price discovery mechanism is entirely broken. At recent price levels, the stock is trading at an increasingly elevated multiple of a redefined EBITDA metric that management has already missed twice, sustained not by the business, but by a lack of available shares to allow the price to correct. This mathematical mistake has made the temporary short squeeze artificial; the structure supporting the move is inherently unstable and susceptible to rapid reversal. The retail shareholders trading at current levels are not partners in a recovery; they are gambling on hype and providing the liquidity for a structurally constrained exit.

• Hijacked Float at the Expense of Minority Shareholders.

Over the course of nine years, SRS Investment Management executed one of the more structurally efficient control acquisitions executed in public markets—without a control premium and without the investors or the market noticing. While its ownership percentage climbed from 20% to 45%, and its entire disclosed share position grew to exceed the non-affiliate public float, SRS never really had to spend meaningful capital to buy its way in. The strategy was straightforward: infiltrate the company, authorize a decade of share buybacks using the company’s own funds, observe the float decrease, and expand their share at the cost of minority shareholders. These buyback programs were not capital allocation but a blatant float hijack executed in plain sight and with the company’s approval. SRS did not end up owning Avis; they engineered Avis Budget Group’s own financial structure to make the ownership free for them.

• Insider Trading Concerns Lead to Litigation.

A shareholder derivative action filed against Avis Budget Group’s directors, officers, and a large minority stockholder alleged five counts: insider trading on material non-public information about vehicle delays in 2022 and 2023, approval of share buybacks that transferred control to this shareholder, a cooperation agreement that was improperly disclosed, breach of oversight duties, and unjust enrichment. The case was dismissed in December 2025, not on the merits of any allegation, but on procedural grounds of futility. However, the presiding judge’s own opinion confirmed that SRS’s influence was a documented governance concern requiring active judicial recognition, acknowledging that Avis’s directors had taken affirmative steps to restrain it. The procedural dismissal was not an exoneration.

• Equity Depleted by Inflated Debt

The $10.75 billion in share buybacks that compressed Avis Budget Group’s float and mechanically transferred effective control to SRS Investment Management were not funded by operating cash flow but were significantly funded by newly acquired debt. Records and filings show that in 2022 (the most aggressive buyback year, which totaled $3.3 billion), Avis borrowed $750 million through a new floating-rate term loan. This pattern repeats across multiple years: issue corporate debt, deploy proceeds into buybacks, watch SRS’s ownership climb, and repeat. The $6.1 billion in corporate debt on Avis’s balance sheet is related to the $10.75 billion in treasury stock that destroyed the equity base and concentrated governance in SRS’s hands. The structure of these transactions concentrated ownership, while leaving minority shareholders exposed to the leverage and financing costs that followed.

Source: CAR Form 10-K year ended December 31, 2025,

• Lenders Can’t Exit and Instead Keep Increasing Debt

Corporate interest expense rose 18% in a single year to $422 million as Avis issued $600 million of 8.375% Senior Notes in May 2025 (the highest in its recent public debt history and a direct signal of deteriorating credit perception, as a percentage-point increase is now the norm year over year). The May 2025 senior notes were issued to repay the 2025 floating-rate term loan and a portion of the 2027 notes. This means that Avis is borrowing at 8.375% to retire cheaper debt and calling it refinancing. Total debt stands at $25.3 billion. The lenders repricing this credit upward while simultaneously extending it are not acting out of confidence; they are managing exposure while extracting a higher return for the risk they cannot exit.

• Conveniently Left Out Details to Mislead Investors

The company’s adjusted EBITDA (the primary performance metric presented to investors) has been redefined multiple times to exclude recurring costs. In 2024, $2.47 billion in fleet impairments were excluded. In 2025, an additional $518 million in impairments was excluded, alongside a new exclusion category called “other fleet charges,” which removed $390 million of costs related to vehicle disposals from adjusted performance. A metric that requires a new exclusion category each time a recurring cost becomes too large to absorb does not reflect operating performance; it obscures it.

Source: CAR Form 10-K year ended December 31, 2025,

CAR Financial Summary

• For the full year ended December 31, 2025, revenue totaled $11.65 billion, while net loss attributable to shareholders for the same period totaled $889 million, representing a -7.6% net margin.

• The $11.65 billion in revenue was generated against total expenses of $12.58 billion, meaning that Avis spent $1.08 for every $1.00 it collected. Vehicle depreciation and lease charges alone accounted for 25.9% of revenue, while corporate interest expense accounted for an additional 3.6%.

• At current operating levels, the company generates approximately $971 million in monthly revenue while incurring $74 million in net losses. Corporate interest expense adds $35 million per month in fixed obligations that must be paid regardless of operating performance.

• The company has accumulated a stockholders’ equity deficit of negative $3.1 billion, reflecting two consecutive years of nine-figure GAAP losses, compounded by $10.75 billion in treasury stock buybacks, funded primarily by debt issuances that now cost shareholders $422 million per year in interest expense.

• Total indebtedness stands at $25.3 billion ($6.1 billion in corporate debt and $19.2 billion in asset-backed vehicle program debt) against a business that has not generated positive GAAP earnings in two consecutive fiscal years.

• The company’s most recently issued senior notes carry a coupon of 8.375%, the highest in its recent history, and a direct market signal of deteriorating credit perception.

• Two consecutive years of net losses attributable to shareholders totaling $2.71 billion occurred while the company paid no dividends and issued its most expensive debt in recent history.

• Retained earnings have fallen from $3.9 billion in 2023 to $1.1 billion in 2025, a 72% erosion over 2 years. At the 2025 loss rate, the remaining retained earnings balance will be fully exhausted in just a year without a fundamental reversal in operating performance.

• The Americas’ rental car industry, which accounts for 76% of Avis’s total revenue, has completely flatlined. The US political environment has pressured tourism volumes throughout 2025 and the beginning of 2026. Travel sentiment has softened amid market volatility and macroeconomic uncertainty. Tariffs on imported vehicles create direct cost pressure on the already $6.8 billion mandatory fleet repurchase commitment. This is not an industry in trend, but a normalized, low-growth, margin-compressed industry that doesn’t show signs of recovery.

• As of the most recent public rating action in February 2025, Moody’s affirmed Avis Budget Group’s corporate family rating at Ba3 with a NEGATIVE outlook. Moody’s own stated downgrade triggers include debt/EBITDA sustained above 4x. With a corporate leverage currently running at approximately 8x adjusted EBITDA, Avis breaches that threshold by a factor of two. As of the date of this publication, it is confirmed that every condition Moody’s identified as a downgrade risk has materially worsened since the last public rating action.

• The $25.3 billion in total indebtedness, against negative stockholders’ equity of $3.1 billion and a corporate gross debt of $6.1 billion, implies a leverage ratio of 8.1x adjusted EBITDA (more than three times the 2.5x first-lien covenant threshold that the company must not breach). The all-in coverage ratio at the current adjusted EBITDA against total corporate and vehicle interest expense of $1.34 billion annually is 0.56x, meaning the business generates 56 cents of adjusted earnings for every dollar of interest it owes. On a GAAP basis, the coverage is currently negative.

Source: CAR Form 10-K year ended December 31, 2025,

Source: MMCG Invest - “U.S. Car Rental Industry: 2025–2030 Market Analysis (Investment Perspective)

Source: Moody’s Ratings, as reported by Investing.com - “Avis ratings affirmed by Moody’s, outlook shifts to negative”

The Business Model (A Debt-Financed Cycle)

Avis Budget Group is not a traditional car rental company. It is a debt-financed asset cycle operating at an industrial scale. The model requires the company to deploy approximately $15.1 billion annually to acquire a rotating fleet of 684,000 vehicles, finance that fleet through $19.2 billion in asset-backed debt at a weighted average rate of 5.29%, generate rental revenue against that asset base, and dispose of the vehicles before depreciation destroys the residual value.

Vehicle depreciation and lease charges rose 73% in two years, from $1.739 billion in 2023 to $3.015 billion in 2025. America’s revenue per day declined 3%. America’s Adjusted EBITDA collapsed 75%, from $2.2 billion to $552 million.

The disposal losses were so large that management created an entirely new non-GAAP exclusion category, “other fleet charges,” to remove $390 million of vehicle disposal losses from the metric it asks investors to use.

The company has $6.8 billion in mandatory vehicle purchase commitments due over the next 12 months. Those commitments do not account for softer pricing, lower residual values, or a tariff environment that could make new vehicles materially pricier. The fleet must be funded regardless.

The 2021 to 2023 period produced results that made the model look structurally superior; it was nothing but an alignment of factors that allowed it to look better on the surface.

First, daily rental rates surged across the industry as fleet availability collapsed following the semiconductor shortage. With supply constrained worldwide, operators sustained elevated pricing for an extended period without meaningful competitive pushback.

Second, used vehicle prices reached historic highs. Avis was selling vehicles at a gain or with minimal depreciation, a dynamic that directly inflated reported margins and obscured the true cost structure of the fleet. In 2023, net gains on vehicle sales reached $656 million, a figure that contributed directly to that year’s $2.2 billion Americas Adjusted EBITDA.

Third, lower effective depreciation combined with elevated pricing produced return metrics that appeared to justify a structural re-rating of the business. Higher margins drove stronger cash flow, which reinforced the narrative.

But this convergence and added conditions never last. Avis Budget Group is not a distressed business waiting for a catalyst, but in reality, it is a cyclical business in the middle of a mean reversion, operating on a borderline liquidity balance sheet. The debt is still there and growing, the interest expense is still there, along with the mandatory fleet commitment. What is no longer there is the pricing power, the residual-value tailwind, and the capital efficiency that made it all look manageable.

Financing Costs are Now a Headwind

Avis’s Budget Group model is structurally inseparable from its debt. The company carries $19.2 billion in asset-backed vehicle program debt and $6.1 billion in corporate debt, a whopping $25.4 billion in total indebtedness against a business that generated negative GAAP earnings in each of the last two fiscal years.

Today, the cost of the debt is rising faster than the revenue it supports. Vehicle interest expense reached $918 million in 2025. Corporate interest expense rose 18% in a single year to $422 million. Total annual interest expense across corporate and vehicle programs stands at $1.34 billion. Against the adjusted EBITDA of $748 million, the all-in coverage ratio is 0.56x. The business generates 56 cents of adjusted earnings for every dollar of interest it owes.

The May 2025 issuance of $600 million in 8.375% Senior Notes (the highest coupon in Avis Budget Group’s recent public debt history) is a market verdict. When sophisticated institutional lenders price a company’s debt at 8.375%, they are communicating their view of the company’s credit risk.

Investment-grade BBB-rated companies were borrowing at approximately 5.0% to 5.2%. Avis paid approximately 200 to 250 basis points above the typical cost of capital for a BB-rated company, a spread that reflected not the general level of interest rates but the specific credit risk premium the market assigned to Avis at that time.

The Moody’s signal

Moody’s most recent public rating action on Avis Budget Group, taken in February 2025, affirmed the corporate family rating at Ba3 (three notches below investment grade) while simultaneously shifting the outlook from stable to negative. Moody’s explicitly published its downgrade triggers: “debt/EBITDA sustained above 4x and pre-tax income as a percentage of sales below 7.5%.”

Moody’s places follow-up actions on negative outlooks within approximately 12 to 18 months of the outlook change. The February 2025 action puts that window squarely at August 2026 to February 2027 (a period during which Avis must also refinance $645 million of 5.750% Senior Notes maturing in July 2027). Every condition Moody’s identified as a downgrade risk has materially worsened since February 2025.

Source: Moody’s Ratings, as reported by Investing.com - “Avis ratings affirmed by Moody’s, outlook shifts to negative”

SRS eats the Float

What appears to be a publicly traded company with 35.26 million shares outstanding is, in practice, a privately controlled enterprise with a publicly listed minority stub.

SRS Investment Management first appeared in Avis Budget Group’s shareholder register around 2010. By 2013, the company launched a share repurchase program. The sequence that followed was craftfully designed. Each buyback reduced the outstanding float; each float reduction increased SRS’s ownership percentage without SRS deploying meaningful additional capital. Each time SRS’s percentage crossed the prior threshold established in the most recent cooperation agreement, a new agreement was signed ratifying the higher number and setting a new cap.

Five agreements over nine years moved the cap from 20% to 45%. The outstanding shares went from approximately 60 million to 35.26 million.

The personnel installations ran in parallel.

• In January 2016, Brian Choi (an SRS partner since October 2008) was placed on the Avis board under the first cooperation agreement.

• In April 2018, Jagdeep Pahwa (President of SRS) joined the board after SRS’s attempt to nominate five directors simultaneously forced a new agreement.

• In May 2020, Karthik Sarma (SRS’s founder and managing partner) joined as an independent director.

• In February 2025, Brian Choi was appointed CEO.

• In March 2025, Jagdeep Pahwa was elevated to the position of Executive Chairman.

Three of the most consequential positions at Avis Budget Group are held by individuals with direct or former SRS affiliation.

The buyback program funded this consolidation with corporate capital. Of the $10.75 billion in treasury stock on the balance sheet, a meaningful portion was not funded by operating cash flow but by newly issued corporate debt. In 2022, the most aggressive single-year buyback at $3.3 billion, Avis simultaneously borrowed $750 million through a new floating-rate term loan. The pattern repeated across multiple years: issue debt, repurchase shares, shrink the float, increase SRS’s ownership, and formalize each step higher through new cooperation agreements. The $6.1 billion in corporate debt, now costing approximately $422 million per year in interest expense, is not separate from the $10.75 billion in treasury stock. They are the same transaction viewed from opposite sides of the balance sheet. $10.75 billion in debt-funded buybacks concentrated ownership, while minority shareholders remain exposed to the leverage and over $400 million in annual interest costs that came with it.

Source: Fugazi Research analysis. Outstanding shares and repurchase data derived from Avis Budget Group, Inc. Definitive Proxy Statements (Form DEF 14A), fiscal years 2021 through 2025, filed with the U.S. Securities and Exchange Commission. SRS Investment Management ownership percentages were derived from Schedule 13D/A filings and DEF 14A beneficial ownership tables for the corresponding periods. All filings are available at SEC EDGAR.

SRS Investment Management has spent nine years building something that does not yet have a formal name, but its shape is unmistakable. A controlling position exceeding the entire non-affiliate public float. A board fixed at five or six members by their cooperation agreement. A transfer restriction clause ensures that any future buyer of their block must maintain the governance structure they designed, which is the organizational architecture of an owner preparing to formalize what is already functionally true: a private company in plain sight.

Ownership Concentration and the Illusion of Float

Avis’s trading behavior is shaped by a more fundamental constraint than most market participants recognize: a large portion of the company is already held in concentrated hands, and the float reported by data providers bears little resemblance to the shares actually available to trade.

Recent filings show approximately 35.3 million shares outstanding. Within that, Pentwater Capital disclosed ownership of approximately 7.8 million shares (roughly 22% of total shares outstanding). SRS Investment Management holds a disclosed direct share position of approximately 17.4 million shares, a figure that, on its own, exceeds the entire non-affiliate public float, as calculated from Avis Budget Group’s 10-K cover page disclosure.

That disclosure (the aggregate market value of common stock held by non-affiliates as of June 30, 2025, divided by the closing price of $169.050) implies a true non-affiliate float of approximately 16.76 million shares. SRS’s disclosed position alone exceeds that figure by approximately 674,000 shares. Pentwater’s 7.8 million shares represent an additional 46.7% of the same float. Between these two holders alone, identified long positions exceed the entire non-affiliate float by more than 8.5 million shares (before any other institutional holder is counted).

Market data providers, including Yahoo Finance, commonly report the public float at approximately 10 million shares. The 10-K disclosure, using the company’s own numbers at a specific date, confirms the real non-affiliate float is approximately 16.76 million, a figure that is itself already smaller than SRS’s disclosed position and already stale, having been calculated as of June 30, 2025. Any accumulation since that date, including SRS moving toward its newly ratified 45% ownership cap, has further compressed the real tradeable supply below even that figure.

This structure changes how the stock moves. When elevated short interest meets a float, this constraint (S3 Partners confirmed that less than 900,000 shares are available to borrow against 7.1 million shares short) means that buying pressure does not need to be large. It just needs to meet the liquidity constraint. When that happens, short sellers are forced to compete for a pool of shares that is functionally insufficient to absorb institutional covering at any rational price. The result is price action that becomes reflexive and disconnected from the underlying business.

However, this constraint is not permanent. On March 27, 2026, Avis established an at-the-market equity program for up to 5,000,000 shares. At recent squeeze-driven price levels, full utilization of this program would represent approximately 14% incremental share issuance and could raise over $2 billion of gross proceeds. The significance is structural: the same supply constraint that is currently amplifying prices can reverse if the company elects to issue shares into strength, introducing new liquidity directly into a market defined by its absence.

Source: Avis Budget Group, Inc. — At-the-Market Equity Offering Prospectus Supplement (424B5), filed March 27, 2026. U.S. Securities and Exchange Commission, EDGAR.

Ownership concentration explains how the stock trades at these levels. It does not explain why it should trade there. It does not explain why it should be done. If anything, it reinforces the central point of this report: structure and positioning, not sustainable earnings power, have determined recent price levels. When that structure stops tightening—when SRS reaches its 45% cap, when short covering exhausts itself, and when the float constraint that has been nine years in the making finally meets a seller of scale—price must stand on fundamentals again. And the fundamentals, as documented throughout this report, do not support current share prices.

Source: S3 Partners, LLC — Ihor Dusaniwsky, Head of Predictive Analytics, “Avis Runs Over Its Short Sellers,” April 9, 2026.

The Prisoners’ Dilemma: Who Pulled the Pin and Why the Grenade Went Off Today

On April 22, 2026, CAR collapsed 40% in a single session, from an intraday high near $847 to a close of $443. The squeeze was not sustained solely by retail momentum or algorithmic feedback. It was sustained by a structural impossibility: two sophisticated institutional funds had independently accumulated combined economic exposure exceeding 100% of shares outstanding, with no coordination between them and no agreed exit mechanism. This created a textbook prisoners’ dilemma.

Neither fund was acting in concert. Explicit coordination between them would constitute illegal market manipulation. As a result, each operated in informational isolation regarding the other’s exit intentions. This is the precise condition that makes a prisoners’ dilemma structurally unstable: both parties have a dominant incentive to act first, but neither can observe the other’s move in real time. The prisoners’ dilemma framework was independently corroborated by two market analysts whose public commentary arrived at substantially the same structural conclusions through different investigative paths. This convergence strengthens the analytical foundation of our thesis.

The following analysis was provided to Fugazi Research by a senior options specialist and financial professional with direct experience in short-squeeze mechanics, whose public commentary on $CAR’s ownership structure and synthetic exposure has been widely circulated on financial social media. Speaking on background, the analyst provided additional technical detail that corroborated Fugazi Research’s original EDGAR-based findings through an entirely separate investigative path.

The following interview was conducted prior to the April 22, 2026, market session and prior to the Globe Newswire announcement confirming Q1 2026 earnings for April 29. All direct quotes below are drawn from the recorded interview. Where the analyst’s public statements overlap with interview content, they are noted as such. The source requested anonymity; accordingly, no identifying information is included in this supplement.

When asked to characterize the structural ownership dynamic driving the squeeze, the analyst provided a precise accounting of the combined economic exposure held by the two dominant funds. His framing centered on the distinction between common stock ownership and cash-settled total return swap exposure:

The analyst’s figure of 10,122,700 shares in cash-settled swap exposure matches the ownership decomposition table he published publicly, which showed total economic claims of 39,041,829 shares against 35,324,685 shares outstanding (a structural overhang of approximately 10.5%).

The analyst was asked directly whether the at-the-market equity facility established on March 27, 2026, represented a live relief valve for the squeeze. His response identified the MNPI constraint as the primary barrier, consistent with our analysis, though stopping short of the four additional hard stops documented in our original 424B5 forensic review.

The analyst provided important context on the official short interest data timeline, distinguishing between FINRA-reported figures and real-time estimates from data vendors. The analyst confirmed that by the time of the interview, the $CAR situation had developed a gamma squeeze component layered on top of the structural short squeeze, with options dealers acting as forced sellers due to delta hedging obligations.

The analyst was asked directly why SRS and Pentwater had not yet exited their positions, given the extraordinary price appreciation. His response identified the Section 16 insider trading constraint as a secondary barrier to exit, layered on top of the structural prisoners’ dilemma dynamic that both analysts had independently documented.

The analyst confirmed that by the time of the interview, the $CAR situation had developed a gamma squeeze component layered on top of the structural short squeeze, with options dealers acting as forced buyers through delta hedging obligations.

Valuation Ridiculous

At current price levels, Avis Budget Group trades at an implied equity valuation increasingly disconnected from its underlying earnings capacity. The business has generated negative GAAP earnings in each of the last two fiscal years, while eroding 72% of its retained earnings over the same period. This is not a case of the market discounting future growth. It is a case of price being driven by structural constraints in supply.

What is currently trading is not a valuation anchored in fundamentals, but the mechanical consequence of a compressed float interacting with elevated short interest and options-driven positioning. When a single shareholder holds a position exceeding the entire non-affiliate float, when additional large holders control a substantial portion of the remaining supply, and when borrowing availability is constrained, price becomes a function of positioning rather than earnings power.

At these levels, valuation is absurd. We do not mince words. It reflects who is forced to transact within a limited pool of shares.

What the Market Is Missing

The market is not misreading the numbers; it is misreading what created them. What looked like durable earnings power was a temporary alignment of favorable conditions, not a structural improvement. As those conditions fade, the reset is structural.

On April 21, 2026 (one day before the crash) Pentwater Capital Management LP and Matthew Halbower filed a Form 4 disclosing transactions dated April 17, 2026. The filing reveals the following:

The squeeze mechanics are not resolved. Low borrow availability and an elevated borrow rate on a 40% down day confirm that the structural supply constraint remains fully intact. What has changed is the composition of the long side (leveraged longs have been cleared, leaving only the two large structural holders and the synthetic swap exposure). The period between now and April 29 earnings represents the most information-dense window in this situation. Every EDGAR filing, every Form 4, and the April 29 shares outstanding figure will determine whether today was the end of Act One, or the intermission before a more consequential Act Two.

Conclusion

$CAR’s recent price action has already demonstrated the instability embedded in the structure. The same forces that drove the stock to extreme levels (constrained supply, forced buying, and positioning) began to reverse within a single session, producing a sharp intraday collapse from peak levels. This was not driven by a change in fundamentals, but by a shift in liquidity and positioning.

The underlying business has not changed. It remains a highly levered, cyclical model facing rising depreciation, elevated financing costs, and declining earnings power. What has changed is the structure supporting the price. As the pool of forced buyers narrows and incremental liquidity returns, the stock becomes increasingly exposed to the underlying economics it has temporarily detached from.

In levered cyclical models like Avis, risk is not defined by recent performance, but by how quickly underlying conditions can reverse. Today’s move is not an anomaly; it is a preview of how quickly price can adjust when the structural imbalance begins to unwind.

In our assessment, SRS’s probable endgame remains unchanged. The conditions for a take-private are already substantially in place: control without a premium paid, management aligned, and a float too small to resist. What remains is timing and price. As the stock moves further away from peak levels, the path toward a transaction becomes more feasible.

The story has carried it this far. The structure is starting to give. At recent price levels following a vertical expansion, the margin for error has effectively disappeared. Buying at these levels is where investors get hurt, after vertical expansion– just because the move has started to settle does not mean it is safe.

Disclaimer

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our,”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority.

All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions-long, short, or otherwise-in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

This report provides a follow-up to our main publication, released on January 26, 2026, with updated information on SIDU’s Q4 and full-year 2025 earnings filing and call.

SIDU’s Q4 and full-year 2025 earnings call on March 31st only reinforced our thesis that this is a company of minimal substance that will continue to exist through shareholder dilution. During the call (which lasted exactly 30 minutes), founder and CEO Carol Craig meandered from one defense and technology buzzword to the next, claiming that her microcap company (slightly above 100 employees) had accomplished building end-to-end satellite design, manufacturing, and operational capabilities, enabling multi-domain operations through proprietary edge software, AI, and an internally developed tech stack. What was completely missing in this fanciful tale of transformation was any mention of revenue-generating contracts.

Since the publication of our initial report on the company, the three main angles we covered have not only persisted but also accelerated. Upon reviewing the company’s most recent 10-K filing, we have found that the situation has only gotten worse.

Related-party revenue has increased beyond what we originally documented.

At the time of our first report, Craig Technical Consulting (or “CTC”) was the company controlled by SIDU’s CEO, Carol Craig, and accounted for approximately 47% of the company’s revenue for the nine-month period ended September 30, 2025. The full-year figure remained at the same level; however, CTC’s share of accounts receivable skyrocketed to 86%, while the two largest remaining independent customers (Bechtel and TNO) have now practically disappeared from the customer base, with Bechtel declining from 40% of total revenue to 14%, and TNO disappearing entirely from the customer concentration altogether. This confirms, once again, that Carol Craig’s position as SIDU’s best customer has only deepened since our original report.

A Business that keeps on Failing. The financial details behind SIDU’s most recent annual results provide a grim insight into the company. Revenue fell 28% year over year to just $3.4 million for the full year. A figure that is dwarfed by the 48% increase in cost of revenue alone. This, combined with SG&A expenses of $22 million, results in a net loss of $29.5 million for the full year. A figure that is nearly nine times the company’s entire annual revenue.

Dilution has now turned into a permanent mechanism. At the time of our original report, we documented the January 2026 filing of a $500 million shelf registration and flagged this as the mechanism for the next dilution cycle. This was confirmed when the company entered into a $100 Million ATM sales agreement with ThinkEquity on February 26, 2026, enabling it to sell stock at market prices with no further notice of a separate offering announcement. Taking advantage of any liquidity event to dump shares into the market, leaving already diluted shareholders exposed to further dilution at any time, without warning.

The company has written off its flagship satellite, and its second satellite may be a failure. SIDU recorded a $4.5 million “Impairment Loss” on LizzieSat-1 (its first and most important satellite) after failing to re-establish contact with the spacecraft and initiating decommissioning protocols after just 18 months in orbit. To put that in perspective, this “Write-off” of their flagship satellite represents more than the company’s entire revenue for the year ended 2025.

Worse, the company’s second satellite, LizzieSat-2, is still not commissioned, despite being launched in December 2024. While Craig characterized the LizzieSat-2 as “still in commissioning”, the average time for a satellite in a similar orbit is 8-12 weeks, not 15 months. While we don’t have technical data confirming that Lizzie Sat-2 is a write-off, the odds of the satellite becoming operational this late are low. Finally, the initial commissioning of LizzieSat-3 reveals on-orbit capabilities–AIS tracking and mounting a commercial optical sensor–that were new and interesting over a decade ago. To put this in perspective, multiple universities’ satellite clubs have launched multi-payload satellites, including those with AIS tracking and commercially available optical sensors.

Most critically, the company has certified in its own filing that its internal controls are NOT effective. This comes in direct contrast to the FY2024 10-K, in which management disclosed the same controls as effective. The FY2025 10-K status of “NOT effective” is damning, meaning that, as of today, the company’s top management cannot reliably ensure that the financial information required to be disclosed is reported, recorded, or processed accurately. Meaning that for investors who rely on narratives like the Lonestar contract, SHIELD IDIQ, and the company’s satellite fleet, the company is now telling them it cannot guarantee that these disclosures are true. This is a glaring and significant point for investors.

Industry Expert Perspective (Follow-up interview)

For this follow-up report, we returned to the same senior industry expert whom we interviewed for our original publication. This space and satellite expert has more than two decades of experience in the aerospace and satellite sector, both in commercial and government roles, and has requested to remain anonymous. This source remains familiar with Sidus Space and its competitors and markets, has spoken with several company executives (including Craig herself), and has listened to Craig speak on multiple occasions.

“SIDU is a dumpster fire. 2025 comps on everything… revenue, margin, cost of sales, loss per share, all significantly worse than 2024. The only bright spot for the company is that they have $43.3 million of cash, and that’s entirely through equity raises (dilution) in Q3 and Q4.”

This aligns with the audited figures filed in their most recent 10-K. Revenue down 28% year over year. Cost of revenue 48% up year over year, a gross margin of -168%, and a net loss of $29.5 million for the year.

“The $120 million contract with Lonestar Data Holdings is questionable. Lonestar is a startup that only recently closed a small Series A round, and is currently in no financial shape to fulfill the total terms of its contract with Sidus. Additionally, Lonestar faces several other extremely well-funded competitors who have better tech and are further along–to include Starcloud (valued at over $1B), which has actually already trained an LLM in space, Google, Aetherflux and Aethero. Axiom Space (worth $2.5B in its latest funding round) also deployed its Data Center Unit-1 on the International Space Station in the fall of 2025, and launched two additional orbital data center nodes in January. Absent a major breakthrough, Lonestar is not a significant nor interesting company in the space datacenter market, and there is little reason to expect they will be able to successfully compete. Putting these two small companies with no differentiating or compelling technology together does not increase the odds either will be successful.”

The Lonestar contract has been the centerpiece of SIDU’s narrative since 2024. Our experts’ assessment of Lonestar, a financially distressed startup competing in a segment now targeted by well-financed, established big players, raises a key question. What happens to SIDU’s flagship opportunity if Lonestar fails to survive? The 2025 10-K discloses only an “initial milestone payment” with no number, no disclosure, and no commitment to a specific number, with the launch of LizzieSat-5 (supporting the Lonestar contract) vaguely described as “sometime in late 2026.”

The current public record around Lonestar does not resolve that uncertainty. SIDU’s latest year-end materials continue to present the Lonestar relationship as a $120 million lunar manufacturing program tied to LizzieSat-5, yet the most recent public Lonestar capital event was a January 2026 raise of only $6.6 million, announced together with a leadership change in which Stephen Eisele became chief executive officer, and founder Chris Stott moved to executive chairman. Lonestar also continues to describe its Freedom payload on Intuitive Machines’ Athena mission as having “performed flawlessly.” NASA states that Athena came to rest on its side, that this prevented full operation of the drill and other instruments before battery depletion, and that the mission ended early. Intuitive Machines likewise described a lander that came to rest on its side and did not return to operations. The customer tied to SIDU’s flagship lunar narrative is therefore still presenting both its capital position and its most visible recent mission in ways that do not remove the central question around the Lonestar opportunity.[l][m][o]

“The SHIELD contract for “Golden Dome” now has 2,440 prime awardees; only 23 companies who applied to this effort were denied, a fact that should not provide shareholders any level of comfort. Additionally, several dozen other satellite manufacturers who will be direct competitors to SIDU are also awardees–and many of them have better solutions, better talent and bigger facilities. Several other dozen have the software, ground command centers and other capabilities SIDU claims to have, but better. Importantly, no task orders have even been initially issued, despite the IDIQ awards being announced 4 months ago. Some government officials are privately indicating that any task orders will be further delayed by up to three more months, making it highly unlikely that any of those funds will hit any company before Q3 2026.”

In our initial report, we flagged this as a legitimate concern. SIDU announced its SHIELD inclusion as a headline, alongside the program’s $151 billion total ceiling. However, this is a program-wide figure, distributed across thousands of competitors (+2,400 awardees and essentially nothing more than a fishing license). Additionally, the first orders have not even been issued, while the timeline has been pushed further out, and there is no guarantee that SIDU will ever get even a small piece, either as a subcontractor or a meaningful contract related to SHIELD.

The conflict of interest is also particularly obvious in the Missile Defense Agency’s SHIELD IDIQ contract, which Craig touted extensively as an accomplishment. Her other company, Craig Technologies, is also an awardee on the same contract; as a certified Woman-Owned Small Business, it will have a contracting preference over SIDU. Given the extensive overlap between what both companies do, shared facilities, and, in some cases, the workforce, Craig Technologies is actually quite an effective competitor to SIDU. Given that SIDU is a public company and Craig is at least the majority owner of Craig Technologies, structurally, she is likely to personally benefit more if any SHIELD contracts are awarded to Craig Technologies rather than to SIDU. To date, we are not aware that Craig has ever addressed this conflict of interest.

“The Tobyhanna contract is extremely small, very low-margin, and not the basis for scaling any meaningful work. Importantly, it is also counter-factual to Craig’s central transformation theme–that SIDU will pursue only high-margin government and commercial work, and deliberately go away from low-margin government contract manufacturing.”

Similar to the SHIELD IDIQ, this small contract also has multiple other awardees (a total of 9), minimizing the amount of work that will go to any one company. Furthermore, the work described in the contract is the kind Craig Technologies would certainly pursue. If any task orders on the Tobyhanna contract are awarded to SIDU, SIDU could simply subcontract that work to Craig Technologies, minimizing the bottom-line impact to SIDU. This would be consistent with our main thesis that Craig is both SIDU’s best customer and that the quality of revenue is extremely concentrated and heavily identified as a circular money play. This is the epitome of self-dealing and a huge red flag. The 10-K also does not disclose the contract’s dollar value, margin, or guidance. Regardless, the size of the contract will not materially impact SIDU’s financial trajectory.

Moreover, SIDU’s own disclosures do not maintain consistency in the Tobyhanna award description. The company’s September 29, 2025, award release and its April 1, 2026, full-year results release both describe Tobyhanna as a five-year IDIQ. The 2025 10-K, however, describes the same award as a ten-year IDIQ. The September 2025 release also states that individual task orders are capped at $750,000 and awarded competitively on a best value or trade-off basis. For a contract already structured as a competitive task-order vehicle rather than a fixed, committed award to SIDU, even the basic term of the award is not described consistently across the company’s own recent materials.[q][r][s]

“The rest of the announcements… the MOU’s, the partnerships, all of it… have zero revenue behind them.”

A detailed review of their most recent 2025 10-K reveals that the filing references with Reflex Aerospace, Saturn Satellite, Vorago, and Little Place do not appear in the revenue breakdown. They are mere non-binding expressions of intent. They are only there to generate press releases without any cash flow numbers, which means that they are fundamentally zero.

Even some of SIDU’s more technical NASA-adjacent announcements shrink on inspection. In December 2025, SIDU announced a subcontractor role with MobLobSpace on a NASA SBIR radar initiative hosted by LizzieSat. NASA’s own abstract identifies MobLobSpace as the prime awardee on a six-month Phase I study with an estimated technology-readiness progression of only TRL 2 to 3, while SIDU’s role was to provide host-spacecraft requirements for possible payload integration. This was therefore an early-stage concept study in which SIDU was a subcontractor, not a larger operating contract awarded to SIDU itself.[t][u]

The Worsening Financial Situation

The financial details behind SIDU’s most recent earnings are particularly grim. The most recent 10-K filing for the year ended 2025 shows not only that SIDU remains a pre-revenue company, with revenue declining while losses widening. The central commercial narrative rests on a single large contract with a pre-revenue startup company. Nearly half of the revenue comes from the CEO’s private company, and raising equity capital has remained the primary way to fund operating losses.

Revenue keeps plummeting, down 28% from the previous year, totaling only $3.4 million for the whole year 2025. To put this in comparison, the company spends nearly THREE times more on payroll alone ($9.97 million) than it generates in annual revenue.

Cost of revenue also skyrocketed 48% during the same year, meaning that for every dollar SIDU earns, it spends $2.68 just to deliver it. The combined effect of declining revenue and rising costs widened the gross loss to negative 168%, which means the company not only fails to profit from its operations, but it actively destroys shareholder value with every dollar of business it conducts.

This, combined with more than $22 million in selling, general, and administrative expenses, produced a net loss of $29.5 million for the full year 2025, an amount that represents nearly nine times the company’s entire annual revenue. To put into perspective, for every dollar SIDU earned in 2025, it lost approximately $8.72. The company keeps burning capital at a rate that no narrative, contract announcement, or satellite launch can sustain.

Craig Technologies (owned by Carol Craig) accounted for 47% of 2025 revenue, a massive jump from 2024 numbers, which, in itself, as we pinpointed in our previous report, is consistent and increasing with quarterly numbers, representing a potential revenue sustainability risk and governance failure. In the previous 2024 numbers, the customer concentration ranged from 3 customers (Craig Technologies). However, now in 2025, TNO has completely left the revenue base, and Bechtel (the previous largest independent customer) has dramatically reduced its business with SIDU.

According to the SEC, Craig earned total compensation of $559K in 2024 (broken into $325K base and $234 “other”). Her 2025 base salary increased to $400K.

Even more, the 2024 filing disclosed that Carol Craig committed approximately 70 hours per week to Sidus. The 2025 filing says 50 hours. Her time at Sidus decreased as her company’s revenue to Sidus increased, indicating that her responsibilities at Craig Technologies may limit her ability to devote time to SIDU and negatively impact SIDU’s ability to implement operations.

Source: SIDU Form 10-K year ended December 31, 2025

Perhaps the most significant year-over-year change has been that the top management has certified that disclosure controls and procedures are now NOT EFFECTIVE. This comes as a stark change from the 2024 10-K, which at the time was reported as effective. This is a binary certification required by SOX law that, as of today, has been reversed.

The auditor (Fruci & Associates) flagged revenue recognition as a critical audit matter requiring a “high degree of auditor judgment.” These two facts together (ineffective controls and highly complex revenue recognition) represent a risk that was not present in the previous filing.

That lack of control is not merely theoretical. The company’s subsequent public materials continued to contain basic inconsistencies. In the January 5, 2026, board-change 8-K, the filing body states that two directors resigned effective January 1, 2026, while the attached exhibit states that they concluded service, effective January 1, 2025. In the February 26, 2026, ATM prospectus, SIDU used different Class A share counts within the same offering document set. In the January 20, 2026, S-3, the company separately stated that 66,419,851 Class A shares and 100,002 Class B shares were outstanding as of that date. In the April 1, 2026, year-end earnings exhibit, the balance sheet duplicated related-party receivable and contract-asset lines and included boilerplate about “expected trading commencement and closing dates” in what was otherwise a financial results release. Read together with management’s year-end conclusion that internal control over financial reporting was not effective, these are specific disclosure errors appearing in the company’s most recent public materials.[h][i][j][k]

Fugazi Research Verdict: $SIDU Remains Fundamentally Uninvestable

When we first published our initial report in January 2026, we highlighted the main structural threats that, taken together, described a company designed to extract shareholder capital and burn through dilution rather than commercial performance. Now, after reviewing the company’s most recent 10-K and its full earnings call, our assessment has not only not changed, it has hardened.

Every problem we initially identified has persisted or worsened: related-party revenue concentration, extreme dilution, the disappearance and erosion of independent customers, declining revenue, increasing operational costs, an increasing cash burn rate, and full reliance on the dilution mechanism. The financial results require no further explanation, but shareholders should be aware that the balance will continue to decline at the current operating burn rate, while the ATM facility will continue to be replenished through shareholder dilution.

Their satellite fleet, which the company uses as its perpetual technical narrative, has sustained material losses that the market has not identified. The company has offered no coverage and no technical explanation for the decommissioning or the lack of commissioning of their satellites. But the company’s own filings now document these operational and existential threats.

Most significantly, management has certified in its own filing that its disclosure controls and procedures are not effective. The auditor simultaneously flagged revenue recognition as a critical audit matter requiring a high degree of judgment. The combination means that the figures underlying every narrative management has offered (IDIQ contract, Lonestar, Satellite Fleet) now carry an explicit disclaimer from the company’s own top executives that those disclosures cannot be guaranteed to be accurately recorded or reported.

The evidence now shows that a company that has become more structurally dependent on its CEO’s private firm has failed to deliver its core business through decommissions and write-offs, has kept diluting shareholders, and has certified that its financial disclosures are ineffective. We called it in January, and we reiterate our findings today. SIDU’s shares are fundamentally uninvestable and of near-zero value.

[h] Sidus Space, Inc. — Form 10-K, Annual Report FY2025, SEC Filing (March 31, 2026)

[i] Sidus Space, Inc. — Form S-3, Shelf Registration Statement, SEC Filing (January 2026)

[j] Sidus Space, Inc. — Form S-3, Registration Statement, SEC Filing (January 20, 2026)

[k] Sidus Space, Inc. — Press Release: Full Year 2025 Financial Results (April 1, 2026)

[l] Sidus Space, Inc. — Exhibit 99-1, SEC Filing (2026)

[m] Data Center Dynamics — “Lunar data center firm Lonestar Data raises $6.6M, swaps CEO” (2025)

[o] NASA — “NASA Receives Some Data Before Intuitive Machines Ends Lunar Mission”, NASA.gov Press Release

[p] Intuitive Machines — IM-2 Mission Page

[q] Sidus Space, Inc. — Press Release: “Sidus Space Awarded Five-Year IDIQ Contract to Support”, Investor Relations (2025)

[r] Sidus Space, Inc. — Press Release: Full Year 2025 Financial Results (April 1, 2026) (same source as [k])

[s] Sidus Space, Inc. — Form 10-K, Annual Report FY2025, SEC Filing — Full Filing Text (March 31, 2026) (same filing as [h], alternate format)

[t] Sidus Space, Inc. — Press Release: “Sidus Space Secures Subcontractor Role with MobLobSpace on”, Investor Relations

[u] NASA — SBIR 2025 Phase I Selection Abstract Archive, NASA.gov (January 2024)

Disclaimer

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our,”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority.

All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions—long, short, or otherwise—in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

Subscribe now

Share

This report provides a follow-up to our main publication, released on March 24, 2026.

Following the publication of our report and the company’s 10-K filings, we discovered that between January 2 and March 23 of the current year, WATT issued approximately 3.3 million new shares. This was done through their current ATM offering, expanding the float by approximately 150%. Taking the 2.2 million shares reported on their 10-Q filing (November 10, 2025) to 5.5 million shares reported on their latest 10-K filing (March 23, 2026).

One of the theses of our main report was that WATT was “overwhelmingly driven by shareholder dilution rather than operating performance,” and this proved true once again in their latest filing.

Adding to this pattern, our researchers identified Mark A Gomes, a stock promoter who has been in trouble with the SEC for acting as an unregistered investment advisor operating under the X (formerly Twitter) handle @MoneyMarkStocks, who has promoted WATT during that period and continues to do so. Gomes was the subject of an SEC enforcement action in 2017, charged with recommending stocks to followers while simultaneously selling his own shares without disclosing the sales. He also operated as a Seeking Alpha contributor, suspended since 2017 for what the permanent notice expresses as “deactivated due to a violation of the platform’s terms of use.”

The combination of these elements confirms the basis of our short thesis.

The Confirmed Dilution

The most important datapoint of our report was the share count explosion during the first quarter of 2026. The table below reveals that the company did not use the ATM during stock lows. Rather, they took advantage of extremely elevated prices around $9 or more to tap the ATM, as the amount the company raised vs. the number of shares issued yields an average issuance price of $9.67 per share. This coincides with the high-volume trading day on January 13, when more than 5 million shares were traded, the exact same day the PR was released. (This represented at the time more than twice the shares outstanding of the company.) Taking advantage of these liquidity events, the company sold equity on high-volume trading days from January 13 to March 24, 2026.

Source: WATT Form 10-K year ended December 31, 2025

Source: WATT Form 10-Q quarterly period ended September 30, 2025

The Distribution Layer

Our initial report covered the stock, part 2 covers the distribution layer around the stock.

This sits one layer above WATT’s filings. Small-cap names trade on narrative flow as much as operating reality. Every company has a story. The real question is who carries it into the market, how it is framed, and what incentives sit behind the voice delivering it.

Enter Mark A. Gomes, AKA @MoneyMarkStocks, a stock commentator with a social media following actively promoting WATT to retail investors during the 83-day window in which Energous tripled its share count, and who is no stranger to SEC scrutiny.

On September 15, 2017, the Securities and Exchange Commission instituted administrative proceedings against Mark A. Gomes, resulting in a settled order (SEC Release No. 33-10414, Exchange Act Release No. 81636). The following facts are drawn directly from the SEC’s Order:

• Gomes acted as an unregistered investment adviser, distributing investment recommendations through websites operated by his company (identified as ‘Company A’ in the order, registered in Delaware with principal offices in Austin, TX).

• On at least five occasions between February 2014 and July 2014, Gomes purchased shares in a stock, published bullish recommendations to subscribers and followers, and then sold his personal shares within days, sometimes hours of the recommendation.

• He never disclosed that he was selling shares while recommending that others buy. The SEC found this constituted a ‘device, scheme, or artifice to defraud his clients.’

• Gomes willfully violated Section 17(a) of the Securities Act, Section 10(b) of the Exchange Act and Rule 10b-5, and Sections 206(1) and 206(2) of the Investment Advisers Act.

• Sanctions: Cease and desist order; bar from association with any broker, dealer, or investment adviser; $130,669.90 in disgorgement; $11,882.48 in prejudgment interest; $130,669.90 civil penalty. Total: approximately $273,222.

Source: SEC, In the Matter of Mark A. Gomes, Release No. 33-10414 (Sept. 15, 2017).

Added to this his own profile on Seeking Alpha, where Gomes was a contributor from 2009, carries a permanent public notice on his author page: ‘NOTE: This account is no longer active due to a violation of Seeking Alpha’s Terms of Use.’

Seeking Alpha does not display this notice for voluntary departures or account closures. This language is specific to disciplinary removal. Seeking Alpha’s contributor terms require disclosure of holdings and prohibit conduct inconsistent with transparent investment research. The violation notice on his profile represents an independent determination that his conduct breached the platform’s standards and terms of use, separate from and in addition to the SEC enforcement action.

Source: Mark Gomes, Seeking Alpha contributor profile.

Public commentary associated with @MoneyMarkStocks, provides the live channel. The 2017 SEC administrative order involving Gomes provides the historical lens. Put the two together, and the picture is straightforward: a documented incentive backdrop, a visible retail-facing distribution route, and a message architecture built to move attention.

Why It Matters

Small-cap narratives do not spread on merit alone. They spread because somebody packages them, sharpens them, and pushes them into the right audience at the right moment.

The company supplies the raw material, and the distribution layer makes it trade.

That is where most investors lose the plot. They read the filing, then assume the market is trading the filing. It usually isn’t. Retail is far more often trading the version of the story that reaches them through commentary, tone, and timing. Once a name depends on market participation, distribution ceases to be background. It becomes part of the capital structure.

The Historical Lens

The 2017 SEC administrative order matters because it documented a familiar mechanism: stock recommendations followed by selling, with no disclosure of intent to sell at the time of those recommendations. The matter was settled without admission or denial.

That record does not prove anything about present conduct. It does something more useful. It establishes that public stock commentary can sit inside a real incentive structure, and that communication and trading do not have to move on the same timeline, while documenting a pattern of prior conduct and current promotional activity for the purpose of informing retail investors.

Once the SEC has laid out the basic architecture, subsequent stock promotions must be read with that architecture in mind. Not as gossip, not as outrage, but more as a structure. For a market operator, that is the key takeaway.

The Channel

The current channel is public and identifiable.

The @MoneyMarkStocks YouTube presence, along with its associated social media accounts, operates as a retail-facing distribution platform for small-cap narratives. The channel presents itself as educational content. The content is framed as expertise-driven analysis, delivered to a recurring retail audience through a consistent format. The stated intent is education. The functional output is attention.

No one needs a conspiracy theory to understand what is happening. A visible platform with a repeat audience and a small-cap focus already tells the story. The only question is how the message is constructed.

The Mechanics

The transcripts do not read like research. They operate like distribution.

The first move is certainty. The listener is not given a wide range of competing outcomes. The presentation narrows the field and hands over a convincing read.

The second move is urgency. Time gets compressed. The focus shifts to the immediate horizon, the next few days, the next turn in the story. That compresses the distance between hearing the pitch and acting.

The third move is asymmetry. The listener is placed in the favored seat: early, informed, ahead of the crowd. That framing is powerful in speculative names because it lets buyers feel smart before they need to be right.

The fourth move is authority. The speaker adopts the posture of a market interpreter rather than an observer. That matters because authority carries the rest of the message. Certainty without authority sounds reckless. Urgency without authority sounds promotional. Authority makes both feel actionable.

None of this is accidental. It is how small-cap narratives are delivered when the job is not merely to describe a stock, but to create receptivity around it.

Where WATT Fits

WATT matters here as a case study in narrative distribution, not as a referendum on the technology.

Part 1 already covered the structure behind the stock: capital needs, financing dependence, and participation. Part 2 addresses the missing piece: how participation gets recruited in the real world.

A stock that depends on market appetite becomes highly sensitive to the way its story is carried into the market. That is the connection. Once belief matters, the delivery system matters.

The distribution layer is what turns a speculative setup into something retail can act on.

The Real Read

There is a tendency in small caps to separate the company from the stock and the stock from the story. That separation does not hold.

The company produces filings, and the market trades narrative.

The distribution layer then bridges that gap.

That bridge is built with channel, tone, timing, and incentive. The SEC order supplies the historical incentive context. The public platform supplies the route to market. The transcripts supply the operating language.

That is enough to identify a functioning distribution layer around the name.

An investor looking only at fundamentals misses half the trade. In this part of the market, the narrative pathway matters every bit as much as the financial output. Sometimes more.

Conclusion

Small-cap stocks do not move on numbers alone.
They move on who frames the story, who delivers it, and how quickly it reaches a receptive audience. That is the edge. Not the biography or the noise, but the mechanism.

Part 1 explained the stock.
Part 2 explains how participation is pulled in.

The filings show the supply. The market absorbs the story.

A YouTube video does not change the fundamentals of a company. It does, however, influence how that company is perceived, discussed, and traded in the market.

Once a stock depends on belief, how that belief spreads through the market becomes part of the trade. That process is visible, it follows a structure, and it is not accidental.

Disclaimer

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our,”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority.

All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions—long, short, or otherwise—in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

Subscribe now

Share

Fugazi Research Analysis

• Energous Corporation (WATT) is a low-revenue, cash-burning, dilution-dependent company that develops and sells early-stage wireless charging for low-powered mobile devices and RF transmitters (used for inventory management). While revenue grew from a very low base, the company has not yet demonstrated a self-sustaining operating model and remains primarily dependent on equity sales to fund operations.

• The company’s roots trace to entities with significant dilution histories. Majority shareholder DivineWave Holdings, owned by founder Michael Leabman (also founder of Movano Inc.), was associated with similar patterns of heavy ATM usage, reverse splits, and value destruction.

• WATT has a history of aggressive dilution, using various equity actions to raise cash a staggering 21 times since 2019, most notably through at-the-market (ATM) registrations. One particularly active offering period increased outstanding shares by more than 140% over just 2 months, followed by a 30-to-1 reverse split to regain compliance with NASDAQ listing requirements.

• A $64 million remaining ATM (3 times the size of its current market cap) provides the company with a pre-existing tool for additional equity issuance: one they have a rich history of using, given their inability to improve sales, business performance, or streamline revenue. The net positive cash balance from cash flow is fully from equity and warrant issuance.

• WATT has burned through enormous amounts of capital with little to show for it. As to their latest filing, the company confirms having accumulated a total deficit of approximately $408 million, reflecting a prolonged gap between commercialization efforts and sustainable revenue growth, despite more than a decade of promising commercial breakthroughs and contracts that have yet to be translated into sustainable increased revenue.

• The company’s governance structure raises serious concerns about significant oversight and internal control gaps, as Burak serves both the CEO and CFO, eliminating an important layer of financial accountability and independent oversight. Additionally, the Board only has four members, including Burak, which is small for a publicly traded company. This concentration of responsibility and power with Burak, coupled with a small and likely distracted board, certainly raises questions as to how much board oversight is actually being exercised, particularly given Burak’s past performance and legal issues with her employers.

• WATT’s leadership has a very poor track record. Mallorie Burak, the CFO/CEO of WATT, has a history of working at companies that ultimately fail. She was the CFO at Knightscope Inc. (a currently listed company with a similar dilution pattern, the same underwriters, and the same split history that turned out to be a serial diluter), leaving shareholders with a 99% loss of their investment. Burak was also involved in litigation with Thin Film Electronics following her termination. Public records show that she was involved in litigation in Santa Clara County (Case No. 20CV367979) after her departure. Allegations surrounding her termination included forecasting errors and deficiencies in internal financial controls.
  
  Source: Santa Clara County Superior Court, Case No. 20CV367979

• WATT’s newly appointed Chief Accounting Officer, Gregory Sadikoff, previously worked under Burak at Knightscope, confirming a network of acquaintances tied to serial diluter companies with a history of substantial shareholder value destruction.

• Based on the current filing record, given the company’s financial situation, including high operational costs, the persistent overhang of potential dilution, history of aggressively using highly dilutive instruments, and the lack of capacity to self-fund its operational model, we consider that WATT’s shares are uninvestable and lack fundamental support at current valuation levels.

$WATT Financial Summary

• For the nine months ended September 30, 2025, revenue totaled $2.6 million, but net loss for the same period totaled $8.3 million, meaning the company lost more than $3 to generate $1 of revenue, or a -319% net margin.

• At current operating levels, the company generates approximately $290K in monthly revenue while burning approximately $1.1 million in cash, indicating that continued operations rely on stock issuance as the primary source of funding.

• Cash increased from $1.4 million to $12.9 million for the 9-month period 2024 vs 2025. However, $21.6 million of this cash came from ATM sales, warrant exercises, and equity issuances, highlighting that the company’s liquidity is overwhelmingly driven by shareholder dilution rather than operating performance.

• Outstanding shares increased from approximately 12.35 million as of December 30, 2024, to 2.3 million as of March 08, 2026. On a split-adjusted basis, outstanding shares increased approximately 458% over the period, reflecting rapid re-expansion following the company’s 30-to-1 reverse split.

• Two customers account for more than 81% of the company’s revenue, and three customers account for 99% of the company’s accounts receivable for the nine-month period ended September 30, 2025, indicating extreme customer concentration risk and a very fragile revenue base.

• In their latest 10-K, the company acknowledges it has no history of generating meaningful product revenue, may never achieve profitability, may be unable to demonstrate the commercial feasibility of its technology, and warns that it may fail to meet Nasdaq’s listing requirements.

Source: WATT Form 10-K year ended December 31, 2024,

Source: WATT Form 10-Q quarterly period ended September 30, 2025

Executive Summary

WATT’s core business is the development of RF wireless power transmitters for low-energy devices and sensor tags for supply chain applications. After more than a decade of commercial promises, the company has yet to demonstrate a self-sustaining operating model, accumulating over $400 million in deficit along the way. Its financials still reflect a low-revenue, cash-burning business with deeply negative margins and no clear path to profitability.

At its current scale, the business simply does not fund itself—and never has. For the nine months ended September 30, 2025, WATT generated just $2.6 million in revenue while posting an $8.3 million net loss, meaning it lost more than $3 for every $1 of revenue, with a net margin of approximately -319%. On a monthly basis, the company generates roughly $290K in revenue while burning about $1.1 million in cash, leaving its internally generated cash flow nowhere near sufficient to support operations. Despite this, management framed recent results as progress during the Q3 2025 earnings call, which coincided with a sharp short-term move higher in the stock—highlighting the gap between narrative-driven momentum and underlying financial reality.

The only reason the company remains operational is continued access to equity markets. Cash increased from $1.4 million at year-end 2024 to $12.9 million as of September 30, 2025—but this was not driven by business performance. Instead, $21.6 million was raised through ATM sales, warrant exercises, and other equity issuances. In other words, liquidity came from shareholders, not customers. This pattern is not new: the company has raised capital through equity actions 21 times since 2019 and still maintains a $64 million ATM registration—an amount that is massive relative to its market capitalization and effectively ensures further dilution.

The balance sheet reflects a business that remains structurally dependent on financing. Even after recent capital raises, the company’s cash runway is limited. Management indicated that the $21.6 million raised only extended the runway by approximately 12 months, while other estimates suggest cash could already be below $6 million, though exact timing depends on ongoing financing activity.

At the same time, the revenue base itself is fragile. Two customers account for 81% of total revenue, underscoring the business’s continued concentration and instability. The company’s own 10-K acknowledges its lack of meaningful product revenue history, ongoing uncertainty regarding commercial viability, and even the risk of failing to maintain Nasdaq listing compliance. This is all against a backdrop of just ~$800K in annual revenue versus roughly $18 million in operating expenses.

Governance adds another layer of concern. Mallorie Burak serves as both CEO and CFO, a dual role that significantly weakens financial oversight—particularly for a company whose survival depends on continuous capital market activity. Her track record includes prior roles at companies such as Knightscope and ThinFilm Electronics, both of which exhibited similar dilution-heavy patterns and governance concerns. Recent executive appointments tied to her past affiliations only reinforce a pattern of leadership networks associated with repeated value destruction.

Meanwhile, shareholder dilution continues to accelerate. Shares outstanding increased from 452,533 at year-end 2024 to 1,824,844 by September 30, 2025, on a split-adjusted basis. Even after a 1-for-30 reverse split, the share count has rapidly re-expanded—highlighting a familiar cycle of reverse splits followed by renewed dilution.

After more than a decade, the conclusion is difficult to avoid: WATT is not a business being funded by operations—it is a business being funded by the market. The technology may be the story, but the financing has become the reality.

SHARE COUNT EXPANSION

• WATT faces significant challenges in meaningfully scaling revenue, with an extremely limited customer base of only three entities, which account for 99% of revenue.

  

• The cap table reflects questionable interconnections. The early cap table also contained founder-family and affiliate-linked counterparties. The 2014 S-1/A disclosed that DivineWave Holdings LLC, formed by Michael Leabman’s parents, beneficially owned approximately 20.3% of the company; that Absolute Ventures LLC, affiliated with former director Greg Brewer, held 668,337 shares purchased for $160,000; and that the company leased former office space from ProSoft Engineering, which the filing identifies as being owned and founded by Brewer. The same filing also disclosed that MS Investments, an affiliate of one of the company’s legal firms, purchased 20,050 shares for $4,800; that Cheryl Sanchez, the sister of a director and stockholder, entered into a consulting agreement at $21,550 per month; and that MDB Capital Group received a consulting warrant for 278,228 shares at an exercise price of $0.04. https://ir.energous.com/static-files/03ff2986-31df-4529-99c6-98ead5451db7

• The capital structure became materially more toxic in March 2023, when WATT issued long-dated warrants with reset features severe enough that they were accounted for as a derivative liability rather than plain equity. The strike on those 2023 warrants fell from $8.00 initially to $1.66 by March 31, 2024, to $0.30 by December 31, 2024, and to $0.28 by June 30, 2025. The June 2025 filing also states that future issuances below the exercise price, including through the ATM, could trigger further downward adjustments. https://ir.energous.com/static-files/7b6b5567-cf86-46d0-ab8c-4dea68da4a79

• During the first nine months of 2025, WATT disclosed approximately $18.2 million of net ATM proceeds, $0.4 million from warrant exercises, and $4.1 million from the September 2025 registered direct offering, versus approximately $10.0 million of cash used in operating activities during the same period. https://ir.energous.com/static-files/03ff2986-31df-4529-99c6-98ead5451db7

$WATT Sales and Product Challenges

The company also faces a crisis of product credibility and adoptability. Energous’s product line focuses on wireless power network technology that integrates wireless power, Bluetooth communication, battery-free sensors, and software to create a real-time communications network within a given facility. This is a highly contested vertical, and Energous’ product line ranks poorly against its competitors.

Leadership has been promising mainstream commercial adoption for nearly a decade, yet it has not achieved any such traction. In the interim, better-financed companies have captured the majority of the market, and other, more compelling technologies have been introduced, making Energous’s technology outdated. Powercast, for example, has shipped over 30 million of its units in the last decade to over 100 global customers across retail, medical, industrial, and consumer electronics. WATT, in comparison, is trying to grow minuscule sales to just a few companies with 1) a less capable product and 2) a minimal balance sheet. Yet another red flag.

The above dynamic is a massive headwind for Energous to ever make meaningful sales. The extremely tight cash position significantly erodes the possibility of large-scale commercial success, as customers need to trust that a vendor will be around for more than a few months before making large purchases. Moreover, any large commercial order will almost guarantee another dilutive equity move, simply to raise the cash needed to buy parts and then build and install the network units. Given recent cost-cutting efforts, it’s also unclear if WATT has the employee base to successfully execute a meaningful order.

The Playbook

Energous’ filings outline a clear and consistent pattern in which operating losses are funded through equity issuance rather than internally generated cash flow.

The company utilizes at-the-market (ATM) programs to raise capital opportunistically, allowing shares to be sold directly into the market over time. In addition, registered offerings and warrant issuances create additional pathways for future share issuance.

Following the August 2025 reverse stock split, which restored Nasdaq compliance without reducing the authorized share count, the company retained significant capacity to issue additional equity.

As of September 30, 2025, the company still had 200 million authorized shares, only 1.824 million common shares outstanding, approximately 1.03 million shares issuable upon warrant exercise, 78,172 shares reserved for future issuance under the 2024 plan, and approximately $64.7 million of remaining ATM capacity.

Subsequent increases in shares outstanding indicate that this capacity has already been utilized.

Warrants issued in connection with financing transactions, including pre-funded and long-dated warrants, further expand the pool of potential shares. Resale registrations allow these instruments to be converted and sold into the market, often subject to ownership caps that pace but do not prevent distribution.

This structure links operating cash burn to continuous equity issuance as the share base expands over time.

• Anatomy of the Mirage

  Despite reported improvements in revenue, the filing record continues to reflect a gap between top-line growth and underlying business durability. The progression in reported metrics does not yet translate into operating scale, revenue quality, or structural stability.

• Minor Revenue Growth Without Customer Breadth

  Revenue has increased off a low base, but lacks breadth. The current revenue base is tied to a few customers, with no clear indication of diversified demand or scalable adoption across a broader customer set. The company’s inability to obtain more than three paying customers is a clear market signal of a lack of demand for their technology. This limits visibility into the stability of that growth and raises questions about its repeatability beyond a small number of relationships.

AskEdgar - Form 10-Q

Additionally, WATT likely sits lower in the value chain than investors assume. The company has highlighted a “Fortune 10” retail deployment across thousands of U.S. locations, while partner disclosures from Wiliot and Avery Dennison suggest a broader ecosystem in which Energous provides the underlying power layer. Public materials indicate that WATT’s transmitters power Wiliot’s IoT Pixels, which are then integrated into a larger Wiliot / Walmart / Avery Dennison stack.

• “Fortune 10 deployment” narrative appears overstated relative to economics.

  Public disclosures suggest WATT is likely supplying a lower-value bridge-power layer within a broader Wiliot / Walmart / Avery Dennison ecosystem, rather than a high-margin platform. The company’s own figures imply ~1,500 transmitters for ~$0.3M (~$200 per unit), and despite highlighting 25,000+ units shipped, preliminary 2025 revenue was only ~$5.6M—consistent with low-dollar hardware, not scalable monetization.

• Balance Sheet Improvement Through Equity Issuance & Dilution

  Changes in the balance sheet reflect access to capital rather than conversion of activity into cash. The improvement in liquidity does not stem from operating efficiency or margin expansion, but from the ability to raise funds externally.
  As a result, the balance sheet does not yet function as evidence of operating strength, but rather as a reflection of capital availability.

• Additional Equity Supply Embedded in the Structure

  The capital structure contains multiple embedded pathways through which additional shares can enter the market. These are not contingent events, but structural features that can be activated over time.
  This creates a forward supply profile that extends beyond current outstanding shares, where new equity can be introduced alongside ongoing funding needs.

• The Disconnect

  The filings describe a company where reported progress exists, but remains narrow in scope, while balance sheet changes are not rooted in operating conversion, and the capital structure continues to accommodate future expansion of the equity base.

The result: a disconnect between what is reported and what is structurally sustained.

Valuation and Downside

Based on current disclosures, the company retains approximately $64 million of remaining ATM capacity, compared to a market capitalization of approximately ~$40 million.

This implies that the company can issue equity that represents more than 100% of its current market value.

Assuming continued operating cash burn at current levels with less than 6 months of runway, the company would require ongoing access to capital markets to fund operations. The ATM structure allows this funding to occur incrementally, but does not eliminate the cumulative effect on the share base.

As a result, even if revenue continues to grow, equity issuance required to sustain operations may offset or exceed any improvement in underlying business performance.

The valuation, therefore, reflects not only the current business but also the embedded capacity for future equity issuance, which may continue to expand the share base over time.

Governance and Track Record

The company’s governance structure and management background raise concerns around oversight, capital allocation, and financial controls. The current CEO also serves as CFO, concentrating operational and financial reporting responsibilities in a single role and reducing the separation between capital allocation decisions and independent oversight.

Proxy disclosures show that Mallorie Burak previously held executive roles at ThinFilm Electronics and Knightscope. ThinFilm filings indicate her employment was terminated in May 2020. Public records further show that she was involved in litigation with Thin Film Electronics in Santa Clara County (Case No. 20CV367979) following her departure. Allegations surrounding her termination included forecasting errors and deficiencies in internal financial controls. Separately, Knightscope filings disclosed material weaknesses in internal control over financial reporting, including limitations in accounting resources and SEC reporting expertise. Energous’ current Chief Accounting Officer, Gregory Sadikoff, also previously worked alongside Burak at Knightscope, reinforcing overlap across management teams with similar histories.
https://www.sec.gov/Archives/edgar/data/1575793/000110465925041253/tm252608-4_def14a.htm

While not determinative on their own, third-party research (e.g., Capybara Research, 2023) has raised similar concerns regarding governance, accounting oversight, and capital structure practices in comparable companies involving overlapping leadership. Company filings also note delays in commercialization tied to regulatory approvals and customer-side factors.

Compensation remains highly elevated relative to business scale. The 2025 proxy shows Burak’s 2024 total compensation at $849,551 and former CEO Cesar Johnston’s at $1,343,485, compared to approximately $0.8 million in annual revenue and roughly $12,000 in gross profit in 2024. The top two executive compensation figures alone exceeded total revenue and were multiple times gross profit. Burak’s compensation included $379,849 in salary, a $150,000 guaranteed bonus, multiple additional bonuses, and $135,452 in stock awards. Johnston’s severance was also significant, with Q1 2024 severance expense totaling $1.563 million—approximately 2,442% of quarterly revenue.
https://www.sec.gov/Archives/edgar/data/1575793/000110465925041253/tm252608-4_def14a.htm

The company has also historically used equity as a transactional currency. In March 2025, Energous amended its headquarters lease, downsized its space, and issued 75,000 shares to the landlord as partial consideration. This follows earlier instances, including a 2014 issuance of 41,563 shares (valued at $500,000) tied to its San Jose lease. These patterns reflect ongoing liquidity pressure and reliance on equity beyond traditional financing channels.
https://ir.energous.com/static-files/03ff2986-31df-4529-99c6-98ead5451db7

The Fugazi Verdict

Based on public filings, $WATT shows improving reported metrics from a low base, limited operating depth, concentrated revenue, and a capital structure that continues to enable equity issuance alongside funding needs.

After more than a decade, WATT has not built a business that funds itself—it has built one that funds itself through shareholders.

Unless that dynamic changes, continued dilution is not a risk; it is the model. The technology may charge devices, but the model charges shareholders.

We stand firm in our view that the company is uninvestable and will likely turn shareholders into bagholders, with shares likely to revisit single-digit pricing.

Disclaimer

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our,”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority.

All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions—long, short, or otherwise—in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

Subscribe now

Share

Near-zero revenue, heavy dilution, and a wannabe biotech story that raises serious questions.

Fugazi Research Analysis

• Cardio Diagnostics Holdings Inc (CDIO) is a 2022 de-SPAC that was born from a blank check company called Mana Capital Acquisition Corp (MAAQ), and an underwriter called Ladenburg Thalmann & Co. Both of them were led by Jonathan Intrater, a known serial SPAC sponsor whose track record includes a civil lawsuit alleging fraud in a private placement, and two completed SPAC’s that have, combined, destroyed 99% of investor capital.

• As the SPAC’s merger deadline approached after a series of unsuccessful targets, MAAQ ultimately settled on Cardio Diagnostics (CDIO): a company that had generated only $901.00 in cumulative revenue over its entire operating history at the time of the merger.

• Hidden, but central to this structure, is Mao Tong, a Hong Kong-based lawyer with a 20-year career at firms such as Squire Patton Boggs, which specialize in structuring Chinese capital into U.S. public markets by navigating disclosure requirements. Mao appears exactly once in CDIO’s entire SEC filing history as the owner of all the voting interests of Mana Capital LLC. In October 2022, the day after the de-SPAC closing, Mana Capital transferred its entire position to a shell vehicle called Juventus LLC and to other undisclosed recipients. From that date forward, no identifiable successor appears to have filed a beneficial ownership report with the SEC, leaving the ultimate holders of those shares unclear in the public record.

• Mana Capital LLC, the holding vehicle controlled entirely by Mao Tong, acquired 1.55 million shares for a heavily discounted price of $25,000, which, if sold at lock-up expiry, would mean a +15,000% return on a company that only generated $901 in revenue up to its de-SPAC.

• According to their most recent 10-Q, 100% of the company’s revenue comes from product tests for cardiovascular disease, totaling $11,270 for the period, compared to $29,264 in spending on office and computer equipment for the same period.

• Also, in its latest 10-Q, CDIO reports an accumulated deficit of $27.8 million, meaning the company has consumed nearly $28 million of investor capital since inception while generating only tens of thousands of dollars in total revenue. At recent trading prices, that deficit is several times larger than the company’s entire market capitalization.

• Since its de-SPAC in October 2022, CDIO has expanded its float by 476%. This aggressive and non-stop, dilutive cycle has left shareholders with a fraction of their initial investment and heavy accumulated losses per share.

• Given

  • a) the opaque ownership transfers following the de-SPAC transaction,

  • b) the involvement of entities whose ultimate beneficiaries are unclear,

  • c) insignificant revenue,

  • d) a clear path to continued operating losses, and

  • e) increasing share issuance resulting in accelerating shareholder dilution

We consider CDIO’s shares to be completely uninvestable and of Zero value.

CDIO Financial Summary

• For the nine months ended September 30, 2025, revenue totaled $11.3k, while net loss for the same period totaled $5.03 million, representing a -44,500% margin, meaning the company lost more than $445 to generate $1 of revenue.

• That $11.3k in revenue also represents a massive 63% decline from the $30.4k generated during the same period in 2024, which the company attributed to the loss of a single customer (Family Medicine Specialists).

• The cash burn rate currently stands at $4.36 million for the 9 months ended 2025, while cash reserves amount to $6.3 million for the same period, indicating a runway of just over a year of operations.

• Cash from sales of common stock and warrants amounted to $3.5 million for the nine months ended September 30, 2025. Compared to the $11.3k of total revenue for the same time period, meaning that the company raised 309x more money from dilution than revenue.

• As of November 12, 2025, the company has raised more than $15 million in capital through sales of common stock. Over time, it has had minimal sales of $65k since its inception, looking more like a failed science experiment than a true company.

• Outstanding shares increased from approximately 9.5 million as of November 7, 2022, to 54.8 million as of March 11, 2026 (30:1 reverse split adjusted), a 476% increase, translating into 83% shareholder dilution since the company’s inception.

• Despite generating only $11.3k in revenue for the nine months ended September 30, 2025, the CEO received a $300k annual salary, more than twenty-five times the company’s total revenue during that period.

Source: CDIO Form 10-Q quarterly period ended September 30, 2025

Source: CDIO Form 10-K annual period ended December 31, 2024

Executive Summary

Cardio Diagnostics Holdings (CDIO) markets itself as an AI-powered, precision cardiovascular diagnostics company positioned to revolutionize early heart disease detection. The financial statements, the capital markets history, and the ownership structure tell a very different story.

CDIO was born from desperation. Mana Capital Acquisition Corp (MAAQ), a blank check company, cycled through at least 12 failed merger candidates, including a beverage distributor, before landing on Cardio Diagnostics. At the time of the de-SPAC closing in October 2022, Cardio Diagnostics had generated a grand total of just $901.00 in revenue during its entire operational history. Central to this structure is Tong Mao, a Hong Kong-based lawyer specializing in structuring Chinese capital into US public markets by navigating disclosure requirements.

Despite years of development and commercialization claims, Cardio Diagnostics generated less than $35,000 of revenue in all of 2024 while losing over $8 million. In the first nine months of 2025, revenue totaled just $11,270. This figure amounts to a few thousand dollars per quarter from a company that has been commercially active since 2021. Total cumulative revenue since inception stands at approximately $65,000, while the company has raised more than $15 million in equity capital over the same period.

Management has repeatedly relied on selling stock to fund operations, executing a 1-for-30 reverse stock split in May 2025 solely to maintain its Nasdaq listing while keeping an active at-the-market (ATM) equity facility open with capacity sufficient to dilute existing shareholders substantially. Since the de-SPAC closing, the public float has expanded by approximately 476%.

CDIO fits a familiar and well-documented microcap pattern: a compelling AI narrative, virtually zero revenue, constant cash burn, founder shares transferred to unidentified recipients at zero cost on the day of the merger closing, a board member profiting from capital raises, and a capital structure built for more dilution.

The core business currently produces only a few thousand dollars per quarter while burning through nearly half a million dollars in cash every month. The result is a stock that trades more like a speculative, low-float momentum vehicle than a healthy operating business.

1. The Undisclosed SPAC Origin

How CDIO became a public company raises important questions. The issue is not simply that the company had generated less than $1,000 in total revenue at the time of the merger, or that it emerged as the final candidate after at least twelve failed SPAC targets. The more relevant question is who ultimately selected this company, why it was chosen, and who benefited from the transaction. At the center of that process are two key players.

Jonathan Intrater, a managing director at Ladenburg Thalmann & Co., served as CEO, Chairman, and sole officer of Mana Capital Acquisition Corp (MAAQ). At the same time, Ladenburg Thalmann acted as the SPAC’s underwriter, creating a dual role that was explicitly disclosed as a potential conflict of interest in MAAQ’s S-4 registration statement.

Above: Jonathan Intrater shown as CEO of MAAQ, and Managing Director at Ladenburg (the underwriter)

Source: Form S-4 MAAQ/Cardio Diagnostics, Inc. Merger October 7, 2022

Intrater previously served as a board member and Audit Committee Chairman of GreenVision Acquisition Corp, whose de-SPAC company, Helbiz Inc. (HLBZ), now trades at $0.22, a 97.83% decline from its original value, and has been delisted from Nasdaq as of February, 2024.

Above: Jonathan Intrater as Audit Committee Chairman and Director at GreenVision Acquisition Corp.

Source: Form S-1 GRNV/ Public offering November 14, 2019

Prior to his SPAC activity, Intrater was named personally as a defendant in a civil lawsuit filed in the New York Supreme Court, alongside Ladenburg Thalmann & Co., alleging fraud, breach of fiduciary duty, aiding and abetting fraud, and breach of contract, all of these accusations arising from Ladenburg Thalmann’s efforts to raise $20 million in a private placement for Digital Broadcast Corporation. The case was ultimately appealed and dismissed on the grounds that the plaintiff (a development-stage company that had never generated any revenue) could not establish damages with certainty.

Above: Jonathan Intrater as defendant in Digital Broadcast Corp. v Ladenburg, Thalmann & Co.

Source: Digital Broadcast Corp. v Ladenburg, Thalmann & Co., Inc. 2008 NY Slip Op 50955

In summary, two completed de-SPACs, two companies that have destroyed the majority of investor capital, one civil lawsuit alleging fraud in a private placement, and a conflict of interest as the underwriter of the original blank-check companies. This is not a coincidence. It’s a pattern.

Mao Tong is the concealed but central player to this structure; his experience as a Hong Kong-based lawyer with a two-decade career at firms like Squire Patton Boggs makes him a specialist in structuring and deploying Chinese capital into US public markets by navigating through disclosure requirements. His role, however, is hidden; as early as the blank-check incorporation, Mao controlled the entire SPAC through a dual-layer ownership structure. Being the sole member and majority voter of Mana Capital LLC, and as the controlling individual for Juventus LLC, a Delaware limited liability company incorporated on March 24, 2021 (2 months before the SPAC itself was formed). Together, both entities held 1.62 million founder shares for a staggering price of $25,000.00 or $.015 per share.

Above: Juventus LLC’s incorporation date and registration in the state of Delaware.

Source: State of Delaware/ Department of State/ Division of Corporations

Mao appears exactly once in CDIO’s post-merger SEC filing history, in a single Form 4 filed on October 26, 2022, the day after the de-SPAC closing. On that date, Mana Capital LLC transferred its entire position (1.56 million shares and 2.5 million warrants) to Juventus LLC (the shell holder) to other undisclosed recipients at zero consideration. From that date forward, not a single identifiable successor has filed a beneficial ownership report with the SEC. Neither Mao Tong, Juventus LLC, nor any other identified recipient has appeared in any subsequent CDIO filing.

Above: Form 4 filed by Mana Capital LLC, disclosing the transfer of 1,565,000 shares and 2,500,000 warrants. The signature block identifies Tong Mao as the sole member of Juventus LLC, and Juventus LLC as the sole member of Mana Capital LLC.

Source: SEC, Form 4, Cardio Diagnostics Holdings, Inc., October 26, 2022

For a transfer of this size, moving to unidentified recipients on the day of closing, the complete absence of disclosure is not a lack of oversight. It is a premeditated structure, one that raises the following questions: who ultimately received those shares, where are these recipients located, and how much did they benefit from them?

2. The Bottom of the Barrel Candidate

According to the S-4 registration statement filed in connection with the merger, MAAQ reviewed more than 20 potential candidates for a business combination before settling with CDIO. The documented failures show a range of candidates from a pharma company, a beverage distributor, an electric vehicle charging company, and a real estate developer. Highlighting that the main SPAC did not have a true strategy or a legitimate business aim for acquisition, but rather they were window shopping for a company in which MAAQ was the main beneficiary, and a structure in which they could take advantage of the dire business conditions.

Above: MAAQ process of candidate review, highlighting 20 potential business candidates and choosing Cardio Diagnostics as the only available alternative.

Source: Form S-4 MAAQ/Cardio Diagnostics, Inc. Merger October 7, 2022

When MAAQ approached Cardio, Cardio itself had already been through a failed merger of its own. Jonathan Intrater was first contacted about Cardio on April 8, 2022. Nine days later, and after 2 deadline extensions in which MAAQ already paid more than +$200k for each, MAAQ and Cardio reached a preliminary agreement. At that moment, Cardio Diagnostics had generated $901 in total lifetime revenue. The merger was closed six months later, but the final candidate was Cardio, not a disruptive healthcare innovator, not a proven technology platform, but a development-stage company with less revenue than a lemonade stand.

Above: Cardio Diagnostics lifetime revenue before de-SPAC.

Source: Form S-4 MAAQ/Cardio Diagnostics, Inc. Merger October 7, 2022

3. The Fragility of the Business Revenue

Cardio Diagnostics promotes two primary products:

Epi+Gen CHD – a blood test designed to detect coronary heart disease
PrecisionCHD – a test intended to predict future cardiovascular risk

The company frequently highlights the enormous global market for cardiovascular diagnostics, and its main flagship products are both the Epi+Gen and the Precision CHD tests; however, the reality of the business is stark.

Since fiscal year 2023, revenue has totaled $63k, or roughly $20k per year, which is less than the company spent on computer equipment in 2025.

Source: CDIO Form 10-Q quarterly period ended September 30, 2025

Source: CDIO Form 10-K annual period ended December 31, 2024

At this stage, it is difficult to characterize CDIO as a commercial diagnostics company at all; instead, it looks more like a development-stage concept that happens to trade publicly.

4. Selling Stock as their true business model

The company’s survival has depended overwhelmingly on selling stock. In 2024 alone, Cardio Diagnostics raised approximately $12.5 million through common stock and warrant sales.

Source: CDIO Form 10-K annual period ended December 31, 2024

During the first nine months of 2025, it raised another $3.5 million through the sale of stock and common warrants, while the revenue for the same time period amounted to just at $11.3k, this extreme ratio disparity means that all 99.7% of the company’s cash flow for the period was from the proceeds of equity sales, and not from operations.

Source: CDIO Form 10-Q quarterly period ended September 30, 2025

In practical terms, this dynamic is typical in microcaps where the business model relies heavily on equity financing rather than commercial revenue.

Like many companies that came public through the SPAC boom, CDIO also carries a complex capital table, including warrants, stock options, and convertibles. While many of these securities currently sit far out of the money due to the reverse split, the broader structure reflects a company that has repeatedly relied on equity markets to finance operations.

However, the more immediate dilution risk comes from the company’s at-the-market (ATM) facility, which allows it to continuously sell newly issued shares into the public market during periods when the stock price is strong.

The Total ATM capacity was registered for $9.48 million, as of March 2026, $5,861,554 are still available for sale. This is particularly concerning given the company’s extremely small size. As of today, CDIO’s entire market capitalization is roughly $9 million, which means the company still has the legal ability to issue stock equivalent to nearly its entire market value, which represents a potentially enormous dilution overhang for shareholders.

5. Reverse Split Signals Structural Fragility

In June 2024, CDIO received a written notice from Nasdaq, indicating that the Company was no longer in compliance because the minimum bid price of the Company’s common stock had been below $1.00 per share for 30 consecutive business days.

CDIO was granted in December 2024, a 180-day extension to comply with such a requirement, it would face delisting. In June 2025, the company executed a 1-for-30 reverse stock split.

Source: CDIO Form 8-K SEC Notice of Delisting June 7, 2024

The stated purpose was solely to regain compliance with Nasdaq’s minimum bid price rule, zero value generated, and just price mechanics to hit a price target. In reality, especially in the small-cap universe, reverse splits do not create value; they are typically the result of prolonged share price declines and listing pressure.

Before the split, CDIO had around 50 million shares outstanding. The split simply consolidated those shares into approximately 1.6 million shares while leaving the underlying economics unchanged

Reverse splits in small caps often precede additional dilution cycles, as companies attempt to maintain listing status while continuing to raise capital.

Source: CDIO Form 10-K annual period ended December 31, 2024

6. The Conference Call Catalyst

The recent surge in CDIO’s share price appears to have been driven largely by the company’s investor conference call. On February 19, 2026, CDIO filed a Form 8-K, attaching a 26-slide investor presentation used in connection with a live conference call held the same day.

In the 8 consecutive trading days from the conference call, CDIO’s share price rose from $1.19 to $6.55, a 450% increase.

During the call, management discussed strategy and future opportunities, but the event did not coincide with any meaningful change in the company’s financial position. The presentation contained no revenue guidance; the company explicitly stated that it was making no projections and providing no guidance regarding its future financial condition.

Source: CDIO Form 8-K Exhibit 99.1 Investor Presentation dated February 19, 2026

Most of the content in the presentation consisted largely of publicly available information, like cardiovascular disease statistics, CDC data, World Health Organization studies, and studies from the American Heart Association. No proven revenue data was truly discussed, and no new breakthrough technology was presented.

Revenue remains minimal, and the underlying business has not materially changed. In small, low-float microcaps like CDIO, investor calls and promotional updates can sometimes trigger sharp price moves even when fundamentals remain largely the same.

7. A Narrative that Far Exceeds the Harsh Reality

The main narrative built around CDIO revolves around AI-driven diagnostics, epigenetic biomarkers, a massive cardiovascular disease market, and insurance reimbursement pathways; this is pure wishful thinking, as the numbers show a company that has yet to demonstrate even minimal commercial traction.

At present, the company’s revenue remains extremely small relative to its operating expenses. Quarterly filings year over year show only a few thousand dollars of revenue and continued multi-million dollar losses. For a company that is currently trading largely on future expectations and promotional press releases, operational results will continue to erode shareholders’ confidence.

At present, the gap between the promotional narrative and the company’s operating results is enormous. CDIO may describe itself as a next-generation precision diagnostics company, but in reality, it is a company that sells equity to fund operations and management expenses.

The following map serves as a warning sign for investors to recognize the pattern of a death spiral before the final stages of delisting and total loss occur. In this case, it is our opinion based on due diligence and analysis that CDIO’s current phase is phase #5, in which the pump already occurred, and it is now heading into downward acceleration.

Final Conclusion

Cardio Diagnostics presents itself as a company operating at the intersection of AI, genomics, and cardiovascular medicine. The financial results, the capital structure, and the ownership record tell a very different story.

Revenue remains minimal and declining. In the nine months ended September 30, 2025, the company generated $11,270 in total revenue while losing $5.03 million — a margin of negative 44,500%. Losses continue to accumulate against an $27.8 million deficit. The company has raised more than $15 million in equity capital since inception, while generating approximately $65,000 in cumulative revenue. By any commercial standard, the business has not demonstrated viability.

At the same time, CDIO trades with all the characteristics of a speculative low-float microcap — capable of dramatic short-term price spikes but highly dependent on trading momentum rather than business performance.

The structural questions raised in this report remain unanswered. On October 26, 2022, the day after the de-SPAC closing, Mana Capital LLC transferred 1,565,000 shares and 2,500,000 warrants to Juventus LLC and other undisclosed recipients. From that date forward, not a single identifiable successor has filed a beneficial ownership report with the SEC. The ultimate holders of those securities, their location, and the extent of any benefit they have derived from the subsequent trading activity in CDIO shares remain unknown. For a transfer of this size, executed on the day of closing, that absence of disclosure is not an administrative oversight. It is a structural choice and it remains unresolved.

Until Cardio Diagnostics demonstrates meaningful commercial adoption, the company appears far more dependent on capital markets than on the underlying success of its products.

For investors, the question is not whether cardiovascular diagnostics represents a large market opportunity. The question is whether CDIO can build a viable business before continued dilution erodes shareholder value. Based on the company’s financial history and operating results to date, that outcome appears highly unlikely.

Disclaimer

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our,”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority.

All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions—long, short, or otherwise—in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

Share

Subscribe now

Fugazi Research Analysis

• Al Kapoor simultaneously served as CEO of the private company (Syntec Optics) and the SPAC sponsor (Omnilit Acquisition Corp.), which merged into OPTX (Syntec Optic Holdings), creating a structure in which he emerged with control of 80+% of the company’s outstanding shares.

• OPTX de-SPAC’s structure provides Kapoor with an asymmetrical upside for a single insider, who, in this case, is only him, creating a big opportunity to cash out now that he has access to equity markets.

• Operating cash flow was driven mostly by new borrowing, not profitability, as the company still reported a $1.45 million net loss and relied on $500,000 of fresh debt to fund capex.

• The company is effectively overleveraged, as cash flows are not enough to cover interest and capital obligations without new borrowing. This leaves the balance sheet net negative and dependent upon continued access to external capital.

• Hidden dilution remains a risk, as Al Kapoor can obtain 21 million additional shares if the price hits a threshold, driving him towards stock price engineering and manipulation. All of these details were stated in the merger registration.

• Past governance failures were reported by one of the board members (who also served as OPTX’s CEO for a brief tenure) to a corporate lawyer. Additionally, a second email with these glaring concerns was sent directly to the CFO, expressing his concern about “lack of oversight allowing Al Kapoor’s fraudulent financial reporting” and Al Kapoor’s “continuous pattern to avoid any questions during earnings calls”. This board member was forced to resign after refusing to sign the 2024 10-K due to serious financial concerns.

• Multiple Nasdaq Non-compliance notices since the company’s inception highlight constant failures to meet minimum listing standards & good financial practices, thus increasing the risk of delisting.

• Some members of the OPTX Board of Directors raise serious governance and business quality concerns. These include a director whose career is largely defined by repeated blank-check companies, and another director with a casino and entertainment background who served as the CEO of a public company from its IPO through its eventual demise and private equity acquisition. This was followed by a period of intensive shareholder litigation after the company’s demise.

• We consider that the company’s current financial situation, along with its negative cash flow and negative net liquidation value at current rates, makes the shares uninvestable and worthless.

OPTX Financial Summary

• Cash plummeted from $2.2 million (10-K, 2023) to $600,000 (10-K, 2024), a 72% decline.

• Negative Operating Cash flow of -$900,000 (10-K, 2024), compared to $2.8 million (10-K, 2023), a $3.7 million difference, indicating financial distress.

• Only $3.8 million is available on an $8 million line of credit, which shows that the available cash and current line of credit are insufficient to maintain operations.

• The bank reduced the existing credit line from $10 million to $8 million due to a breach of the maximum leverage ratio, requiring two waivers from the lender in November 2024 and March 2025.

• The leverage ratio was allowed to increase to 5.25x, indicating that it would take the company 5 years of current operating cash flow to pay its current debt.

• Sales down 3.4% year over year, from $29.4 million to $28.4 million.

• Net income crashed from $1.5 million (10-K, 2023) to a net loss of -$2.6 million (10-K, 2024), a 225% collapse.

• Three customers account for 47% of revenue and 54% of accounts receivable.

Source: OPTX Form 10-K year ended December 31, 2024

Executive Summary

Syntec Optics Holdings, Inc. entered the public markets in late 2023 through a de-SPAC transaction with OmniLit Acquisition Corp., converting a long-operating, privately controlled manufacturer into a publicly traded equity. The transaction preserved concentrated control and embedded it within a capital structure characterized by staged liquidity, conditional dilution, and price-linked incentives.

At the center of the structure is Al Kapoor, the CEO and controlling shareholder, who holds more than 80% of the outstanding equity. This concentration qualifies the company as a controlled issuer under Nasdaq rules. The SPAC sponsor was also controlled by the same individual who now serves as Chairman and Chief Executive Officer, reflecting continuity of authority rather than a transition to independent public-market governance.

While the underlying operating business is real and longstanding, the public equity wrapper relies on constrained float and deferred monetization. Although approximately 37 million shares are outstanding, affiliate ownership leaves only a limited portion available for trading. Behind that trading supply sits substantial contingent dilution, including a ~26 million-share earnout tied solely to stock-price thresholds and allocated primarily to insiders. Additional dilution is staged behind warrants and registration constraints.

The resulting dynamic is structural: insiders can benefit from price appreciation while a limited float concentrates trading activity. Earnouts can vest, warrants can become more valuable, and dilution can be deferred until contractual or regulatory gates are met.

The balance sheet reinforces these incentives. Following the de-SPAC transaction, the company disclosed covenant breaches under its revolving credit facility and relied on waivers and amendments rather than a market recapitalization. During this period, liquidity was supplemented through insider financing from Kapoor, further concentrating control, financing, and decision-making during a period of financial stress.

At the same time, the company’s narrative emphasizes exposure to defense, aerospace, and advanced imaging markets. Syntec has announced orders tied to U.S. military augmented-reality initiatives; however, the disclosed scope and financial contribution of those awards appear limited and are not consistently quantified across filings and communications.

Taken together, these elements describe a recognizable configuration: concentrated ownership, constrained trading supply, staged dilution, insider financing during balance-sheet pressure, and narrative positioning in end-markets that lend themselves to forward-looking framing. This report does not assess product legitimacy; it evaluates the public equity structure and how incentives, liquidity timing, and market behavior interact.

The Playbook

Venture Capital Creation

Kapoor previously owned Millennium Pioneer Ventures, an investment firm that invested in or acquired companies. Public records indicate the entity is no longer active and is registered as closed. The firm was based in Waltham, Massachusetts, and its website appears inactive.

Public companies formed through de-SPAC transactions often position themselves as newly capitalized growth platforms. The surface narrative emphasizes access to public capital, accelerated expansion, and a transition from private constraint to public scale. In practice, a subset of these transactions preserves control and stages liquidity, aligning insider economics more closely with stock price behavior than operating cash generation.

Syntec Optics aligns with several of those characteristics.

In a traditional IPO, dilution is generally front-loaded: shares are sold, float expands immediately, and insiders begin a gradual exit subject to lockups. In many de-SPACs, dilution is back-loaded. Large volumes of equity are withheld from the market and tied to contingencies, keeping the effective float constrained even when shares outstanding appear large on paper. This can increase price sensitivity to modest trading volume and can make price-linked incentives more consequential.

Syntec’s merger agreement reflects this logic. The earnout introduces up to ~26 million contingent shares, with a substantial portion allocated to legacy holders (including the controlling shareholder). These shares do not trade until defined price thresholds are met over specified measurement periods. Importantly, those thresholds are tied to trading prices rather than operating benchmarks such as revenue, margins, or cash flow.

Control matters because it affects coordination and timing. With more than 80% beneficial ownership held by affiliates of a single individual, the company operates as a controlled company under Nasdaq rules, reducing certain independence requirements and limiting minority-shareholder governance influence. In this configuration, public shareholders primarily participate through trading rather than voting.

Narrative can become functionally important in such structures. Markets like defense, aerospace, and advanced manufacturing naturally lend themselves to long timelines and incremental progress disclosures (prototypes, customer engagements, certifications) that may not immediately translate into revenue recognition. The filings acknowledge real operations while also describing customer concentration, limited visibility, and reliance on covenant management. These realities can coexist in a capital structure where price plays an outsized role in determining when contingent mechanisms activate.

Under financial stress, the source of liquidity becomes informative. When operating cash flow and external credit tighten, insiders in tightly controlled structures can become liquidity providers. Syntec’s disclosures indicate that during covenant pressure and reduced borrowing capacity, related-party debt supported liquidity needs. In effect, control and capital converged further during the period of greatest constraint.

The sections that follow move from the framework to specific disclosures on governance, compliance history, customer concentration, and capital structure. The aim is not to predict outcomes but to clarify mechanics. Once those mechanics are understood, observed market behavior becomes easier to interpret.

The Insider Emails

In March 2025, former CEO and board director Joseph Mohr described significant governance concerns in emails included as SEC exhibits. In his resignation letter to the board and to Dean Rudy (now CFO), Mohr cited “significant governance concerns” that he stated had persisted since before the company became public in November 2023. He also stated that he refused to sign the 2024 Form 10-K, citing disagreements regarding financial decisions, including revenue recognition and unrealized customer credits.

Source: SEC OPTX Exhibit 99.1

In a separate email to corporate counsel Christopher Rodi, Mohr expanded on these concerns and alleged deficiencies in oversight. He referenced issues including forecasting practices, revenue recognition, customer credits, vendor timing, and board responsiveness to questions and concerns. In fact, no questions were answered during earnings calls.

Source: SEC OPTX Exhibit 99.2

A former CEO and sitting board director refusing to sign the 10-K and alleging serious reporting and oversight issues constitutes a material governance signal for investors. The claims also raise questions about internal controls, board independence, and disclosure discipline.

The History of Non-Compliance

OPTX has received multiple Nasdaq deficiency notices and disclosure-related notices since becoming public. Between 2023 and 2025, the company received notices related to late periodic filings (10-Q/10-K) and, at times, minimum market-value thresholds.

Rather than isolated incidents, the notices appear to reflect repeated delays and compliance remediation driven by extensions. For public shareholders, timeliness matters because periodic filings are foundational to transparency. Repeated failures can undermine confidence in internal controls and management credibility.

The company received an extension through October 2025, which it utilized fully, and the period coincided with disclosed governance conflict and board turnover.

Key dates (per 8-Ks):

Source: OPTX form 8-K April 10, 2024

Source: OPTX form 8-K September 4, 2025

Source: OPTX form 8-K April 23, 2025

Source: OPTX form 8-K June 2, 2025

Source: OPTX form 8-K October 2, 2025

Customer Concentration Risk

Customer concentration remains a material business risk. In the latest fiscal year, three customers accounted for ~48% of revenue (vs. ~67% in 2023). Accounts receivable from these customers were ~$3.2 million (down from ~$4.5 million), indicating meaningful reliance on timely payment behavior from a small customer set.

The company’s risk disclosures acknowledge that the loss of one or more of these customers could materially harm operations and revenue.

Source: OPTX Form 10-K year ended December 21, 2024

The company’s own risk disclosures acknowledge that if any of these customers terminate their relationship, it could severely harm operations and affect revenue.

Source: OPTX Form 10-K year ended December 21, 2024

Board Background Risk

Certain board backgrounds raise governance-quality questions relevant to public shareholders, particularly in a controlled-company context where minority governance leverage is limited.

Walter Bishop, described as a financial services executive, has been associated with multiple SPAC-related roles. Several referenced de-SPAC outcomes have experienced substantial post-combination underperformance or failed to complete compliance milestones.

Albert Manzone, with a casino/entertainment background, previously served as CEO and director of Whole Earth Brands through a SPAC transition and later through a take-private transaction. Shareholder litigation followed the company’s decline and acquisition.

According to public records, this period is marked by Manzone’s direction and leadership from the company’s Nasdaq listing, which began as a blank-check company named Act II Global Acquisition Corp, based in the Cayman Islands, and culminated in its De-SPAC as Whole Earth Brands on June 24, 2020. Going from a high of $13.85 per share (June 24, 2020), until its imminent collapse and private equity acquisition at $4.875 (August 2, 2024). This triggered a wave of litigation against the company and its directors by several law firms on behalf of shareholders. Also worth noting is that he quietly disposed of his company shares in 2022, when stock prices were still favorable.

Source: SEC EDGAR Database Form 4

For investors, these histories matter because they may inform expectations regarding governance rigor, disclosure discipline, and alignment between insiders and minority shareholders.

Scale vs. Financial Capacity

Syntec Optics presents itself as a specialized manufacturer operating in the defense, aerospace, and advanced imaging industries. The company highlights participation in industry exhibitions, the development of new optical assemblies, and engagement with customers whose end markets entail high manufacturing costs and significant technical barriers.

What matters is not whether the business exists, but whether the scale implied by the narrative is supported by the financial statements disclosed in the filings.

Above: The company’s flagship products reflecting their “300 million” market cap and industry leadership.

The company’s own risk disclosures provide a first glimpse into the company’s structural vulnerability. As we mentioned before, customer concentration, debt accumulation, and the fact that the company does not disclose long-term contracts, program-of-record designations, or backlog to sustain continued operations.

Source: OPTX Form 10-K year ended December 21, 2024

This disclosure is not unusual for a niche manufacturer. What is notable is how it sits alongside the broader positioning. Defense and aerospace narratives often imply durability, multi-year visibility, and institutional demand. In Syntec’s case, the filings describe exposure to those end markets without the contractual or backlog disclosures that typically accompany them.

Liquidity constraints reinforce this disconnect. Following the de-SPAC transaction, Syntec disclosed breaches of financial covenants under its revolving credit facility. The company required multiple waivers and amendments to remain in compliance. Rather than expanding borrowing capacity to fund growth or working capital, the amendments reduced flexibility and imposed tighter terms.

Source: OPTX Form 10-K year ended December 21, 2024

During this period, Syntec supplemented liquidity through debt financing from a related party, namely its majority stockholder and Chief Executive Officer, Al Kapoor. Approximately $1.5 million of insider liquidity and financing was disclosed as debt and used to satisfy obligations under amended credit terms. This financing did not represent growth capital. It functioned as a bridge to maintain lender compliance.

Source: OPTX Form 10-Q September 30, 2025

These disclosures matter because they describe a net negative operating company that is not deploying excess capital into expansion. It is managing debt, preserving access to a constrained revolver, and relying on insider support during continuous periods of stress.

At the same time, the capital structure introduces incentive mechanisms that reward stock price performance independently of operating cash generation. The merger agreement explicitly allows the release of 26 million shares as “contingent earnout shares”, in case certain price thresholds are met. However, these shares are not to be released to the public float but rather remain as majority-controlled shares (Kapoor would receive around 21.6 million shares) under the merger agreement. Providing him with a strong incentive for price engineering and stock walking up in order to have the ability to cash out.

Source: OPTX Form 10-K year ended December 21, 2024

The company just turned Income to a net loss in the span of one year.

Source: OPTX Form 10-K year ended December 21, 2024

Year over year, cash reserves have declined; however, they remain positive only through borrowing.

Source: OPTX Form 10-K year ended December 21, 2024

The illusion of scale comes not from falsehood but from leaving out important context. When narrative positioning is considered without the balance sheet, it suggests stability and growth. When the balance sheet is viewed alongside the narrative, it shows a company operating under tight financial limits while holding significant, price-linked equity incentives.

This distinction is critical for understanding market behavior. In a structure where effective float is limited and large volumes of equity sit behind contingent triggers, incremental visibility can move the price even if underlying cash flows remain unchanged. Public shareholders trade what is available. Insiders wait for what is not.

Control Before Listing

Control at Syntec did not result from the public listing; it preceded it. The de-SPAC transaction formalized an existing concentration of authority rather than diluting it.

As disclosed in the company’s proxy materials, affiliates of a single individual beneficially own more than 80% of outstanding shares—sufficient to control shareholder votes, elect directors, and approve major corporate actions without reliance on minority holders. The company elects controlled-company exemptions under Nasdaq governance rules.

Source: OPTX Form 10-K year ended December 21, 2024

The merger filings also disclose that the SPAC sponsor was controlled by the same individual who later assumed the CEO and Chairman roles post-close. Subsequent management transitions further reflect consolidation: sponsor-aligned leadership assumed the CEO role, and the prior CEO later resigned from the board following disclosed disagreements regarding operations, policies, and practices.

None of this requires allegations of misconduct. It describes a governance system: ownership, authority, and decision-making are unified.

When the Balance Sheet Speaks

Balance-sheet stress often reveals how a controlled structure functions in practice. Syntec disclosed covenant breaches under its revolving credit facility during FY 2024 and required lender consent to avoid default and preserve access.

The company’s response was not a recapitalization or an expansion of credit capacity; it was a series of waivers and amendments. These amendments provided temporary relief while reducing borrowing availability and tightening terms, narrowing flexibility rather than restoring it.

During this period, liquidity support was supplemented through related-party debt from the controlling shareholder. This is structurally significant: when credit tightened, the company leaned inward rather than outward. Equity holders, executive authority, and liquidity provider roles converged in a single insider during a period of constraint.

The filings also disclose historical related-party arrangements (including prior management fees) that underscore the financial interdependence between the operating company and its controlling owner.

Individually, these disclosures do not prove wrongdoing. Collectively, they describe an enterprise in which the controlling shareholder occupies multiple roles: majority owner, executive decision-maker, and liquidity backstop.

Conclusion

Syntec entered the public markets with a real operating business and a longstanding private-market history. The transition to a publicly traded entity did not materially alter who controls the business; it did, however, alter how control is expressed within a public equity framework.

The de-SPAC transaction formalized a structure defined by concentrated ownership, constrained float, staged dilution, and price-linked incentives. In such a configuration, market pricing can be influenced by float scarcity and the timing of contingent mechanisms as much as by operating performance. When the balance sheet tightened, the company relied on waivers, amendments, and insider liquidity rather than a broad market recapitalization, reinforcing the convergence of control and capital during stress.

Syntec has announced orders tied to U.S. defense initiatives, indicating some traction in mission-critical end markets. However, the scope and financial contribution of those awards are not consistently quantified in public disclosures, limiting visibility into how materially they change near-term cash generation.

Taken together, these disclosures describe a public equity structure that emphasizes timing and control: concentrated ownership, constrained float, staged dilution, and price-linked incentives, reinforced by insider liquidity during periods of balance-sheet pressure. Recent share price gains reflect constrained float dynamics and incentive-driven mechanics more than underlying business performance, leaving current valuation increasingly disconnected and ultimately unjustified.

Disclaimer

The research, commentary, reports, and other materials published by Fugazi Research LLC (“Fugazi Research,” “we,” “us,” or “our,”) are provided solely for informational and educational purposes. Fugazi Research is an independent research publisher and is not registered as an investment adviser, broker-dealer, or commodity trading advisor with the U.S. Securities and Exchange Commission or any other regulatory authority.

All content published by Fugazi Research represents our opinions as of the date of publication and is based on publicly available information, independent research, interviews, and analytical judgment. Our opinions are inherently subjective, may be incomplete, and are subject to change at any time without notice. We do not undertake any obligation to update or revise our content to reflect subsequent events, market developments, or new information.

Nothing published by Fugazi Research constitutes investment advice, financial advice, legal advice, tax advice, or a recommendation to buy, sell, or hold any security or financial instrument. The information should not be construed as tailored to the investment objectives, financial situation, or particular needs of any individual or entity. Readers should conduct their own independent research and consult their own financial, legal, and tax advisors before making any investment decision.

Fugazi Research, its affiliates, principals, members, employees, consultants, or clients may have positions—long, short, or otherwise—in the securities discussed, and such positions may change at any time for any reason, including risk management, market conditions, or liquidity considerations. We may trade in securities covered by our research before, during, or after publication, and we may reduce, close, or reverse positions at any time without notice. Readers should assume that Fugazi Research has a financial interest in the securities discussed.

Our research may include forward-looking statements, estimates, projections, or opinions that involve known and unknown risks, uncertainties, and assumptions. Actual outcomes may differ materially from those expressed or implied. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

While we believe the information we present is accurate and reliable, it is provided “as is” and “as available,” without any representation or warranty, express or implied, as to accuracy, completeness, timeliness, or fitness for any particular purpose. Fugazi Research disclaims any liability for errors, omissions, or losses arising from the use of our content.

By accessing or using Fugazi Research’s materials, you acknowledge and agree that Fugazi Research shall not be liable for any direct, indirect, incidental, consequential, or other losses arising from reliance on our research or opinions. Use of our content is entirely at your own risk.

All content is the intellectual property of Fugazi Research and may not be reproduced, distributed, or shared without prior written consent.

Share

Subscribe now

In recent quarters, most of SIDU’s revenue has originated from Craig Technologies, a company controlled by SIDU’s CEO, Carol Craig. While this relationship is disclosed in the company’s filings, it raises a structural concern: it calls into question the quality of reported revenue, the independence of demand, and whether reported sales reflect genuine commercial traction. This risk is compounded by the fact that a significant portion of this revenue does not convert into cash and remains recorded as accounts receivable, maintaining ongoing liquidity pressure.

• SIDU: Industry Expert (IE) Perspective on a Structurally Unviable Business:

  • Financial Instability and Contract Risk:
    According to a senior space and satellite industry expert with more than 20 years of experience, SIDU’s precarious cash position materially limits its ability to secure meaningful government contracts. Federal agencies prioritize financially stable counterparties to mitigate execution risk, and SIDU’s ongoing losses and liquidity constraints raise concerns about its long-term viability. High-profile announcements such as inclusion on the SHIELD / Golden Dome IDIQ—shared with more than 2,000 companies—were described as largely symbolic, providing eligibility rather than revenue. The expert noted that any potential task orders would likely be immaterial and unlikely to arrive at a pace or scale sufficient to repair the company’s balance sheet, reinforcing a cycle of continued dilution.

  • Lack of Competitive Differentiation or Path to Scale:
    The expert assessed SIDU’s offerings as unremarkable across its satellite, engineering, and software verticals. The LizzieSat platform does not meaningfully differentiate from competing smallsat providers, the engineering services offering lacks distinction, and SIDU appears to be a late and underdeveloped entrant in space software. The company’s backlog was characterized as low quality, including contracts with smaller counterparties that themselves require additional equity financing to perform. In the expert’s view, SIDU lacks a credible pathway to scale, margin expansion, or durable, independent demand.

  • Conflicts of Interest and Governance Concerns:
    The expert agreed with our findings regarding significant conflicts of interest involving SIDU’s CEO, who also owns and operates Craig Technologies, a private company active in the same business vertical. Shared senior leadership, related-party transactions disclosed in SIDU’s filings, overlapping facilities located approximately one mile apart, and shared corporate addresses further blur the separation between the two entities. These concerns are compounded by repeated capital raises in 2025, amended financial filings, replaced audit reports, and a sudden change in audit committee leadership in January 2026. While no direct evidence of financial wrongdoing has been identified, the expert viewed the timing and pattern of these events as material governance and stewardship risks.

• SIDU Space has burned over $100M since going public in 2021, has only produced 3 satellites, and is still losing nearly $2M per month. We believe this is clearly a failed business model, having lost 99.85% of equity value as a public company. There is no indication that the company will turn around.
  

• Related-party receivables increased from approximately $67k to $641k year over year, while asset-based borrowing secured against receivables nearly tripled from roughly $2.6M to $6.9M—highlighting that reported revenue is not converting to cash and that equity raises alone have been insufficient to sustain operations.

• The company generates modest annual revenue, approximately $4–6 million, while continuing to incur widening operating losses. For the year ended December 31, 2024, SIDU reported an operating loss of approximately $18 million. The only viable sign of operating leverage to sustain operations is further dilution. In practical terms, the business does not sustain itself through its core business operations.

• Because operations do not generate sufficient cash to support ongoing activity, SIDU has relied mainly on dilution as its primary financing mechanism. Following a 1-for-100 reverse split on December 20, 2023, in order to regain Nasdaq compliance, the company rapidly re-expanded its share count via equity offerings and warrants. Capital issuance has become the company’s primary source of liquidity - not its core business operations.

• In late 2025, SIDU completed a series of equity raises, including a registered direct offering priced at $1.50 per share. These transactions followed sharp upward movements in the stock price. They were managed by ThinkEquity, reinforcing a pattern in which price rallies appear to function as liquidity windows for new capital raises rather than as signals of improving business fundamentals.

SIDU Financial Summary

Annual Revenue Decline:

• In 2024, SIDU’s annual revenue fell to $4.67 million, a 21.64% decrease from $5.96 million in 2023.

• The 2023 revenue of $5.96 million was also down 18.24% from $7.29 million in 2022.

Trailing Twelve Months Revenue:

• As of Q3 2025, the TTM revenue was 4.19 million, marking a 2.60% year over year decline.

Quarterly Revenue Trends:

• Q3 2025 revenue was $1.30 million, which is a decline of 30.55% compared to Q3 2024.

AskEdgar SIDU Co-Pilot Deep Dive

SIDU Operational Forecast

AskEdgar SIDU 10-K Mar 31, 2025

The SIDU Playbook

A “space company” that funds itself by selling stock

SIDU’s filings show that the business does not fund itself through operations. Instead, it repeatedly taps equity markets while riding hype in space, defense, and technology branding.

Step 1: Revenue that relies on a related party, the CEO’s other businesses

A substantial share of revenue comes from Craig Technologies, which is owned by SIDU’s CEO. The disclosure is there, but the signal is weakened: revenue looks less like broad commercial demand and more like a controlled channel.

Step 2: Revenue that doesn’t show up as cash

Much of that revenue remains in accounts receivable. Liquidity pressure remains, and losses continue.

Step 3: Fill the gap with equity… Rinse & Repeat

Because operations don’t pay the bills, SIDU issues stock. More offerings. More warrants. More dilution. No visible improvement in margins.

The 1-for-100 reverse split was not a turning point; it was a reset with fresh capital at the expense of existing shareholders, further devaluing their investment.

Step 4: Selling into strength & keeping the narrative alive

When volume and hype appear, SIDU raises money quickly. The December 2025 deals are a clear example: rapid, discounted offerings executed back-to-back.

Space, defense, national security — the themes stay loud. The economics don’t change. The loop is closed: related-party revenue, receivables instead of cash, dilution to survive, narrative to support it.

The “Craig Money Play”

Money flows between four entities:

• SIDU Space

• Carol Craig

• Craig Technical Consulting (CTC)

• Craig Technologies

CTC wins customer contracts, subcontracts work to SIDU, SIDU books revenue, much of it sits in receivables, and SIDU then pays most of the money back to CTC as cost of revenue. This is simple, mostly because SIDU outsources its assembly to CTC.

Example:

-CTC “pays” SIDU $1.38 Million
-SIDU pays CTC back $650 k as cost of revenue

-SIDU owes CTC $870k (to fund operations)

-CTC “owes” SIDU 1.4 Million (carries the unpaid balance)

Meanwhile, Craig benefits through professional services, subleases, administrative fees, and compensation, while related-party revenue grows and SIDU carries receivables.

SIDU Revenue & Receivables

For the nine months ended in September 2025, SIDU recognized revenue of $1,386,696 from Craig Technical Consulting. This represents 49.6% of Total Revenue for the same period. Even more serious is the fact that accounts receivable from Craig Technical Consulting exceed its revenue, meaning Craig owes SIDU more than SIDU has booked in sales from them. The trend is also very telling, with a 239% increase in related party revenue and a 118% increase in accounts receivable from related parties. Which means that SIDU´s reliance on manufactured revenue is only increasing.

Craig as SIDU Biggest Customer and Largest debtor

For the nine months ended in September 2025, Craig Technologies accounted for 47% of total revenue, which means a whopping 488% of relative increase from the same period year over year. Craig Technologies also represented 62% of total accounts receivable, meaning the majority of SIDU’s revenue is unpaid and owed by the CEO’s own company. This highlights overall extreme customer concentration and dependence on non-cash revenue.

SIDU Cost of Revenue

For the nine months ended in September 2025, SIDU recorded a 141% year over year increase of payments to Craig Technical Consulting meaning that a disproportionate amount of operating costs went to Craig’s own side company, this stops looking like normal operations and more like self-dealing disguised as expense.

SIDU Accounts Payable

As of September 30, 2025, SIDU owed $869,789 to related parties, a 30% increase from the same period year over year. These advances are unsecured, due on demand, non-interest-bearing, and effectively callable at the discretion of management.

Craig as Landlord

AskEdgar SIDU 10-Q Sep 30, 2025

AskEdgar SIDU 10-K Mar 31, 2025

Under this scheme, in theory, Craig Technologies can practically force SIDU to sell at a loss to its main company, and we speculate that Craig can keep all the profits from any contracts. Craig can also heavily price the manufacturing costs directly to SIDU, making SIDU pay more for any assembly and resulting in losses. Craig can also ramp up SIDU’s rent without prior notice. (As it is its landlord).

In addition to the fact that Craig is SIDUS’s best customer (amounting to 47% of the revenue), and biggest debtor (62% of accounts receivable) a high-interest creditor, and also receives a juicy salary for a company that burns through cash, has no forecast for the future, and generates zero profit, but that works perfectly well as a circular money play, in which both counterparties are controlled by the CEO.

Inside the Numbers

Losses, receivables, and dilution-funded survival

SIDU discloses continued losses:

• ~$18 million (9 months 2025)

• ~$11.8 million (9 months 2024)

• A 53% increase in Net Loss.

SIDU Consolidated Balance Sheet

AskEdgar SIDU 10-Q Sep 30, 2025

Related party receivables increased substantially, reflecting revenue that does not consistently convert to cash. It is also important to pinpoint the fact that the company is borrowing against receivables, and the loan balance almost doubled in the same period year over year, which is alarming, as it shows that equity raises are not enough to keep the company operational.

Share count expansion illustrates how their losses are funded:

• ~983k shares (Dec 2023)

• ~15.9M shares (Dec 2024)

• ~35.1M shares (Sept 2025)

• ~64.1M shares (Jan 2026)

Liquidity increases through capital issuance, not operations. Revenue does not reliably convert to cash, losses continue, and operating performance does not materially improve.

Share count expansion illustrates how their losses are funded:

Completed Offerings

Since its inception, SIDU has completed approximately $130 million in equity offerings, registered directs, private placements, warrant exercises, and ATM issuances, as reflected in its offering history. Despite this scale of capital raised, the company continues to burn cash at a rate approaching $2 million per month, having effectively exhausted the proceeds of prior financings without achieving operating sustainability, scale, or durable revenue growth. The implication is straightforward: capital raised to date has funded ongoing losses rather than value creation, and, absent a fundamental change in the business model, SIDU’s continued operations will require additional equity issuance, resulting in ongoing further dilution of shareholders.

Capital Markets Timeline

Reverse split → dilution → repeat

The December 2023 reverse split restored Nasdaq compliance, improved optics, and reopened the door to new offerings — but it didn’t change the business.

Afterward, SIDU leaned heavily on its S-3 shelf to raise cash. ThinkEquity frequently acted as a placement agent, with standard fees and warrants layered in.

The December 2025 deals highlight the strategy:

• 12/23/25 – 19.2M shares at $1.30

• 12/29/25 – 10.8M shares at $1.50 + warrants

Both are priced at discounts, freely tradable, and dilutive.

This isn’t one-off dilution. It’s the business's structure and strategy.

On December 22 2025, the company announced a proposed public offering. The following day, $SIDU filed a Form 424B5 for a registered direct offering of 19,230,800 shares of Class A common stock at a public offering price of $1.30 per share, for maximum gross proceeds of approximately $25.0 million. The stock closed at $2.28 on the prior trading day, making the offering price a discount of roughly 43% to the last reported close.

AskEdgar SIDU 8-K Dec 22, 2025

Less than one week later, on December 29, 2025, $SIDU filed an additional Form 8 K announcing a second registered direct offering. In this transaction, the company sold 10,800,000 shares of Class A common stock at $1.50 per share, generating gross proceeds of approximately $16.2 million. The offering included placement agent warrants exercisable immediately at $1.875 per share for a five-year term, issued to ThinkEquity or its designees.

AskEdgar SIDU 8-K Dec 26, 2025

Share Count Re Inflation

After the reverse split, $SIDU rapidly expanded its share count through repeated equity issuance. On December 31, 2023, the company reported approximately 983 thousand Class A shares outstanding. By December 31, 2024, that number had increased to approximately 15.9 million shares. As of September 30, 2025, Class A shares outstanding had increased to approximately 35.1 million.

This expansion occurred alongside continued operating losses and without evidence of operating leverage or margin improvement. The increase in outstanding shares reflects capital raised to fund losses rather than growth driven by operating success. Subsequent registered S-3 offerings in December 2025—19.23 million shares at $1.30 and 10.8 million shares at $1.50—further expanded the share count, bringing the current float to approximately 65.25 million shares.

Source: AskEdgar SIDU 10-K Mar 31, 2025

Source: AskEdgar SIDU 10-Q Sep 30, 2025

ThinkEquity and the Offering Sequence

Throughout this period, $SIDU relied repeatedly on ThinkEquity to facilitate equity transactions. The offerings were conducted under an existing Form S-3 registration statement, enabling the rapid issuance of registered, immediately tradable shares.

In 2025 alone, the company completed multiple equity offerings, including registered direct transactions in July and September. These transactions established a pattern of frequent capital raises rather than isolated financing events.

Source: AskEdgar https://app.askedgar.io/ticker/SIDU/dilution

The December 2025 Back-to-Back Offerings